Modelling the Impacts of Demographic Ageing on the Demand for Health Care Services by Clark, Stephen Darren
 
 
 
 
 
 
Modelling the Impacts of Demographic Ageing 
on the Demand for Health Care Services 
 
Stephen Darren Clark 
 
Submitted in accordance with the requirements for the degree of 
Doctor of Philosophy 
 
The University of Leeds 
School of Geography 
 
July 2015 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The candidate confirms that the work submitted is his own and that appropriate credit 
has been given where reference has been made to the work of others. 
 
This copy has been supplied on the understanding that it is copyright material and that 
no quotation from the thesis may be published without proper acknowledgement. 
 
The right of Stephen Darren Clark to be identified as Author of this work has been 
asserted by him in accordance with the Copyright, Designs and Patents Act 1988. 
 
© 2015 the University of Leeds and Stephen Darren Clark 
 
 
i 
 
Acknowledgements 
I would like to thank those here at the School of Geography who have been helpful in 
the provision of guidance and advice during my time undertaking this PhD. I would like 
to thank Professor Mark Birkin, Dr Alison Heppenstall, Dr Kirk Harland and Professor 
Phil Rees who, in various combinations, have formed part of my supervision team. 
Professor Rees has been particularly helpful in the later stages of the PhD to motivate 
me towards completion. Thanks are also due to the members of my Research and 
Support team, Dr Paul Norman, Dr Andrew Evans, Dr Myles Gould and Professor John 
Stillwell and my examiners. I would also like to thank Rachel Homer who was always 
on hand for sensible and reassuring advice on aspects of the statistics within this PhD. 
The staff at the Office for National Statistics and the National Centre for Social 
Research have provided much needed assistance and clarification with the data used in 
this thesis. 
Thanks are also due to my fellow students for welcoming me into the School and 
providing help through their inspiration. My roommates, Crystal, Ying and Holly and 
neighbour Emma were always available for a chat when things were not at their best. I 
have also found my lunch time conversations with fellow student Chris to be reassuring 
and uplifting. Also Bill, who, like me, came to a PhD late and is someone whom I still 
miss in so many ways. 
Finally the most heartfelt thanks are due to my parents, Maurice and Sheila, who have 
shown some forbearance in the choices and decisions of their youngest child. 
  
ii 
 
Abstract 
This thesis presents a methodology that predicts the number of individuals aged 50 and 
older who have one or more of three morbidities within each English local authority 
district to 2031. The three morbidities are cardiovascular disease, diabetes or high blood 
sugar and respiratory illnesses. 
The methodology uses spatial microsimulation to create a representative 2011 base 
population in each district. This population is then dynamically simulated through time 
using a process that: ages the population, changes its morbidity status, restructures its 
composition along demographic lines and replenishes the population at younger ages. 
An accounting system is used to examine how the demographic changes within each 
district influence its health status. 
In terms of prevalence counts and rates the prediction is for significant reductions in 
both these measures for CVD. For respiratory illness, the prevalence count remains 
fairly constant but due the increases in the size of the population at risk, the prevalence 
rate decreases. With diabetes or high blood sugar, both the prevalence counts and rates 
increase. Examination of the demographic changes affecting these prevalences shows 
that for the more ethnically diverse districts the changing ethnic structure has a large 
impact whilst for the more prospering districts the changing age structure has the largest 
impact. 
These results suggest that public health messages on circulatory and heart conditions 
and the reduction in smoking will have beneficial health effects in the future, which will 
help to mitigate the strains placed on the health care system in England. The prospects 
for diabetes or high blood sugar are however not so good and some considerations on 
how best to utilise scarce resources to prevent or treat this morbidity are urgently 
required. 
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1 RESEARCH AIMS 
Questions and Objectives 
This thesis is an applied piece of methodological research in the area of health planning. 
In particular it is concerned with gaining an understanding of the impacts of population 
ageing on local health care demand. 
This research has the potential to make an important contribution to the understanding 
of a crucial area of health policy. This importance is linked to recognition that an ageing 
society is an inevitable process in the context of the United Kingdom population. If 
anticipated well, there is the potential to mitigate against the negative impacts from such 
ageing, both in terms of the treatments available to those affected and the efficient use 
of financial, technological and labour resources. 
1.1 MEASURING HEALTH CARE 
Health care is a significant item of public and private expenditure in most countries. 
Recent World Bank (2012) statistics for 2012 estimate that the countries belonging to 
the Organisation for Economic Co-operation and Development (OECD) spent 12.6% of 
their Gross Domestic Product (GDP) on health care related costs, with the United States 
spending the highest at 17.9%. The United Kingdom (UK) is estimated to have spent 
around 9.4% of its GDP on health, which is below both the average OECD value and 
that for the European Union of 10.2%. 
Whilst the above figures are precise in terms of measuring the costs at a national level, 
the practical definition of the health of a nation is vaguer. The World Health 
Organization (WHO) has a definition of health that was formalised over half a century 
ago; “a complete state of physical, mental and social well-being, and not merely the 
absence of disease or infirmity.” (WHO, 1946). Under this umbrella definition, 
personal perceptions of health and ill health can however be wide ranging and can be 
perceived in either an objective or subjective manner. Objectively, it may be measured 
as the presence of one or more morbidities, usually diagnosed by a health practitioner. 
These may be present as physical morbidities, that can be either chronic or acute, or as a 
psychological illness. A subjective perception may be obtained by asking individuals to 
rate their own health or declare the presence of an illness that might limit their day to 
day activities. This latter form of health definition is potentially subjective since two 
individuals with ostensibly the same set of illnesses may describe their category of 
general health or the limiting nature of these illnesses differently. 
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Irrespective of how the presence of an illness is defined, once the number of individuals 
who consider their health to be impaired is known then organisations, both public and 
private, can begin to plan their services to meet this need. This need maybe met through 
the primary care sector, such as a local family doctor, nurse or other medical 
practitioner or may require a referral to secondary provider such as a local clinic or 
hospital. Accompanying this medical care there may also be the need for social care to 
provide the patient with convalesce or on-going care in their home or residential 
institution.  
In this study health is defined in an objective manner as the medical practitioner 
diagnosed presence of one or more of three morbidities that commonly affect the aged 
population, namely cardio vascular disease (CVD), diabetes or high blood sugar 
(DHBS) and respiratory illness. This measure of health can be quantified as an actual 
prevalence count of people with a morbidity or as a prevalence rate, which is this count 
expressed relative to the population at risk. 
1.2 FACTORS AFFECTING POPULATION HEALTH 
There are many factors that have the potential to influence a person’s health outcome – 
particularly when looking at specific morbidities. Some factors can be categorised as 
socio-demographic in nature, such as a person’s gender, age or ethnicity. Others can be 
categorised as more socio-economic, for example the level of education, occupation, 
wealth or income.  A third category covers factors related to the lifestyle of the person, 
either currently or historically. These factors include their smoking status, the presence 
of obesity and the degree of alcohol consumption. The remaining factors that impact on 
health include such determinants as their access to health care (including medication), 
living or working environment (exposure to harmful or hazardous materials) or injury 
(work-related or traffic). 
1.3 POPULATION OF INTEREST 
This study is concerned with those individuals who are aged 50 or older and live in 
England. This age threshold is chosen to capture the ages at which the morbidities 
commonly associated with ageing begin to become apparent. A reflection of this is that 
both data sources used in this study, the 2011 population Census and the English 
Longitudinal Study of Ageing (ELSA), use this threshold for tabulations (in the case of 
the Census) and for participation (in the case of ELSA). In terms of geographic area, 
spending and decision making in the UK National Health Service (NHS)  is devolved to 
the four home countries. Of these home countries, England is chosen as the area for 
analysis since it is a large, diverse and autonomous home country within the UK with 
regards to health service provision. Within England, there are a range of health 
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geographies employed to cover the commissioning, oversight and delivery of health 
care services. In particular, responsibility for public health planning is devolved to the 
326 local authority districts (LADs) in England. In recognition of this role and level of 
responsibility, the analysis is applied here to each of these LADs. Estimates of 
prevalence counts and rates for morbidities in LADs are not common in the literature, 
and even less common are forecasts. This thesis aims to address this deficiency by 
providing such estimates of current prevalences and forecasting future prevalences. 
1.4 RESEARCH QUESTIONS 
This thesis provides this contribution by addressing a number of policy related research 
questions: 
1. What is the likely number of people aged 50 and older, who will have one or more 
of these specific morbidities: CVD; DHBS; or respiratory illness in each English 
LAD, up to 2031? 
2. How do these morbidities vary by the gender, age, ethnicity and other socio-
demographic characteristics of the population in the area? 
3. How are these predictions influenced by both changes in the demographic 
composition of an area and by changing trends in health outcomes? 
4. What are the public policy implications of the work? How can the scarce health care 
resources, both financial and personal, be best used to meet this demand? 
1.5 OBJECTIVES 
To answer these research questions, a number of objectives have been set: 
a) The first objective is to gain an understanding of the anticipated challenge 
associated with an ageing population, and paint a broad, aggregate, picture of the 
likely size and health status of this population. Allied to this understanding is a 
review into the literature that describes the trends, determinants and needs 
associated with health care in an ageing population. Here also there is a requirement 
to look at the methodologies that have been used in the literature. It is important that 
the review involves a consideration of both the domestic UK and international 
literature in this area. 
b) The second objective is to identify the data that are available to model the health 
status of individuals. Data that is both aggregate and dis-aggregate in nature is 
included in the assessment with a discussion of the strengths and weaknesses of 
each data set. In concert with the following objective, that explores methodologies, a 
range of data sources useful to the study are identified. 
c) The third objective builds on what has been learnt to identify and outline a 
methodology to estimate the future prevalence for a range of morbidities. 
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d) The fourth objective is to apply the methodology and illustrate the outcomes in both 
a tabular and geographic manner that allows trends and features to be explored. 
e) The final objective is to provide an overall summary of the research findings, 
highlighting the public policy implications of the work, and illustrates how the work 
may be enhanced and taken forward. 
1.6 THESIS STRUCTURE 
Following on from this introductory chapter, the second chapter sets the context for the 
research. This chapter draws mainly on the available official statistics for England 
collected and published by such organisations as the UK Office for National Statistics 
(ONS) and the Health and Social Care Information Centre (HSCIC), which is part of the 
NHS. The third chapter provides a review of published studies relevant to this area of 
study. This review includes evidence for the significant health care determinants and the 
types of data and models used in such studies. It also includes a review of the important 
field of population projection, since the future composition of the population is likely to 
be an important driver of health care use. These two chapters relate to the first objective. 
The fourth chapter discusses in detail the two sources of data used in this study, the 
2011 Census and ELSA, which meets the second objective. Objective three is dealt with 
in Chapter 5, which outlines the modelling framework adopted in this study, breaking 
each component down and showing how they interact.  
There then follow five results chapters that achieve the penultimate objective. The sixth 
chapter is concerned with the spatial microsimulation that establishes the base 
population in 2011 for each LAD. The seventh chapter is concerned with the 
adjustments applied to an ethnic group population projection to account for the 
performance of the projection methodology between the 2001 and 2011 Censuses. The 
eighth chapter covers the estimation and calculation of the probabilities to be used in the 
Monte Carlo simulations. The next results chapter, Chapter  9, presents the headline 
outcomes of the research - the prevalence for a range of morbidities in each LAD - 
biennially from 2013 to 2031. The final results chapter, ten, decomposes these headline 
estimates to examine the relative contribution to changes in health prevalences due to 
changes in the demographic nature of the LAD.  
Following these results chapters, the eleventh chapter provides a discussion on the 
research and satisfies the final objective. This chapter summarises the thesis and 
includes a discussion of the policy implications of the work and how it might be 
enhanced. After the final chapter there is a glossary, reference maps and the thesis 
references. 
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2 RESEARCH CONTEXT  
Population Ageing, Population Projections and Health Forecast 
2.1 INTRODUCTION 
The first objective of this thesis is to gain an understanding of the likely challenges 
associated with an ageing population and the likely trends in health care need associated 
with this ageing.  This chapter provides the demographic context of this study which 
will help to provide this understanding.  
The chapter primarily involves an examination of the size and spatial distribution of the 
older population within England and how this population is expected to change, both in 
absolute and relative terms, over the medium term. This change will be explored using 
official Principal population projections and a number of variants to this Principal 
projection. There is recognition, however, that the size of the older population will not 
itself fully determine future health care demand and it is also necessary to consider 
trends in the health status of the population. This status is explored using the concept of 
healthy or disability free life expectancy. Use is also made of administrative health data 
to show where both the demand for care of the older population and the provision of 
services is concentrated.  
The section 2.2 of this chapter provides the international context to the research and 
illustrates how the demographic shift to an ageing population in the UK compares with 
other EU nations. Sections 2.3 to 2.7 use a range of official ONS population projections 
to show how the population structure of the English population is anticipated to change 
over the period 2011 to 2031, and also provide a geographic perspective on how these 
changes may vary across England. In section 2.8 a historic and geographic perspective 
is provided on variations in life and disability free life expectancies, again using official 
ONS estimates. Section 2.9 presents administrative data obtained from the HSCIC to 
map the demand for health care from the older population and where this care is 
provided. The final section, 2.10, provides a summary of the findings identified in this 
chapter. The interested reader may also like to view the slides on the health and health 
care of older people produced by the HSCIC (2014a). 
2.2 INTERNATIONAL PERSPECTIVE 
Many western societies are predicting an important shift in the structure of their 
populations. The clear and anticipated trend is for the elderly population to increase 
both in terms of the number of such people and as a proportion of the total population 
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(Rechel et al, 2009). Published 2015 projected trends in this demographic, calculated 
using a common set of assumptions and methodologies, for the 28 EU nations (plus 
Iceland, Norway and Switzerland) are illustrated in Table 2-1  (European Commission, 
2014). This figure illustrates the universality of this trend amongst these countries, at 
the extremes the percentage point growths vary from a low of a 2.0% increase for 
Sweden to a 9.2% increase for Lithuania. For the EU as a whole, the proportion of the 
population in the age 65 and older age band is anticipated to increase from 19% of the 
total population in 2015 to 24% in 2031. Using these projections and highlighting the 
position of the UK, the proportion of those aged 65 and older is seen to increase 
modestly from 17.7% to 21.6% (+3.9%), moving the UK from the country with the 18
th
 
highest percentage to the 23
rd
 highest in 2031. One possible driver for this relative 
change in the position of the UK is that it has historically had higher levels of inward 
net migration at younger age bands than other countries (Wadsworth and Vaitilingam, 
2014) helping inflate the denominator in this calculation.  
Turning to alternative population projections that are concerned with just England, and 
broadening the age range to those aged 50 and older, the latest Principal 2012 
population projections from the ONS project that by 2031 the number of such older 
people in England will be 24,027,000 (ONS, 2013a). This is an increase of nearly a 
third on 2011 estimates and in 2031 those over 50 will make up nearly 40% of the 
population. 
The question arises as to what this ageing phenomenon will mean for society at large 
(Rutherford, 2011 and House of Lords, 2013 and, in an English regional context, Rees 
et al., 2013a). Whilst longer life expectancies are to be celebrated, the ageing of the 
population is, at best, seen as a challenge (Christensen et al., 2009) and at worst, a threat 
(Laurence, 2002). Much of the challenge lies in how this longer life expectancy is 
utilised. If the individual has the necessary skills, work is available and they are healthy, 
these three factors mean that some of these extra years of life expectancy may be spent 
working, assuaging concerns over  productivity (Department of Business, Innovation 
and Science, 2010a and 2010b) and pension commitments (Harper et al., 2011).  
In terms of provision of services for an ageing population, health is an area where the 
impact of an ageing population may be most keenly felt (Wanless, 2004 and Craig and 
Mindell, 2005). As hypothesised above, if many of the extra years of life expectancy are 
spent in a healthy or disability-free state, then concerns over the health, activity and care 
levels of society may be addressed. If, however, an ageing population is associated with 
a less healthy population, it may also impact on the ability of the remaining population 
to physically and financially support and care for the aged population. 
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Table 2-1 : Trends in the projected proportion of population aged 65 or older, EU28 
plus Norway, Switzerland and Iceland, 2015 to 2031 
Country 2015 2019 2023 2027 2031 
Change 2015 
to 2031 
Sweden 20% 20% 21% 21% 22% 2.0% 
Luxembourg 14% 15% 15% 16% 17% 2.8% 
Norway 16% 17% 18% 18% 19% 3.0% 
Belgium 18% 19% 19% 20% 21% 3.5% 
United Kingdom 18% 18% 19% 20% 22% 3.8% 
Romania 17% 18% 20% 21% 21% 3.9% 
Denmark 19% 20% 21% 21% 23% 4.0% 
Italy 21% 22% 23% 24% 26% 4.1% 
Hungary 18% 19% 21% 22% 22% 4.1% 
Bulgaria 20% 21% 22% 24% 24% 4.5% 
Czech Republic 18% 20% 21% 22% 22% 4.6% 
Finland 20% 22% 23% 24% 25% 4.6% 
Switzerland 18% 19% 20% 21% 23% 4.7% 
France 18% 20% 21% 22% 23% 5.0% 
Austria 19% 19% 20% 22% 24% 5.2% 
Greece 21% 22% 23% 24% 26% 5.3% 
EU28 19% 20% 21% 23% 24% 5.4% 
Estonia 19% 20% 22% 23% 24% 5.7% 
Croatia 19% 20% 22% 23% 24% 5.7% 
Malta 19% 21% 22% 24% 24% 5.9% 
Iceland 14% 15% 17% 18% 20% 6.4% 
Latvia 19% 20% 22% 24% 26% 6.4% 
Cyprus 14% 16% 17% 19% 21% 6.6% 
Ireland 13% 14% 16% 18% 20% 6.7% 
Netherlands 18% 19% 21% 23% 25% 6.7% 
Portugal 20% 22% 23% 25% 27% 6.8% 
Germany 21% 23% 24% 26% 28% 6.9% 
Spain 18% 20% 21% 23% 26% 7.1% 
Slovenia 18% 20% 22% 24% 25% 7.4% 
Poland 15% 17% 20% 22% 23% 7.6% 
Slovakia 14% 16% 18% 20% 22% 7.9% 
Lithuania 19% 20% 22% 25% 28% 9.2% 
(source : Health in Europe: Information and Data Interface, 2013) 
8 
 
2.3 POPULATION AGE AND GENDER STRUCTURE 
How the structure of the English population is projected to change is illustrated in the 
population structure diagram in Figure 2-1. This shows the English male and female 
population structure in 2011 and by how this is anticipated to change by 2031. For the 
ages 50 and older, the net change in the size of the population from 2011 to 2031 for 
each five year age band is shown within the bars of this diagram. 
The structure of the population does not alter radically between 2011 and 2031, with 
most age bands showing some growth over this period. There is, however, a broadening 
of the structure at the older age bands. These projections suggest that the 50 year and 
older population age band will increase by 5.7 million by 2031. Whilst the younger age 
population of 20 to 50 year olds will also grow, this growth is expected to be a more 
modest 323,000. Calculations based on these data shown in Figure 2-1, estimates that 
the mean male age was 38.8 years in 2011, and the prediction is that this will increase to 
41.6 in 2031. For females, the mean age will increase from 40.9 years in 2011 to 43.6 in 
2031. The difference in the mean age between the genders will therefore decrease 
slightly from 2.1 years to 2.0 by 2031. 
 
Figure 2-1 : Projected Principal population structure, England, 2011 and 2031 
(source : 2011 counts are 2011 mid-year estimates, ONS, 2012a, and 2031 are Principal 2012-
based projections, ONS, 2013a) 
Thus whilst most age bands in the population are predicted to increase and therefore 
require additional health care resources, the increase in the size of the older population 
is particularly large. The evidence from studies suggests that the use of health care 
resources by the older population is disproportionately larger than that of the population 
as a whole (for hospital and social care utilisation at the end of life see Dixon et al., 
2004, and Bardsley et al., 2010, whilst for general practice consultations see Hippisley-
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Cox and Vinogradova, 2008). The expectation is therefore that, all other things being 
equal, there will be a larger increase in health costs in comparison to population size, 
occurring at a time of expected tighter government fiscal circumstances (Appleby, 2013 
and Wittenberg et al., 2013). 
2.4 GEOGRAPHIC DISTRIBUTION 
This growth in the older population will vary by location. The ONS provide Principal 
sub national population projections for English LADs (ONS, 2014a). Figure 2-2 below 
shows the number of older people aged 50 or older projected to be living in each of 
these 324 local authorities in 2011 and 2031 (in this thesis the City of London is merged 
with Westminster and the Isles of Scilly are merged with Cornwall). 
 
Figure 2-2 : Number of people aged 50 and older, LADs, 2011 (lhs) and 2031 (rhs)  
(source : 2011 counts are 2011 interim sub national projections, ONS, 2012b, and 2031 are 
Principal 2012-based sub national projections, ONS, 2014a) 
In 2011 the areas with the largest population of older people are either the larger 
metropolitan urban areas (e.g. Greater Manchester; West Midlands and South and West 
Yorkshire) or the geographically larger local authorities (e.g. Cornwall, Wiltshire; East 
Yorkshire; Durham and Northumberland). This is to be expected since these areas have 
high population by virtue of them being very densely populated or covering a large 
geographic area. By 2031 these areas have been joined by other of authorities. The 
authorities around core cities (e.g. Nottingham; Leicester; Derby and Bristol) as well as 
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many more authorities in the South and East of England now have a large older 
population. The fringes of Greater London also show a much larger older population. 
The growth in the older population between 2011 and 2031 for each local authority is 
shown in Figure 2-3 (lhs) as an absolute change in numbers and in Figure 2-3 (rhs) as a 
proportionate change, relative to the 2011 elderly population.   
 
Figure 2-3 : Change (lhs) and proportionate growth (rhs) in 50 year and older 
population, LADs, 2011 to 2031 
(source : 2011 counts are 2011 interim sub national projections, ONS, 2012b, and 2031 are 
Principal 2012-based sub national projections, ONS, 2014a) 
The map showing the size of the older population in 2011 (Figure 2-2, lhs) is not 
dissimilar from the map here that shows the growth in the size of the population (Figure 
2-3, lhs), in that larger areas, either in terms of population or geographic area show the 
largest growths in the older population. This feature is confirmed in Figure 2-4 (lhs) 
which shows a scatter plot of the population in 2011 against the absolute change in the 
size of the 50 and older population, and has a positive correlation.  
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Figure 2-4 : 2011 population verses change in population to 2031 (lhs) and percentage 
change to 2021 (rhs) 
(source : 2011 counts are 2011 interim sub national projections, ONS, 2012b, and 2031 are 
Principal 2012-based sub national projections, ONS, 2014a) 
Looking at the map of the proportionate growth in the older population (Figure 2-3, rhs) 
and the scatter plot of the 2011 population verses percentage growth (Figure 2-4, lhs) 
however shows a different pattern. Here there is a significant and disproportionate 
growth in a band of local authorities just to the north of London and the LADs with 
small older populations in 2011. These types of areas are starting from a low population 
in 2011 and may also be seen as attractive locations for those aged over 50, particularly 
the recently retired, to relocate to.  Many local authorities in this area will see their older 
population increase by a third over this 20 year period. A consideration of Figure 2-2, 
Figure 2-3 and Figure 2-4 would indicate that those areas that already have a high older 
population are going to see the biggest increases in this population, but some LADS 
with smaller older population and those located in the northern Home Counties are 
going to see a larger proportionate growth.  
The changes seen here are the result of two processes, the ageing of the in-situ 
population who become older and the in- and out- flows of elderly people. Using a log-
linear model of both 2001 Census and NHS registration data, Raymer et al. (2007) 
showed trends in the tendency for migration by those aged 65 or older between 12 ONS 
area classifications (ONS, 2003). They concentrated on two flows of particular interest: 
the younger, healthier, migrating from centres of industry; and the older elderly, with 
health issues, migrating from coastal and countryside areas. Over their short time 
horizon between 2000/01 and 2003/4 the first flow was seen to increase by 8% whilst 
the second flow decreased slightly by 2%. Work by Baylis and Slay (2010) in their 
Figure 1.10 show large migrations of residents aged 50 years and older from London to 
the East and South West Regions. This migration flow may be triggered by a variety of 
life course events, e.g. re-location of family, location of amenities, health status or need 
for long term care. Evandrou et al. (2010) used panel survey data to measure internal 
migration of the elderly participants and how this activity relates to life events and 
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socio-demographic status and Stockdale (2011) highlights issues around the geographic 
variation in ageing – particularly in connection with migration; labour markets and 
health and care status. 
2.5 AGEING 
Using the 2011-interim and 2012 sub national population projections published by ONS 
it is possible to estimate the mean age of those who are aged 50 and older in each LAD 
from 2011 to 2031. Since the ages are banded in 5 year age bands up to 90, the mid age 
in each band is used as the estimated age for those in the band. For the open age band of 
90 years old the estimated age is 95 in 2011, and to reflect the ageing in this open age 
band, is increased annually by 0.1 of a year to age 97 by 2031. Figure 2-5 shows the 
geographical distribution of this mean age estimate for LADs in 2011 and 2031.  
 
Figure 2-5 : Mean ages, LADs, 2011 (lhs) and 2031 (rhs) 
(source : 2011 ages based on 2011-interim mid-year estimates, ONS, 2012b, and 2031 based 
on Principal 2012-based projections, ONS, 2014a) 
In 2011 the LAD with the youngest population is Newham in central London (mean age 
of 63.7 years old) whilst the oldest is Christchurch in the South west (69.4 years). By 
2031 another London Borough, Tower Hamlets has the youngest population (63.2 
years) (and actually shows a decrease in the mean age over this 20 year period by 1.1 
years) whilst North Norfolk has the oldest population (71.3 years). Eden in the North 
West shows the greatest increase in the mean age of an additional 4.0 years. More 
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generally, central London and the more urban LADs are seen to retain a youthful 
population whilst the large rural authorities outside the South East of England not only 
have an older population but also show the greatest ageing. 
2.6 POPULATION RATIO 
Dependency ratios are commonly used to measure the relative sizes of the young (aged 
0 to 16) and old population (aged 65 and older) against that of a broader working 
middle aged population in an area (OECD, 2007). The rationale is that support is 
provided to these two groups by the middle aged population, both from their family 
members and also more generally through taxation and labour resources. 
In the context of this study where a threshold of aged 50 is adopted for a transition into 
an older age group the term dependency ratio is not appropriate. Many people are still 
economically active and also proving support to younger or older family members 
during their 50’s and 60’s. Instead a more neutral term of ‘population ratio’ is adopted. 
This balance of growth between the generations is therefore expressed as the ratio of the 
number of people of an older population, aged 50 years or older, to a middle age 
population (taken to be 20 to 49 years old here) (see equation 2-1). Based on ONS 
Principal population projections, the anticipated future trends in this population ratio for 
England are shown in Figure 2-6. In 2011 the national ratio is 0.830 and rises rapidly, 
until it reaches a value close to 1.0 in 2021. By 2031 the ratio is 1.073.  
Population ratio=
Population aged 50 and older
Population aged 20 to 49
  
 
2-1 
 
 
Figure 2-6 : Trend in population ratio, England, 2011 to 2031 
(source : 2011 counts are 2011-interim mid-year estimates, ONS, 2012b, and 2012 to 2031 are 
Principal 2012-based projections, ONS, 2014a) 
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Just as the number of older people will vary by location as shown in Figure 2-2 so will 
the population ratio. The provision of funding for elderly health care in the United 
Kingdom is provided centrally (to avoid perpetuating disadvantage and implementing a 
‘postcode lottery’ – see Barr, et al. (2014), for a discussion of the rationale behind NHS 
resource allocation) and as such the local population ratio is not relevant to the 
resourcing of most health care provision. The ratio may, however, be relevant in regard 
to how the care services needed by an ageing population can be met from within its own 
catchment population, particularly in terms of labour resources. Figure 2-7 shows how 
this ratio varies by each local authority in 2011 and the projected case for 2031. 
 
Figure 2-7 : Older (50 or older) to middle age (20-49) population ratio, LADs, 2011 
(lhs) and 2031 (rhs) 
(source : 2011 counts are 2011 interim sub national projections, ONS, 2012b, and 2031 are 
Principal 2012-based sub national projections, ONS, 2014a) 
The impact of the increasing older population is particularly stark. Whilst only 10 
LADs, mainly in coastal locations in the south and east of England, have a population 
ratio above 1.5 in 2011 (3%), there are 91 such authorities in 2031 (28%). The areas 
where the ratio remains low are the larger urban areas and inner London. In fact, the 
urban areas that were seen to have both high older populations (Figure 2-2) and a high 
absolute growth in the older population (Figure 2-3 lhs) (e.g. West and South Yorkshire 
and the Greater Manchester area) are seen to have low population ratios in both 2011 
and 2031. This suggests that the overall growth in the older population in urban areas is 
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better balanced with increases in the middle age population.  This is further illustrated in 
Figure 2-6 which plots the population of the LAD against its population ratio in 2011 
and 2031. The smaller authorities tend to have the higher population ratios.  
 
Figure 2-8 : Plot of total population aged 50 and older against the population ratio, 
LADs, 2011 and 2031 
(source : 2011 counts are 2011 interim sub national projections, ONS, 2012b, and 2031 are 
Principal 2012-based sub national projections, ONS, 2014a) 
On this evidence, it is likely that these larger LADs with low population ratios will be 
more able to provide the health care professionals and care support needed for an ageing 
population from their own local catchment. The spatial arrangement of this feature is 
most visible when the ratios are plotted on a cartogram map of England where the size 
of each area is proportional to its 2001 Census population rather than its geographic 
area (Social and Spatial Inequalities Research Group, 2004). Figure 2-9 shows the 2011 
and 2031 population ratios in Figure 2-7 in this cartogram format. The lower population 
ratios are clearly more prominently visible in London and the other urban areas of 
England in this representation. The large visual impact of local authorities with large 
population ratios is diminished in this cartographic representation. 
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Figure 2-9 : Cartogram of older (50 or older) to middle age (20-49) population ratio, 
LADs, 2011 (lhs) and 2031 (rhs) 
(source : 2011 counts are 2011 interim sub national projections, ONS, 2012b, and 2031 are 
Principal 2012-based sub national projections, ONS, 2014a) 
2.7 VARIANT POPULATION PROJECTIONS 
The population projections used so far are just one of many variant population 
projections produced by the ONS (ONS, 2013b). Each population variant is based on a 
set of assumptions regarding the three driving components of population change: 
fertility, life expectancy and migration. Each of these components will have a Principal 
assumption and an alternative high and low assumption. In addition there are other 
assumptions: that fertility occurs at a replacement or at a constant (un-changing) level; 
that there is no improvement in life expectancies and that net migration is zero. 
These components are then used to produce a number of variant projections. There is a 
Principal projection (which is the version used up to now in this chapter); six single 
variant projections (where only one of the three components at a time are varied to a 
low or high level); a high and low variant (all components varied at the same time to 
either the low or high level) and a variant that assumes zero net migration. A further set 
of special variants assume the special cases with regard to fertility, life expectancies and 
migration. Table 2-2 specifies which assumptions make up each variant and the 
resulting total population in 2031 and the old and elderly population in 2031.The range 
of population projections from these variants is wide. The total population in 2031 
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could be between 57.7 million and 63.1 million if this collection of variants is sufficient 
to cover most eventualities. The range of the older population is also wide, being 2.0 
million for those aged 50 and older and 1.8 million for those 65 and older. This wide 
range in the population projections to 2031 will be significant in predicting future health 
care needs since the size of the population is one of the most important drivers of total 
health care need. It is not, however, known in a probabilistic sense where these variant 
outcomes lie in a probability distribution of possible outcomes. 
2.8 LIFE AND DISABILITY FREE LIFE EXPECTANCIES 
Whilst the size of the older population will undoubtedly have an impact on the need for 
health care, the health condition of the older population will also have an impact. A 
large but generally healthy population will have a need of fewer health care resources 
than one of a similar size but which is poorer in health (Mayhew, 2009). Regular 
estimates are made by the ONS to establish the life and disability free life expectancy of 
the population (ONS, 2014b). To calculate the disability free life expectancy, 
information is obtained from range of household surveys that include an assessment of 
any long-standing illnesses, disability or infirmity. Recent trends in these ONS 
expectancies for males and for females are shown in Figure 2-10 – here the age is the 
age that someone who is aged 65 can expected to live to or be free of disability. 
 
Figure 2-10 : Trends in male and female age and disability free age expectancies at age 
65, England, 2000-02 to 2009-11 
(source : ONS, 2014b) 
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Table 2-2 : Summary Statistics from ONS 2012 variant population projections, England, 2031 
Variant Fertility 
Life 
Expectancy Migration 
2031 population projection 2031 population projection (% of Principal) 
All ages 
Aged 50 or 
older 
Aged 65 or 
older All ages 
Aged 50 or 
older 
Aged 65 or 
older 
No mortality improvement P N P 58,821 22,500 12,130 97% 94% 90% 
No change C N P 58,789 22,500 12,130 97% 94% 90% 
Low population − − − 57,747 23,528 13,167 96% 98% 97% 
Low life expectancy P − P 60,052 23,678 13,212 99% 99% 98% 
Young population + − + 62,409 23,832 13,258 103% 99% 98% 
Low migration P P − 59,261 23,875 13,485 98% 99% 100% 
Zero immigration P P Z 56,721 24,013 13,507 94% 100% 100% 
Low fertility − P P 59,248 24,027 13,530 98% 100% 100% 
Principal P P P 60,419 24,027 13,530 100% 100% 100% 
Constant fertility C P P 60,386 24,027 13,530 100% 100% 100% 
Replacement fertility R P P 61,599 24,027 13,530 102% 100% 100% 
High fertility + P P 61,584 24,027 13,530 102% 100% 100% 
High migration P P + 61,589 24,181 13,576 102% 101% 100% 
Older population − + − 58,467 24,215 13,795 97% 101% 102% 
High life expectancy P + P 60,775 24,367 13,842 101% 101% 102% 
High population + + + 63,135 24,521 13,888 104% 102% 103% 
Range       6,414 2,022 1,759 11% 8% 13% 
Keys : 
Principal projection    
Single variant  Fertility : P principal; − low; + high; R replacement; C constant 
(source : ONS, 2013b) Combined variant  Life expectancies : P principal; − low; + high; N no improvement 
Special variant  Migration : P principal; − low; + high; Z zero (net) 
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This figure shows that females have a consistently longer age expectancy than males, 
although this difference has narrowed over time, from 65 year old females living 3.1 
years longer than males in 2000-02, to living longer by just 2.6 years in 2009-11. 
Trends used in ONS population projections predict that by 2030 males will still have a 
age expectancy three years fewer than females although Mayhew and Smith (2012) 
estimate that by 2030, this gender gap in such expectancies at age 30 will almost have 
vanished. Females also have longer disability free age expectancies than men, but more 
recently this difference in disability age expectancy between the genders has become 
less pronounced. 
The number of years spent in disability is the difference between these two trends for 
each gender. This interpretation means that females spend much longer in a disabled 
condition than males, on average, 9.8 years for females versus 7.3 for men (‘men die, 
women suffer’, Bruggink, 2011). There is also a trend for this disability gap to increase 
over time, starting at 7.1 years for men in 2000-02 and growing to 7.3 in 2008-10; and 
for females, growing from 8.7 years in 2000-02 to 9.8 in 2008-10.  
The ONS has also produced a set of experimental statistics that provide both life and 
disability free life expectancies during 2010-12 (ONS, 2014c) for health care 
commissioning consortia termed Clinical Commissioning Groups (CCG) (Boyle, 2011). 
Figure 2-11 shows these expectancies, again as ages, for someone who has reached the 
age of 50 across the 211 CCGs in England, sorted by age expectancy (hence the 
smoothness of this series in the figure). The differences in the two expectancies are 
variable across the CCGs groups. Fifty year old Males living in South Reading and in 
Knowsley, Merseyside, can both expect to live to 79½ years, however in South Reading 
a 50 year old man can expect to live to age 68½ years without a disability but this figure 
is over four years lower in Knowsley, at only 64 years. For females there are similar 
disparities, the East Riding of Yorkshire and Newham, both have a similar female age 
expectancy of just greater than 84 years but different disability free Age expectancies, 
70 years in the East Riding but only 64½ years in Newham. These age expectancies can 
also be mapped to examine if there are any geographical patterns. Figure 2-12 displays 
these two age expectancies for males and for females. 
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Figure 2-11 : Life and disability free age expectancies at aged 50 years for male (top) 
and female (bottom), Clinical Commissioning Groups, 2009-11 
(source : ONS, 2014c) 
As shown by Figure 2-12, top row, in all CCGs the age expectancies of females aged 50 
exceed that of males. Both males and females have lower age expectancies in the areas 
around Durham and Newcastle, Lancashire and parts of Manchester, South and West 
Yorkshire and a band through the East Midlands and into the West Midlands. These 
areas were all once heavily industrialised areas with a large proportion of the workforce 
engaged in manual trades such as textiles, coal mining and steel making. Working in 
these occupations, particularly the work undertaken by males, would contribute to a 
range of disabling medical conditions that would tend to lead to lower life and disability 
free life expectancies (Johnson, 2011). 
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Figure 2-12 : Age expectancies at aged 50, CCGs, 2010-12, clockwise from top right : 
male life expectancy; female life expectancy; female disability free life 
expectancy and male disability free life expectancy,  
(source : ONS, 2014c) 
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Looking at the geographic spread of disability free age expectancies the differences 
between the genders is once again, as Figure 2-10 shows, less pronounced. What is most 
striking about the disability free age expectancies shown in Figure 2-12 is the greater 
variation between locations and this variation is much more pronounced than for the 
related age expectancies. Once again the previously industrialised areas have much 
lower disability free age expectancies and the more rural, Home Counties and South 
West authorities which have disability free life expectancies not that much lower than 
their already elevated life expectancies. 
By subtracting the number of years of disability free living from the life expectancy it is 
possible to measure the number of years in a disabled condition. The significance of this 
measure is that it is likely that individuals with a disabling condition will require greater 
use of social and medical services. How this measure varies by CCG is shown in Figure 
2-13. In the left hand side map, the pattern of increased male years spent living with a 
disability is apparent in the more industrialised areas of northern England. In other 
areas, males die at older ages, but they do not become disabled until these later years. 
The contrast that is perhaps most insightful here is that between the genders, where once 
again this shows that females spend many more years with a disabling condition than 
males do, and also that there is a weaker of pattern in the geographic variation for this 
measure for females.  
2.9 HEALTH CARE 
As mentioned at the beginning of this chapter, one of the most important impacts of an 
ageing population will be felt on health care demand and delivery. The United Kingdom 
possess a well-resourced and integrated national health service, whose activities range 
from community based general practitioner teams through local clinics and hospitals 
and onto world renowned treatment centres. This high quality and integrated approach 
to health care provision puts the NHS in a good position to deliver and co-ordinate 
health care in an efficient manner (Karlsson et al 2007). 
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Figure 2-13 : Years spent in a disabled condition for male (lhs) and female (rhs), by 
CCG, 2010-12 
(source : ONS, 2014c) 
2.9.1 Trends in geriatric provision 
Figure 2-14 shows the recent trend in the number of geriatric in-patient beds available 
within the NHS in England.  
 
Figure 2-14 : The number of geriatric beds available overnight, England, 1987/88 to 
2009/10 
(source : Harker, 2009) 
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In the decade from 1987/88, the number of geriatric beds has more than halved in 
English NHS hospitals, but the trend in more recent times has been for this number to 
stabilise at around 20,000 beds. This reduction cannot, however, be assumed to be a 
reflection of a reduced need for elderly hospital care. A recent trend in many medical 
treatments has been a move towards day surgery cases, where an overnight stay in 
hospital is not necessary. These patients are usually accommodated in day beds and the 
use of such day beds by the elderly is not reflected in these figures (over this time 
period the number of NHS day beds has increased from 2,000 per day to nearly 11,000).  
2.9.2 Geographic provision 
Geographically referenced information on the demand for health care is made available 
by the HSCIC, through commissioning statistics and, separately, the delivery of health 
care, through provider statistics (HSCIC, 2015). 
The primary measure of inpatient health care use is the inpatient Finished Consultant 
Episodes (FCEs) which are derived from the Hospital Episode Statistics (HES) 
(Cowper, 2004). An FCE consolidates together a series of related treatments that an 
individual may receive over a short to medium period of time, all whilst under the 
direction of the same consultant. Thus each FCE may be regarded as a series of medical 
interventions over a short term, but all related to the same illness. 
2.9.3 Commissioner inpatient data 
Looking at the commissioning of health care, Figure 2-15 shows the number of 
commissioned FCEs by CCG during 2012-13 for the 50 to 65 (lhs) and the 65 year and 
older age bands (rhs), both counts divided by the ONS’s estimate of the CCGs 2012 
mid-year age band population. This provides a measure of the geographic demand for 
health care, relative to its population - the higher the measure the greater the demand for 
per capita health care. 
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Figure 2-15 : Ratio of commissioned inpatient FCEs per capita for aged 50 to 64 (lhs) 
and aged 65 or older (rhs), Clinical Commissioning Groups, 2012 
(source : HSCIC, 2015, and ONS, 2012b) 
For the 50 to 64 age band in only four CCGs is the rate above 0.5 FCEs per head of 
population (Manchester North and South, Bradford City and Blackpool). More 
generally, CCGs where the number of inpatient FCEs per person are low tend to be in 
the Home Counties surrounding Greater London, along the Welsh border and in North 
Yorkshire. This picture is not dis-similar to that shown in Figure 2-13 which shows a 
measure of duration of disability in each CCG by gender. For the oldest age band, the 
number of FCEs per capita is higher, which is to be expected because of their greater 
need for medical treatment and the smaller population size of this age band. In this age 
band, the urban centres of northern England tend to have the highest ratios, whilst the 
Isle of White has a particularly low rate, at 0.4913 FCEs per person. Areas in southern 
England tend to have lower FCEs demand.  
There may not be an exact match between the local need (as quantified in Figure 2-13) 
and the number of treatments required (as quantified in Figure 2-15). This most often 
manifests as unmet demand where the capacity to deliver health care services in an area 
is less than the demand. 
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2.9.4 Provider inpatient data 
As well as providing information on the commissioning of health care provision, the 
HSCIC also provides information on where the FCE’s are delivered, this is usually in a 
hospital or clinic context (HSCIC, 2015). Figure 2-16 shows the number of inpatient 
FCEs provided at hospitals and clinics in England for the period 2012-2013 for the 60 to 
74 year age band (lhs) and the 75 and older age band (rhs). These figures show where 
the FCE’s are delivered for patients. As would be expected they tend to cluster strongly 
in cities and towns where the facilities are located (insert maps provide greater 
geographic detail for London).  
 
Figure 2-16 : Location and extent of inpatient FCEs provision for aged 50 to 64 (lhs) 
and aged 65 or older (rhs), England, 2012/13  
(source : HSCIC, 2015) 
Note : The shading of LADs is for discrimination and identification purposes only and has no 
meaning attached. 
First inspection shows that there is actually very little difference in the relative volume 
and the spatial distribution of FCEs from these two age groups. There are large clusters 
of providers in the urban centres, particularly in Greater Manchester and London. It is, 
however, not easy to scale this measure by population since the catchment of each 
provider is not well defined. 
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2.9.5 Provider outpatient data 
In a similar manner to the inpatient FCEs, the HSCIC also provides information on the 
location and volume of outpatient appointments. The location of these appointments for 
the 50 years and older age group in 2012-2013 is shown in Figure 2-17. 
 
Figure 2-17 : Location of outpatient appointment provision for aged 50 and older, 
England, 2012/13 
(source : HSCIC, 2015) 
Note : The shading of LADs is for discrimination and identification purposes only and has no 
meaning attached. 
Once again, many of the providers of outpatient care are concentrated in the urban 
centres, as was the case for the inpatient care.  This is not a surprising finding since 
many of the providers will provide both inpatient and outpatient services.  
2.10 CONCLUSION 
Looking at the range of official statistics presented in the chapter a number of themes 
have emerged.  
Whilst there is some uncertainty about the exact numbers, there is a widely held 
consensus that population ageing within England is inevitable. Modest increases in the 
mean age of the population as a whole mask a disproportionate large growth in the older 
population aged 50 or older. Not only is this growth concentrated in a particular age 
band but also the growth is not uniform across England. Larger local authorities, 
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determined by high population density or large geographic size, will have the largest 
growth in the number of older people, although for the dense urban areas the population 
ratio (defined in equation 2-1) will remain fairly constant, as these large centres attract 
young adults and experience an out-migration of retirees.  
Recent trends in the life and disability free life expectancies suggest two features. 
Firstly, that the difference in both of these life expectancies between males and females 
is narrowing and secondly, that the gap between the two expectancies is growing, for 
both genders. This latter feature indicates that individuals will spend more years with a 
disabling condition. People who live in the traditionally industrialised cities of the north 
and midlands tend to have lower life and disability free life expectancies than people 
who live in the south and east of England. When considering time spent in disability 
these regional differences are still present, and females tend to spend more years in a 
disabled condition than males. 
Both the demand and delivery of health care for the old tend to be concentrated in the 
urban centres of England, even when (in the case of demand) accounting for the size of 
the aged population of the area. This concentration is for historic reasons, since many of 
the providers are long established in these locations, and given their situation, they have 
a large catchment population. 
Considering how these features will impact on future health care provision highlights a 
number of likely trends: 
1. By 2031, there will be a larger older population spending a greater length of time 
with disabling conditions; 
2. Areas that already have a large older population in 2011 will see the largest 
increases in the older population by 2031, however, relative to their size, these 
increases will be more modest than in smaller authorities; 
3. The population ratio will remain stable in the larger urban areas, which will 
facilitate the availability of formal and informal care support in such areas; 
4. The differences in health care use by gender will narrow over time; 
5. Provision of health care is currently concentrated in urban centres and this is likely 
to be the case for the foreseeable future; 
This chapter has begun to meet the first objective set out in section 1.5, to understand 
the challenges associated with an ageing population. This is further enhanced in the next 
chapter which provides a review of the published literature in the area of ageing and its 
impact on health. The review also includes material on the modelling methodologies 
that have been adopted to look at the issues of an ageing population and their health care 
needs, which also goes towards meeting the first objective. 
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3 LITERATURE REVIEW 
What is known about Elderly Health and Health Care 
3.1 INTRODUCTION 
Chapter 2 of this thesis presents a picture of the demographic characteristics for a future 
ageing population and a flavour of its current health care delivery. As discussed in 
section 2.2, this ageing will have profound consequences in several areas. For example, 
the will be financial pressures associated with pension provision and the ability of the 
workforce to support an ageing population. One sector in particular that these pressures 
will be most keenly felt is in the health care sector. To aid in an understanding of this 
issue, this chapter provides a consideration of the existing literature on the determinants 
of the health needs of an ageing population and on the delivery of health care to an 
ageing population. 
Health care is a multi-faceted phenomenon. The definitions used can be inconsistent and 
conflicting – arising from the diversity of the backgrounds of the researchers, their 
geographic context or the period during which the work was conducted. Within the 
scope of this work, constant definitions are used: health care is used to refer to all 
aspects of the delivery of health care, be it inpatient; outpatient, nursing, residential, 
pharmaceutical or other services. The term primary care is used to denote care that 
takes place within a general practitioner setting, which, in the UK context, is an 
individual’s usual first point of contact with the health care system. Similarly, 
secondary care is used to refer to those services traditionally provided either in a 
hospital or a clinic setting, usually after referral by a general practitioner and can range 
from consultations with specialists through to participating in leading edge treatments. 
Residential care refers to care delivered in a residential setting (e.g. the persons own 
home, a nursing home or a residential care home). Residential care may be further sub 
divided into institutional (e.g. in a nursing or residential home) or home based (if 
provided in the person’s own home). This home based care can be either formal 
(provided by an outside agency, usually at a cost) or informal (provided by a family 
member or friend).  Occasionally there may be references to other costs, such as 
prescription drugs and optical or dental costs, and where necessary these will be 
explicitly mentioned.  
Increasingly in the literature there is recognition that the health care needs of the elderly 
population are not homogeneous with respect to the important determinant of age. Many 
studies differentiate between the young-old and the old-old population (in a similar 
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manner, Baltes and Smith 2003, highlight the contrasts between the third and fourth 
ages of the life course). The exact distinction between these two populations is difficult 
to define and is dynamic over time, but unless otherwise stated, the assumption here is 
that the young-old constitute those aged between 65 and 74 years, whilst the old-old are 
aged 85 or more. Those aged 75 to 84 constitute the middle-old. 
The first substantive section of this chapter, section 3.2, reviews the concepts of life 
expectancies and healthy life expectancies, concepts which help to determine both the 
size of the elderly population and its health status. Section 3.3 considers studies that 
have attempted to model the demand for and cost of health care in an elderly population. 
The factors reported to be significant in this relationship are considered in turn. These 
two sections inform the choice of constraint variables for the spatial microsimulation 
(Chapter 6) and the probability modelling (Chapter 8). This section is followed by 
section 3.4 which examines the characteristics of the three case study morbidities used 
in this thesis, CVD, DHBS and respiratory illnesses. Section 3.5 contains a discussion 
of the range of health data that have been employed in the literature (in Chapter 4 two 
data sets arising from this consideration, and of particular value to this thesis, are 
described in more detail). The review then moves on to a consideration of the types of 
models that have been used to understand and predict future health care needs (section 
3.6). This will inform the choice of methodology adopted in the thesis which is 
described in detail in Chapter 5. Since the future size and composition of the elderly 
population will be an important factor in determining the amount of health care 
required, the following section, 3.7, examines the range of English population 
projections. One of these projections and a mechanism to revise its projected population 
is covered in Chapter 7. The penultimate section, 3.8, looks at studies that have 
considered how to meet the demand for health care once a need has been established. 
Finally section 3.9 provides a summary of these review findings. 
3.2 LIFE EXPECTANCIES 
Many studies use the well understood concept of life expectancy to explore the impacts 
of an ageing population on society (Mayhew, 2005; Mayhew, 2009, and Christensen et 
al., 2009). The general trend in recent years has been for consistent increases in life 
expectancy, however, there is some debate as to whether this trend will continue into the 
far future. This continuation is proposed by Oeppen and Vaupel (2002) and Wilmoth et 
al. (2000) whilst others propose that at some stage a maximum life expectancy will be 
reached, either through a biological mechanism or societal changes (see Olshansky et 
al., 2005, where the hypothesis is that increases in obesity at younger ages may lead to 
shorter life expectancies).  
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When life expectancy is coupled with the concept of healthy life expectancy, it is 
possible to begin to examine future health care needs. If healthy life expectancy 
increases by the same amount as life expectancy then individuals will roughly spend a 
constant amount of time in an unhealthy condition (termed morbidity postponement, 
where ill health is moved to later ages, Payne et al., 2007). If, however, the life 
expectancy increases at a faster rate than healthy life expectancy then individuals can 
expect to spend more years in an unhealthy condition (termed morbidity expansion, 
Gruenberg, 1977 and Kramer, 1980). Conversely if healthy life expectancy increases at 
a faster rate than life expectancy then the more years will be spent in a healthy condition 
(morbidity compression, Fries, 1980). A fourth possibility is beginning to emerge in the 
literature, morbidity equilibrium (Manton, 1982), where the expectation is that more 
years will be spent in a disabled condition but that the severity of this disability will be 
more varied and dynamic. 
A complication arises if these changes are measured not as an absolute number of years 
in morbidity but are measured relative to either total life expectancy or remaining years 
of life (Hoffmann and Nachtmann, 2010). Thus there is the concept of relative 
expansion or relative compression of morbidity. 
3.2.1 Life expectancy 
The Office for National Statistics (ONS) regularly produces estimates of life 
expectancies in the UK and Shaw (2007) examined the accuracy of the official national 
life expectancy projections over the last 50 years. Figure 5 from Shaw (2007) shows life 
expectancy estimates from successive reports from the ONS between 1971 and 2004 for 
males and females (here updated to cover projections in the period 1994 to 2012 and 
shown as Figure 3-1).  In both cases, over time there is a consistent pattern of increases 
in life expectancy from one estimate to the next.  This work highlights the fact that 
improvements in mortality, particularly at older ages, have been consistently 
underestimated in the UK and would point to adopting more optimistic assumptions 
with regard to future to life expectancies. This suggestion is reinforced in work by 
Mayhew and Smith (2012) and Bennett et al. (2015) who provide modelling evidence 
that there will be a convergence in the life expectancies between the genders over the 
next 20 years to an extent greater than that envisaged by ONS. 
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Figure 3-1 : Historical revisions to expected years of life at birth (EOLB), males (lhs) 
and females (rhs), England, 1994 to 2012 projections. 
(after : Shaw, 2007) 
Specific conditions may, however, limit the increases in life expectancy (Hoffmann and 
Nachtmann, 2010, cite obesity and an ‘impending’ global influenza pandemic as 
possibilities).  Lubitz et al., 2003, predicted how life expectancy at 70 years of age was 
affected by the ability of the individual to perform certain tasks; whether they were 
cared for in an institutional care setting and what their self-reported health status was. 
They found that the life expectancy of an individual with good functional status was 
greater than for an individual with poor functional status, but the total cost of health 
care beyond age 70 was similar across all function groups, with the exception that the 
cost for those in institutional care was seen to be the largest, although they had the 
lowest life expectancy.  
3.2.2 Healthy life expectancy 
The calculations of healthy life expectancy are subject to some sampling variability 
since they use the results of survey data which sometimes makes absolute conclusions 
with regards to past trends difficult to draw (Parliamentary Office for Science and 
Technology, 2006). Caley and Sidhu (2010) claim that the trend in the UK over the 25 
years to 2007 is for an absolute morbidity expansion, with life expectancy at birth 
increasing by 5.05 years but disabled free life expectancy increasing by only 3.64 years. 
ONS (2008), in consideration of similar data covering the period 2000/2 to 2007/9 
implies that there has been a relative compression of morbidity for both males and 
females at age 65. Clark et al. (2004) asserts that in the US the trend is for morbidity 
compression, “This trend now suggests an improvement in functioning and mobility 
of older Americans.” (p275 and comments on p323). Murphy and Martikainen (2010), 
report that in their opinion “more experts expect a reduction in the proportion 
(although not the absolute numbers) of people with poor health”. This relative 
compression is consistent with the scenario that the number of years in disability may 
be increasing (Caley and Sidhu, 2010) but the proportion of life in disability is 
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decreasing (ONS, 2008). Hoffmann and Nachtmann (2010) review and present their 
own evidence from Germany and whilst acknowledging some contradictory results, 
suggest that the morbidity trend is “positive”.  
The study by Lubitz et al. (2003) estimates the proportion of remaining life spent in 
poor/fair; good and very good/excellent health based on an individual’s self-reported 
health status at the age of 70.  This research shows that better health leads not only to 
greater life expectancy but also higher quality of life.  Individuals who report their 
health as being excellent spent just 2.7 of their remaining 13.8 years in either a fair or 
poor state of health. For those whose reported health was poor however, over half of 
their remaining 10 years of life were spent in poor or fair health.  
A consideration of these studies would suggest that the two most likely outcomes in the 
future are for a morbidity expansion with either a relative expansion or a relative 
compression. In their report to the Wanless Social Care Review on the future cost of 
residential elderly health care, Jagger et al. (2006), state that “It thus seems unlikely 
that a compression of disability will occur unless the severity of disability associated 
with diseases diminishes.”  (page vi). For this thesis it is likely that the trends measured 
as absolute rather than relative morbidity will be the more relevant since the amount of 
actual time in a disabled condition will more accurately determine the health care needs. 
This interpretation is in line with that used in the study of future pension provision by 
Harper, Howse and Baxter (2011) “… historical data for the UK suggests that for both 
men and women the increases in ‘healthy life expectancy’ (HLE), and ‘disability free 
life expectancy’ (DFLE) in particular, have not kept pace with total gains in life 
expectancy. This is important as both of these measures provide an indication of the 
length of time an individual remains ‘healthy’ …” (pages 8-9). 
3.2.3 Summary 
The expectation for the medium term over the next 20 to 30 years is that life 
expectancies in the UK will continue to increase at least at the same rate as seen in 
recent years. Whilst there have also been increases in healthy and disability free life 
expectancies, these increases have been at a slower rate than life expectancies; this 
means that individuals are likely to spend more time in an unhealthy or disabled 
condition.  
3.3 ELDERLY HEALTH CARE DETERMINANTS 
In this section, a wide range of factors that influence an individual’s use of health care 
resources will be considered. These are related to the characteristics of the individual 
themselves, such as age and ethnicity, but may also relate to their employment history, 
lifestyle or environment in which they live.  
34 
 
Many of the studies reported below measure the current and future need for health care 
for the elderly population in terms of costs rather than direct measures such as the 
number of procedures carried out, hospital admissions or bed days. Care is however 
needed when trying to equate increasing costs with poorer health status (Westerhout, 
2014). Certainly as the health of a population deteriorates, the total costs associated with 
treatment of these illnesses would be expected to increase. However there may be other 
factors that drive up health care costs. Firstly, there is the rising cost of treatments, as 
medicines become more sophisticated and as life spans increase, longer term use of such 
treatments will drive up costs. Secondly, the ‘over treatment’ by doctors practicing 
‘defensive medicine’ who, either yield to a desire from the patients to receive some 
form of treatment or, particular in a United States context, wish to minimise potential 
mal practice actions (Garcia-Retamero and Galesic, 2014). Thirdly, the medical 
profession and its institutions are a quasi-monopoly, able to inflate their remuneration, 
even in the context of stable workloads. Finally, there may be incentives in the system 
that reward treating illness rather than maintaining good health, e.g. the Quality 
Outcomes Framework in the UK which financially rewards aspects such as diagnosis 
and treatments (HSCIC, 2014b) which may shift the judgement boundary towards the 
diagnosis of an illness. 
3.3.1 Age since birth 
One of the most often cited factors in determining an individual’s health care need is 
age. A study by Alemayehu and Warner (2004) apportions whole life health care costs 
by age and gender. Their results show that just over half the total lifetime health care 
expenditure for an individual took place by the age of 65. Between 65 and 84 over a 
third of the remaining expenditure occurred, with 12% occurring after the age of 84. 
This may appear at odds with a study by Seshamani and Gray (2004a) which indicates 
that increased longevity after the age of 65 does not cause significantly additional 
hospital care costs over time. However, the Alemayehu and Warner (2004) study found 
that for the elderly population, a significant proportion of the high costs was attributable 
to Institutional care rather than hospital care, and even more so for the old-old. This 
phenomenon is also found in a study by Spillman and Lubitz (2000) who considered the 
cost of health care provision based on the age of the individual at death. Unsurprisingly 
the longer someone lives, the higher their cumulative health costs, although for 
someone who dies at 90 the majority of their costs are from sources such as residential 
care, prescription drugs and other services rather than hospital care. Further 
corroboration is found in Murphy and Martikainen (2010) who analyse the number of 
bed days in hospital and residential care in Finland and show that generally, up until the 
age of 85, more bed days are spent in hospital care whilst at subsequent ages the greater 
number of bed days are spent in residential care. 
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After some methodological modifications by Seshamani and Gray (2004a) to work by 
Zweifel et al. (1999) and using a two-part estimation model of the likelihood to incur 
costs (i.e. be admitted into hospital) and to estimate the costs once in hospital, they 
found that a non-linear function of age was a significant factor (as was time to death). 
The cost shape was concave down, peaking in the 85-89 age band, indicating an 
escalation of costs up to this age band, followed by reductions at latter ages. 
These studies suggest that age is a significant factor in determining health care costs 
(although see below for counter arguments) and that as individuals age these health care 
costs increase. However, the mix of costs varies, with institutional care taking a larger 
proportion of costs at old-old ages, even to the extent that hospital care would decrease 
amongst the old-old. 
3.3.2 Time to death 
A second factor that has been often quoted as a significant determinant of health care 
costs is how close the individual is to dying. Using linked data from NHS care and local 
authority‐funded social care in three primary care trusts in England, Bardsley et al. 
(2010) were able to identify patterns in hospital and residential care use by over 16,000 
individuals in the period up to their death. The pattern found was for increasing costs 
during this period - for hospital care this increase began in the final two months of life 
whilst for residential care costs, it began in the final 12 months. They also noted 
changes in the mix of the two types of provision by age at death and that there was 
some variation in patterns of use between the three trusts, with one trust having a 
distinctly higher pattern of hospital care usage than the other two. 
Whilst the modelling studies reported above have identified age as a significant factor in 
health costs, other work has suggested that age is acting merely as a proxy for some 
other feature. Zweifel et al. (1999) found that for the old population, once time to death 
(measured in quarter years to death) was used in the modelling framework, age specific 
regression terms were no longer significant in explaining hospital costs. This is also 
generally true when the components of health care are broken down (Werblow et al., 
2007). Spillman and Lubitz (2000) found that health care costs in the final two years of 
life did not vary by age at death; however beyond the age of 90 at death, it was more 
likely that these costs would be from institutional care rather than hospital care. 
Seshamani and Gray (2004b) estimated that the 5% of patients aged 65 and over who 
were in their last year of life accounted for approximately half of the hospital care 
expenditure for all those in this age band. A similar result was found by Clark et al. 
(2004) studying the US, who quote that 28% of total acute hospital and other care costs 
were incurred by the 5% of state Medicare members who were in the last year of their 
life (p 276). In their study Alemayehu and Warner (2004) estimated remaining health 
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care costs for the surviving population and the total cohort population (which includes 
both survivors and those who will die within the year). The remaining costs for 
survivors are seen to be lower than the total population, and by significant amounts for 
the old (75%) and the old-old (45%). Conversely in the age vs. time to death debate, 
Atella and Conti (2013) examined the relative impacts of age and time to death for 
outpatient costs in Italy and found that age had a bigger impact on costs (a 500% 
increase from age 40 to 80) than time to death (a 30% increase in the last four years of 
life). 
The importance of any potential time to death effect, where death and hence health care 
use may shift to later ages, can be illustrated by using data presented by McCulloch 
(2012a) on population ageing and mortality. This article examines the trends in age at 
death in England and Wales between 1968 and 2010 and presents two age at death 
population diagrams (reproduced below as Figure 3-2) which show how the age at death 
has shifted significantly to the older age bands, especially so for males. Whilst 
historically the majority of males would experience their final year of life sometime 
between the ages of 65 and 80, in recent times this final year of death is more likely to 
occur after the age of 75.  
 
Figure 3-2 : Population pyramid showing age distribution of mortality, England and 
Wales, 1968 (lhs) and 2010 (rhs) 
 (source : McCulloch, 2012a)  
Whilst the studies reported above have highlighted the significance of time to death 
rather than just age in determining health care costs, de Meijer et al. (2011) in a Dutch 
study of the cost of long term residential care (and separately by institutional and formal 
home based care) found that for formal home based care the time to death for an 
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individual became less significant in determining costs, after controlling for age, co-
habitation status, cause of death and most interestingly, disability.  
There appears to be an acceptance in the literature that there is some overlapping role to 
be played by age, time to death and disability in determining an individual’s health 
status. Incorporating time to death in a model is seen to impact on the age specific 
effect, and the time to death effect is itself weakened when a measure of disability status 
is included. In the absence of time to death information, Dormont et al. (2006) advocate 
the use of a Death Risk and chronic illness indicator terms. 
3.3.3 Gender 
It is well recognised that females tend to have longer life expectancies than their male 
counterparts. What is also beginning to emerge is that the healthy life expectancy for 
females is, however, not that much different than that of males. This indicates that 
females spend a greater number of years of their later life in poor health. 
The study of functional status and self-reported health at age 70 by Lubitz et al. (2003) 
examined differences between the genders. Their work shows that females had a longer 
life expectancy at age 70 than males (14.3 years vs. 11.8) but spend fewer of these years 
in an active state (6.5 years vs. 7.4). This is supported by the earlier finding by Spillman 
and Lubitz (2000) that cumulative health care expenditure at death, controlling for 
greater longevity amongst females, is between 15 and 27 percent higher for females 
than males. In a study of use of general and special physician services in Switzerland, 
Schellhorn et al. (2000) estimated that females made 15% more visits to medical 
practitioners. A consideration of the use of bed days in Murphy and Martikainen (2010) 
showed that, on average, females used 20% more of this resource than males of the 
same age.  The whole life health care costs for females was estimated at 34% higher 
than that for males in the study by Alemayehu and Warner (2004), with the majority of 
this additional cost attributable to both greater female life expectancy and much greater 
expenditure on residential care costs in later life. Hoffmann and Nachtmann (2010) 
implies that females tend to need greater care than males for a number of reasons: 
firstly, they tend to live longer; secondly, they suffer more often than males from non-
fatal chronic illnesses or comorbidities; and thirdly, since they tend to outlive their male 
partners, are less able to depend on such partners for help and support. 
This evidence suggests that females have historically had greater health care needs than 
males, due mainly to their increased longevity and some specific morbidities linked to 
their gender. However, the recent trend is for this differential between males and 
females to narrow (particularly in life expectancies) (Karlsson et al., 2009) – and given 
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that males are now living longer, previously late onset, male only morbidities, such as 
prostate cancer, may become more significant in the larger old-old male population. 
3.3.4 Disability 
In modelling of the influence of greater health costs later in life and changes in 
morbidity, Caley and Sidhu (2010) note that “The potential for different conditions to 
compress or expand morbidity varies greatly and the future consequences of modern 
healthcare are still unpredictable.”  
In a model of the health care costs associated with specific morbidities, the cause of 
death was incorporated into models of residential care costs by de Meijer et al. (2011).  
Diabetes, mental illness, cardiovascular disease, a respiratory or digestive disease were 
seen to have significantly higher total lifetime care costs whilst cancer deaths have 
lower costs. Looking at just hospital costs however, Seshamani and Gray (2004a) show 
that cancer, stroke and other diagnoses are associated with higher costs relative to 
respiratory and heart conditions. Denton et al. (2002) present a consideration of the 
average individual’s physician costs for 19 categories of physician services in Ontario 
by gender and age band, derived from administrative data. The cost of many of these 
services is seen to peak in the elderly population (and decline for the old-old), the only 
exceptions being paediatrics, psychiatry and obstetrics/gynaecology which show peaks 
at earlier ages.  
Looking at comorbidities, work by Rasulo et al. (2009) estimated disease free life 
expectancy (which is potentially less limiting in the activities that an individual can 
undertake than disability free life expectancy) broken down by both single disease 
morbidities (cardio vascular; infections; cancer; respiratory; other acute) and by 
comorbidity groupings of these morbidities.  This work suggests that years of life in 
morbidity due to a single morbidity has declined in the UK since the 1990’s, but this 
decline has been matched by an increase in years of life with a variety of comorbidities. 
Care is needed when projecting past trends in the prevalence of morbidities. Based on 
the extrapolation of recent trends in standardised death-ratios, McCulloch (2012b) 
presents a calculation of such ratios for cancer and coronary heart disease (CHD). These 
standardised death ratios are country specific death rates applied to an international 
standard population profile of 100,000 individuals – so as to eliminate the effects of 
changing population structures both between countries and over time that a raw death-
ratio would provide. These calculations show that by simply extrapolating past trends, 
deaths due to morbidities such as coronary heart disease (CHD) may be almost 
eliminated in the not too distant future! (His figure is reproduced here as Figure 3-3.) 
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Figure 3-3 : Trends in standardised death ratios for Cancer and CHD, England and 
Wales, 2010 
(source : McCulloch, 2012b)  
The reductions in deaths with CHD as the main cause of death seen in Figure 3-3 are 
dramatic, especially for males. These reductions may result from two mechanisms: 
firstly, individuals may be less likely to develop CHD in the first place, driven by 
changes to occupations, lifestyles or pharmacological interventions (e.g. the 
introduction of cholesterol lowering stains, see Law et al, 2003) or secondly, that the 
morbidity is managed better, so that individuals with CHD live to die from other 
morbidities. 
The differing impact of various morbidities on health care is well understood. Some 
morbidities such as cancer can cause an intensive use of resources and thereafter the use 
is minimal, either because the individual has recovered or deceased. Other morbidities, 
such as respiratory illnesses, are much less intensive in their use of health care but the 
period of use is more protracted. However, the combined impact of comorbidities is less 
well understood – is the impact simply the worst amongst the morbidities or to what 
extent does the presence of other morbidities increase the impact?  
3.3.5 Socio-demographic status 
As well as age and gender, there will potentially be other demographic factors that 
affect an individual’s use of health care. Grundy and Sloggett (2003) showed that lack 
of education qualifications and lack of social support systems were linked to increased 
likelihood of reported bad health for the old population. Additionally the influence of 
marital status (married; single; widowed and divorced or separated) for females in 
particular, was found to be weak or counter intuitive (with married females enjoying no 
40 
 
significant better health than those in other categories). A study by Murphy and 
Martikainen (2010) however showed that being married or widowed greatly reduced the 
number of bed days (both in hospital and in a residential setting) compared to their 
divorced or single counterparts. Seshamani and Gray (2004b) were only able to 
demonstrate reduced hospital costs for married individuals over those who were single, 
widowed or divorced (however widowed showed the smallest difference). Simeonova 
(2013) explored a possible link between a bereavement event and subsequent 
deteriorations in health outcomes. 
A consideration of health statistics indicates that health status varies by ethnicity 
(HSCIC, 2005a and 2005b, Parliamentary Office for Science and Technology, 2007). 
These studies found that generally poorer health and increased likelihood of an acute 
sickness is reported amongst the elderly (55 or older) south Asian population of both 
genders. This population also experienced greater incidences of cardio-vascular 
morbidities, stroke and diabetes (this latter morbidity was also common amongst the 
black Caribbean population). The Chinese population were seen to have generally better 
health and lower incidence of these morbidities. There is little consensus so far on how 
much these differences are attributable to lifestyle, socio-economic factors or genetic 
pre-dispositions. Modelling may help to dis-entangle these impacts. With regard to 
ethnicity, probit modelling of survival, cohabitation, working and health status by 
Karlsson et al. (2009) shows that controlling for many factors, white ethnicity (and 
higher education) were associated with greater healthy life expectancy. Lubitz et al. 
(2003) estimated that members of the black community had lower life expectancy at age 
70 than the white community (11.5 years vs. 13.5) and fewer of these years were active 
(5.4 years vs. 7.2). 
3.3.6 Socio-economic status 
The economic status of an individual is likely to impact on their need for health care, 
not just in their elder years but throughout life. McCulloch (2011) illustrates this by 
plotting the proportion of residents on benefits against the number of recorded FCEs for 
English LADs. His chart (together with a similar chart for the proportion of the 
population aged 75 and older versus FCEs) is reproduced below as Figure 3-4. In this 
chart, there is clear evidence of a positive, but weak, correlation between levels of 
receipt of income benefits and the number of FCEs. A consideration of the socio-
economic impacts on self-reported and objective measures of health by Grundy and 
Sloggett (2003) also suggests that health outcomes are poorer for those in receipt of 
income support payments and those housed with social sector housing tenancies. This 
finding was relatively consistent across all the measures of health outcomes and for both 
males and females.  
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Figure 3-4 : Hospital admissions per 100 people, by income (lhs) and by age (rhs), 
LADs, 2008  
(source : McCulloch, 2011) 
Melzer et al. (2000) using two point survey data and NHS death records showed that 
males aged 65-69 from the first quartile of social status (professional or managerial) not 
only enjoyed greater life expectancies than those with other social status (15.0 years vs. 
13.1 years) but they also enjoyed fewer years in disability (1.0 year vs. 1.6). Whilst 
females from the first quartile also enjoyed longer lives (18.7 years vs. 17.2) the 
numbers of years in disability were similar amongst the two groups (3.4 years vs. 3.2). 
These general findings were seen to be invariant to the degree and definition of 
disability. An ONS study on disabled free life expectancies also showed that these 
expectancies were lower in the more deprived the areas of England (Smith et al., 
2011a). 
Possessing a higher education qualification and having higher incomes was shown to 
reduce the number of visits by individuals to medical practitioners by Schellhorn et al. 
(2000), with a further indication that such people were more likely to access specialist 
practitioners than the population at large. A simulation study by Karlsson et al. (2009) 
showed that a 50 year old male who has a university degree and is working, cohabiting 
and healthy can expect to live for 15 years more than their male opposite number 
(lowest education, non-working, non-cohabiting and ill), and remarkably, spend 25 
more years in a healthy condition. 
A comparison between the number of bed days by manual and non-manual workers in 
Murphy and Martikainen (2010) shows that whilst manual workers had greater use of 
bed days, this difference was only slight. Seshamani and Gray (2004b) also estimated 
that non-manual workers had significantly lower quarterly hospital costs. 
Clearly higher incomes and wealth, however they are measured (living environment; 
tenure of accommodation; educational attainment; employment) are positively related to 
a healthier lifestyle and a consequent reduction in health care needs. 
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3.3.7 Geography 
What emerges from many of the studies is the lack of geographic differentiation in the 
reported findings. When considering the needs and the delivery of health care provision 
the variability between locations is critically important. Many reported studies simply 
model data from a specific region (using a bespoke survey) or a country (using a 
national data set). Where a study is conducted for a specific region, using locally 
collected data, there is the potential for arguments over whether these results would be 
still valid at a national scale, but even in such a case however, they would still not allow 
for any geographic differentiation (e.g. Seshamani and Gray, 2004a, who claim that 
their study which is based on Oxfordshire data, is representative of England and Wales 
as a whole). 
One study that has both national coverage and a detailed geography is that by Smith et 
al. (2011a) who used a geographically specific measure of deprivation to highlight 
health inequalities, showing greater ill health in more deprived neighbourhoods. A 
similar piece of work by Webber (2004) also examines how total hospital admissions 
with certain diagnosis vary by type of neighbourhood, as characterised by the MOSAIC 
classification (Experian, 2003). This work also provides a methodology to identify 
which neighbourhoods need targeted resources so as to effectively tackle a range of 19 
diagnoses. The morbidities of Chronic Obstructive Pulmonary Disease (COPD), 
strokes, emergency admissions and injuries and poisonings are seen to have particular 
high admission rates in elderly neighbourhood types. Staying with classifications, work 
by CACI (2007) classifies postcodes within the UK according to their health status and 
diet, so that again, health improvement resources may be targeted at local areas. The 
headline classification categories used are: Existing problems (15% of postcodes); 
Future problems (12%); Possible future concerns (35%) and Healthy (37%, not 33% as 
given in the report). Selected sub categories contain elderly traits, e.g. “Elderly with 
associated health issues” (3%); “Affluent healthy pensioners, dining out” (7%). The 
authors comment that “Looking at existing illness alone is unlikely to focus resource 
on those areas that will present major health issues over the next 20 years.” 
3.3.8 Summary 
Whilst many of the early studies into the health care costs of the elderly population cite 
age as an important factor, subsequent work suggests that once time to death is 
considered, age itself becomes less of a contributory factor. For some studies this 
finding presents a data challenge, since knowledge that an individual is within say, one 
year of death, is only available retrospectively.  Subsequent work that revisited this 
issue, restored age to some significance in explaining health care costs, but time to 
death was still a more important factor. The most recent work has however suggests that 
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time to death is itself not the real driver for health care costs; instead it is the disability 
of the individual that is important. This simplifies the task of assembling a data set for 
modelling purposes since disability can be observed contemporaneously. The 
conclusion here is that some accurate assessment of an individual’s state of disability is 
an important factor in not only assessing their ‘on-going’ health care need but also is 
critically important in assessing their magnified health care need in the period leading to 
their death. 
Females currently have longer life expectancies than males but they also tend to have 
longer periods in disability and this means that they have greater lifetime health care 
costs than males. The trend, however, is for this difference to narrow. 
The type of morbidity affects the profile of need for health care. Some morbidities may 
require an intense period of treatment followed by a return to almost full health or death 
(e.g. cancer); some may also be linked to a specific health event but the prognosis is for 
continuing treatments (e.g. a stroke) whilst others will be more subtle but still 
debilitating over a longer period of time (e.g. dementia, heart and respiratory diseases). 
This latter category probably constitutes the larger group in terms of health care use.  
Considering socio-economic and demographic factors together, individuals who are 
white, have higher levels of qualification, higher incomes or wealth and do or did do 
non-manual work will tend to have longer life expectancies and spend many more years 
in a healthy state than their opposite counterparts. To an extent all these five factors will 
be measuring similar effects.  
Many of the quoted studies here do not tend to incorporate any geographic 
differentiation in their findings. This is primarily a data issue with the required 
geographic detail not being present in these data or these data relate to just one specific 
location. This deficiency is important since it is likely that the makeup of an area is 
determined by its history, culture and population, and therefore health outcomes will 
vary by area. 
3.4 CASE STUDY MORBIDITIES 
In this thesis three case study morbidities that particularly affect the elderly population 
are studied. Examining statistics on the causes of death in 2012 for those aged 50 and 
older, the three most common causes of death are: neoplasms (also known as cancers) 
(ICD-10 codes C00-D48) which account for 29% of such deaths, diseases of the 
circulatory system (ICD-10 codes I00-I99) 28% of deaths, and diseases of the 
respiratory system (ICD-10 codes J00-J99) 15% (ONS, 2014d and Table 5 of the 
associated data table). Examination of usage of secondary care, measured through FCEs 
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shows that in 2013-14, 15% of such episodes are associated with neoplasms, 12% with 
CVD and 8% with respiratory illnesses (HSCIC, 2015).  
In terms of specific definitions, for circulatory diseases the term CVD is used to cover 
both ischaemic heart (IHD) and cerebrovascular diseases, the former including the 
occurrence of a myocardial infarction (a heart attack) or angina whilst the latter is 
commonly results from a stroke. For respiratory diseases, these are typically signified 
by the presence of a lung disease or asthma. Cancers can occur in many locations within 
the body and can have diverse causes, some of which are lifestyle related whilst others 
are part of the ageing process. It is this variety and range of causal factors that make it 
challenging to attribute the onset of the generality of cancer to specific and significant 
factors. Of these three major causes of death, only the morbidities of the circulatory and 
respiratory systems are studied here.  
Deaths attributable to endocrine, nutritional and metabolic diseases (ICD-10 codes E00-
E99) such as diabetes are less common at 2% of all deaths and 2% of FCEs for those 
aged 50 and older. However diabetes is still a significant morbidity and was estimated 
to be a direct cost to the NHS of £13.9 billion in 2010 (Kanavos et al., 2012). These 
costs do not include the additional indirect costs associated with common complications 
such as glaucoma, foot conditions and strokes and the economic costs of absenteeism, 
early retirement and increased social benefits. Notwithstanding the low proportion of 
deaths and hospital admissions, but recognising the cost of diabetes and, the 
comorbidity links between diabetes and CVD, DHBS is the third case study adopted in 
this thesis. 
In the remainder of this section, the determinants found in the literature that are 
particularly associated with the onset of these three case study morbidities are 
considered.  
3.4.1 Cardio vascular disease 
The now abolished Yorkshire and Humber Public Health Observatory published a series 
of fact sheets for CVD in 2013 (Public Health England, 2013a) that report on findings 
in the literature around CVD. Each sheet covers a significant influence that determines 
an individual’s propensity to acquire CVD. Some are themed on lifestyle or behavioural 
influences (sheets 1 to 5), whilst others to non-behavioural influences (sheet 6) and 
some to information on linked morbidities (sheets 7 to 16). 
3.4.1.1 Behaviour 
There are five main lifestyle or behaviour influences that contribute to an individual 
developing CVD. The first influence is smoking – studies have estimated that current 
smokers increase their risk by a factor of up to three times when compared with those 
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who have never smoked. Even ex-smokers have a near doubling in risk. These increased 
risks are however moderated by age, as individuals get older the relative risk associated 
with smoking tends to decrease. Exanimation of long terms trends in smoking status 
suggests that fewer individuals will have smoked in future cohorts which means that the 
prevalence of CVD should be lower in future (Murphy and Di Cesare, 2012, illustrate in 
figures 1 to 5 the likely reductions in future smoking behaviour and go onto to estimate 
that much of the improvement in the mortality of those born in the 1930s is due to 
variations in smoking).  
The remaining behavioural influences covered in fact sheets 2 to 5 are linked together 
and concern obesity, physical activity, nutrition and alcohol consumption. Obesity 
primarily impacts on CVD through type-2 diabetes, with females who are obese having 
a 12.7 increased risk of type-2 diabetes and obese males a 5.2 increased risk. Unlike 
smoking, the trends are for increasing obesity in the English population. Regular 
physical exercise combats the effects of obesity and thereby helps to reduce CVD. It can 
also help to lower blood pressure and reduce stress further helping to guard against 
CVD. Like lack of physical exercise, poor nutrition contributes to obesity and hence 
CVD, however diet can also have a direct impact on CVD. The adoption of a 
‘Mediterranean’ diet based on consumption of vegetables, nuts, seeds, fish and certain 
types of unsaturated fats is seen to be beneficial in protecting against CVD whilst salt, 
which increases blood pressure, increases the risk of CVD, as do saturated fats. Low to 
moderate alcohol consumption is reported to offer some protection against CVD but this 
benefit quickly turns to harm with heavy consumption.  It is estimated that 5.8% 
(54,700) of all hospital admissions with a primary diagnosis of CVD in 2011/12 could 
be attributed to alcohol, and to provide some context, 137,400 could be attributable to 
smoking. 
3.4.1.2 Non-behavioural 
Non-behaviour factors include gender, age, ethnicity and deprivation. There appears to 
be little difference in the prevalence rate of CVD between males and females, although 
at older ages the morbidity is more prevalent for males. By ethnic group the higher rates 
of CVD overall are seen in the male Pakistani and Indian groups whilst the lowest rates 
are reported in the Black African and Chinese groups. For stroke, however, older Black 
Caribbean males have the highest prevalence, followed by Bangladeshi and Indian 
females. Evidence points to a social gradient with CVD, people living in areas that are 
more deprived and less affluent tend to have higher prevalences for CVD.  
The separation of behavioural and non-behavioural factors that contribute to CVD can 
be problematic. For example there may be a (non-behavioural) genetic component that 
links to a propensity to become obese (behavioural). Also (non-behavioural) deprivation 
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can impact on an individual’s ability to eat healthier and take regular physical exercise 
(behavioural). 
3.4.2 Diabetes or high blood sugar 
The campaigning charity Diabetes UK produces a periodic report on the statistics 
related to diabetes (Diabetes UK, 2012). The report covers the extent of diabetes in the 
population and various sub populations, distinguished by age and region. The report 
also highlights the risk factors associated with the morbidity and how it impacts on 
individual’s lives, both directly and through medical complications. The report also 
contains a comprehensive list of references to the major studies into the morbidity. 
Given the cited link between CVD and diabetes it is not surprising that there are 
commonalities in the risk factors that influence the prevalence of DHBS (see Morrissey 
et al., 2014, who explicitly modelled this comorbidity). The behavioural factors of 
obesity and nutrition are commonly cited; increasing levels of obesity linked to poor 
diet increases the chances of acquiring diabetes or having high blood sugar. The link 
with smoking, physical activity and alcohol is less certain, other than how these factors 
affect obesity. With regards to non-behavioural factors, once again those of a south 
Asian ethnic background have a higher risk of DHBS by a factor of up to 6 times (see 
Khunti et al., 2009, for recommendations on how to explore this finding). Those of a 
Black African or Caribbean ethnicity also have an increased risk factor of 3 times in 
comparison to the general population (HSCIC, 2005a). Also genetics plays a greater 
role with DHBS - having a parent or a sibling with the morbidity increases the risk. 
3.4.3 Respiratory Illness 
Respiratory diseases manifest in a number of forms. Beside cancers the commonest 
forms are COPD, pneumonia, tuberculosis and asthma. COPD manifests commonly in 
two forms, either bronchitis or emphysema. A statistical consideration of the diseases is 
provided in the Burden of Lung Disease report published by the British Thoracic 
Society (2006).  
Unsurprisingly smoking is the most important contributory factor to developing a 
respiratory illness. Half of smokers develop some form of COPD whilst 10%-20% 
develop clinical symptoms (Devereux, 2006). Other causes of COPD include exposure 
to air pollution and from employment (e.g. inhaling noxious gases and dust particles) 
although the exposure to these causes in the UK has diminished over time. Both 
pneumonia and tuberculosis are infectious diseases, spread through contact with the 
bacterial agent. Whilst not caused directly by smoking there is evidence that smoking 
not only compromises the ability of the lungs to function whilst suffering an infection, 
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but smoking makes the acquisition of the infection in the first place more likely (Nuorti 
et al., 2000, Kolappan and Gopi, 2002, and Maurya et al., 2002). 
Whilst it is unclear what causes asthma, the commonly cited cause is a result of an 
atopic reaction to living in a too hygienic environment – the ‘hygiene hypothesis’ 
(Strachan, 2000). Some studies have suggested that the causes of asthma are otherwise 
primarily linked to either a family history of the morbidity or childhood events. These 
childhood events include: having bronchiolitis as a child; childhood exposure to tobacco 
smoke; if your mother smoked during pregnancy; being born prematurely; or having a 
low birth weight. The extent of these childhood events varies over time – people aged 
50 in 2010 for example will have been children during the 1960’s when these events, 
particularly in regards to smoking, were more common. After a steady growth in the 
incidence of diagnosis of asthma in the population until the early part of this century, 
the trend is now for reduced incident diagnosis (Anderson et al., 2007 and Simpson and 
Sheikh, 2010).  
More generally, there is little difference between the genders in the prevalence of 
respiratory illness but as people age the prevalences increase. The female south Asian 
and Chinese populations have the lowest rates of such diseases, linked to their low rates 
of smoking (reported in HSCIC, 2005a, and shown later in Table 8-15). Socio-economic 
status will influence the chances of acquiring a respiratory illness, those employed in 
manufacturing industries having a higher prevalence than those who work in the retail, 
service or professional sectors. 
3.4.4 Summary 
Two of the three morbidities selected for study in this thesis together account for nearly 
a half of all deaths in the 50 year and older population of England. CVD is just behind 
cancer in terms of the number of deaths whilst respiratory illness is the third largest 
cause. The morbidity of DHBS is often linked with CVD and so has also been included 
as the third case study morbidity. There is little evidence to suggest general gender or 
age differences in the incidence of these morbidities, although, if the morbidity does not 
significantly increase mortality, the prevalence of the morbidity will naturally increase 
with age. Lifestyle or behavioural factors are seen to have a large influence on the 
morbidities. The higher levels of obesity and its associated factors of less physical 
activity and poor nutrition are seen to increase the incidence of the linked morbidities of 
CVD and DHBS. Smoking has an impact on all three morbidities – more so for those 
who are current smokers. The most consistent and important non-behavioural factor that 
emerges for consideration is ethnicity. This finding may have an underlying genetic or 
lifestyle cause. The south Asian population have greater risk than the general population 
for CVD and DHBS but less risk for respiratory illness. Black ethnic groups have lower 
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risk for CVD (but within CVD, higher risk of stroke) but higher risk of DHBS. The 
Chinese ethnic group appears to have a lower risk for all three morbidities. 
3.5 HEALTH DATA 
This section provides a review of the types of data that have been used to describe and 
model elderly health care use. To a degree there will be an overlap here with section 3.3 
on elderly health care determinants and the following section on modelling approaches. 
However, this section will also present an opportunity to step back and consider the 
specific features of a fuller range of health care data. In particular a consideration will 
be given of the strengths and weaknesses of each type of data and how any weaknesses 
may be addressed. 
There are four potential sources for data on elderly health care which are most 
commonly identified in the literature. The first source is sample survey data that are 
collected for specific health related purpose within a defined region or locality such as 
the Oxfordshire (Seshamani and Gray, 2004a) and EIGER (Schellhorn et al., 2000) data 
sets.  
The second source is also sample survey data but is collected on a national level. These 
surveys may be health specific (e.g. the Health Survey for England, HSfE) (Grundy and 
Sloggett, 2003) or may be general but still containing a significant health element (e.g. 
ELSA) (Institute for Fiscal Studies, 2015a and 2015b). One important consideration in 
connection with an elderly population is the nature of the population which is being 
sampled, often the surveys may not include individuals who are resident in an 
institutional care setting. 
An important distinction for both regional and national survey data sets concerns 
whether they are cross sectional or longitudinal in nature (ONS, 2010a, section B.3). 
Cross sectional data may be collected as either as a one-off exercise or periodically, but 
the important feature is that each individual participates in the survey just once. With 
longitudinal surveys there is a desire to re-survey the same panel of individuals at a 
number of different points in time. The advantages of cross sectional surveys are that 
they are easier to implement and they produce larger samples than longitudinal surveys. 
A longitudinal survey however, allows a life course picture to be built up for individuals 
and transitions within this life course can be observed contemporaneously (rather than 
through recall). Also, estimates derived from longitudinal surveys tend to be more 
precise and less variable since they do not incorporate the person to person variability 
that is present in cross sectional surveys. The disadvantages for longitudinal surveys are 
related to the administrative work involved in locating the same participants at each 
survey ‘wave’, how to accommodate dynamic shifts in people’s arrangements (e.g. 
 
 
49 
 
marriages and divorces) and the need to refresh the panel as attrition takes place over 
time. 
The third source of data arises from administrative data sets collected as part of the 
health administration process. Examples of these are the Hospital Episode Statistics in 
the UK (Cowper, 2004), Medicare related databases in the USA (Spillman and Lubitz, 
2000) and various European systems (Zweifel et al., 1999, de Meijer et al., 2011, 
Ziegler and Doblhammer, 2010, Hoffmann and Nachtmann, 2010 and Murphy and 
Martikainen, 2010). 
A fourth source of health data are those collected as part of a periodic census of the 
population. For example, the English and Welsh 2011 Census contained questions on 
self-reported general health status, long-term illness and provision of care (ONS, 
2010b).  
3.5.1 Survey data 
Most on-going general household surveys will capture some information on the state of 
health or the disability status of the members of the household. The largest such data set 
within the UK is the Integrated Household Survey which is composed of a set of 100 
core responses extracted and combined from a number of ONS surveys. This 
combination of responses from a number of surveys allows for a higher precision in any 
estimates derived from these data and the potential for greater geographic detail (to 
local authority level) than any single survey (ONS, 2012c). The range of health 
questions in this survey is limited; concerned primarily with a self-assessment of the 
degree of ill health, its duration and the limitations it places on daily activities. 
The United Kingdom Household Longitudinal Study (UKHLS) (branded as 
‘Understanding Society’ and previously known as the British Household Panel Survey) 
(Brice et al., 2010) is an on-going longitudinal survey designed to capture the changing 
behaviour of individuals and households in the UK. The survey collects a similar range 
of health related data to the now discontinued General Household Survey (ONS, 2011). 
These data have been used to study income-inequalities in the use of health care 
amongst the elderly (Allin et al., 2006 and Hanratty et al., 2008); provision of care for 
the elderly (Hirst, 2004, Glaser et al., 2008) and how social capital influences health 
care needs (Sessions et al., 2011, Gray, 2009 and Pevalin and Rose, 2004).  
Moving away from general household surveys, the HSfE is perhaps the most detailed 
source of health related survey information for England (equivalent surveys are 
conducted in Scotland and Wales) (Joint Health Surveys Unit, 2012). The HSfE is a 
cross sectional survey begun in 1991 and was initially made up of a sample of 16,000 
individuals but this was reduced to 8,600 individuals in 2009. The survey not only 
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contains information on self-assessed health conditions that are commonly found in 
other such survey it is also supplemented with a nurse practitioner collected medication 
survey and a samples for biomarkers. These biomarkers include: body shape; 
physiology; blood anylates: physical function; sensory tests and samples of saliva, 
cheek cells, cortisol and DNA. Occasional booster samples are used to gain insight into 
a particular topic, for example in 2005 there was a sample boost for elderly respondents 
(Craig and Mindell, 2005). In 2011 the HSfE was reformed as the Health and Social 
Care Survey (HSCS) resulting in a revision to the set of core questions within the 
survey and the introduction of additional questions around social care 
ELSA is a survey dedicated to capturing the behaviour and lifestyle of an ageing 
population. The survey was started in 1998 and is currently in wave 7 (2014-15). The 
initial sample members were recruited from respondents to the HSfE in 1998, 1999 and 
2001 and ELSA is periodically refreshed using respondents from the HSfE. Like the 
HSfE, the survey also periodically collects medication and biomarker data from 
individuals at waves 0, 2, 4 and 6. Recent studies using ELSA have included work by 
Tanaka et al. (2011) that used ELSA data to estimate how the socio-demographic status 
of an individual affected their susceptibility to develop diabetes. Shankar et al. (2010) 
used ELSA to report on the likelihood of individuals engaging in risky health 
behaviours (smoking; excessive alcohol consumption and lack of exercise) as a result of 
their socio-economic and demographic background. Steel et al. (2006) used self-
reported data by individuals within ELSA on the quality of the health care that they 
received in regards to various health conditions. 
3.5.2 Administrative data 
As a result of how the American health care system is funded, many American based 
studies use data held by medical insurance companies or provided through state 
(Medicaid) and federal (Medicare) programmes, with the Medicare scheme being 
primarily concerned with the 65 year and older population. Many studies using these 
data sources have been concerned with the modelling of cost for health care (Lubitz et 
al., 2003). Where available, some studies have advanced the work by considering the 
cost of individual physician services as recorded in such databases e.g. in Ontario, 
Canada using a Health Insurance Plan database constructed to administer fee-for-
services system (Denton et al., 2002). 
A more ambitious undertaking is to attempt to link together a number of administrative 
data sources. For a population model de Meijer et al. (2011) used three types of 
administrative data linked at the individual level. These data are able to provide the cost 
of care (an Administrative Office Exceptional Medical Expenses data set from 2004); 
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the time to death and cause of death (the Death Causes Registration 2004–2007 data set) 
and household and individual characteristics (the Municipality Register 1998–2006).  
With regard to hospital admissions in the UK, the English HES data provides a 
comprehensive source of in and out patient data, measured in terms of FCEs. The 
primary intended purpose of these data are to provide a mechanism to enable health 
commissioning bodies to reimburse clinical providers for the cost of care and to provide 
data for various performance indicators.  These data do however have the potential to be 
a rich source of data for research purposes (Garratt et al., 2010). The HES contains 
admitted patient care data from 1989 onwards, with more than 14 million new records 
added each year, and outpatient attendance data from 2003 onwards, with more than 40 
million new records added to this database each year. These data are made available 
either in aggregated tabular format or, under certain conditions, at individual FCE level. 
The data quality for inpatient diagnosis is good (since payment is linked to the quality 
of this field that provider’s record) but the data quality for outpatient diagnosis is not so 
good. 
Looking at studies of morbidities affecting an elderly population that have used the HES 
data, many studies use HES data to assess clinical outcomes or discharge destination. 
For example Jeyarajah et al. (2009) and Faiz et al. (2010) predict as outcomes the length 
of stay/re-admission/mortality for digestive conditions that dis-proportionately affects 
the elderly population. Gilbert et al. (2009) predict the probability of a discharge to the 
patient’s home or to an institutional setting after a fall using HES data from a single 
hospital in the South east of England.  
However, the studies which are perhaps most relevant to this thesis are those that 
consider factors that lead to admissions or re-admissions to hospital. An early study by 
Birrell et al. (1999) used population projections and age/sex specific rates of hip 
replacements, derived from HES, to forecast the need for such operations to 2006, 2016 
and 2026, assuming rates remained constant. As part of a wider consideration of 
‘unintentional’ falls amongst the elderly, Scuffham et al. (2003) used HES data to 
estimate the incidence and cost of hospital admissions due to falls, by four elderly aged 
bands. Hospital admission rates were seen to increase by an order of magnitude between 
the 60-64 age band and the 75 plus age band.  Roland et al. (2005) investigated the re-
admission pattern of a high-risk elderly group (those having two or more hospital 
admissions in one year) against a general elderly population. Their study, using HES 
data from 1997 to 2003, found that eventually the admission pattern of the high-risk 
group (after 3 to 5 years) is not dissimilar to that of the general elderly population. 
Billings et al. (2006) used a 10% sample of HES data to also predict future likelihood of 
hospital re-admission across a range of morbidities. From a sequence of logistic 
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regressions they found that of all the age bands, only belonging to the two oldest age 
bands, aged 65-74, and 75 or older, were significant in influencing the likelihood of re-
admission. 
3.5.3 Summary 
Each type of data set has its own strengths and weaknesses. The general survey data sets 
are generally large and able to provide accurate estimates for general health at some 
intermediate level of geography. Unfortunately, in these types of survey the range of 
health information is usually limited to self-assessments of the individual’s general 
health condition and whether they have a number of functional limitations. The specific 
health and elderly survey data sets are much richer in their coverage of health, using 
both self-reported measures of health status and more objective biomarkers. These data 
sets also record use of health care resources. However, such surveys are usually small in 
size and are less able to produce reliable estimates for certain variables, particularly 
when segregated by some characteristic or geography. Whilst the administrative data 
sets are primarily designed for payment and monitoring purposes, they can be useful for 
research purposes and are able to provide an almost universal coverage of health care 
use by a population, especially when health care is free at the point of use. This 
universality enables the information to be provided at detailed geographic level (and at a 
greater regularity than periodic censuses). The detail of the characteristics of the patient 
may however be lacking in this data set, as can, surprisingly, the diagnosis accuracy, see 
Mathur et al. (2014), for an example that considers the quality of ethnicity information 
in HES and Khan et al. (2010) and Herrett et al. (2009), for an assessment of the quality 
of diagnosis information in the General Practice Research Database. A later study by 
Herrett et al. (2015) concludes that the quality of the data in the (rebranded) Clinical 
Practice Research Datalink is improving over time as its research value becomes 
apparent.  
From this consideration it is clear that no one data set is likely to be able to provide the 
entire picture on elderly health care and how this use is influenced by various factors. 
Ways of combining these data sets are required so as to bring their varied strengths to 
bear on these considerations, whilst minimising their weakness.   
3.6 MODELLING METHODOLOGIES 
Due to its economic and policy importance, health care modelling is a fertile field of 
academic study. Brailsford et al. (2009) report a study that both defines a strategy for 
conducting a review of health care modelling and reports the outcome from such a 
review. The need for a systematic approach is highlighted by their estimate that a simple 
‘((healthcare or health care) and (modelling or modeling or simulation))’, search term 
produces an extra 30 articles per day. After a distillation of nearly 10,000 articles they 
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conducted full reviews of over 300 to identify date, country of origin, primary and 
secondary analysis methodologies, funding sources and level of implementation.  They 
find that the vast majority (nearly 200) of articles use either statistical modelling or 
statistical analysis techniques, with the third most common methodology being 
simulation. They describe as “depressing” the low level of implementation of the 
results of the studies (5.3%), which is ascribed to the lack of grey literature in their 
initial search. 
As Brailsford et al. (2009), identified the predominant techniques used in studies of 
elderly health care have been either statistical or ‘mathematical’. Mathematical 
techniques are those that involve some form of simple calculations. This may be the use 
of population estimates or projections which are then multiplied by some estimated age 
and gender specific rates of disease prevalence or health care use. This is the approach 
developed by the Projecting Older People Population Information organisation (Poppi 
User Guide, 2011) to predict the prevalence for a range of morbidities to 2030, and used 
by the Mental Health Observatory (Glover, 2008) to produce forecasts of dementia 
suffers to 2025. These rates are commonly static over time (which can lead to over 
estimates, see Mason et al., 2015) but may be evolved along some identified or 
extrapolated trend.  
Some of the studies identified by Brailsford et al. (2009) involve the use of published 
life tables. These tables show, at each age, the probability that a person in a given 
population will die before their next birthday. They can be used to calculate both life 
expectancy and (with certain assumptions concerning disability rates) healthy life 
expectancy for people of different ages (Jagger et al., 2007). An example of such an 
application is Ziegler and Doblhammer (2010) who used life tables/population 
projections and dementia prevalence assumptions (that evolve over time) to estimate 
future levels of dementia within the German population to 2047. 
Another approach is to model how a population evolves over time using transition 
probabilities in a Markov context (Sato and Zouain, 2010). Such studies involve the 
enumeration of a number of mutually exclusive states that individuals can occupy and 
the calculation or estimation of the probabilities that individuals transition between 
these states over time. For their study, Lubitz et al. (2003) developed a series of age, 
gender and race specific state transition probabilities, with states ranging from no health 
limitation to institutionalised. A Monte-Carlo/Markov Chain simulation exercise was 
then conducted to see how the health of a population of 100,000 over 70 year olds 
evolved, with individuals moving between states of health using a comparison between 
sampled pseudo random numbers and these transition probabilities.  Another simulation 
study, conditioned by probit parameter estimates, was also used by Karlsson et al. 
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(2009) to examine how life and healthy life expectancies varied by socio-economic 
characteristics. 
3.6.1 Statistical modelling 
Many of the studies reported in the earlier sections of this review used statistical 
estimation techniques. This is to be expected since such techniques are well understood 
and have a strong theoretical grounding. They allow for the modelling of both 
individual and aggregate data and for an objective consideration of the importance of 
influences through significance levels.  
For modelling aggregate data such as health care costs or length of stay, traditional 
linear or generalised linear models are often used. For individual level data a common 
approach adopted in the modelling of elderly health care use involves a two stage 
process. The first stage establishes the likelihood of accessing health care, usually by 
the use of a choice model. A second stage is then to estimate the extent of the health 
care use (usually though a cost measure) by the subset of users identified in the first 
stage, using a regression model, either ordinary least squares or a more generalised 
linear model (Seshamani et al., 2004a and 2004b, Dormont et al., 2006, and deMeijer, 
2011). 
3.6.2 Static microsimulation 
Static microsimulation systems are complex mathematical systems that are able to 
measure the impact of policy changes on individual’s behaviour. Such models are 
widely used for a variety of purposes including pension planning; changes to tax-benefit 
systems; higher education funding and inter-general issues (Anderson and Hicks, 2011). 
Many models attempt to synthesise or predict a population’s demographic structure, 
since such a structure is expected to have a large impact on welfare, pension and health 
care need. 
These models are typically based on a regional or national survey data set that contains 
detailed information about individuals or their households. These data sets are normally 
issued with a set of weights attached that measure how this individual or household 
represents the population as a whole. Techniques are then applied to these weights to 
evolve the surveyed population, typically through time, to represent alternative or future 
populations. Where these data are financial, such as incomes or costs these can also be 
updated based on gross domestic product or inflation growth assumptions. Once this 
evolved population has been estimated, it can be examined to explore issues such as its 
age and gender make-up, its labour force status, health status and income distribution. 
Also the cumulative wealth of the population can be established by accumulating 
information as the evolution occurs. The impact of policy changes (e.g. tax and benefit 
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rates) can be modelled by changing the rules that are applied to the populations through 
time. 
Many examples of the application of static microsimulations in the area of health care 
are provided in the book Gupta and Harding (2007). The book includes papers that 
consider:  
 the measurement of health status (through analysis of birth cohorts in Britain and the 
care needs and delivery of care for the elderly in Scotland);  
 the costs of pharmaceutical treatments (predominantly within the Australian health 
care system);  
 the financing of health care, through a short horizon (2002-2006) simulation of 
medical insurance costs in China; 
 various studies into the availability of care for an ageing population, covering both 
formal care (the number of nurses and physicians) and informal care (the size of the 
‘middle’ generation);  
 data issues,  around non-response and how the desire for confidentiality impacts on 
data quality; 
The book also contains a section that provides a review of ten static microsimulation 
models, providing summaries of their history, scope, data source, technical detail and 
uses. 
Elsewhere, Pearson et al. (2011) describe a static microsimulation model of the 2002 
New Zealand population built to measure patient visits to general practitioners (GPs); 
practitioners activities and the range of morbidities in the population. The verified and 
validated model was then used to explore various family support and GP retention 
scenarios to the year 2021. Shi et al. (2011) used a microsimulation of the Californian 
population to estimate the future prevalence of type-2 diabetes under various Body 
Mass Index trends to the year 2021.  A microsimulation model of the future elderly 
population (FEM) is developed in Goldman et al. (2004) to help predict the likely 
impact of a wide range of medical breakthroughs on health care status and costs. The 
same model is used in Michaud et al. (2009) to compare health status and life 
expectancies in Europe and the USA. 
3.6.3 Dynamic microsimulation 
The next step beyond static microsimulation is dynamic microsimulation (O'Donoghue, 
2001, and Zucchelli et al., 2010). The major difference in a dynamic microsimulation is 
that individuals move between ‘major life events’, e.g. marriage, parenthood, divorce, 
labour force participation, morbidity and mortality. This is primarily accomplished 
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using information on transition probabilities between each state. These probabilities 
may also be conditional on other characteristics such as age and gender.   
Given the complexity of such models they are less commonly found in the literature 
than static models. Zaidi and Rake (2001), Spielauer (2007) and Rutter et al. (2010) 
contain reviews of the use of such models in the context of an ageing population and 
health status. As with static microsimulations, a further review of the details and 
technicalities of seven dynamic microsimulation models is provided in Gupta and 
Harding (2007).  
Like static models, dynamic models are able to provide basic statistics on the projected 
age and gender breakdown of a population with some able to additionally supply 
information on levels of elderly residential status within the population and disability 
(for example the Canadian LifePaths model, Légaré, 2011). The details on health status 
are more limited. It is possible with most of these models to augment them so as to 
produce more detailed health projections. A paper by Walker (2007) describes an 
illustrative study of the use of a health ‘add in’ to a dynamic microsimulation model to 
measure the ability of older Australian citizens to stay in the work force to the year 
2018.  Fukawa (2011) used a dynamic microsimulation model to simulate the health 
care expenditure costs on the elderly in Japan to 2050, claiming that, under various 
scenarios, these costs would increase from 8% of GDP in 2006 to near 11% in 2050, 
which appears to be an optimistic outcome. 
3.6.4 Small area population estimation 
As mentioned previously many of the studies in elderly health care have estimated 
either national models or region specific models, with no consideration of geographic 
variation. Commonly this is either because there is insufficient detail of data at smaller 
geographies to provide reliable estimates or the data set used did not actually contain 
any detailed geographic information. In planning where future demand for health care is 
likely to occur, a consideration of sub-national geographies is essential. This leads to a 
requirement that any such modelling should have a strong spatial element (Rahman et 
al., 2010). 
Whilst the England and Wales decennial population Census and some administrative 
data sets are able to provide information at a very detailed level of geography, certainly 
sufficient for health care planning, their richness in the field of health information is 
limited. Self-reported counts are available to highlight individual’s general health (on a 
five point scale) or the presence of a long term limiting illness (on a three point scale).  
Other data sources, such as HSfE and ELSA are able to provide the required richness of 
information, but unfortunately the detail of the geographic coverage is poor. To 
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overcome these limitations a range of synthesis techniques are available to augment or 
simulate a richer, small area geography data set. 
A simple approach to combining information from both these two types of data is to use 
the survey data to establish a rate of occurrence of a measure of interest by a set of 
characteristics common to both data sets (e.g. how incidence of Alzheimer’s relates to 
age and gender). These rates can then be applied to a cross tabulation of these 
characteristics from the population data set, which is available at a detailed geography, 
to arrive at a local estimate of the measure of interest. 
A slightly more sophisticated approach involves modelling the relationship between the 
measure of interest and the common characteristics. The process begins by estimating a 
relationship between the measure of interest and any common characteristics using just 
the survey data set. This model can then be used to estimate the measure of interest for 
any population that possesses these same common characteristics, at any level of 
geography. This technique was used by Scholes et al. (2007) to estimate four health 
indicators (smoking, drinking, obesity and healthy eating) for Middle layer Super 
Output Areas in England and by Schofield et al. (2012) to estimate the ease of access to 
general practitioner services in rural Australia. A similar approach for disaggregate data 
involves the estimation of choice models using the survey data and using these models 
to predict whether individuals from a population data set will have the attribute of 
interest. This approach was used by Charlton (1998) to estimate the prevalence of 
serious illness for English local authorities.  The disadvantage of this approach is that 
models have to be separately estimated for each measure of interest in the survey data.  
A further technique that is able to produce estimates of a measure of interest at a 
detailed geographic level is termed small area microsimulation (Birkin and Clarke, 1989 
and Hermes and Poulsen, 2012a). This technique attempts to allocate individuals from a 
survey data set (which has a coarse geography) to a geographic area based upon the 
commonality of various attributes. The aim is that individuals will be wholly or 
proportionally allocated to those areas whose inhabitants they have the most in common 
with. What this requires is a set of characteristics common to the survey data and the 
area in order to establish this similarity. Rather than providing one or more modelled 
measures of interest, here all the attributes of the individuals newly acquired by an area 
are then available to describe the area.  
The use of small area population synthesis methods have been used widely in the field 
of health (Brown, 2011). These techniques are able to produce synthesised local 
populations which may then be used in further modelling exercises.  Such uses include 
producing evaluations of policy interventions or projections of future populations. 
Ballas et al. (2006) used SimBritain (a national small area microsimulation model) and 
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Ballas et al. (2005) examine how health status was related to income for electoral wards 
within the City of York in northern England. The comparison was made using British 
Household Panel Survey data simulated at the ward level. Other similar health studies 
have included investigating the prevalence of obesity (Procter et al., 2008; Edwards and 
Clarke, 2009, Edwards et al., 2011); diabetes (Brown et al., 2009); people who smoke 
(Tomintz et al., 2008; Hermes and Poulsen, 2012b; and Smith et al., 2011b); care needs 
(Lymer et al., 2008, and Lymer et al., 2009) and general practitioner utilisation rates 
(Morrissey et al., 2008).  
3.6.5 Spatial microsimulations 
Many of the microsimulation models so far considered have used a national or regional 
data set to model policy interventions and demographic trends. There are a further range 
of models that attempt to model these impacts at a variety of locations, allowing for 
some geographic differentiation. Since data with the geographic detail required for such 
models is not commonly available, some small area population microsimulation may be 
required to produce the information rich base population for an area. Reviews of some 
of these models and their specific health relevance can be found in Gupta and Harding 
(2007).  
Applications of spatial microsimulation models are relatively rare. A study by Harding 
et al. (2011) used a spatial microsimulation technique to project to 2027 a population 
age structure for each of the 1,422 Statistical Local Areas in Australia. The purpose of 
these projections was to assess both the health care needs of an ageing population and 
the childcare needs of young families. Future projections of the population age 
structure, ethnicity and disability status to 2031 are presented as example outcomes 
from an (event-driven) spatial microsimulation model of electoral wards in Leeds 
described in a paper by Townend et al. (2009). 
3.6.6 Simulation 
Brailsford (2007) provides a review of simulation case studies in health care, 
concentrating on Discrete Event Simulation (DES) and Systems Dynamics (SD). A 
DES models entities (e.g. patients) as flows through a system of queues prior to 
obtaining some kind of service (e.g. treatment). Each entity has its own characteristics 
that determine its path through the system and monitoring data can be collected on the 
entity and the service units. Such DES models usually have a random or stochastic 
element that simulates the choices available to the entity. A different approach is 
adopted by SD models. Here there are no individual entities, instead groups of entities 
move through a system spending time occupied in a variety of states. Speed of 
movement is usually controlled by restrictions on this flow of individuals. Such models 
do not require a stochastic element since there is no concept of an entity taking 
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independent decisions in these models. Brailsford (2007) reviewed how these two 
models have been applied in a health care context. They considered models at 
increasing levels of scale from disease models (patients) at the lowest scale, through 
capacity planning models (medical units) and onto strategic models (whole systems). 
They found that lower level models were more common and that these tended to be 
DES models whilst models at the third level were rarer and tended to be SD models.  
Homer and Hirsch (2006) outline various systems dynamic approaches to modelling 
health care. They outline a range of suitable application areas, such as: disease and 
substance abuse epidemiology; patient flows and capacity studies. The article gives an 
example of a small hypothetical system to explore how best to deploy resources to meet 
an epidemic over a 50 year time span. The choice is between using resources to mitigate 
the complications from the disease or to fund prevention programmes. The model found 
that resources are more effectively spent on prevention rather than mitigation. The 
article refers to more comprehensive systems that are able to model wider health care 
systems, one such being Health Care Microworld (Hirsch and Immediato, 1999), which 
has been used as a training/what-if tool for American health care providers. 
3.6.7 Agent based models 
Agent based modelling is a population modelling technique that has seen application in 
a wide variety of fields (Crooks and Heppenstall, 2012 and Macal and North 2010). 
These models are implemented in software and are composed of a number of agents 
each of which represents an ‘actor’ in the system. In a health context these agents could 
be patients (with their own coded characteristics, e.g. gender, age, ethnicity); medical 
practitioners (e.g. with a speciality and cost) or health clinics or hospitals (with 
treatment specialities and capacities). Rules are then defined on now the various agents 
evolve over time and interact with other agents (of the same type or different). The 
advantages of this technique are that it: is flexible; it allows for the emergence of 
complex behaviours from a seemingly simple set of rules; it can model phenomena at 
different and multiple scales or time frames; and it may contain a notion of location or 
space that influences behaviour (Crooks et al., 2008). 
Applications in the field of health care are limited (see Auchincloss and Diez Roux, 
2008). A paper by Bilge and Saka (2006) refers to two Agent Based models, one of 
COPD prevalence and a second on the social network in a hospital department. For the 
COPD model, their simulator consisted of three elements: patients (with socio-
demographic characteristics and morbidities); health care units (providing treatments) 
and events (such as weather, flu epidemics). They were able to forecast, over a 15-20 
year time span, regional incidents of COPD on a weekly basis and claim that “[The 
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simulator] is producing plausible estimates of number of COPD patients for the 
future.” 
The study by Charfeddine and Montreuil (2010) also looks at COPD prevalence and 
contains two ‘agent-orientated’ elements. A population model firstly defines a total 
population (with various socio-demographic, clinical and life-style characteristics) that 
evolves into vulnerable, affected and registered populations (the latter being a 
population that has accessed the health care system). The second model is a health care 
delivery model consisting of agents that interact to provide care, e.g. patients; 
administrative and clinical staff. Rules define how an individual in the affected 
population accesses the agents within the health care delivery model. The model utilises 
regional data related to prevalence of COPD and the regional availability of treatment 
centres. Using the AnyLogic simulation platform the model is able to show the daily 
evolution of COPD vulnerable, affected or registered individuals and the utilisation of 
treatment centres. 
Meng et al. (2010) used agent based models to examine the daily colonisation of drug 
resistant infections in a hospital ward environment. The model incorporates a patient 
location and movement model and a patient colonisation, detection and treatment model 
and is able to model the rate of colonisation within the ward. Kanagarajah et al. (2006) 
present an agent based simulation model of the hourly use of an emergency reception 
unit in a hospital. They consider the interaction of various resources, e.g. doctors; 
nurses; treatment rooms and administrative staff and also patient arrival rates and 
spikes. Within their model, agents are able to adapt to the environment, e.g. as queues 
grow doctors spend less time on initial consultations and additional on-call doctors can 
be utilised. Outcomes are measured in terms of waiting times and resource utilisation. 
What is noticeable in a consideration of these reported studies is how few have gone 
through a formal “verification, calibration and validation” process (Crooks and 
Heppenstall, 2012) and perhaps explains why so few have been implemented 
(Brailsford et al., 2009) 
3.6.8 Summary 
This section has highlighted the range and diversity of modelling approaches. Firstly 
there are mathematical or mechanistic models that apply some formula to data to arrive 
at an outcome. Many of these models are based on the use of life tables. Secondly, 
statistical modelling is often performed in order to summarise the relationships within 
these data, and highlight the important factors that contribute to elderly health care.  
The third most often used technique is simulation. This technique is implemented in a 
variety of ways and under different titles but essentially involves representing the 
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population that is of interest and using rules to modify this population, implemented 
using the Monte-Carlo technique. The parameters of this simulation can be informed by 
expert judgement, access to relevant data or by outcomes from statistical models. 
In many cases the existing data may not be sufficiently rich to perform this modelling, 
estimation or simulation task and some initial manipulation of the data sets may be 
required. One such task is the ability to synthesise a population using a range of data 
sets that possess the required richness of both information and geography. Once this 
geographic and information rich data are available then techniques of simulation, 
(static/dynamic) microsimulation and Agent Based modelling are able to evolve the 
population and examine its interaction with health care provision. 
3.7 POPULATION PROJECTIONS 
The earlier sections of this review identified those characteristics of the population that 
have an important influence on morbidity. Whilst such a consideration is, in itself, 
essential to establishing future health care need, there is an additional requirement to 
establish the size of the population which will, potentially, experience these morbidities. 
These projections can be used to establish the size of at risk populations or to act as 
constraints on other population projection methodologies (e.g. dynamic microsimulation 
or agent based models). 
3.7.1 Official projections and variants 
The ONS is the body responsible for the production of official English population 
projections. These cohort component projections are normally produced biennially, with 
the latest estimates calculated on a 2012-base, and are broken down by age and gender. 
In the production of recent projections the ONS has been able to produce future 
projections that incorporate variations in future trends in fertility, migration and 
mortality. This means that in addition to the Principal projection, variants are also 
available (as highlighted in section 2.7). These variants are categorised as standard 
‘single component’ variants; standard ‘combination’ variants and special case variants 
(ONS, 2013a and 2013b). By way of illustration, Figure 3-5(lhs) shows the projected 
population to 2031 for a range of these variant whilst Figure 3-5 (rhs) shows the variant 
population projections expressed as the percentage of the population aged 65 and over. 
This shows a similar picture with regard to the range of the projections, with the 
estimate of the proportion of old people in the population by 2031 varying from 21.5% 
to 23.8%. Clearly, any forecast of health care need will be highly sensitive to which 
projection variant is used 
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Figure 3-5 : Variant total population projections, counts (lhs) and percentage (rhs), UK, 
2001 to 2031 
 (source : ONS,2013a and ONS, 2013b) 
3.7.2 Projections of disability 
A consideration of studies in the area of elderly health care need suggests that factors 
beyond age and gender are important: time to death, disability, socio-economic or 
socio-demographic status being some of the more prominent. Unfortunately, there are 
few readily available population projections for the population disaggregated by these 
characteristics. 
Taking time to death and disability, standard actuarial techniques are available to 
predict what proportion of an age band is likely to die within the year, denoted by the 
death-rate at age x, mx. Changes in these can be projected into the future to estimate 
what proportion of a future population is likely to die within the year (ONS, 2014e). For 
measuring disability itself, Marshall (2009) produced a set of projections to 2021 of 
disability rates for eight categories of disability, by age and gender, for each LAD.  
The POPGROUP EXCEL software (Simpson, 2004) is able to produce a range of 
population projections, of both people and households. These projections can be 
disaggregated by household composition (and hence co-habitation status) and by 
economic activity. They are also available by age bands for UK LADs. Whilst the 
software is pre-configured to produce these sets of projections as standard, there appears 
to be the functionality to produce projections by other characteristics after an investment 
of expertise and time to set up a ‘derived projection’. 
3.7.3 Projections by ethnicity 
Studies have shown that some ethnic groups are more predisposed towards certain 
morbidities than others. Given these differences it would appear that some consideration 
of the future ethnic composition of any population projection would be essential when 
establishing the prevalence of certain morbidities. Lievesley (2010) produced 
projections of the population of England and Wales by 16 ethnic groups to 2051 under 
three migration variants. Whilst not constrained to the ONS projections, the total 
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populations were see to be close to those produced by the ONS. The report notes that 
currently the ethnic population has a generally younger population profile than that of 
the population as a whole, and that this feature will impact on future predictions for 
older members of these populations beyond 2030. Other population projections for the 
ethnic population have attempted to produce projections of the ethnic composition for 
small, sub national, geographic areas. Norman et al., 2010 produce five variant 
population projections to 2051 by 16 ethnic population groupings for English LADs. 
With the variant that was designed to most closely match the methodology used by the 
ONS, TREND-EF, the geographically aggregated difference between the two 
projections was small (0.6 million) and attributable to known issues. However, for the 
other four variants, the two of the four that were benchmark projections were seen to 
produce very much smaller aggregate population projections than the ONS whilst the 
two trend projections were seen to produce slightly larger projections. Comparisons in 
this study were also made with other ethnic group projections, such as those from the 
Greater London Authority (Klodawski, 2009) (where the agreement was good) and 
those by Coleman (2010) (where the agreement was not so good).  
3.7.4 Summary 
What begins to emerge from a consideration of this topic is that population prediction is 
a challenging task and the long term outcomes are sensitive to a range of assumptions. 
The value in the variant projections is that they provide a range of alternative scenarios 
that may be used in the conduct of model sensitivity analysis. 
The challenge of prediction is made all the more difficult when there is a desire to 
disaggregate the projections by some characteristic. At best it would appear that in 
addition to age and gender only one other characteristic can be projected, with 
projections by more than three variables, especially at a local level, being unavailable. 
There may be scope to additionally incorporate some consideration of likelihood of 
death within the year, through national or regional death rate estimates and projections 
(which are already part of the methodology to produce population projections). Thus 
information on: gender; age; ethnicity and survivor status may be available. 
3.8 HEALTH CARE DELIVERY 
How to meet the health care needs of a future ageing population efficiently is as 
substantial a task as predicting what the actual demand for health care might be. 
Mayhew (2009) in section 3c, notes that “… estimating health care costs is notoriously 
difficult, because consumption of health care tends to reflect the resources available 
and not underlying need. So to constrain actual demand to these totals would require 
health improvements in combination with supply side adjustments running in 
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parallel.”. Linking both the demand and the delivery of health care is therefore 
important in establishing either. Howse (2012) highlights a need to also consider health 
care in a wider context, recognising the value of earlier interventions in life and the 
treatment of people rather diseases, in particular that “[health care services] have to get 
better at proactively seeking need rather than responding to demand, at involving 
patients in their own care, and at using alternative care settings to hospitals.”. 
Concerns and suggestions on how to “fundamentally shift” the health care delivery in 
the UK for an ageing population is provided in Oliver et al. (2014) and Mayhew and 
Rickayzen (2012). 
3.8.1 Health care organisation in England 
A summary of the previous and current structure of the demand (commissioner) and 
supply (provider) model of health care in England is provided by Roland et al. (2012). 
The paper comments on identifiable strengths and weaknesses in the previous 
arrangements and anticipates the challenges associated with a change to a model of 
general practitioner commissioning and greater competition within the health service. 
Additionally, Pollock et al. (2012) argue specifically that the move to area based CCGs 
of GPs will pose problems in the equitable allocation and monitoring of health care 
resources. Erler et al. (2011) present some issues and challenges on how primary care 
may develop, not just in England, but in the Netherlands and the USA. Challenges that 
are highlighted include an ageing population, the greater number of patients with 
complex chronic morbidities, patients with comorbidities and increases in patient 
expectations. The health systems in England and the Netherlands are characterised as 
“strong” with a well-developed and regarded primary care infrastructure. However, 
none of these systems are seen to be immune to the financial and resourcing challenges 
of an ageing population. 
3.8.2 Modelling demand and supply 
At a local level it is important to match together both the demand for health care and its 
supply. The study by Judge et al. (2010) used ELSA survey data to predict the need for 
hip and knee operations and HES data to estimate the provision for such operations. 
Using these predictions they were able to calculate for each local authority the equity of 
provision, expressed as a provision to need ratio. The highest values for this ratio were 
seen to cluster in local authorities within the South East of England, suggesting 
disproportionate over-provision of such treatments in these locations.  
Tomintz et al. (2008) use small area estimation techniques to model the residential 
location of people who smoke, thereby establishing the potential demand for smoking 
cessation services. They then use a location-allocation model to establish how well the 
existing provision of smoking cessation services meets this need and suggest more 
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optimal locations (in terms of minimum travel distances). A recent study by Morrissey 
et al. (2015) uses a similar small area estimation approach coupled with location of 
acute psychiatric facilities to establish how the access to such facilities impacted on 
individual’s own mental health. 
Many agent based models in health care are able to model simultaneously both the 
patient demand for services and the utilisation of the resources that provide the 
treatments (i.e. the hospital or clinic) (Charfeddine and Montreuil, 2010, and Bilge and 
Saka, 2006). Using this approach it is also possible to model different delivery 
frameworks and monitor their impact, which can be measured in terms of treatment 
volume and efficiency for both the users and providers. 
3.8.3 Health care innovations 
Predicting how pharmaceutical and treatment innovations may impact on the need for 
health care is problematic. One approach is to establish some historic trends in 
treatment effectiveness and project these trends into the near future. Another more 
challenging aspect is to try and imagine what new and innovative technologies may 
become available.  The report by Goldman et al. (2004) provides a table listing the 
outcome of a consideration of review material by an expert medical panel on likely 
medical breakthroughs, e.g. stem cell and genome derived treatments. The morbidities 
they considered included cardiovascular, ageing, cancer and neurological conditions. 
These breakthroughs were quantified in terms of the likelihood of them occurring 
within the next 20 years and the impact on the prevalence and severity of the morbidity.  
One other areas of potential expansion in health care are provided by: the increased use 
of technology in both the monitoring and delivery of health care (Lindeman et al., 
2011a and 2011b, Darkins et al., 2008 and Sood et al., 2007); education in drug and 
disease management (Bodenheimer et al., 2002 and Lam et al., 2011); greater assisted 
living (Audit Commission, 2004 and Department of Health, 2011) and greater 
involvement of local pharmacists in diagnosis and treatments (Barr et al., 2012). Less 
invasive medical technologies (endoscopes, MRI/CT and key hole surgery) may also 
make some medical procedures for a vulnerable elderly population more feasible (Clark 
et al., 2004), thereby increasing the number of such interventions but delivering each at 
a lower unit cost.  
3.8.4 Summary 
Whilst most of the previous sections have dealt with gaining an understanding of the 
drivers of health care demand this section has highlighted the issues around how this 
health care is delivered to meet these demands. This is a set of multi-faceted and 
complex issues. An important issue is the institutional organisation of the health care 
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system. The nature of the split between the organisations that commission health care 
(demand) and the organisations that provide the health care (supply) will define a high 
level architecture for the coordination of health care provision. For the providers there 
are a range of possible models, from a large diversified centrally located facility to more 
disparate clinics located in the community. This latter point also stresses the importance 
of establishing the local demand and supply for health care so that they can be 
effectively matched. 
A further dimension of uncertainty is around the future developments in medical and 
pharmacological technology and how this may transform the current prevalence, 
severity and treatment pathways associated with certain morbidities.   
3.9 CONCLUSION 
Past trends in the United Kingdom point to the likelihood that there will be further 
increases in the life expectancy of individuals, particularly for males, and to the extent 
that such gender differences may be eliminated. Of these extra years, past trends also 
indicate that more of this time will be spent in ill health. These trends imply an 
expansion of absolute morbidity.  
If age is the significant factor in determining health care costs then the prospect of an 
ageing population would appear to indicate that these costs and the associated need for 
medical interventions will increase substantially. If however time to death is more 
important than age then these increases in costs are likely to be more modest, with some 
of the costs ‘pushed back’ to the later years of life. Years to death, however, may not be 
the true measure of need; it may be simply acting as a proxy for an increasing state of 
disability towards the end of life. 
Gender has been found to play a role in health care need, either in differences between 
the genders or in the ability to form support mechanisms through mutual care and co-
habitation. In future, however, gender differences may no longer be a significant factor 
in explaining health care need. Ethnicity may however begin to play a more significant 
role as the size of the elderly ethnic population increases with a consequential re-
balancing of the relative occurrence of certain medical morbidities. There is also a 
distinction between the later life health outcomes for manual and non-manual 
occupations, and as the nature of the workforce changes in this regard, another re-
balancing will occur. 
Trends in a person’s lifestyle choices may increase the prevalence of some morbidities 
(e.g. increased obesity, linked to diabetes) whilst decreasing others (e.g. less smoking, 
linked to COPD). Different morbidities may also become more or less amenable to 
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enhanced or new technological and pharmaceutical interventions, which, whilst not 
offering cures, can help alleviate the symptoms of the morbidity. 
There appears to be a wealth of data available to measure health care, through access to 
administrative data sets or household surveys. Whilst many of the surveys collect 
information on disability, only a few surveys are devoted to an in-depth consideration of 
wider health care needs and use. Fortunately, some well-developed and understood 
techniques are available to allow the strengths of the two data forms to be combined. 
Much of the literature that explores the determinants of elderly health care use 
(measured primarily through cost) involves the building of mathematical or statistical 
models. Such models are well suited to identifying these determinants. Other techniques 
are, however, more suited to the exploration of future ‘what-if’ type scenarios. Such 
techniques include microsimulation (with an additional spatial consideration) and agent 
based modelling. The advantage of this latter approach is that the link between health 
care need and delivery can be explicitly modelled. 
In terms of first research question set out in Chapter 1, which is to estimate some 
measure of health care demand, this thesis will model the prevalence counts and rates 
for a range of morbidities (see section 3.4). This is in contrast to the alternative 
measures of demand such as cost of health care or general health/disability which are 
used in some studies. For planning purposes the concept of general health provides little 
guidance in distinguishing the type of care required: primary, secondary, long term or 
acute. Health care costs are also a measure which provides little specificity in terms of 
resources requirements beyond the financial, and may be an imperfect measure of health 
demand. In terms of methodology, a simulation approach is adopted in preference to a 
statistical modelling approach so that it will be possible to segment the simulated spatial 
population of the local area by its characteristics, e.g. gender, age or ethnicity, as 
required by the second research question. The availability of the spatial population also 
allows the health impacts of demographic population change to be investigated, as 
required by the third research question. 
Looking at the specific objectives, this chapter, together with the previous chapter on 
the research context has gone towards meeting the first objective of this thesis which 
was to paint a broad picture of the likely size and health condition of the elderly 
population of England and identify those factors that directly influence its health status. 
Parts of the second objective, to identify potentially useful data sources, and the third, to 
gain an understanding of the range of modelling methodologies used in this area of 
study, have also been addressed here.   
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The following chapter contains a detailed description and discussion about three sources 
of data that will be used extensively in this thesis: the 2011 population Census, ELSA 
and the ETHPOP population projections. As part of this discussion there is a 
consideration of the commonality of information between these data sets and how this 
knowledge helps to determine the extent of morbidities in the elderly population. 
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4 DATA 
The 2011 Population Census and the English Longitudinal Study of 
Ageing 
4.1 INTRODUCTION 
The three data sets that are highlighted in section 3.5 and section 3.7.3 as being of 
particular relevance for studies into the impacts of ageing in the English population are 
described in detail here. Firstly, there is the annual Censuses of Population, which 
provides a detailed and quality assured picture of the English population at a range of 
geographic scales (see sections 4.2 and 4.3). Secondly, there is ELSA which has an 
almost unique depth of information on the nature of the older population of England 
(section 4.4). Through its longitudinal nature it is able to provide information on 
participant’s changes in circumstances and how these may impact on their health status. 
The compatibility of these two data sets is explored in section 4.5. A third data set that 
was referred to in the review section on population forecasts is also relevant to this 
study. This is the ETHPOP population projections for English LADs that provide 
projections for the size of the population for a range of ethnic groups in each district. 
This data set is introduced in section 4.6. This chapter finishes with a discussion of its 
findings, in section 4.7. 
In line with the second objective in section 1.5, this chapter provides the reader with an 
introduction to these three data sets and covers the nature of each data set, their 
composition and the advantages and disadvantages that they offer. As the following 
Methodology chapter will illustrate, ELSA data are used to provide a sample population 
for use in a spatial microsimulation and in the estimation of hazard models. The Census 
data are used to construct equivalent constraint tables for the spatial microsimulation 
and to guide the revision of the original ETHPOP projections. These revised ETHPOP 
projections are used to ensure that the future population structure in each LAD evolves 
to represent changes in its demographic composition. 
4.2 2011 POPULATION CENSUS 
The twenty second UK national Census took place on Sunday the 27
th
 March, 2011. The 
primary purpose of each Census is to collect detailed information on the characteristics 
of individuals and households that are resident in the UK on the night of the Census 
(White, 2009). Each household within the United Kingdom was required to return a 
Census form, either on paper or electronically, that provided information on the 
household composition, household attributes (e.g. type of accommodation, car 
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ownership) and the characteristics of all individuals within the household (e.g. 
employment status, educational qualifications). A companion data collection exercise 
also took place for those individuals living in institutional establishments such as 
prisons and care homes. 
4.2.1 Data outputs 
The outputs from the Census come in many forms. The predominant dissemination 
format is through published tabular counts of individuals and households. These 
predefined tables are either univariate or multivariate in nature. For the 2011 Census, 
the Key Statistics (KS) and Quick Statistics (QS) versions of the tables are univariate 
and they are usually the tables that provide the most detail and are available for a wide 
range of population scales. The Detailed and Local Characteristics (DC and LC) tables 
are multivariate, presenting counts on a number of related census topics in a cross 
tabulation. Of the two, the DC tables, as implied by the name, contain categorical detail 
within each topic almost as great as that for the KS and QS tables. The DC tables are, 
however, more restricted in their population scale, typically only providing counts for 
area types with larger populations. By contrast, the LC tables provide multivariate 
counts for a full range of population scales but the compromise here is that the 
categorisation within each topic is less detailed. 
A number of different population bases are provided by the Census. The most common 
basis is the residential population of an area, i.e. those people who usually live in a 
property located within its boundaries. A further distinction is made between the 
population who are resident in private households and those resident in institutional 
establishments such as nursing homes, student halls of residence, military 
establishments or prisons. Residents in such establishments may be further classified as 
to whether they are residents as a result of their employment, e.g. they own the 
establishment (which may also be their home), or they are clients of the establishment. 
Also there are tabulations that are based on the characteristics of a household reference 
person, with the choice of which individual in the household who satisfies this 
definition being left to each household. 
After the residential basis the next most commonly used population basis is the 
workplace population in an area. This is simply the people who are in employment and 
work in the area. A third population basis is the day time population which is composed 
of the workplace population plus those who would normally be expected to be at their 
usual place of residence during the day, e.g. the retired and unemployed. The 2011 
census innovated on previous Censuses by collecting information on second residences. 
This would cover children who live at separate addresses during the week, those who 
spend time at a holiday home, or those that have a part time, work related, residence. 
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In addition to the tabulated counts described above, a sub-sample of individual records 
is provided as an output from the Census. This information is available in either a 
longitudinal or cross-sectional format. Starting with the 1971 Census, the ONS 
Longitudinal Study (ONS, 2014f) has been available for individuals in England and 
Wales. This data set links together records for individuals across a number of Censuses 
and also links in data from other ‘vital statistics’ sources, such as births, deaths and a 
limited range of health events (e.g. information from the Cancer Registry). Cross-
sectional samples of individual’s records are also available (ONS, 2014g).  
4.2.2 Geographic outputs 
In the discussion above on data outputs reference is made to the geographic areas on 
which data are reported. Within the 2011 Census there are a range of geographies that 
define these areas. Some of these areas are hierarchical, in that one level of geography 
nests within a higher geography, whilst others are completely separate and be-spoke 
geographies. The ONS provides a range of products to help navigate these geographies, 
ranging from simple look-ups between geographies to complete GIS format files (ONS, 
2015). 
4.2.2.1 OA based statistical geographies 
The basic building block of the 2011 Census reporting geographies is the Output Area 
(OA). The OA is a purely statistical construct devised for the release of Census data and 
was first used in the 2001 Census - it is not an attempt to define neighbourhoods - but 
their boundaries do respect certain administrative divisions, e.g. local authority 
boundaries. In the original design of the OAs the ideal was to have close to 125 
households within each OA, with a strict requirement that there should not be fewer 
than 40 households and, additionally, more than 100 residents (Martin et al., 2001). At 
the time of the 2011 Census ONS recognised that it was not feasible to maintain all the 
OAs created at the time of the 2001 Census. As the household population within areas 
grew and shrank, some OAs became either too large to be of sufficient detail or too 
small so as to become potentially disclosive. The strategy adopted by ONS was to use 
2011 Census returns to split those OAs identified as being too large into two or more 
new OAs and merge smaller OAs with neighbouring OAs (Cockings et al., 2011). The 
final set of 2011 Census OAs are therefore largely consistent with the 2001 versions but 
their populations were also within the desired ranges.  
In 2001 the ONS designed a further statistical geography of larger areas on which to 
report statistics termed Lower Super OAs and Middle Super OAs (LSOA and MSOA).  
The LSOA geography was constructed by the aggregation of a small number of 
neighbouring OAs, typically between 4 and 6. Similarly, the MSOA geography was 
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constructed by the aggregation of between 4 and 6 neighbouring LSOAs. There are 
2011 Census equivalents for LSOA and MSOAs. 
4.2.2.2 Administrative based geographies 
Whilst the OA geographies described above are a statistical creation, designed to remain 
stable over time, counts and measures based on alternative geographies are also 
available that reflect the organisation of political and governmental bodies. These areas 
are more likely to readily identifiable by people but the boundaries of these areas could 
easily vary over time. These areas are thus less stable than the OAs and this makes 
statistical comparisons at a local level across Censuses difficult using these 
administrative geographies. 
The most significant administrative geography within England is the local authority 
district (the LADs). There are single tier unitary authorities who have control over all 
the functions of a local authority within their area. The alternative is a two-tier structure 
consisting of an upper tier of county authorities and within each county there are a 
number of lower tier districts. In this latter case some functions are carried out by the 
district authority (e.g. housing and planning) whilst others by the county (e.g. education 
and highways). For organisation and efficiency purposes this authority structure can 
change through local government reorganisations. The tendency recently has been 
towards the creation of unitary authorities. 
Beyond the local authority there are other larger geographic entities, e.g. the former 
metropolitan counties or former government office regions, but these have no 
administrative function and counts on these geographies are largely maintained for 
continuity and convenience purposes only.  
The two remaining important administrative geographies on which 2011 Census data 
are released are the Parliamentary constituencies (both for Westminster and the 
devolved Parliaments/Assemblies) and health geographies (see below). 
4.2.3 Health geographies 
Both the 2001 and 2011 Censuses released counts for administrative areas based on 
health geographies. In the 2001 Census these were the 28 Strategic Health Authorities 
(SHA) and 304 Primary Care Organisations (PCO) in England. By the time of the 
release of 2011 Census data the health geography within England had undergone a 
major re-organisation (Shapiro, 2013). The PCOs (which latterly became Primary Care 
Trusts) were completely replaced by a set of 211 Clinical Commissioning Groups 
(CCGs); and the SHAs replaced by 25 NHS Commissioning Area Teams (NHS 
England, 2012).  
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4.2.3.1 NHS commissioning groups 
The area covered by each CCG is constructed from an aggregation of the LSOAs that 
are judged to provide a reasonable coverage of the constituent GP practice’s patient 
lists. Some CCGs span a number of LADs, particularly in rural areas, whilst more urban 
LADs contain a number of CCGs within their boundaries. There are also a limited 
number of cases where a CCG has a boundary that does not align with a LAD boundary. 
The population of these CCGs, based on the ONS 2010 population projections for 2013, 
ranges from NHS Corby with 67,800 residents through to NHS North, East and West 
Devon with 901,200 residents (NHS England, 2012). The average population is 
260,644.  
In regards to 2011 Census data, there is an almost complete release of the Local 
Characteristics tables from the 2011 Census tables available on the CCG geography. 
Tabular counts for the 25 NHS Area Commissioning teams are not provided as a 
standard release by ONS but they may be built by aggregating together the equivalent 
counts for constituent CCGs. 
4.2.3.2 Public health 
The health sector in England also has a parallel structure of public health bodies. These 
bodies have a responsibility to promoted behaviours that encourage healthy outcomes. 
There are four Public Health Regions, covering northern England, the Midlands and the 
East of England, southern England and London. The regions have a strategic view of 
the wider public health system, and work with partner organisations such as NHS 
England, LADs and health education providers to coordinate activity. Within each 
region are a number of Centres (15 in total throughout England) that mainly work with 
LADs by providing guidance and expertise. They also work with other bodies such as 
education authorities, training organisations and academic institutions to further public 
health initiatives. 
In terms of the delivery of the bulk of public health services, this rests with the LADs 
(Department of Health, 2012). The role of the authorities is to provide services in the 
three main areas that form part of the public health remit: health improvement, health 
protection and public health. They also have responsibility for some treatment services 
such as sexual health services and alcohol and drug abuse/addition services. Whilst such 
authorities had previously had some involvement in promoting public health, the newly 
introduced responsibilities represented a step change in responsibility for the authorities. 
The Local Government Association (2014) has recently published a report on how 
successfully these roles have been tackled in the first year and what lessons could be 
learnt. 
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4.2.4 Statistical disclosure control 
A legislative requirement of the Census is that it should not be possible to discover 
something previously unknown about an individual simply by examining the Census 
outputs. This desire to enforce the non-disclosive nature of the Census requires the 
implementation of a number of techniques to minimise this possibility (Shlomo, 2007). 
Commonly, these techniques can applied either pre or post-tabular. With the pre-tabular 
approach the necessary changes to these data to avoid disclosure are carried out at the 
individual level of data. The quality of these data are purposely degraded to avoid 
knowledge on one aspect of information within a sub-group of the population (e.g. 
small ethnic communities or large families) revealing other knowledge. This is 
commonly achieved by identifying such groups and: altering their data; randomly 
swapping information amongst this group; or moving households or individuals 
between neighbouring areas.  
Post-tabular techniques make changes to a table after its production but before its 
publication. One common approach is the small cell adjustment methodology (SCAM) 
(Stillwell and Duke-Williams, 2007). This methodology requires that any count in a 
table below a certain threshold should be rounded down to 0 or up to the threshold. In 
which direction the adjustment is applied is based on a Monte-Carlo probabilistic 
outcome.  
For the 2001 Census a combination of both pre- and post-tabular disclosure control was 
applied by ONS, however for the 2011 Census only pre-tabular disclosure control was 
applied. 
4.3 2011 CENSUS TABULATIONS 
The technique of spatial microsimulation used in this study requires the availability of a 
constraint population data set that covers the entire population of interest and is 
available at a useful population scale. The 2011 Census is able to provide such 
constraint tables, either as univariate (KS or QS) or multivariate (DC or LC) formats. In 
regards to which format is most suitable, Hermes and Poulsen (2012a) provides a 
thorough overview of the processes and considerations necessary when carrying out a 
spatial microsimulation. One of the recommendations is to use multivariate cross 
classification tables that capture not only the main effects of the significant determinants 
but also the interactions between these determinants.  In the current context for 
example, gender and age are thought to influence the morbidity of the older population 
but there may also be an interaction effect, where the impact of a particular morbidity as 
an individual ages varies by gender. This impact can be captured if some knowledge of 
the joint gender and age structure of a population is known. 
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Ideally these tabulations should be provided separately for both the household resident 
population and the institutionally resident population. This is not always the case, with 
tabulations of the whole population (all people) or the former group (all people in 
households) being more common. 
4.3.1 Household resident population 
The review of literature suggests that the important determinants of health care need 
amongst the older population are potentially: age, gender, general health, illness, 
ethnicity, lifestyle, wealth and income. The 2011 Census has good coverage of the first 
five of these determinants but asks no direct questions on lifestyles (e.g. diet, exercise or 
smoking); wealth (e.g. assets or savings) or income (e.g. wages or pensions). Proxies 
are available that may be correlated with these determinants. For lifestyle, counts by 
marital status, the social grade or highest level of educational qualification may act as a 
discriminatory measure capturing some aspects of an individual’s lifestyle. Tenure of 
accommodation is a strong indicator of wealth, with an implied positive wealth gradient 
starting with low wealth for those living in social/private rented accommodation, 
through mortgaged and onto owned houses. For income, social grade (again) or level of 
vehicle ownership may be useful proxies but they are not perfect in this regard. For 
example vehicle ownership also varies with the residential density of an area and the 
availability of public transport. 
4.3.2 Institutional resident population 
The nature of the institutionally resident population is complex and diverse. The first 
consideration is the type of institutional establishment. The 2011 Census provides 
counts according to a breakdown of types of establishment. Those in medical and care 
establishments comprise about forty percent of the institutional population, the rest are 
accommodated in judicial, educational or leisure settings. Within the medical category 
the significant locations for those aged 50 and older are NHS run hospitals, nursing 
homes, residential care homes (these two latter separated between local authority and 
private run homes) and housing association properties. As well as distinguishing by the 
type of establishment and the age structure of their residents, the Census also provides 
separate headcounts of staff and families resident in these establishments. The 
availability of information beyond gender and age counts in the 2011 Census for 
institutional residents is limited. Some information on general health, long term limiting 
illness, marital status, and education qualification are available. There is, obviously, no 
information on household attributes, such as tenure or vehicle ownership. 
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4.4 ENGLISH LONGITUDINAL STUDY OF AGEING 
ELSA was established as a study of the English population aged 50 and older who were 
resident in a private household during the period 2002 to 2003. The survey is half 
funded by a consortium of UK Government departments and half by the National 
Institute on Aging in the US. The purpose of the survey is to examine the lifestyles of 
the ageing population of England in order to better understand the impact of this 
changing demographic. This interest is not just limited to physical and psychological 
health outcomes but involves a range of objective and subjective measures concerning: 
household and participant demographics, work and pensions, income and assets, 
housing and social participation. 
It is designed as a longitudinal survey in that it attempts to re-contact the same 
participants through time, measured as survey waves. The aim of the survey is to collect 
information on complete households where one of the members of the household is 
aged 50 or older. The core participants, who are followed up at subsequent waves, are 
those who are aged 50 or older within the household and have provided a baseline 
survey at their initial contact wave. Information is also collected on the other members 
of these households but, unless they qualify later as new core members, they are not 
necessarily followed up at subsequent waves if they move out of the core participant’s 
household.  
The first survey wave of ELSA surveys took place from March 2002 to March 2003 and 
recruited eligible participants from the 1998, 1999 and 2001 HSfE. The interview 
period for each subsequent wave is given in Table 4-1. Wave 1 data was made available 
in 2004. Subsequent waves were reported every two years, i.e. 2006, 2008, 2010, 2012 
and 2014, currently providing six waves of data.  
Table 4-1 : ELSA survey periods 
 
Survey Period 
Start date End date 
Wave 1 March 2002 March 2003 
Wave 2 June 2004 July 2005 
Wave 3 May 2006 August 2007 
Wave 4 June 2008 July 2009 
Wave 5 July 2010 June 2011 
Wave 6 May 2012 June 2013 
Source : ELSA Main Reports (Institute for Fiscal Studies, 2015a) 
Ideally, on visiting the household the interviewer attempts an interview with each 
participant in person. The interview is primarily conducted face-to-face and is computer 
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assisted. There is also a self-completion questionnaire that the participant completes in 
private, on the same occasion as the face-to-face interview. Where it is not possible to 
conduct the interview in person (the participant may be in poor health, absent from 
home or died) then a proxy interview is conducted with a nominated individual. 
Periodically the main interview survey is supplemented with other surveys. The most 
important of these are a nurse visit to collect biomarker data from the participant, e.g. 
physical body dimensions; health related physical performance; blood and saliva 
samples. These visits are conducted at even numbered waves for those participants who 
have consented to such visits, so currently there have been such visits at waves 2, 4 and 
6. Aside from these nurse visits, during wave 3 core participants were asked to complete 
a life history questionnaire that captured significant events in their lives before their 
enrolment in ELSA (Wood, 2011). This survey asked the participant to provide 
information on their marriage history, places of residence, working patterns and child 
rearing. Also information was collected on overall health behaviours, e.g. if and when 
they started smoking. 
4.4.1 Survey size (cross-sectional) 
Like any longitudinal survey, ELSA may also be regarded as a series of cross-sectional 
surveys. Whilst the use of such surveys as cross-sectional data sets is not ideal - they 
suffer from selection bias (through attrition) and are typically of a smaller size due to 
the expense of such surveys (Scholes et al, 2009) - they can be of use to analysts. For 
each ELSA wave, Table 4-2 list the (unweighted) achieved sample size for the wave. 
Typically each wave consists of around 10,000 interviews.  
Table 4-2 : Cross sectional size of ELSA survey at each wave 
 In person By proxy 
Full 
interview 
Partial 
interview 
Institutional 
interview 
Full 
interview 
Partial 
interview 
Institutional 
interview 
Wave 1 11,709 215 (Note 1) 171 4 (Note 1) 
Wave 2 9,265 42 (Note 2) 123 2 (Note 2) 
Wave 3 9,431 93 15 199 0 33 
Wave 4 10,532 58 14 389 3 54 
Wave 5 9,623 102 12 472 5 60 
Wave 6 9,923 52 12 550 1 63 
Notes: 
1 - All wave 1 participants are resident in a household; 
2 - At wave 2 there is no distinction between interviews in person or by proxy for institutional residents, 
but the total number of institutional interviews is 54. 
Source : Tabulated from individual wave core data files using each wave’s individual outcome 
variable. 
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To facilitate the cross-sectional analysis of ELSA, the National Centre for Social 
Research provides a set of cross-sectional weights to correct for non-survey response at 
each wave (Cheshire et al, 2012). Since it is the longitudinal nature of ELSA that is of 
interest here, no more will be said about the cross-sectional nature of the survey. 
4.4.2 ELSA composition 
To fully understand the size and complexity of longitudinal nature of ELSA requires an 
understanding of various concepts and contexts. What is presented here is a distillation 
of these concepts, a fuller picture is available in the various wave Technical Reports 
(Institute for Fiscal Studies, 2015b).  
Within ELSA there are four cohorts. The first cohort was recruited from the 1998, 1999 
and 2001 HSfE and participated in ELSA wave 1. The next cohort was a refreshment 
cohort and they were recruited at wave 3 by virtue of their 2001 to 2004 HSfE 
participation if they were about to become 50 to 54 years old at wave 3 (this age range 
ensures that ELSA still represented all ages of 50 and above). A further cohort was 
recruited at wave 4 from 2006 HSfE participants aged 50 to 51 to refresh the sample and 
also to top-up the sample using HSfE participants aged 52 to 74. The final cohort was 
constructed in a similar manner to the second, its purpose to ensure that at wave 6 the 
age range for ELSA still included a suitable number of those aged 50 to 54. 
Each cohort is composed of a range of different types of participant. The most important 
are the core members. These are participants who are aged 50 years or older, 
volunteered to be part of ELSA, gave an ELSA baseline interview at their initial wave 
and were not living in an institution. These people are variously described as cohort 1 
core members (C1CM); cohort 3 core members (C3CM); cohort 4 core members 
(C4CM) or cohort 6 core members (C6CM). Strenuous efforts are made to ensure that 
Core members are contacted and interviewed at every possible subsequent wave.  
Associated with the core members are other ELSA participants who are usually living in 
the same household as the core member, but are not eligible to be core members. They 
are termed as core partners, younger partners or core sample members. Core partners 
are participants who are living with a core member and would be eligible to participate 
in ELSA but they did not provide an ELSA interview at their first wave, so they are 
unable to provide a baseline. These participants are termed cohort 1 core partners 
(C1CP), cohort 3 core partners (C3CP), cohort 4 core partners (C4CP) or cohort 6 core 
partners (C6CP). Interviews are attempted with them whilst they are still a partner of a 
core member but if they are no longer a partner of the core member then an attempt at 
an ‘exit’ interview is made, in person or in proxy, and they are not followed at waves 
subsequent to this exit. Younger partners are similar to core partners but by virtue of 
their age (i.e. they are younger than 50 years of age) they do not qualify as a core 
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member or partner. Like core partners, they are surveyed until they exit from the 
sample. They are termed C1YP, C3YP, C4YP and C6YP. Core sample members are 
also similar to core partners but they refuse to participate in any wave of ELSA and 
only limited information is known about them, e.g. gender, age and year of death. They 
are termed C1SM, C3SM, C4SM or C6SM. 
As well as participants leaving an eligible household, individuals may also join a 
household that contains a core member. They are considered new partners of these core 
members. They can be introduced into the ELSA sample at any of the waves and this is 
designated in their type coding. New partners of cohort 1 core members at wave 1 (i.e. 
they joined the core member after the core member’s HSfE interview but before ELSA 
wave 1 interview) are termed cohort 1 new partners at wave 1 (C1NP1). Similarly 
partners who joined a cohort 1 core member after wave 1 but before wave 2 are termed 
cohort 1 new partner at wave 2 (C1NP2). By extension there are also new partners 
termed C1NP3; C1NP4; C1NP5 and C1NP6 for subsequent partners of cohort 1 core 
members. The natural extension to this are the new partners of cohorts 3; 4 and 6 core 
members, these are termed C3NP3; C3NP4; C3NP5; C3NP6 and C4NP4; C4NP5; 
C4NP6 and C6NP6. 
A type of participant introduced for cohorts 3; 4 and 6 are the older partners of cohort 3; 
cohort 4 and cohort 6 members, who are designated C3OP; C4OP and C6OP. The final 
category of individual are those who are non-eligible to be part of ELSA (i.e. they are 
not a sample member or a partner of a core member) and are not surveyed but like, 
sample members, there is some limited information available about them. These 
individuals tend to be of a different, younger, generation to the core member.  
It is rare, but possible that participants in ELSA may change their type, e.g. at wave 3 
some 104 participants who were classified as C1YP were reclassified as C3CM at 
subsequent waves since they were, at that stage, 50 years of age or older, in an ELSA 
household and had  a productive baseline interview at wave 3.  
The number of participants within each of these categories at wave 6 is given in Table 
4-3. The largest group in the survey are the cohort 1 core members. The next biggest 
group are the sample members at wave 1, those who are resident in a core member’s 
household but refused to take part in the survey. 
This rather complex designation structure in ELSA is there to provide flexibility on who 
should and should not be included in any analysis. In most analysis it is the core 
members that are of most value, but information on partners may also be of some value, 
even if this is only provided by virtue of their association with the core member. Also 
with partners, the distinction between (ordinary) partners, younger or older partners may 
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also be important. Such complex participation designations are not uncommon in 
longitudinal surveys. The British Household Panel Survey and its successor, 
Understanding Society, also have rules concerning different types of panel members and 
how they are treated for follow up at subsequent waves, e.g. Original Sample Members 
(OSM) vs Temporary Sample Members (TSM) (Buck and McFall, 2012). 
Table 4-3 : Final response status after wave 6 
Core Members   Core member Older Partner 
C1CM 11,391 
 
C1OP  (Note 1) 
C3CM 1,276 
 
C3OP 325 
C4CM 2,290 
 
C4OP 298 
C6CM 826 
 
C6OP 144 
Core member Partners 
 
Core member New Partners 
C1CP 366 
 
C1NP1 106 
C3CP 31 
 
C1NP2 58 
C4CP 64 
 
C1NP3 41 
C6CP 28 
 
C1NP4 26 
Core member Younger Partners 
 
C1NP5 14 
C1YP 1,147 
 
C1NP6 10 
C3YP 569 
 
C3NP3 34 
C4YP 236 
 
C3NP4 18 
C6YP 146 
 
C3NP5 16 
Core member Sample Members 
 
C3NP6 3 
C1SM 8,148 
 
C4NP4 24 
C3SM 1,228 
 
C4NP5 16 
C4SM 1,380 
 
C4NP6 7 
C6SM  (Note 2) 
 
C6NP6 10 
    
 
    
Not eligible (Note 3) 8,836   TOTAL 39,112 
Notes: 
1 - C1OP are interviewed as Core or Sample Members at wave 1; 
2 - Data to derive this count is not available; 
3 - Not a sample member or partner. 
Source : Tabulated from the wave 0 to 5 index file and the wave 6 core data file using the final 
status of respondent variable. 
4.4.3 ELSA attrition 
Table 4-3 provides a picture of the make-up of the ELSA sample in terms of their 
recruitment into the survey and the type of participation that they provide. Separate to 
this is the pattern of their participation at each wave.  
Reasons for non-participation or response at a wave can be a result of known events 
such as a death or a move out of England. In such cases an ‘exit’ interview is attempted, 
either with the individual concerned or, in the event of death, with a nominated 
survivor. Other reasons for non-response for a survey member can be a refusal to 
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participate, protracted illness during the interview period or they become un-
contactable. Figure 4-1 below shows the contact pattern for cohort 1 core members 
(C1CM). In this coding, where there is a numeral in place at position i then this 
indicates participation at wave i.  Where there is an X at position i, then this indicates a 
non-response at the wave. Thus the pattern 1 2 3 signifies that at wave 3 there are full 
responses at all three waves, whilst 1 2 3 4 5 6 at wave 6 indicates full responses at 
waves 1 to 6. The pattern 1 2 3 X at wave 4 signifies a response at waves 1, 2 and 3 but 
no response at wave 4 and the pattern 1 X 3 X 5 at wave 5 indicates responses at waves 
1, 3, and 5 but no responses at waves 2 and 4. In these figures only the largest patterns 
of response have been labelled and only where space permits. 
Figure 4-1 shows that the number of cohort 1 core members who completed an 
interview at all waves (coded without an X) has decreased gradually from wave to wave 
so that at wave 6 just over 40% of the original cohort 1 core members have fully 
participated in all waves.  The next most common pattern is of participants contributing 
up to a particular wave and then not participating subsequently (e.g. there are 1,988 
participants who only complete wave 1 and are never interviewed again). There are also 
a small number of participants who do not provide a responses at a particular wave but 
do return at a subsequent wave, e.g. 229 people respond at waves 1, 2, 3, and 5 but not 
at wave 4 (pattern 1 2 3 X 5).  
 
Figure 4-1 : Pattern of participation across six waves by cohort 1 core members 
Source : Tabulated from the wave 0 to 5 index file and the wave 6 core data file using the 
individual outcome variable. 
Similar tables and figures are provided for cohort 3 and 4 core members.  Figure 4-2 
shows this pattern for cohort 3 core members and Figure 4-3 shows this for cohort 4 
core members. In Figure 4-2 the retention rate for cohort 3 core members for two 
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subsequent waves is similar to that in Figure 4-1, 76% provide responses for the first 
two waves and 67% provide responses for the first three waves, whilst a slightly 
improved percentage here of 61% provide responses at all four subsequent waves. The 
retention rate in Figure 4-3 for cohort 4 core members is greater for the two subsequent 
waves, at 84% and 75%, than the two preceding cohorts. 
The National Centre for Social Research provides a set of longitudinal weights at each 
wave (Cheshire et al, 2012). At wave 6, the purpose of these weights is to ensure that 
the 42% of cohort 1 core members who responded from waves 1 to 6, when weighted, 
are representative of all the cohort 1 core members. These weights are therefore able to 
correct to some degree the impact of attrition across the waves. Such attrition weights 
are only provided for cohort 1 core members who responded at all waves and as such 
this weighted sample probably provides the most representative longitudinal sample 
within ELSA. In the statistical analysis that is reported here, it is these weighted cohort 
1 core members who are of most interest. 
 
Figure 4-2 : Pattern of participation across four waves by cohort 3 core members 
Source : Tabulated from the wave 0 to 5 index file and the wave 6 core data file using the 
individual outcome variable. 
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Figure 4-3 : Pattern of participation across three waves by cohort 4 core members 
Source : Tabulated from the wave 0 to 5 index file and the wave 6 core data file using the 
individual outcome variable. 
4.4.4 Institutional residents 
One condition of recruitment into ELSA is that the participant is resident in a household 
and not in an institution (e.g. a nursing home). Thus, at wave 1, no cohort 1 core 
members are living in an institution, and at wave 3, no cohort 3 core members are living 
in an institution, etcetera for wave 4 and 6 core members.  At subsequent waves 
however core members who have moved to become a resident in an institution are 
interviewed. In these cases the interview is still conducted in person by the interviewer 
visiting the institution or, if this is not possible, by proxy with a nominated individual. 
These interviews are attempted at all subsequent waves even if the respondent is still 
living in an institution. Non-core members who move into an institution are surveyed 
one last time as an ‘exit’ interview.  
Whilst ELSA is to be commended for actively collecting data from institutional 
residents (Moore and Hanratty, 2013), the number of productive interviews from 
institutional residents is low. Table 4-4 shows the number of responses from 
institutional residents. The coding here is similar to that above except X now includes a 
response outside an institutional setting, as well as refusals and ineligibility. A numeral 
at position i indicates a productive interview with someone in an institutional setting at 
wave i. All the patterns start with an X at position 1 since people cannot be recruited 
into ELSA at wave 1 if they are resident in an institution. 
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Table 4-4 : Pattern of productive institutional interviews 
Pattern Count  
X 2 3 4 5 X 1 
X 2 3 4 X X 2 
X 2 3 X X X 9 
X 2 X 4 X X 1 
X 2 X X X X 41 
X X 3 4 5 6 1 
X X 3 4 5 X 1 
X X 3 4 X 6 1 
X X 3 4 X X 10 
X X 3 X 5 X 1 
X X 3 X X X 21 
X X X 4 5 6 7 
X X X 4 5 X 14 
X X X 4 X X 30 
X X X X 5 6 19 
X X X X 5 X 28 
X X X X X 6 47 
X X X X X X 37,704 
Total 37,938 
Source : Tabulated from individual wave core data files using each wave’s individual outcome 
variable 
There is no one who was interviewed in a household at the first wave and then spent all 
the subsequent waves in an institution (would be coded as X 2 3 4 5 6).  Institutional 
interviews become more common at later waves. 
4.4.5 Health in ELSA 
ELSA is a large data set containing over 5,700 variables of original content; content fed 
forward from the previous waves; and some derived information. About 700 of these 
questions directly relate to self-reported health status and outcomes.  In the health 
outcome sections of the wave reports that accompany the release of each wave’s data, 
the commonly reported prevalences for a subset of health morbidities that affect the 50 
years and older population are provided (Institute for Fiscal Studies, 2012). The 
morbidities are: coronary heart disease; diabetes; cancer; respiratory illness; arthritis and 
depression. The definition used for prevalence is, “Respondents were asked whether a 
doctor had ever told them that they suffered from any of the following conditions: 
coronary heart disease (angina or myocardial infarction), diabetes, cancer, 
respiratory illness (asthma or pulmonary disease), arthritis and depression.” (my 
bold emphasis). The definition of diabetes also includes the presence of high blood 
sugar and the definition for arthritis includes osteoarthritis, rheumatoid arthritis and 
other kinds of arthritis.  
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At wave 1 there is a simple coding of a range of variables that enumerate whether a 
participant has one or more of these morbidities. For waves 2 to 5 the standard logic 
used to establish if the respondent has a morbidity uses a combination of the 
respondent’s reply for this morbidity at the previous wave (if such a reply exists) and 
whether, when prompted, they mention that the morbidity has been newly diagnosed 
since the previous wave.  This is termed ‘dependent interviewing’ and allows the 
presence of a morbidity to be established without having to make explicit reference to 
the participant’s history of diagnosis at all previous waves. 
There are, however, three exceptions to this rule in the published prevalences. Firstly, 
for depression no information is fed forward, instead reliance is placed on a single 
question at each wave as to whether they currently have depression. Secondly, the 
published figure for diabetes in wave 2, the diagnosis depends on the answer to a single 
question as to whether the participant has ever been told by a doctor that they have 
diabetes, with no feed forward information used and no explicit reference to high blood 
sugars. Finally, for reported wave 6 prevalence rates a participant was recorded as 
having a morbidity if this information had been feed forward or newly diagnosed at any 
previous wave, not just the previous wave. This requires an explicit reference back to 
the participant’s diagnosis history at all previous waves. The prevalences reported in the 
ELSA Reports are crude rates and not standardised to any standard population profile 
(Bains, 1990). 
4.4.6 Re-producing ELSA prevalences 
Using the ELSA data sets and the logic outline above, it is possible to reproduce the 
majority of the published prevalences reported in the ELSA wave reports. There are 
three exceptions: 
• For cancer in wave 2, there was an error in the syntax code provided by the ELSA 
team. This error meant newly diagnosed cancer cases were not counted. Here the 
error is corrected. 
• For diabetes or high blood sugar in wave 2, the ELSA team used the response to the 
single question asking “Whether ever been told has diabetes by doctor”. Here 
instead the wave 2 to 5 logic of feed forward plus newly diagnosed cases is used, and 
high blood sugar is included in the diagnosis. 
• For arthritis in waves 4 and 5, the wave 2 to 5 logic is used but the published rates 
are not re-producible. There is no available explanation or validation of this finding 
from the ELSA team. 
The differences between the published prevalences and those calculated here are shown 
in Table 4-5. The Published rows are the prevalences in the appropriate wave report 
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whilst the Revised rows show the re-calculation using corrected syntax (cancer at wave 
2) or the feed-forward plus new cases logic (the rest). 
Table 4-5 : Reported ELSA and revised prevalence percentage rates for those waves and 
morbidities where they are different 
Wave and 
morbidity 
Gender Source 50/52 
to 54 
55 to 
59 
60 to 
64 
65 to 
69 
70 to 
74 
75 to 
79 
80 
plus 
Total 
Wave 2 
Diabetes 
Males 
Published 5.0 6.8 7.3 11.6 13.9 14.4 10.3 9.5 
Revised 5.4 6.5 6.6 10.5 12.2 12.9 8.6 8.7 
Females 
Published 2.9 3.9 6.8 7.0 9.8 10.2 9.0 7.0 
Revised 3.2 3.3 6.2 5.9 8.2 7.6 7.4 5.9 
Wave 2 
Cancer 
Males 
Published 1.7 2.0 3.7 5.7 6.7 8.3 6.8 4.6 
Revised 2.0 3.1 5.6 8.4 10.3 11.3 9.7 6.8 
Females 
Published 3.4 5.7 7.9 6.8 6.1 8.0 7.6 6.6 
Revised 3.9 7.2 9.6 8.4 8.7 10.6 9.0 8.4 
Wave 4 
Arthritis 
Males 
Published 15.3 18.1 25.8 27.7 30.8 20.6 38.8 24.9 
Revised 17.5 19.0 28.1 29.9 33.7 33.0 42.3 27.2 
Females 
Published 23.3 31.8 38.9 42.2 47.7 52.4 53.1 39.9 
Revised 24.7 32.9 41.1 44.2 50.2 56.2 56.9 42.4 
Wave 5 
Arthritis 
Males 
Published 13.5 18.1 27.2 29.0 33.5 35.5 38.1 27.6 
Revised 15.8 20.3 28.8 30.9 35.7 38.0 41.9 30.9 
Females 
Published 25.1 30.7 39.0 45.6 49.8 54.2 57.5 43.5 
Revised 26.3 32.3 41.1 47.4 51.4 57.7 60.3 45.8 
Source : Published rates are taken from ELSA Main reports (Institute for Fiscal Studies, 2015a) 
whilst the Revised rates are derived using feed forward and newly reported diagnosis 
information in each wave’s core data file 
The newly calculated cancer prevalences are always higher than those published since 
they now account for new cases since wave 1. There is also an expectation that, since 
the calculated rates for diabetes at wave 2 now include a diagnosis of high blood sugars, 
the calculated prevalences would also be higher. This is not the case and may be 
explained by a fault in the feeding forward of wave 1 information to wave 2 (see next 
section). The revised arthritis rates are consistently higher than those published. 
4.4.7 Feed forward mechanism in ELSA 
If participants are consistent in their recollections and the interviewing technology is 
correctly configured to record these recollections, then the dependent interviewing 
techniques is ideal. It reduces the recall burden on the interviewee and allows the 
current health diagnosis status of the participant to be known at any wave by examining 
just two pieces of information that accompany the wave. Unfortunately circumstances 
are not always ideal. 
There is evidence in the diagnosis pattern for certain morbidities of a systematic failing 
that has the potential to affect the prevalence rate. Looking at the logic to establish when 
a participant acquires a morbidity, it is clear that it is not possible for a participant to be 
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cured of a morbidity (and also consequently, they should not relapse back into the 
morbidity). However, there are a number of instances where this does actually occur. In 
particular there is a pattern of participants acquiring a morbidity at wave 1, appearing 
not to have the morbidity at wave 2, and then re-acquiring the morbidity at subsequent 
waves. Contact with researchers at the National Centre for Social Research revealed that 
there were issues with certain morbidities not being fed forward for some participants 
between waves 1 and 2.  
To explore this further, the individual diagnosis pattern for CHD, using the same logic 
as that used to reproduce the published prevalence rates, is constructed for each 
participant from waves 1 to 5. Wave 6 is not included in this examination of the feed 
forward logic since the logic to define the diagnosis of a morbidity changed at wave 
6.The pattern adopted to represent the history of diagnosis is similar to that for 
participation and institutional residence. If a participant has the diagnosis of CHD at 
wave i, the numeral at position i is set to be the wave number. If they do not have CHD 
at wave i then the character at position i is N. If they did not participate at wave i then 
the character at position i is X. Thus a pattern of N N 3 4 5 represents someone who 
participated in all waves and was first diagnosed with CHD at wave 3. The pattern 
N X N 4 5 is someone who participated in all waves except wave 2 and was diagnosed 
with CHD at wave 4. Clearly if the logic of dependant interviewing is correct and the 
participant is consistent in their responses across waves, a pattern where an N follows a 
numeral is not possible - once someone has the morbidity then that information should 
be feed forward to all subsequent waves. Such a pattern where an N follows a numeral 
reveals a false negative. For the CHD diagnosis there are a number of these false 
negative patterns. The top ten such patterns by their frequency are shown in Table 4-6 
along with the total number of participants with such a false negative pattern. 
Table 4-6 : Frequency of occurrence for the ten most common false negative patterns 
 Pattern Frequency 
1 N 3 4 5 144 
1 N X X X 72 
1 N 3 X X 56 
1 N 3 4 X 36 
1 N 3 N N 19 
1 2 N N N 18 
1 N 3 N 5 14 
N 2 3 N N 12 
1 2 3 N N 10 
1 2 N N 5 9 
Total 507 
Source : Derived using feed forward and newly reported diagnosis information from each 
wave’s core data file. 
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This table identifies 144 participants who had CHD at wave 1, ‘recovered’ at wave 2 
and then had CHD for the remaining three waves. Looking at these patterns, there is 
clearly something systematic that is causing a diagnosis at wave 1 of CHD to be 
forgotten at wave 2 before being recorded at wave 3 and thereafter. There also appears 
to be other issues at subsequent waves. 
The task is therefore to try and reconcile the irreconcilable or gain a true as possible 
picture of the participant’s pattern of morbidity diagnosis. The method adopted here is a 
modification of that adopted for the wave 6 report. In that method a participant has a 
diagnosis at wave 6 if at any wave from 1 to 6, the morbidity was fed forward or 
recorded as a new diagnosis. Of the two pieces of information, the feed forward would 
appear to be the least reliable, leading to a number of false negatives in the diagnosis. 
Therefore here the feed forward information is not used. Thus a participant has the 
morbidity at wave i if they have reported a new diagnosis of the morbidity at any wave 
up to and including wave i. Using this new definition, all the top ten patterns in Table 
4-1, (except the pattern N 2 3 N N) are re-defined as having a CHD diagnosis at all 
waves (1 2 3 4 5), since the wave 1 diagnosis feeds forward to all subsequent waves. 
The 12 participants with the pattern N 2 3 N N have a diagnosis of CHD starting at wave 
2 and become N 2 3 4 5. This is exactly how the feed forward mechanism should 
operate.  
A calculation of the prevalence rates at wave 6 using the wave 6 report methodology 
(which takes account of feed forward information at all waves) and the methodology 
adopted here (which ignores all feed forward information) shows that only for CHD is 
there a difference in the rates at wave 6. These differences are reported in Table 4-7. 
Table 4-7 : Comparison of ELSA wave 6 prevalences and those calculated using the 
revised methodology 
Wave and 
morbidity 
Gender Source 50-
54 
55-
59 
60-
64 
65-
69 
70-
74 
75-
79 
80+ Total 
Wave 6 
CHD 
Men 
ELSA 2.2 8.2 11.9 18.1 24.3 25.9 38.5 15.7 
Revised 2.2 5.7 9.3 14.3 19.1 19.7 31.2 12.4 
Females 
ELSA 1.3 3.4 5.8 9.1 13.7 21.1 29.6 10.8 
Revised 1.3 2.4 4.1 6.5 10.2 15.3 25.0 8.4 
Source : ELSA rates are taken from ELSA wave 6 main report (The Institute for Fiscal Studies, 
2015) whilst the Revised rates are derived using only newly reported diagnosis information in 
each wave’s core data file 
Incorporating the fed forward information for CHD shows that there are also some false 
positives at previous waves. An examination of instances where there is a record of 
CHD being fed forward from the previous wave but there is no evidence of CHD at any 
previous wave (either as new diagnosis or feed forward) reveals issues at wave 5. Table 
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4-8 shows that there are nearly 240 participants who have CHD fed forward at the two 
later waves (5 and 6) but have no previous diagnosis of CHD. 
Table 4-8 : Instances where diagnosis information is falsely fed forward 
Circumstance Count 
Fed forward at wave 5 but no new diagnosis at waves 1 to 4 195 
Fed forward at waves 5 and 6 but no new diagnosis at waves 1 to 5 40 
Fed forward at wave 6 but no new diagnosis at waves 1 to 5 4 
Source : Derived from the waves diagnosis fed forward and newly diagnosed variables in the 
core data files. 
Given the ability to reproduce the published wave 6 prevalences for the other four 
morbidities implies that there are no issues of false positives with these other 
morbidities.  
Correspondence with those responsible for producing the wave 6 prevalences on this 
issue has once again raised concerns over the accuracy of the feed forward information, 
both in generating false negatives and false positives. This re-enforces the rationale 
behind ignoring the feed forward information in establishing the diagnosis of a 
morbidity. More generally it emphasises the importance of understanding these data and 
the generating mechanisms within these data and being able to validate the operation (or 
otherwise) of the mechanism.  
4.4.8 Geography in ELSA 
The standard version of ELSA data only identifies the (now abolished) Government 
Office Region of residence for the participant. The reason for this is to avoid 
inadvertently disclosing the identity of the participant through a combination of 
geographic and demographic information. It is however possible to make a special 
request for a subset of geographic information that can be linked to the participant 
without necessarily disclosing their identity. The level of disclosure risk is classified 
from Low, to High and onto Very High. The example provided of Very Highly 
disclosive geographic information is the OA in which the participant lives. Examples of 
Highly disclosive information are a post code sector; the 2003 statistical ward of 
residence and the index of multiple deprivation for the LSOA in which the participant 
lives. Such data are not commonly made available to researchers outside a secure 
setting. Information that is of low disclosivity can, however, be requested. This 
information includes the local authority of residence; quintiles of postcode population 
density; quintile of index of deprivation and type of area (urban or rural). 
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4.5 COMPATIBILITY OF 2011 CENSUS AND ELSA WAVE 5 
As part of this study it is necessary to link together information from the 2011 Census 
and ELSA to carry out a spatial microsimulation. This is achieved by defining a 
population base and identifying information that is in common to both surveys. There is 
some merit in trying to replicate a population at a household level, especially when the 
composition of such households can have an important impact on matters such as 
wealth, income and health. As mentioned earlier there are some tabulations from the 
census that describe each LAD in terms of the characteristics of its households, for 
example table DC4201 provides a count of “Tenure by ethnic group by age - Household 
Reference Persons” however this count is just of the ethic group of the household 
reference person, no other family members are included in this table. Census tables on 
“Families” also have issues in that they do not allow the segmentation of the 50 year 
and older population and they are primarily concerned with the characterisation of 
dependent children within the family. Even if it were possible to usefully construct a 
picture of a LAD’s households on all the potentially useful characteristics there may be 
issues with constructing and equivalent study population from within ELSA. Recall that 
whilst ELSA is in essence a household survey it is possible that not everyone in the 
household will be surveyed to the required degree. In particular there are sample 
members (SM) within households, for whom very little information is known, and it 
would be difficult to use such members to complete a household with some desired 
characteristics. These issues on both the Census and ELSA side lead to a move toward a 
methodology that matched individuals rather than households between the two data sets.   
For this association of individual information between both the Census and ELSA to be 
successful it is important that the degree of compatibility in how these attributes are 
recorded in each survey is understood. Usefully, age and gender are defined in the same 
way in both data sets. 
The Census contains two questions directly related to health: an assessment of general 
health and the presence of a limiting long term illness. Both the Census and ELSA use a 
5-point scale for rating general health, but the descriptive text associated with the scales 
are different. The Census allows the individual to choose one of: very good; good; fair; 
bad; or very bad, in rating their general health whilst the ELSA participant has a choice 
of: excellent; very good; good; fair; or poor.  The obvious approach to harmonising 
these two scales is by merging together adjacent categories but is not always straight 
forward (Smith and White, 2009). 
There is also a discrepancy in how information on the presence of a limiting long term 
illness is recorded in each data set. The Census has three possible responses: limited a 
lot; limited a little and not limited, whilst ELSA asks a two part question - if they have a 
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long term illness and, if so, is this illness limiting? Again there are issues on how to 
harmonise these two questions. Clearly those with no limiting long term illness or those 
whose illness limits them a lot are easy to reconcile between the two surveys. However, 
should those who describe their illness as limiting them a little in the Census be classed 
as someone with or without a long term limiting illness in the ELSA sense? Here, there 
is an assumption that even though the reported limitation in the Census is not severe it is 
still a limitation and as such is grouped with those who are limited a lot. 
The Census has a broad list of sixteen different ethnic groups. The range of ethnic 
groups in ELSA is, however, more limited. Each wave contains an indication as to 
whether the participant’s ethnicity is white or non-white (i.e. Black or Minority Ethnic, 
BME). Wave 5 however, contains feed forward information on ethnicity with a broader 
range of 7 classes: White, Mixed, Black, Black British, Asian, Asian British and any 
other group. The wave 5 questionnaire document (NATCEN, 2012) clarifies further that 
Asian covers Indian; Pakistani; Bangladeshi and African-Indian whilst ‘Any other’ 
includes Chinese, Japanese, Philippino and Vietnamese. It is therefore possible to 
reconcile the ethnicity coding of the two data sets to a consistent five class ethnicity 
classification of: White, Mixed, Black, Asian or Other (including Chinese). 
Education is categorised using slightly different philosophies in the two data sets. The 
Census defines a set of four levels of highest education plus having no qualifications 
and an ‘other’ category. Actual qualifications are split between levels, e.g. having 1 to 4 
O levels/GCSEs is Level 1 whilst having five or more is Level 2. In ELSA, however, 
the highest education is solely determined by the type of qualification, e.g. having any 
number of O level/GCSE qualifications yields the same highest qualification 
categorisation. Thus categories of qualification as defined in ELSA span categories as 
defined in the Census. However, it is possible to reconcile these categories into one of 
four categories: no qualifications, qualification below degree level, degree level or 
higher qualification and foreign/other qualification. 
The National Statistics socio-economic classification (NS-SEC) is a well-defined and 
utilised categorisation of an individual based on their current or past employment. The 
Census publishes counts according to the 8-class scheme with class 1 (Higher 
managerial, administrative and professional occupations) further divided into two sub 
classes and the 8
th
 class (never worked and full time unemployed) split into three sub 
classes. ELSA has NS-SEC coded as the long form ‘Operational categories and sub-
categories classes’ and from this the 8-; 5-; and 3-class ‘Analytical classes’ are derived. 
Therefore there is a good agreement for this attribute in both data sets. 
In terms of the provision of unpaid care to other people, the Census categorises the 
amount of such care by its duration, using categories of 1 to 19 hours; 20 to 49 hours 
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and more than 50 hours, plus a count of those who do not provide any care. In ELSA 
the amount of unpaid care is specified as an explicit amount in hours and thus can easily 
be categorised in accordance with the Census definitions. 
Within the Census marital status or living arrangements are defined using a combination 
of information collected about the relationships of individuals within the household and 
their individually declared marital status. Individuals are counted as either being in a 
couple or not. If they are in a couple, then their marital is status is used to define 
whether they are married or cohabiting. If they are not in a couple then the marital status 
is again used to decide if they are single (never married), married, separated, divorced 
or widowed (each with civil partner equivalents). ELSA also has information on the 
living arrangements of participants, whether they are living as a married couple, 
cohabiting or neither of these, and also information on their marital status. It is therefore 
possible to define an ELSA participant’s living arrangements in a manner consistent 
with the Census definition. 
Finally, ownership or having access to a vehicle from within the household is a 
categorised variable in the Census. Depending on the tabulation, this can be five 
categories that range from none to four or more cars or van; to a more limited range of: 
no cars or vans to a highest category of two or more cars or vans. In ELSA each vehicle 
owned by the household is separately identified and such vehicles may include 
motorcycles (but not motorised scooters) in addition to cars and vans. An important 
distinction in ELSA is that a vehicle owned by someone outside the interviewee’s 
household is only counted if the interviewee’s household is the sole or main user of that 
vehicle. This is clearly a more restricted definition of use than the one employed by the 
Census. None the less, in ELSA it is possible to count the number of cars or vans owned 
by the household and categorise them according to whatever tabulation is needed. 
4.6 POPULATION PROJECTIONS BY GENDER, AGE AND 
ETHNICITY 
In the review chapter a number of studies and reports were highlighted that indicated a 
difference in prevalence rates for some morbidities by ethnicity. If this is the case, it is 
highly likely that the prevalence rate in an area for these morbidities will be heavily 
influenced by the size of the ethnic population within the area. 
The ONS only produces sub national population projections for LADs by gender and 
age. Alternative projections are, however, available that do provide a breakdown of 
projected local authority populations by ethnicity. One such projection is from the 
ESRC project funded under the Understanding Population Trends and Processes 
programme, UPTAP. These projections were subsequently made available as ETHPOP 
projections (Rees et al, 2011). 
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The methodology employed uses a bi-region cohort component model to produce, for 
each English LAD, gender specific, single year of age population projections, up to age 
100 (plus a 100 years and older band), for 16 ethnic groups.  Four scenario projections 
are provided, one that assumes that trends in the components of population change 
established during the period 2002-07 continue to 2051. A second scenario aligns the 
trends as much as possible to those assumed in the ONS 2008 national population 
projection methodology. The two remaining scenarios are those that are most distinctive 
to the work. Both use specifically derived ethnic estimates for the various components, 
but the difference between the two scenarios is that one variant treats emigration as a 
flow whilst the alternative treats it as a proportion of the ‘population at risk’. There are 
thus four possible projections arising out of the work and some consideration is required 
into which projection or combination of projections is most suitable. 
4.7 CONCLUSION 
This chapter has provided the background and some depth of knowledge on three data 
sets that are of particular relevance to this study in order to satisfy the second objective 
of this thesis. The 2011 Census is seen to be a representative and comprehensive 
enumeration of the English population with information being provided for a wide 
range of geographies. It is representative in that it attempts to capture details on the 
entire population of an area. It is informative in the range of tabulated counts that are 
provided, both in detailed univariate tables and multivariate cross-tabulations. However, 
it is unable to provide all the detail that is required for this study. It is primarily 
published in the form of aggregate counts of the population making it difficult, beyond a 
few dimensions, link the behaviour by patterns of characteristics in the population. 
Also, of particular relevance to this study is that it does not gather detailed information 
on health outcomes in the population; in particular no information is provided for actual 
morbidity status.  
ELSA is, however, able to provide a wide range of information on the population of 
interest at the disaggregate level of the individual. Since it is an individual survey it is 
possible to tie together information on the same individual and because of its 
longitudinal nature it is possible to study the evolution of these ties over time. There are, 
however, issues with ELSA that also mean it is unable to provide all the information 
requited. Firstly, there is coverage. ELSA is a national survey consisting of around 
16,000 core members, and, whilst this appears to be a large survey it is not in itself of 
sufficient size to provide reliable prevalence rate estimates at LAD level. Secondly, the 
composition of the survey is complex, possessing a range of different categories of 
participant, from qualifying core members to ancillary sample members. In any analysis 
careful though is required into which categories of membership to include and what 
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trade-offs are consequential on this decision. The third issue is inherent in all 
longitudinal surveys and concerns the commitment of the participants. Do they provide 
responses at all waves or do they dip in and out of the survey? The final issue is around 
the consistency of the information provided when it is correlated across waves. These 
inconsistencies may be a result of the interviewee being inaccurate or mistaken in their 
knowledge or recollection. In such circumstances it is difficult to identify the true 
situation. The related issue is when inconsistency is introduced as part of the survey 
process. Just looking at one aspect of the survey, self-reported diagnosis of six 
morbidities, reveals evidence of system generated false negatives and false positives. 
This concern over the quality of diagnosis in health related databases is common (see 
Khan et al. (2010) and Herrett et al. (2009) for similar concerns in a general practitioner 
administrative database). Fortunately it is possible to identify such cases using the 
longitudinal nature of ELSA and use a revised logic that corrects for the inconsistency. 
In gaining an understanding of future trends in the prevalence of a morbidity in an area, 
after age and gender, it is perhaps the ethnic makeup of an area that will have a sizeable 
impact. It is therefore useful to know what the ethnic composition of an area is likely to 
be in order to accurately account for this demographic effect. 
The following Methodology chapter illustrates how these three data sets interact within 
a modelling framework to produce a set of prevalence forecasts in the 50 years and 
older population in each English LAD from 2013 to 2031.  
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5 METHODOLOGY 
A Combined Microsimulation and Macrosimulation Approach 
5.1 INTRODUCTION 
This chapter introduces the overall modelling methodology that is used to produce the 
forecasts of the number of older people in each English LAD with a range of 
morbidities to the year 2031. The third objective in section 1.5 requires that this 
methodology be identified and outlined.  
The methodology is composed of a number of components and each component is 
described in turn. The first component is to obtain a spatially relevant individual 
microsimulated population of each LAD. This population is defined by a LAD specific, 
re-weighting of a sample of the wave 5 ELSA participants. The next component is to 
evolve each of these LAD populations through time by ageing the population and 
adapting the weights to accord with an externally derived aggregate population 
projection. As the population is evolved, the morbidity status of individuals is updated 
in accordance with their individual characteristics. In this model the demographic 
dynamics are captured through the initial spatial microsimulation and the adaptation of 
individual weights over time, whilst the health dynamics are captured through the 
updating of individual’s health status over time.  
This model is able to forecast any discrete health outcomes and for illustrative purposes 
the following three morbidities of: CVD, DHBS and respiratory illness are chosen.  
CVD is indicated by a doctor diagnosis of a heart attack, angina or a stroke whilst 
respiratory illness results from a diagnosis of lung disease or asthma. Data on the causes 
of death (ONS, 2014d) shows that nearly 30% of all deaths of those aged 50 and over 
have an underlying cause related to diseases of the circulatory system (including CVD) 
and 15% are attributable to diseases of the respiratory system. A much lower 2% die 
from diseases related to endocrine, nutritional and metabolic causes, which includes 
DHBS. 
The resulting health status of the population can be gauged using a number of measures. 
For health planning purposes it is the actual prevalence count within the population that 
have a particular morbidity, possibly categorised by some characteristic of the 
population. However, in comparing the relative health of the population between each 
LAD, the prevalence rate is more insightful. Using the approach proposed in this study, 
it is possible to provide both these measures. 
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The overall structure of the modelling methodology is presented in Figure 5-1. The 
rectangular sharp angle cornered boxes represent processes, e.g. a statistical model 
estimation (the purple boxes) or a computation (the blue boxes), whilst the rounded 
corner rectangles represent a data source. The outputs from the models are shown in the 
angular boxes, some of which are intermediate. The layered angular boxes represent 
different ‘versions’ of the intermediate output. Surrounding a number of the elements in 
this figure is a thick dashed outline, this compartmentalises the components of the 
model and identifies which of the chapters in this thesis report the results from this 
component. 
 
Figure 5-1 : Modelling methodology summary 
The structure of this chapter mirrors the components of this figure. Following on from 
this introduction, the definition of a hazard model is provided in section 5.2 and an 
explanation is given on how these models are used in the modelling process (the results 
are to be found in Chapter 8). Section 5.3 describes the spatial microsimulation that re-
weights the ELSA data for each LAD to produce the spatially relevant populations in 
each LAD in 2011 (the results of this are reported in Chapter 6). In addition to having a 
spatially relevant population for each LAD there is also the need for a population 
projection in each LAD to 2031. This is provided by applying revisions to an external 
population projection and this revision process is described in section 5.4 (Chapter 7 
describes the results of this process). Section 5.5 explains the mechanisms that bring 
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together the hazard models, the spatially relevant LAD populations and the population 
projections to produce the morbidity forecasts (see Chapter 9 for the results). Section 
5.6 presents a way to decompose the overall trends in morbidity outcomes by various 
demographic and health trends (see Chapter 10 for the results). The chapter finishes 
with section 5.7 on the strategy for presenting the results and section 5.8 which provides 
a summary of the methodology and its rationale 
5.2 HAZARD MODELS 
In Figure 5-1 hazard models are used for a number of purposes: to identify significant 
constraint variables for the spatial microsimulation, to predict the acquisition of a 
morbidity and to predict how likely an individual is to die or migrate. In this section a 
general overview of the utility and fitting of such models is provided (also see Singer 
and Willett, 2003). 
5.2.1 Functional form of hazard models  
Discrete-time hazard models are estimated on individual level data where the outcome 
of interest is typically a binary event. Such models are often used in the context of 
longitudinal data analysis where: individuals are present in a data set for a number of 
time periods or waves; and the event is ‘absorptive’, i.e. once an event has occurred it 
cannot be undone (e.g. death or, as discussed in section 4.4.5 in the context of ELSA, 
the acquisition of a morbidity). 
Using such models it is possible to estimate the impact and significance of other 
variables on the outcome and estimate a probability that the outcome occurs. This is 
achieved using the concept of ‘logits’. A logit is not dis-similar to traditional ordinary 
least squares regression in that the logit for an individual is expressed as a linear 
combination of a number of explanatory variables. 
logiti= loge (
probabilityi
1 ‐ probabilityi
)=α+ β1x1,i+β2x2,i+…+ βkxk,i+εi 5-1 
where logiti is the estimated logit for individual i; 
 probabilityi is the probability that the event occurs for individual i; 
 α, β1, β2, … , βk, are parameters to be estimated; 
x1,i, x2,i, … , x3,i are explanatory variables associated with individual i; 
εi is an error term for individual i; 
loge is the natural logarithm. 
The explanatory variables may be a continuous measure (e.g. income) or categorical 
(e.g. male/female). Depending on the assumptions concerning the distribution of the 
error term, εi, these logits can then be transformed into other, more meaningful, 
measures such as odds or probabilities. The odds measure the ratio between the 
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probabilities of the event occurring verses the probability that it does. More 
straightforwardly, the probability represents the likelihood that the event occurs. If the 
error term is assumed to follow a logistic distribution then the logit or probability may 
be transformed into the odds as follows: 
oddsi= e
logiti=
probabilityi
1‐probabilityi
 5-2 
and the probability can be expressed using either odds or logits.: 
probabilityi= 
oddsi
1+ oddsi
= 
elogiti
1+ elogiti
=
1
1+e‐logiti
  5-3 
The values of logiti can vary from minus infinity to plus infinity, the oddsi are strictly 
positive whilst the probability is constrained to lie between zero and plus one. These 
relationships can be seen in Figure 5-2 which shows the form of these transformations 
based on the logit function with a single explanatory variable, x1,i.  
logiti= ‐1.0+ 1.0 x1,i 5-4 
It is clear that as x1,i increases in value so do all the measures, although in a non-linear 
fashion. Most notable, low values of logits are associated with low probabilities whilst 
high values are associated with high probabilities. 
 
Figure 5-2 : Graphical relationship between logits, odds and probabilities  
5.2.2 Estimation of hazard models 
The estimation of discrete time logit hazard models is relatively straight forward in most 
statistical packages once these data are formatted correctly. Typically, these data should 
be arranged in a person-period format (see Box ‎5-1) rather than the alternative person-
level format. 
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Once these data have been 
arranged in this format the 
models can be estimated 
using the standard logistic 
regression algorithms found 
in most statistical software.  
Although the formulation of 
the hazard model in logits is 
linear, the standard ordinary 
least squares regression 
equations cannot be used to 
estimate the parameters of the 
model. Instead a maximum 
likelihood estimation 
technique is often used.  
This technique formulates the 
model as a likelihood 
function that measures how 
likely the observed outcomes 
are, given a set of parameter 
estimates. The estimation 
algorithm optimises the choice of these parameters so as to achieve the greatest 
likelihood of generating the observed outcomes. The value of this likelihood is termed 
the model’s maximum likelihood value and is useful in comparing the fit of alternative 
models. 
Since hazard models are commonly used to model the absorptive transition from one 
state to another (i.e. there is no possibly of returning to the earlier state e.g. alive to 
dead) these data are normally censored after the occurrence of the event, i.e. there is no 
information to be gained from knowing that someone persisted in the state. In a health 
context this is akin to using the hazard model to predict the incidence of a morbidity, i.e. 
the first time occurrence of the morbidity rather than. Of course the two are related, 
accumulated incidence measures prevalence (which is exploited here as described later 
in section 5.5.3). 
5.2.3 Goodness of fit for hazard models 
In comparing the fit of ordinary least squares regression models use is commonly made 
of t-ratios, R
2
adj values and ANOVA tables. With hazard models such comparisons are 
 
A person-period dataset has these data arranged so that 
each row represents the information on each person for 
one time period. Information on the same person is 
usually linked together using an identification field.  An 
example of such a dataset is given below. In this 
example, individual 23 contributed at waves 1 and 2 and 
was alive at the time of the wave 2 interview. Individual 
24 only contributed at wave 1. Finally, individual 28 
contributed to waves 1, 2, 3 and 5, but at wave 5 it was 
found they died aged 69. 
id wave gender age ethnicity Dead? 
23 1 Male 54 White No 
23 2 Male 56 White No 
24 1 Female 62 Black No 
28 1 Female 61 Other No 
28 2 Female 63 Other No 
28 4 Female 68 Other No 
28 5 Female 69 Other Yes 
 
Box 5-1 Person-Period Format 
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not so straightforward. Whilst the traditional interpretation of t-ratios from hazard 
models is possible, there is no direct equivalent of an R
2
adj or the ANOVA. 
A method for comparing the goodness 
of fit of two alternative models is 
however possible using a function of 
the maximum likelihood value obtained 
from the fitted model. For this 
comparison to be valid both models 
must be estimated using the same data 
set (i.e. they must be use the same 
observations). The models must also be 
nested, in the sense that one model can 
be obtained from the other by setting a 
sub-set of the parameters to zero. 
The first task in conducting this test is 
to convert the likelihood value into a 
deviance value by taking its logarithm 
and multiplying this by -2.0. The 
difference in this deviance value 
between the two models is then calculated. This value follows a χ2 distribution with the 
degrees of freedom equal to the difference in the number of parameters in each model. 
If the observed value of the deviance statistic is greater than the critical value of this 
distribution then the model with the extra parameters is deemed to be a better model in 
that it reduces the deviance in proportion to the change in the number of parameters. An 
example of this test is provided in Box ‎5-2. 
A further assessment of the accuracy of prediction of an individual model is the 
Homser-Lemshow test (Homser and Lemshow, 1980). This test works by firstly using 
the estimated model to predict the probably of the event occurring. The data set is then 
sorted in increasing order by these probabilities. Once sorted the data set is then divided 
into an equal number of groups, usually ten groups. The first group contains the 10% of 
observations that are least likely to have occurred, whilst the top group contains the 
10% most likely. The estimated probabilities in each group are then summed and this 
can be viewed as the expected number of occurrences within the group. A count is also 
made of the actual number of occurrences observed in each group to obtain the observed 
number of occurrences. A χ2 test is then conducted to see if there is a significant 
difference between the expected and observed counts across the ten groups. In a model 
that fits well, there should be no significant difference in these counts. 
 
Suppose model A includes gender and age as 
explanatory variables and its maximum log 
likelihood value is -245.0. Model B is then 
estimated that includes ethnicity as a two 
category variable and its maximum log 
likelihood is -242.0. The respective deviances 
are 490.0 and 484.0, with a difference of 6.0. 
The extra number of parameters in model B 
is one, and the appropriate critical values are 
χ21(10%)=2.706; χ
2
1(5%)=3.841 and 
χ21(1%)=6.635. Therefore at the 10% and 5% 
levels model B is preferable to model A 
whilst at the 1% level model A is preferable. 
 
Box 5-2 : Test for improvement of fit 
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5.2.4 Choice of constraint variables 
Anderson, 2007 outlined four criteria to be used in the selection of appropriate 
constraint variables for use in his spatial microsimulation of household incomes. The 
four criteria are: 
1. Compatibility of definition in the constraint and sample populations; 
2. Be available at the unit of analysis (in his case, households); 
3. Known to be reasonable predictors at the small area level; 
4. Good predictors at the level of the household. 
A judgement on the first point is largely mechanistic and can be made after studying the 
definitions of the candidate variables in both populations. The second point can be 
addressed by excluding those constraints that are not consistent with the proposed unit 
of analysis, here individuals, rather than households. Point three is informed by a review 
of the literature.  
For the fourth point Anderson used logistic regression techniques to identify which 
combination of potential constraint variables best predicted the outcome of interest in 
his sample population. A stepwise fitting procedure was adopted which orders these 
candidate constraints by increasing usefulness 
In this study, a similar approach is adopted. Issues around points 1 and 2 are largely 
addressed in Section 4-5. The literature review chapter also provides some insight into 
what characteristics are strong determinants. What remains is the adoption of his 
logistic regression modelling approach to identity the important set of constraint 
variables. In this study this is done by fitting hazard models to waves 1 to 6 of ELSA 
data, using the absence and presence of a morbidity as the outcome of interest. Here the 
criteria used for assessing the contribution of each constraint to the goodness of fit is 
measured by the decrease in the deviance and also the Hosmer-Lemshow test. 
5.2.5 Morbidity hazard 
During the health microsimulation stage of the model there is a need to update an 
individual’s morbidity status to simulate the acquisition of the morbidity. This updating 
takes place using hazard models. To an extent such models are not dis-similar to those 
that identified which constraints to use in the spatial microsimulation but are different in 
two respects. Firstly, the range of constraints available at this stage of the health 
microsimulation are more restricted than those at the spatial microsimulation stage. For 
example the NS-SEC of an individual is known in 2011 in both the Census and wave 5 
of ELSA, however in future such information about the individual may have changed or 
be unknown. Thus NS-SEC may be used as a constraint to estimate the 2011 spatially 
relevant population but may not be used to predict future morbidity diagnoses. 
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Secondly, the purpose of these models is predictive whilst the models to identify 
significant constraints are explanatory. There is therefore greater emphasis on the 
predictive power of such models here since they are used to estimate a probability of 
morbidity diagnosis for an individual. 
5.2.6 Mortality and migration hazard 
As described below, during the health microsimulation it is necessary to select and de-
select individuals so as to achieve a desired population demographic. Given a number of 
potential candidates for selection or de-selection the question arises as to who to select. 
The most straight forward approach is to perform the selection or de-selection with 
equal weight. An alternative is to vary this weight according to some characteristics of 
the individual. To do this it is necessary to estimate a probability and this is done using 
hazard models. Hazard models are required to predict the probability of death (a de-
selection outcome) and to predict the probability of migration (both a selection and de-
selection outcome). 
5.3 SPATIAL MICROSIMULATION 
The top half of Figure 5-1 shows the spatial microsimulation modelling. The purpose of 
the spatial microsimulation is to estimate LAD specific weights for individuals within 
the wave 5 ELSA sample population so that the aggregate counts for the constraint 
variables in the weighted sample accurately reproduce the equivalent LAD specific 
2011 Census counts in a range of constraint tables. Wave 5 of ELSA is chosen in 
preference to the other waves since it is the most contemporaneous with the 2011 
Census. There are a number of techniques available to estimate the weights in this 9,987 
by 324 table of weights (here there are 9,987 individuals within the sample population 
and 324 LADs), the two most common are iterative proportional fitting (IPF) and 
combinatorial optimisation (CO).  
IPF is a long established methodology for adjusting a set of weights to meet a series of 
constraints (Deming and Stephan, 1940 and Zaloznik, 2011) and has been adapted for 
application in the field of spatial microsimulation (Ballas et al., 2007). Its name is fairly 
descriptive in that it is an iterative approach that requires a number of passes through 
these data to achieve some level of convergence. Each pass operates on a number of 
tables (e.g. gender, ethnicity) and categories within these tables (e.g. male/female; 
white/BME). The convergence is improved at each step by proportionally adjusting 
selected weights in the sample population so that aggregated weighted counts agree 
with constraint counts (equation 5-5).  
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[weighti+1(n)=weighti(n) × 
table(t,c)
∑ weighti(n)n∈t,c
] ⩝ t∈T,c∈C(t) 5-5 
where weighti(n) is the weight at iteration i for individual n who has attribute c in 
constraint table t; 
 t is the constraint table; 
c is the category within the constraint table; 
table(t,c) is the count of constraint c in table t; 
T is the set of tables; 
C(t) is the set of constraints in table t. 
These adjustments are conducted in sequence for all the constraints C(t) in all the tables 
T. The iterations stop when the adjustments that are applied to successive weights are 
small or, equivalently, that some threshold measure of overall fit between aggregate 
weights and tabulated counts is achieved. 
The alternative combinatorial optimisation approach re-formats the task as a 
optimisation problem (Voas and Williamson, 2000). An objective function is defined 
that measures how well the aggregate counts in a weighted sample population agree 
with constraint counts. Commonly the Total Absolute Error (TAE) formulation is 
chosen as the form of this objective function and for each constraint table, the absolute 
value of the difference between the aggregate counts and the tabulated counts is used as 
a measure of goodness of fit (equation 5-6). 
𝑇𝐴𝐸𝑖 = ∑ |{∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖(𝑛)
𝑛∈𝑡,𝑐
} − 𝑡𝑎𝑏𝑙𝑒(𝑡, 𝑐)|
𝑡∈𝑇,𝑐∈𝐶(𝑡)
 5-6 
where TAEi is the absolute error at iteration i; 
weighti(n) is the weight at iteration i for individual n who has attribute c in 
constraint table t; 
 t is the constraint table; 
c is the category within the constraint table; 
T is the set of tables; 
C(t) is the set of constraints in table t. 
The outer sum ranges over all tables (T) and constraints within a given table, t. The 
inner sum aggregates the weights for those individuals who have the same attribute as 
the constraint c in table t. The objective is to minimise the value of TAE to zero, or as 
close to zero as possible. 
In this study, the combinatorial optimisation approach has been adopted. The reasons 
behind this choice are given below. 
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Integer sample weights required. This is perhaps the most important consideration. 
The health microsimulation operates by selecting and de-selecting individuals to 
achieve a desired demographic profile for an area. This is best achieved if individuals 
are represented as complete whole units in the weighted sample. The operation of IPF 
produces non-integer weights whilst CO produces integer weights. Of course, various 
schemes exist to integerise these non-integer ipf weights (Ballas et al., 2006) but this 
post processing has the potential to introduce further error into the fitting procedure. 
Zero weights are perpetuated 
through the sample. Using the IPF 
approach, if in equation 5-5 the count 
of category c within table t is zero 
then the estimated weight for 
individuals with this category is zero. 
This in itself is not a problem since 
there is no requirement for 
individuals in this category. However 
the person possesses other 
characteristics that are categories in 
other tables and since weights are 
updated by multiplication, such an 
individual’s weight can never be 
other than zero (see Box ‎5-3). With 
CO, at each iteration, the weight of 
an individual can be adjusted to any 
value to achieve an improvement in fit and is not constrained by the value at any 
previous iteration. 
Division by zero. If there are no individuals with the desired characteristics in the 
sample population then the sum of weights in the denominator of equation 5-5 is zero 
and the proportionate adjustment is undefined. The usual solution to this is to either re-
design the sample population by merging categories of individuals to ensure that 
individuals with the desired characteristics are present in the sample population or 
abandon this iteration step. Using the CO approach there is no need to implement a 
special mechanism to account for such a situation. The inner sum of weights in equation 
5-6 will simply be zero and the inability to represent individuals with the desired 
characteristics in the sample population is captured by an increased TAE. 
Importance of table order. The outcome of IPF is sensitive to the order in which the 
tables are considered, with a perfect fit achieved for the final table used in the iterative 
 
Suppose in a particular LAD there are no 
individuals with an ethnicity of Black. When 
the weights are adjusted using the Black 
category within the ethnicity table, the 
weights are set to zero for all individuals in 
the sampling population who are Black. 
However some of these Black individuals 
may be male and when it comes to re-
weighting to achieve a given number of 
males, Black males cannot be given a non-
zero weight. Thus such individuals are 
excluded from contributing to any constraint 
count and therefore the diversity of the 
sampling population is reduced. 
Box 5-3 : Impact of zero weights 
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procedure. In the absence of any guidance on what this order should be this decision 
becomes a subjective decision of the analyst. (Although the stepwise procedure adopted 
by Anderson, 2007, does provide such guidance to the analyst.) In CO all tables are 
considered jointly and equally in assessing the quality of fit at each iteration. 
Execution time. Traditionally the drawback for CO has been the long execution time of 
algorithms to minimise the goodness of fit function. This is understandable given that 
the problem represents an optimisation in N dimensions where N is the size of the 
sample population. However the adoption of efficient optimisation algorithms and 
efficient implementation of such algorithms on multi-core computers has tended to 
overcome this deficiency (Harland, 2013). 
5.3.1 Construction of constraint tables 
In section 4.5 a range of candidate constraint variables are identified that have the 
potential to be related to the morbidity diagnosis of an individuals and are compatible 
with equivalent ELSA variables. Table 5-1 lists those 2011 Census tables that the 
literature identifies as potentially informative constraint variables and have their 
equivalents in the wave 5 ELSA data. All these tables are multi-dimensional cross 
tabulations which follows from recommendations by Hermes and Poulsen (2012a). 
As well as compatibility in the definition of constraints between the two populations 
(Anderson, 2007, point 1), another desirable objective in constructing the constraint 
tables is that there is consistency amongst the tables. This consistency should include 
having the same population size irrespective of the constraint table. This is was not 
possible with 2001 Census tabular output since each output table was individually 
adjusted before publication to mask small counts but it is possible with the 2011 
Census, since only pre-tabular disclosure control has been used (see Section 4.2.6).  
Most of the constraint tables are based on a population of usual residents living in an 
area, there being 18,229,893 such residents aged 50 and over in England in 2011. There 
are however five tables where the population is based on residents in households only 
(signified with a ‘*’ in Table 5-1) and one which is based on residents in institutional 
establishments only (there are 17,857,816 people resident in households and 372,077 
people resident in institutional establishments).  
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Table 5-1 : Summary of 2011 Census constraint tables 
Table Age bands Categories 
DC1117  
(Age structure) 
Single year 
of age 
Not applicable 
LC3101  
(Disability)* 
50, 55, 60, 
65, 70, 75, 
80, 85 and 
older 
No LLTI, Some LLTI 
DC2101  
(Ethnicity) 
English/Welsh/Scottish/Northern Irish/British, Irish, Gypsy or Irish 
Traveller, Other White, White and Black Caribbean, White and 
Black African, White and Asian, Other Mixed, Indian, Pakistani, 
Bangladeshi, Chinese, Other Asian, African Caribbean, Other Black, 
Arab, Any other ethnic group 
DC1108  
(Living 
Arrangements)* 
Married couple, Cohabiting, Single, Married (not a couple), 
Separated, Divorced, Widowed 
DC4109  
(Vehicle 
ownership or 
use)* 
No vehicle, 1 vehicle, 2 or more vehicles 
DC6114  
(NS-Sec) 
50, 65 and 
older 
1.1 Large employers and higher managerial and administrative 
occupations, 1.2 Higher professional occupations, 2. Lower 
managerial, administrative and professional occupations, 3. 
Intermediate occupations, 4. Small employers and own account 
workers, 5. Lower supervisory and technical occupations, 6. Semi-
routine occupations, 7. Routine occupations, 8. Never worked and 
long-term unemployed, L14.1 Never worked, L14.2 Long-term 
unemployed, L15 Full-time students 
LC3301  
(Unpaid care)* 
Provides no unpaid care, Provides 1 to 19 hours unpaid care a week, 
Provides 20 to 49 hours unpaid care a week, Provides 50 or more 
hours unpaid care a week 
DC3408  
(Tenure)* 
Owned outright; Owned with a mortgage or loan or shared 
ownership; Social rented; Private rented or living rent free 
DC5107  
(Education) 
50, 55, 60, 
65 and 
older 
No qualifications, Level 1 qualifications, Level 2 qualifications, 
Apprenticeship, Level 3 qualifications, Level 4 qualifications and 
above, Other qualifications 
DC3402 
(Disability) + 
50, 65, 75, 
85 and 
older 
No LLTI, Some LLTI (a little), Some LLTI (a lot), staff member, 
family member 
Note :  
* population base is residents in households;  
+ population base is residents in institutional establishments 
 
After some consideration it is clear why this distinction is made. With the living 
arrangements table, one component used to categorise an individual is the relationships 
between household members recorded within the household grid. Clearly, if someone is 
not resident in the household then they are not present in this grid and their living 
arrangements cannot be defined. Tenure and the ownership or use of a vehicle are 
attributes that are associated with households and thus only household residents can be 
included in these counts. The provision of unpaid care is something that occurs outside 
an institutional context, so is only reported for those who live in households. Finally the 
presence of a disability is separately tabulated for both household residents and 
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residents in an institutional establishment (signified with a ‘+’ in Table 5-1). In the 
context of disability this distinction between household and institutional establishment 
residents is important – it is likely that the health profile of these two populations are 
different, with residents in institutional establishment having greater disability (Gordon 
et al, 2014). 
The issue then arises on how to reconcile these two population basis. One answer is to 
have within each table based on residents in households, a ‘residual’ category of people 
who are resident in the area but not living in a household. However, some individuals 
who live in institutional establishments do so by virtue of their employment or through 
ownership of the establishment, in fact there are 35,774 people age 50 or older in 
England who live in an institutional establishment as owners, staff or their family. The 
question is whether they resemble more closely, on attributes such as car ownership and 
disability, the household or the institutionally resident ‘client’ population. If the 
assumption is the former then there needs to be a mechanism to identify how many 
people there are in this category (institutional residents who are not clients) and a way 
to infer the household characteristics for such individuals. This mechanism is now 
discussed. 
The task of identifying how many and the gender and age distribution of such 
individuals can be achieved by the differencing of two published Census tables. The 
Census table on Residence type (DC1104) provides a gender by age by residence type 
(Lives in a household; Lives in an institutional establishment) count for each LAD. 
Unfortunately for residents in an institutional establishment, there is no differentiation 
between those who reside there as clients and those who reside by virtue of their 
employment or ownership. A further census table, DC3402 however separately counts 
those institutional residents who are clients and those who are not clients into four post 
50 age bands. By differencing the counts from these two tables, it is possible to 
construct the true age distribution of those who are living in an institutional 
establishment but are not clients in the establishment. In the case of one LAD, 
Plymouth, the calculations in Box ‎5-4 shows that in the 50 years and older population 
there are 85,250 individuals who live in households plus 1,773 individuals who are 
clients in an institutional establishment and 154 who are resident in a institutional 
establishment but not a client. The distributions of the gender and age counts derived 
from these calculations are not estimates but true counts since the counts are have been 
derived by the differencing of published counts from two Census tables.  
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Male 
DC1104 DC3402 Difference 
Female 
DC1104 DC3402 Difference 
In household 
In Institutional 
Establishment 
Clients Not Clients In household 
In Institutional 
Establishment 
Clients Not Clients 
50 to 54 8,259 51 
139 29 
50 to 54 8,010 47 
99 32 55 to 59 6,730 52 55 to 59 7,131 42 
60 to 64 7,377 65 60 to 64 7,656 42 
65 to 69 5,944 56 
84 5 
65 to 69 6,104 52 
122 7 
70 to 74 4,565 33 70 to 74 5,168 77 
75 to 79 3,565 63 
163 7 
75 to 79 4,388 104 
286 22 
80 to 84 2,384 107 80 to 84 3,283 204 
85 and older 1,589 168 162 6 85 and older 3,097 764 718 46 
Total 40,413 595 548 47 Total 44,837 1,332 1,225 107 
The total household population aged 50 and over in Plymouth is 85,250. Additionally there are 1,927 residents living in institutional establishments. Of 
those 1,773 are clients of the establishments whilst 154 are employed by, own the establishment or are family members. This latter figure its gender and 
age distribution (derived here) are not an estimate but would be the actual number of individuals aged 50 and older who live in institutional 
establishments, but are not clients within the establishment, if such a count was provided. 
Box 5-4 : Residence type counts for Plymouth 
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The question then arises of how to account for these non-client residents in institutional 
establishments in those tables where they are not included in the population base. Using 
disability status as an illustration, Census table LC3301 already categorises the 85,250 
Plymouth household residents who live in households according to their disability 
status. There is also Census table DC3402 that categorises the 1,773 individuals who are 
clients into disability categories according to their disability status. However, there is no 
information in the Census (either explicitly or derivable) on the disability status by age 
of the 154 individuals who are resident in an institutional establishment but are not 
clients within the establishment. For these individuals the solution adopted here is to 
allocate each gender and age band counts in proportion to that recorded for household 
residents shown in table LC3301. Thus in the case of presence of a disability, those 
individuals who are male and aged 50 to 64 who are resident in a institutional 
establishment, but not clients, are allocated to a category of having a limiting long term 
illness or not in the same ratio as that for male household residents aged 50 to 64 (see 
Box 5-5 for an example of how this applies to males in Plymouth).  These final counts 
are not true counts but estimates based on this allocation assumption. 
In summary the Census tables used as constraints have been handled in the following 
ways: 
1) Census tables based on the usual resident population are as published (see Table 
13-11 for an example); 
2) Census tables based on the household resident population (tables denoted with a 
‘*’ in Table 5-1 and see Table 13-12 for an extract) are constructed from: 
a) Published counts of household residents; 
b) Residents of institutional establishments who are not clients allocated 
according to the gender and age specific splits in the household resident 
population; 
c) A univariate count of residents of institutional establishments who are 
clients. 
3) Census tables based on the institutional establishment populations (just table 
DC3402, see Table 13-13) are constructed from: 
a) Published counts of clients resident in institutional establishments; 
b) A univariate count of household residents and non-client residents in 
institutional establishments. 
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Males No LLTI LLTI Total 
50 to 64 16,326 6,040 22,366 
65 to 69 5,926 4,583 10,509 
75 to 74 2,195 3,754 5,949 
85 and older 296 1,293 1,589 
    
Males No LLTI LLTI Total 
50 to 64 73.0% 27.0% 100% 
65 to 69 56.4% 43.6% 100% 
75 to 74 36.9% 63.1% 100% 
85 and older 18.6% 81.4% 100% 
    
Males No LLTI LLTI Total 
50 to 64 21.17 7.83 29 
65 to 69 2.82 2.18 5 
75 to 74 2.58 4.42 7 
85 and older 1.12 4.88 6 
    
Males No LLTI LLTI Total 
50 to 64 21 8 29 
65 to 69 3 2 5 
75 to 74 3 4 7 
85 and older 1 5 6 
    
Males No LLTI LLTI Total 
50 to 64 16,347 6,048 22,395 
65 to 69 5,928 4,586 10,514 
75 to 74 2,198 3,758 5,956 
85 and older 297 1,298 1,595 
The final table here is not a true count from the Census but an estimate based on 
the assumption that those who are not clients, but are residing in an institutional 
establishment, have similar disability status to those who live in households. 
The distribution of disability by 
age for males living in 
households. 
 
 
 
These counts expressed as a 
percentage.  
 
 
 
 
The counts of males who are 
resident in a institutional 
establishment, but are not clients 
(see Box 5-4) distributed 
according to these percentages. 
 
 
The counts above converted 
integers.  
 
 
 
 
The counts above added into the 
household residents’ counts, 
giving the final estimate of the 
distribution of disability for non-
clients of institutional 
establishments. 
Box 5-5 : Allocation of non-client institutional residents for Plymouth 
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5.3.2 Definition of sample population from ELSA 
The second data requirement in a spatial microsimulation is a sample population. These 
are the individuals whose weights are adjusted to reproduce the constraint counts 
provided by the 2011 Census tables. The sample population here is taken from wave 5 
of ELSA. It consists of participants of any type (core members and new partners) who 
are aged 50 or older and have a valid response to any of the constraint variables. This 
latter requirement excludes all sample members, about whom very little is known.  In 
addition, information is required in the health microsimulation on whether the 
participant has ever smoked. The correspondences between the structure of the 
constraint tables and the coding of individuals within the sample population are shown 
in Table 13-1 to Table 13-13 located in the Appendix. 
Due to the sparse nature of the ELSA population in regards to certain types of 
individual, it is necessary to merge some age band categories. This is particularly so for 
the ethnic categorisation. The gender, age and ethnic composition of the sample 
population is provided in Table 5-2 and it is apparent that some combinations of these 
characteristics are not represented in this sample population (shown as 0). This 
represents a problem for the spatial microsimulation since it is unable to find any 
individuals with the required combination of characteristics. To ensure that there are 
individuals available for all combinations of characteristics, categories within each 
characteristic may be merged.  For example the ethnic classification uses just two age 
bands (Table 13-2) rather than the eight shown in Table 5-2. 
An extract of the sampling population is provided in Table 13-14 which categorises 
each individual according to the structures in Table 13-1 to Table 13-13. Note that this 
extract contains two individuals (103730 and 103955) who are resident in an institution 
as clients and therefore have generic information (INSTITIUTION) for those constraint 
tables that are based on the household resident population (tables of type 2 in Section 
5.3.1). Similarly residents in households or non-clients resident in institutional 
establishments have generic information (HOUSEHOLD) for table DC3402. This 
structure helps to ensure that the process of choosing sample weights recognises the 
existence of the two sub-populations, those who are clients in an institutional 
establishment and those who are not. 
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Table 5-2 : Composition of the sample population by gender, age and ethnic group 
 
 Age band White Mixed Asian Black Other Total 
Male Aged 50 to 54 153 1 6 1 1 162 
 
Aged 55 to 59 843 2 31 7 6 889 
 
Aged 60 to 64 963 6 14 4 5 992 
 
Aged 65 to 69 735 2 10 10 3 760 
 
Aged 70 to 74 665 1 12 5 2 685 
 
Aged 75 to 79 483 0 7 2 2 494 
 
Aged 80 to 84 272 0 2 2 1 277 
 
Aged 85 and older 206 0 1 2 0 209 
Female Aged 50 to 54 350 1 18 4 5 378 
 
Aged 55 to 59 1,045 2 34 13 8 1,102 
 
Aged 60 to 64 1,107 4 10 11 4 1,136 
 
Aged 65 to 69 808 1 12 4 3 828 
 
Aged 70 to 74 745 1 5 5 0 756 
 
Aged 75 to 79 561 1 2 9 3 576 
 
Aged 80 to 84 390 1 1 2 0 394 
 
Aged 85 and older 348 0 1 0 0 349 
Total 9,674 23 166 81 43 9,987 
5.3.3 Validation of spatial population 
To validate the robustness of the spatially microsimulated population it is useful to 
examine how well the simulated population within each LAD reproduces 2011 Census 
counts for a table not used as a constraint (a procedure outlined in Edwards et al., 2011). 
The degree of agreement between the 2011 Census counts and the synthetically derived 
equivalent counts can be assessed in a number of ways, but perhaps the simplest is to 
scatter plot one count against the other. Ideally these points should lie close to a 45º line 
that passes through the origin. 
5.4 ETHPOP PROJECTION REVISIONS 
The ETHPOP sub national population projections produced in 2010 provide projections 
of the sub national population in each English LAD by gender, age and ethnic group for 
each year to 2051 (Rees et al., 2011). The important role for these projections in the 
health microsimulation is to ensure that the gender, age and ethnic structure of future 
populations in each LAD evolves to represent the dynamic nature of these demographic 
trends, see Figure 5-1. 
Whilst the projections are available for single years of age, by 16 ethnic groups and 352 
English LADs, here these single years are aggregated to five year age bands, the number 
of ethnic groups is reduced to five broad groups and the information is aggregated to the 
324 LADs in place for 2013 rather than the actual current 326. This reduction results 
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from a merger of the City of London with Westminster and the Scilly Isles with 
Cornwall. The time frame of the microsimulation here is also limited to 2031 as the 
final year of estimation. 
The published ETHPOP projections used a mix of information: 2001 Census 
tabulations, both published and commissioned; vital statistics on fertility and mortality; 
and administrative data sources e.g. national insurance registrations and the National 
Health Service Central Register. Unfortunately the data from the 2011 Census had yet 
to be collected when the projections were carried out so it was not possible to use these 
counts. Now, however, the performance of the ETHPOP projections for 2011 may be 
judged against 2011 Census counts (this comparison is explored in detail in Section 
7.2). In light of this performance, LAD specific revisions are proposed to the trends in 
these original ETHPOP projections, producing a set of revised ETHPOP projections. 
This revision process consists of a number of elements (Rees and Clark, 2014): 
Step 1. Re-bases projections to 2011 Census counts; 
Step 2. Utilises subsequent ETHPOP cohort projections;  
Step 3. Incorporates a projection adjustment factor based on 2001 to 2011 
performance; and  
Step 4. Constrains the population by gender and age to ONS 2012-sub national mid-
year population projections (ONS, 2014a). 
5.4.1 Yearly adjustment factor 
For each LAD and ethnic group, the growth observed in the 40 years and older 
population between the 2001 and 2011 Censuses and the 2001 and 2011 ETHPOP 
projections is compared using equation 5-7. 
yearly adjustment = [
2011 Census
2001 Census
2011 ETHPOP
2001 ETHPOP
]
1
10
 
5-7 
where 2001 Census is the ethnic specific count of the 40 and older population in the 
LAD from the 2001 Census (Table S101); 
2011 Census is the ethnic specific count of the 40 and older population in the 
LAD from the 2011 Census (Table DC2101);  
2001 ETHPOP is the mean of the TREND-EF and UPTAP-ER 2001 projection 
of the 40 and older population in the LAD from ETHPOP;  
2011 ETHPOP is the mean of the TREND-EF and UPTAP-ER 2011 projection 
of the 40 and older population in the LAD from ETHPOP. 
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This yearly adjustment factor reflects how the ETHPOP projection needs to be adjusted 
to reproduce the 2011 outcome (see Box ‎5-6 for an example calculation): 
In practice some of these adjustment factors can be very large or small, due to the 
calculation involving small counts in the denominators. The repercussions are that there 
is the potential for some large growths (or declines) in some sub-populations. To limit 
this impact information about the area type of the LAD is used in order to apply a 
constraint around these adjustment factors (ONS, 2003). The hypothesis is that the bulk 
of LADs of the same type experience the same shifts in population growth and hence 
should have similar correction factors. To identify those LADs that are untypical of 
similar LADs, the raw adjustment factors of each authority and ethnicity are calculated 
(as shown in Box ‎5-6) and within each LAD area type a 10% and 90% empirical 
confidence interval of these raw factors is calculated for each ethnicity. If the 
authority’s raw adjustment factor is outside this range then it is re-set to the appropriate 
lower (10%) or upper (90%) bound (see Box ‎5-7). 
 
 
White 2001 2011 growth yearly adjustment 
Census 110,314 120,221 
120,221
110,314
= 1.090 
 
1.090
1.158
 
1
10
= 0.9940 
ETHPOP 110,506 128,000 
128,000
110,506
= 1.158 
 
 
To reproduce the observed growth between the 2001 and 2011 Census, the ETHPOP 
projections need to be reduced by 0.0061 (1-0.9939) or 0.61% per annum. 
Box 5-6 : Yearly adjustment for the White population of Plymouth 
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5.4.2 Re-base and adjust ETHPOP projection 
Once these yearly correction factors are known for each ethnicity within each LAD, the 
appropriate ethnic population in a LAD for year y (y=2011; 2013, …, 2031) may then 
calculated using equation 5-8. 
𝐸𝑃𝑒
𝐿𝐴𝐷,𝑦 = 𝐶𝑒
𝐿𝐴𝐷 2011 ∗ (
𝐸𝑒
𝐿𝐴𝐷,𝑦
𝐸𝑒
𝐿𝐴𝐷,2011) ∗ (𝐴𝐹𝑒
𝐿𝐴𝐷)(𝑦−2011) 5-8 
Where EPe
LAD,y
 is the adjusted ETHPOP sub-population aged 40 and older of ethnicity 
e, in LAD for year y; 
 Ce
LAD,y
 is the 2011 Census sub-population aged 40 and older of ethnicity e, in 
LAD (step 1); 
 Ee
LAD,y
 is the original ETHPOP sub-population aged 40 and older of ethnicity 
e, in LAD for year y (step 2); 
 
 
White 2001 2011 growth yearly adjustment 
Census 208 666 
666
208
= 3.202 
 
3.202
1.620
 
1
10
= 1.070 
ETHPOP 258 418 
418
258
= 1.620 
 
 
To reproduce the observed growth between the 2001 and 2011 Census, the ETHPOP 
projections need to be adjusted by +7.0% pa. The [10%,90%] range for Asian in Cities 
and Services type LADs is [-0.3%,+4.5%], therefore actual yearly correction factor for 
Plymouth Asian population is adjusted from +7.0% down to +4.5%. 
Box 5-7 : Yearly adjustment for the Asian population of Plymouth 
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Box 5-8 : Adjustment to ETHPOP projection 
2011 Census ETHPOP 
GROWTH 
Adjustment 
factor 
ETHPOP 
population share 
Revised 
estimate 
equation 5-8 equation 5-9  
White people aged 
40 and older in 
Plymouth 
(step 1) 
White people aged 
40 and older in 
Plymouth from 
2011 to 2015 
(step 2) 
(step 3) White males 
aged 50 to 54 
relative to all 
white people 
aged 40 and 
older  
 
120,221 * 
133,697
128,000
 * 0.9939
4
 * 
9,112
133,697
 
 
= 8,352.1 
 
The original ETHPOP projection of white males aged 50 to 54 in Plymouth in 2015 is 
revised from 9,112 to 8,352.1. 
 
AFg,e
LAD
 is the adjustment factor for adjust for 2001 to 2011 ETHPOP 
projection performance for ethnicity e, in LAD (step 3). 
The quantity EP is the size of the total sub-population aged 40 and older of a given 
ethnicity. This is then apportioned to each 5-year age band using the ETHPOP LAD 
gender, age and ethnic specific counts (equation 5-9). 
𝐸𝑃𝑔,𝑎,𝑒
𝐿𝐴𝐷,𝑦 = 𝐸𝑃𝑒
𝐿𝐴𝐷,𝑦 ∗
𝐸𝑔,𝑎,𝑒
𝐿𝐴𝐷,𝑦
𝐸+,+,𝑒
𝐿𝐴𝐷,𝑦  5-9 
An illustration of this process is provided in Box ‎5-8 . 
5.4.3 Constrain to ONS sub national population projections 
The final step is to constrain the gender and five year age bands to the ONS 2012 sub 
national population projections (ONS, 2014a): 
𝑃𝑔,𝑎,𝑒
𝐿𝐴𝐷,𝑦 =  
𝐸𝑃𝑔,𝑎,𝑒
𝐿𝐴𝐷,𝑦
𝐸𝑃𝑔,𝑎,+
𝐿𝐴𝐷,𝑦 ∗  𝑆𝑁𝑃𝑃𝑔,𝑎
𝐿𝐴𝐷,𝑦
 5-10 
where 𝑃𝑔,𝑎,𝑒
𝐿𝐴𝐷,𝑦
 is the revised population of gender g, age a, ethnicity e, in LAD for year 
y; 
 𝐸𝑃𝑔,𝑎,𝑒
𝐿𝐴𝐷,𝑦
 is the ETHPOP population of gender g, age a, ethnicity e, in LAD for 
year y; 
𝑆𝑁𝑃𝑃𝑔,𝑎
𝐿𝐴𝐷,𝑦
 is the ONS 2012-based sub national population projection of gender 
g, age a, in LAD for year y. 
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Box 5-9 : Constrained to ONS 2012-SNPP 
Males aged 
50 to 54 
𝐸𝑃𝑀𝑎𝑙𝑒,50 𝑡𝑜 54,𝑒
𝑃𝑙𝑦𝑚𝑜𝑢𝑡ℎ,2015
 𝐸𝑃𝑀𝑎𝑙𝑒,50 𝑡𝑜 54,𝑒
𝑃𝑙𝑦𝑚𝑜𝑢𝑡ℎ,2015
𝐸𝑃𝑀𝑎𝑙𝑒,50 𝑡𝑜 54,+
𝑃𝑙𝑦𝑚𝑜𝑢𝑡ℎ,2015 
𝑆𝑁𝑃𝑃𝑀𝑎𝑙𝑒,50 𝑡𝑜 54
𝑃𝑙𝑦𝑚𝑜𝑢𝑡ℎ,2015
 𝑃𝑀𝑎𝑙𝑒,50 𝑡𝑜 54,𝑒
𝑃𝑙𝑦𝑚𝑜𝑢𝑡ℎ,2015
 
White 8,352.1 0.9694 8,400 8,142.8 
(9,112) 
Mixed 67.5 0.0078 8,400 65.8 
(40) 
Asian 91.3 0.0106 8,400 89.0 
(48) 
Black 50.3 0.0058 8,400 49.1 
(31) 
Other 54.7 0.0063 8,400 53.3 
(67) 
Total 8,615.9 1.0000  8,400 
(9,304) 
The total male population aged 50 to 54 for Plymouth in 2015, of 8,615.9 is, pro-rata, 
reduced to equal the 2012-SNPP of 8,400. To give an indication of the scale of the 
adjustments, the original ETHPOP projections are given in ()’s in the final column. 
This process is illustrated in Box ‎5-9. 
Since the health microsimulation is a microsimulation of the behaviour of individuals, 
there is a requirement that the population projections are composed of integer counts. 
This achieved by rounding the counts Pg,a,e
LAD,y
 to the nearest integer.  
5.5 HEALTH MICROSIMULATION 
The outcome of the spatial microsimulation is a series of LAD specific weights for the 
ELSA wave 5 derived sample population. These weights synthesise the makeup of each 
LADs 50 years and older population in March 2011. The task of the health 
microsimulation is to evolve this population through time to represent future LAD 
population structures. This is achieved by firstly ageing the population as time 
progresses, replenishing the younger ages in the population, and adjusting the weights 
to reproduce future population structures. Since this is a health microsimulation and not 
just a demographic projection, the health status of individuals is also updated. In Figure 
5-1 the health microsimulation is shown at the heart of the figure and is seen to take 
information from the spatial microsimulation, the adjusted ETHPOP projections, 
information from the 2011 HSfE and uses hazard models for morbidity, mortality and 
migration propensities. 
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5.5.1 Ageing 
In this study, each LAD’s population is evolved through time to produce biennial mid-
year forecasts of the health status of its population for a 20 year time horizon. Thus the 
2011 March Census population is evolved to 2013, 2015, … , 2031 mid-year 
populations. This adoption of a two year step in forecasts is in keeping with the two-
year wave cycle of ELSA. In terms of ageing, there is a slight mismatch for the first 
microsimulation step from March 2011 to mid-year 2013. Between these two dates an 
individual will of aged 2¼ years rather than 2. To infer someone’s age mid-year 2013 
age from their age in March 2011 requires information on their month of birth. 
Unfortunately ELSA does not provide information on the date or month of birth so it is 
not possible to perform this calculation. In any case the time spans in this study are 
already to a degree inconsistent - ELSA data are collected over a one year period that 
starts 9 months before the 2011 Census and finishes 3 months after.  
5.5.2 Morbidity status 
As the synthetic population is aged, the morbidity status of the individuals who do not 
have a specific morbidity is updated. This is achieved using a Monte-Carlo approach. In 
this approach, hazard models are estimated that use gender, age, time (wave) trend, 
ethnicity, smoking status, the presence of a comorbidity, and the type of LAD to 
estimate the probability that an individual acquired a morbidity in the past two years. A 
pseudo random number taking a value between 0.000 and 1.000 is then generated 
(Matsumoto and Kurita, 1994) and if the value is less than the hazard probability, the 
individual is deemed to have acquired the morbidity, otherwise they continue without 
the morbidity. 
The two morbidities of CVD and DHBS are linked - individuals with DHBS are more 
likely to develop CVD. To build on this linkage, the presence of DHBS at the previous 
wave is used as a potential predictor of CVD. For the remaining morbidity of having a 
respiratory illness, there is no similar comorbidity link. 
5.5.3 Replenishers 
A consequence of the ageing of participants in the LAD population is that the 
population no longer covers the full age range. At each microsimulation step the age of 
the youngest individuals increases by 2 years. Thus by 2031 there would be no one 
younger than 70 in the population. There therefore needs to be some mechanism to 
replenish the synthetic population with younger participants and the problem then 
becomes how to give sufficient detail to these Replenishers so that they can be fully 
functioning individuals within the population.  
The gender, age and ethnicity makeup of the 50 and 51 years old Replenishers can be 
determined easily enough by the revised ETHPOP population projections. Within this 
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study these populations are only known in five year age bands. To estimate the single 
year of age populations for 50 and 51 years olds the methodology proposed by Sprague 
(1880) is used (Calot and Sardon, 2003). In application, the method uses the five year 
age band containing the single year of age required (here the 50 to 54 year age band) 
plus the two five year age bands below this (aged 40 to 49 and aged 45 to 49) and the 
two five year age bands above (aged 55 to 59 and aged 60 to 64).  This requirement is 
the reason that the revised ETHPOP projections covered the 40 years and older group 
and not just the more obvious 50 years and older group. 
Reliable future predictions on other aspects of the population are more problematic. 
Considering the determinants that are discussed in Chapter 3, it is difficult to infer them 
for future populations. The marital status of individuals changes through time, so it is a 
challenge to accurately ascertain their living arrangements at age 50 and 51 and how 
these arrangements change subsequently. There are similar issues with all the other 
main socio-economic factors : highest education; NS-SEC classification; tenure; care 
giving and vehicle ownership or use. 
One determinant that is health related and has some form of stability is whether the 
individual has ever smoked. To reliably use this information in any model the 
hypothesis that people rarely begin smoking after the age of 30 needs to be true. The 
age 30 is significant because it is the smoking status of those aged 30 in 2011 who will 
be 50 in 2031, the final Replenishers. If it is known how many people aged 30 to 50 in 
2011 who had ever smoked (say from the HSfE) then, as long as no one in this age 
group starts smoking after 2011, their smoking status when they replenish the synthetic 
population will also be known. Evidence on how true this hypothesis is can be found in 
the life course data collected during the ELSA wave 3 interview. In that interview a 
question was asked on when the individual first started to smoke cigarettes. Box ‎5-10 
tabulates the weighted counts of wave 3 life course participant’s age by the age at which 
they started to smoke cigarettes. This provides evidence that amongst this cohort, a very 
small percentage of participants (2.5%) started smoking after they were aged 30. 
Statistics based on the UK General Household Survey quoted in Chatterjee et al. (2008) 
also shows that few people start smoking after the age of 30, there, 9% of males and 
15% of female smokers started smoking after the age of 25. The assumption here is that 
the Replenishers, aged 30 to 50 in 2011, who do not already smoke, are unlikely to start. 
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Age at wave 3 
Don't 
know 
Never 
smoked 
Aged started smoking cigarettes 
Total 
Younger 
than 10 
Aged 
between 10 
and 19 
Aged 
between 20 
and 29 
Aged 
between 30 
and 39 
Aged 
between 40 
and 49 
Aged 
between 50 
and 59 
Aged 60 or 
older 
Aged 50 to 59 3% 40% 1% 47% 8% 1.0% 0.5% 0.0% 0.0% 2,288 
Aged 60 to 69 3% 37% 1% 47% 11% 1.5% 0.4% 0.2% 0.0% 2,252 
Aged 70 to 79 3% 39% 1% 41% 12% 2.8% 1.3% 0.3% 0.1% 1,580 
Aged 80 to 89 4% 36% 0% 40% 16% 2.4% 0.5% 0.4% 0.0% 805 
Aged 90 and older 40% 38% 0% 15% 5% 2.4% 0.0% 0.0% 0.0% 127 
All 4% 38% 1% 44% 11% 1.7% 0.6% 0.2% 0.0% 7,053 
Of those aged 50 to 90, the greatest percentage (nearly a half) started smoking cigarettes when they were aged between 10 and 19. About 2.5% started 
smoking aged 30 or older.  A consistent percentage, around 40%, never smoked cigarettes. The recall information for those aged 90 and older is poor, 
however the never smoked percentage for this very old age group looks to be in line with the percentage reported for younger cohorts. 
 
 
 
 
Box 5-10 : Age at which ELSA wave 3 participants started smoking 
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To gain some understanding of the smoking prevalence within this younger cohort, use 
is made of the 2011 HSfE. The percentage of those aged  30 to 50 in 2011 who have 
ever smoked is likely to provide accurate estimates of the percentage who smoke when 
they become the Replenishers during the period 2013 to 2031, since very few change 
their status from never having smoked to smoked during that period (see Box ‎5-10). 
Using the HSfE it is possible to estimate separate rates by gender; age cohort (aged 30 
to 39 and aged 40 to 49) and ethnicity. When introducing Replenishers into the LAD 
population these HSfE derived smoking rates can be used to ensure they are 
representative. This smoking status is assigned using a Monte-Carlo approach in 
combination with these rates. Clearly this information on whether someone has ever 
smoked is not the most powerful determinant of health status. Whether they are a 
current smoker, the number of years they have smoked or the amount smoked would be 
better determinants, however all these measures have the capability of changing in 
unknown ways over a life course. 
A further requirement is the need to designate a proportion of these Replenishers as 
having morbidities when they are introduced into the synthetic population. It would be 
unreasonable to assume that all the 50 and 51 year olds are completely healthy. To 
estimate this probability use is made of the morbidity hazard models. Starting at the age 
of 30, with an assumption of not having the morbidity, and repeatedly applying the 
hazard model to predict the probability of acquiring a morbidity through the ages 30 to 
49 and across the waves, the accumulated probability over 20 years of acquiring a 
morbidity can be estimated. When the Replenishers are introduced into the synthetic 
population, the Monte-Carlo approach 
using these accumulated probabilities is 
used to decide whether the individual 
has the morbidity at age 50 or 51. 
5.5.4 Constraining weights 
Ageing and replenishing the synthetic 
population are not the only 
demographic processes that need to 
occur. There is the need to ensure that 
the population is of the correct size and 
structure. This is achieved by selecting 
individuals and adjusting their weights 
to represent growth in the population 
(cloning) or decline (removal), to 
ensure that the population is structured 
 
 
Supposing the population was 1,000 
individuals, split 900 without and 100 with a 
morbidity, and the size of the population 
needed to be reduced by 100. With equal 
probabilities this would produce, on average, 
a split of 810 vs 90 (each is reduced by 10%), 
with an estimated prevalence of 90 / 900 = 
10%. However supposing that much MORE 
of the reduction is in the sub population with 
the morbidity (by ¼ vs ¾) then the split 
would be 875 vs 25, a much lower prevalence 
of 25 / 900 = 2.8%. 
Box 5-11 : Impact of using unequal 
selection probabilities 
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correctly. Removal from the population represents two demographic processes, those of 
death and out-migration from the LAD, whilst cloning represents in-migration.  The 
question then arises of how to select the individual to clone or remove. The simplest 
approach would be to select with equal probability. This would however not be a true 
reflection of the dynamics within the population. Consider the need to remove an 
individual of a particular type, potentially representing a death. It is more likely that 
death occurs to someone who is older or who has a morbidity. This suggests that there is 
the need to estimate the probability of mortality as a function of the characteristics of 
the individual. Once again this is achieved using a hazard model to predict the 
probability of death. Selection then takes place not with equal probability but with a 
probability equal to that estimated by the mortality hazard model. How this change in 
approach has the potential to influence estimated prevalences is illustrated in Box ‎5-11. 
There is similarly a need to estimate the probability of migration. When selecting an 
individual for cloning, only the migration probability is used, whilst selection for 
removal, both the mortality and migration probabilities are used. It is important to 
recognise that these mortality and migration probabilities are not used to determine the 
size of the population in future years - that is determined by the adjusted ETHPOP 
projections. They are merely used to determine who should be cloned or removed to 
achieve a population structure that resembles the adjusted ETHPOP projections.  
A cloned individual inherits all the characteristics of the original individual (obviously 
gender, age and ethnicity) including their smoking status and morbidity status. After the 
cloning however, they become independent, thus if at a later stage the source individual 
acquires a morbidity or is removed from the population, the clone does not necessarily 
do the same (and vice-versa).  
A final issue arises when there are no suitable individuals within the sample population 
to create a clone from. It is entirely possible that in the spatially microsimulated 
population that represents the 2011 population within the LAD there is no requirement 
for individuals with a combination of attributes (e.g. older males of mixed ethnicity). 
However, in future years the ETHPOP projections may indicate that there will be 
people living in the LAD with this combination, but there may be none available for 
cloning. The approach here is to offer, in these exceptional circumstances, the original 
spatial  microsimulation sample population as sources for clones. These ‘shadow’ 
individuals are only cloned if there are no suitable individuals already in the sample 
population available for cloning (either in the original synthetic population or from 
Replenishers). Before their potential use, the shadow individuals are subject to the same 
processes (e.g. ageing and changes to their morbidity status) as the synthetic population, 
so that when and if they are cloned they are truly representative.  Also, since ageing 
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takes place there is a need for ‘shadow Replenishers’. Once a shadow individual has 
been cloned they are treated as an original individual within the synthetic population. 
5.5.5 Merged categories 
A matter not unrelated to the need for shadow individuals is apparent from looking at 
Table 5-2. Outside the White and younger Asian populations the representation of the 
population is fairly sparse and for some combinations there is no representation in the 
sample population. Older, mixed ethnicity, males are particularly poorly represented 
and the ageing of the younger individuals in this demographic will only start to fill out 
this age range at 2023 (the oldest mixed ethnicity male is aged 74 in 2011 and will be 
86 in 2023). It is therefore impossible to re-shape the future population of this 
demographic because there are no individuals (shadow or otherwise) in the sample. 
More generally even where there are some individuals available for cloning if this pool 
of individuals is small then the sample becomes too homogeneous – one or two 
individuals are repeatedly cloned. To overcome these concerns rather than attempting to 
reproduce all gender, age and ethnic combination populations using the adjusted 
ETHPOP projections, certain age bands are merged to ensure a diversity of individuals 
within the synthetic population from which to create clones. These merged categories 
and the number of sample population individuals within the merged categories is shown 
in Table 5-3.  
Table 5-3 : Composition of sample population with merged categories 
  
White Mixed Asian Black Other 
Male Aged 50 to 54 153 
9 
6 
12 12 
 
Aged 55 to 59 843 31 
 
Aged 60 to 64 963 14 
 
Aged 65 to 69 735 
3 
10 
15 
8  
Aged 70 to 74 665 12 
 
Aged 75 to 79 483 
10 6 
 
Aged 80 to 84 272 
 
Aged 85 and Older 206 
Female Aged 50 to 54 350 
7 
18 
28 17 
 
Aged 55 to 59 1,045 34 
 
Aged 60 to 64 1,107 10 
 
Aged 65 to 69 808 
4 
12 
9 
6  
Aged 70 to 74 745 5 
 
Aged 75 to 79 561 
4 11 
 
Aged 80 to 84 390 
 
Aged 85 and Older 348 
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For the White ethnicity the selection and de-selection of individuals reproduces the full 
gender, age and ethnicity projections. For the other more sparse ethnicities the selection 
and de-selection reproduces the merged projections. For the mixed ethnicity this means 
that the ETHPOP projections for those younger than 65 are merged and those over 65 
are merged so that, in the worst case, initially 3 individuals are available as potential 
clones to represent the older mixed male ethnicity (although over time younger mixed 
ethnicity males will age into this age group and become eligible for cloning). 
5.6 HEALTH IMPACT DECOMPOSITION 
The health microsimulation described above has two main drivers that affect the 
prevalence of morbidities. One is a demographic dimension that is driven by the change 
in the gender, age and ethnic structure of a LAD and the second is the trends in the 
morbidity hazard driven by the estimated hazard equation. Some insight into the relative 
contribution of these two drivers can be obtained using an accounting system. 
The demographic drivers have a number of elements. Firstly there is the size of the 
population. Naturally as the population grows the number of individuals with 
morbidities also grows.  If the composition within this population (in terms of gender, 
age and ethnic splits) does not change (an unlikely occurrence) then the prevalence rates 
would remain unaffected by this growth. However, the structure of the population will 
change over time and these changes can be decomposed into a number of scenarios 
enabling the health contribution of each component of demographic change to be 
assessed (Bongaarts and Bulatao, 1999). 
The final scenario revolves around assumption on health trends within the populations. 
The morbidity hazard change is driven by a time trend in the hazard equations and how 
these equations differentiate by gender, age and ethnicity in the estimation of hazard 
probabilities. If this hazard function is not used to update morbidity status; the 
population is not aged; and selection probabilities are not used, then this is equivalent to 
assuming constant morbidity prevalence within each sub population, fixed at 2011 
estimates. 
5.6.1 Demographic drivers 
The approach taken here to measure the impact of various demographic factors on the 
prevalence rates is to start with an assumption that the demographic structure and size of 
the population of a LAD resembles that in the 2011 Census. Incrementally these 
assumptions are relaxed, the order of which, can to a degree, be arbitrary. The first 
change is trivial and assumes that the total size of the 50 and older population increases 
in line with the revised ETHPOP projection with no mortality improvement, but the 
2011 Census gender, age and ethnic composition persists. Next, the first critical 
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demographic characteristic to be relaxed is the gender structure of the population. Thus 
the population follows the gender structure predicted by the adjusted ETHPOP 
projections for the forecast year but the age and ethnic structures are those from the 
2011 Census. The next stage is to adjust both the gender and ethnic structures to those 
in the ETHPOP projections whilst retaining the 2011 Census age structure. The final 
stage is to relax all three demographic factors, gender, ethnicity and age. However, the 
age structure is relaxed in two stages. The ageing of the population occurs through two 
processes, the first is by cohort replacement and migration, where the natural ageing of 
a population and migration change its structure; the second is through mortality 
improvements where over time, individuals of a given age are less likely to die. The 
latter process of mortality improvement can be negated by the use of factors derived 
from the no mortality improvement variant of ONS’s 2012-based national population 
projections (ONS, 2013b). These factors are gender and age specific but not specific for 
a particular LAD or ethnic group. 
It should be emphasised that these alternative versions of the future population structure 
presented here are not in any way thought to be plausible structures (except for Pg,a,e
LAD,y),  
they are just artificial constructs to help to quantify the contribution of various 
components to trends in health outcomes. In a similar manner to how Rees et al. 
(2013b) decomposed the components of population change, the health outcomes from 
using each of these versions in the health microsimulation enables the estimation of the 
incremental or proportionate impact of relaxing each assumption. 
Constructing populations that meet these population constraint structures is a 
challenging task and is accomplished in two stages. The first stage is to calculate broad 
adjustment factors that can be applied to a previous population to bring it more into line 
with a new structure. The second stage is to use this adjusted population as the starting 
point in an optimisation procedure to exactly produce the new structure. To help with 
the description of the first stage, some notation is introduced here (which follows on 
from equation 5-10) (also to aid in the process of understanding the mechanisms and 
how they relate to this notation, a hypothetical scenario is provided in Table 5-4 to 
Table 5-7).  
Pg,a,e
LAD,y
 is the revised ETHPOP population for local authority LAD in 
year y of gender g, age band a and ethnicity e (see Table 5-5); 
Pg,a,e
LAD,2011
 the population for local authority LAD in the 2011 Census of 
gender g, age band a and ethnicity e (see Table 5-4); 
NMIg,a,°
°,y
 the no mortality improvement factor in year y for gender g, age 
band a (see Table 5-6). 
126 
 
The dot (
○
) denotes a characteristic that does not vary by the relevant attribute. This 
means that in the notation above, the no mortality improvement factors are the same for 
all LAD’s and for each ethnic group, but vary by year, gender and age. In what follows, 
a plus (+) signifies a summation across all categories for the characteristic. Thus 
Pg,+,+
LAD,2011
 is the sum of males (g=male) or females (g=female) for local authority LAD 
in the 2011 Census (over all age bands and ethnic groups).  
Table 5-4 : Hypothetical 2011 Census Counts 
2011 Male Female age by gender age by ethnicity   
Census White BME White BME Male Female White BME age 
Aged 50 to 64 200 20 250 20 220 270 450 40 490 
Aged 65 to 75 150 15 200 20 165 220 350 35 385 
Aged 75 and older 100 5 150 10 105 160 250 15 265 
gender by ethnicity 450 40 600 50 
1140 gender 490 650 
ethnicity White 1050 BME 90 
Table 5-5 : Hypothetical 2021 ETHPOP projections 
2021 Male Female age by gender age by ethnicity   
Principal /ETHPOP White BME White BME Male Female White BME age 
Aged 50 to 64 150 25 200 35 175 235 350 60 410 
Aged 65 to 75 200 20 250 25 220 275 450 45 495 
Aged 75 and older 150 15 200 20 165 220 350 35 385 
gender by ethnicity 500 60 650 80 
1290 gender 560 730 
ethnicity White 1150 BME 140 
Table 5-6 : Hypothetical factors to remove mortality improvement (NMI) 
2021 Principal NMI variant 
Male Female Principal to NMI Male Female Male Female 
Aged 50 to 64 175 235 157 211 0.9 0.9 
Aged 65 to 75 220 275 176 248 0.8 0.9 
Aged 75 and older 165 220 116 132 0.7 0.6 
Table 5-7 : 2021 ETHPOP projection without mortality improvement 
2021 Male Female age by gender age by ethnicity   
NMI White BME White BME Male Female White BME age 
Aged 50 to 64 135 22.5 180 31.5 157.5 211.5 315 54 369 
Aged 65 to 75 160 16 225 22.5 176 247.5 385 38.5 423.5 
Aged 75 and older 105 10.5 120 12 115.5 132 225 22.5 247.5 
gender by ethnicity 400 49 525 66 
1040 gender 449 591 
ethnicity White 925 BME 115 
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These quantities are then aggregated to produce some useful totals. The first is the size 
of the population under the assumption of no mortality improvement, i.e. life 
expectancies remain unchanged (1,040 in Table 5-7). 
PNg,a,e
LAD,y
=Pg,a,e
LAD,y
× NMIg,a,●
●,y
 5-11 
and 
PN+,+,+
LAD,y
=∑(PNg,a,e
LAD,y
)
g,a,e
 
5-12 
5.6.1.1 Original population 
The starting point is the assumption that the size and structure of future populations is 
exactly the same as that in the 2011 Census (Table 5-4): 
POg,a,e
LAD,y
= Pg,a,e
LAD,2011
 5-13 
5.6.1.2 Population size 
The next step is to grow the population in future years so that it reflects the change in 
the size of the population without any mortality improvement but the gender, age and 
ethnic distribution of the population is the same as the 2011 Census (Table 5-8). 
PSg,a,e
LAD,y
=
Pg,a,e
LAD,2011
P+,+,+
LAD,2011 ×PN+,+,+
LAD,y
 
5-14 
5.6.1.3 Population gender 
The third step is to create a population that reflects the change in the population size and 
its gender structure, but retains the ethnic and age structure from the 2011 Census 
(Table 5-9). 
PGg,a,e
LAD,y
= 
Pg,a,e
LAD,2011
Pg,+,+
LAD,2011 ×PNg,+,+
LAD,y
 
5-15 
5.6.1.4 Population ethnicity 
The fourth step is to create a population that reflects the change in the population size 
and its gender and ethnic structure, but retains the age structure from the 2011 Census 
(Table 5-10). 
PEg,a,e
LAD,y
=
Pg,a,e
LAD,y
Pg,+,e
LAD,y ×PNg,+,e
LAD,y
 
5-16 
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5.6.1.5 Population age 
The penultimate step is a population that reflects the change in the population size and 
the three demographic characteristics of gender, age and ethnicity (Table 5-7) but no 
mortality improvement. This is simply PNg,a,e
LAD,y
. 
Table 5-8 : The 2011 Census gender, age and ethnic structure re-sized to produce the 
2021 population with no mortality improvement 
2021 Male Female age by gender age by ethnicity   
SIZE White BME White BME Male Female White BME age 
Aged 50 to 64 182.5 18.2 228.1 18.2 200.7 246.3 410.5 36.5 447.0 
Aged 65 to 75 136.8 13.7 182.5 18.2 150.5 200.7 319.3 31.9 351.2 
Aged 75 and older 91.2 4.6 136.8 9.1 95.8 146.0 228.1 13.7 241.8 
gender by ethnicity 410.5 36.5 547.4 45.6 
1040 Gender 447.0 593.0 
ethnicity White 957.9 BME 82.1 
Table 5-9 : The 2011 Census age and ethnic structure BUT the gender split and 2021 
population size is the same as the no mortality improvement 
2021 Male Female age by gender age by ethnicity   
GENDER White BME White BME Male Female White BME age 
Aged 50 to 64 183.3 18.3 227.3 18.2 201.6 245.5 410.6 36.5 447.1 
Aged 65 to 75 137.4 13.7 181.8 18.2 151.2 200.0 319.3 31.9 351.2 
Aged 75 and older 91.6 4.6 136.4 9.1 96.2 145.5 228.0 13.7 241.7 
gender by ethnicity 412.3 36.7 545.5 45.5 
1040 gender 449.0 591.0 
ethnicity White 957.9 BME 82.1 
Table 5-10 : The 2011 Census age structure BUT the gender and ethnic split and  2021 
population size is the same as the no mortality improvement 
2021 Male Female age by gender age by ethnicity   
ETHNIC White BME White BME Male Female White BME age 
Aged 50 to 64 177.8 24.5 218.8 26.4 202.3 245.2 396.5 50.9 447.4 
Aged 65 to 75 133.3 18.4 175.0 26.4 151.7 201.4 308.3 44.8 353.1 
Aged 75 and older 88.9 6.1 131.3 13.2 95.0 144.5 220.1 19.3 239.5 
gender by ethnicity 400.0 49.0 525.0 66.0 
1040 gender 449.0 591.0 
ethnicity White 925.0 BME 115.0 
5.6.1.6 Population mortality 
The final structure is a population that reflects changes in the three demographic 
characteristics and also incorporates mortality improvement (Table 5-5). This is simply 
Pg,a,e
LAD,y
. 
 
 
129 
 
5.6.1.7 Optimisation 
If these adjustments work perfectly then there should be exact agreement between the 
relevant marginal totals in Table 5-4 to Table 5-10. The gender totals in Table 5-9 
should match with the gender totals in Table 5-7 (they do) and the age, gender and age 
by ethnicity totals in Table 5-9 should match with those in Table 5-8 (they don’t quite). 
Similarly the gender, ethnic and gender by ethnicity totals in Table 5-10 should match 
those in Table 5-7 (they do) whilst the age totals in Table 5-10 should match those in 
Table 5-8 (they don’t quite). 
Whilst the factoring described above has, in this hypothetical example, produced 
population structures that nearly meet the required constraints of re-producing a mix of 
population structures, this cannot be guaranteed and whilst they may be a  good starting 
point for a suitable structure, further work is required. 
Here this extra level of agreement is achieved by optimising the counts within the table 
so that they meet the required margin totals dictated by the required structure. This is 
achieved by optimising the cells in the table to minimise the differences between the 
optimised and required totals. The starting values in this optimisation are those derived 
above using the factoring approach. For the Population Gender counts this involves: 
Choose PGg,a,e
* LAD,y
such that they minimise: 
TAEG= ∑|PGg,+,+
* LAD,y
− PNg,+,+
LAD,y
|
2
g=1
+∑∑|PG+,a,e
* LAD,y
− PS+,a,e
 LAD,y
|
5
e=1
8
a=1
 
5-17 
The first part of equation 5-17 attempts to reproduce the gender totals of Table 5-7 
whilst the second part attempts to reproduce the age by ethnicity marginal totals of 
Table 5-8. For Population ethnicity counts the expression is: 
Choose PEg,a,e
* LAD,y
 such that they minimise: 
TAEGE=∑∑|PEg,+,e
* LAD,y
− PNg,+,e
LAD,y
|
5
e=1
2
g=1
+∑|PE+,a,+
* LAD,y
− PS+,a,+
LAD,y
|
8
a=1
 
5-18 
The first part of equation 5-18 attempts to reproduce the gender by ethnicity marginal 
totals of Table 5-7 whilst the second part attempts to reproduce the age totals of Table 
5-8. 
The success of the optimisation can be judged by the values of equations 5-17 or 5-18 at 
the minimum and the impact of the changes can be judged by the difference between the 
initial PGg,a,e
LAD,y
and the optimised PGg,a,e
* LAD,y
 (and similarly between PEg,a,e
LAD,y
 and PEg,a,e
* LAD,y
). 
It is hoped that these changes are small. 
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For the hypothetical example using Table 5-10 as the starting point and minimising the 
function in equation 5-18 using the EXCEL solver add-in (FrontlineSolvers, 2015) 
produces the population structure PEg,a,e
* LAD,2021
in Table 5-11. 
Table 5-11 : The optimised 2011 Census age structure BUT the gender and ethnic split 
and 2021 population size is the same as the no mortality improvement  
2021 Male Female age by gender age by ethnicity   
ETHNIC (OPT) White BME White BME Male Female White BME age 
Aged 50 to 64 177.6 24.4 218.5 26.4 202.1 244.9 396.2 50.8 447.0 
Aged 65 to 75 132.6 18.4 173.9 26.4 151.0 200.2 306.4 44.8 351.2 
Aged 75 and older 89.8 6.2 132.6 13.2 95.9 145.8 222.4 19.4 241.8 
gender by ethnicity 400.0 49.0 525.0 66.0 
1040 gender 449.0 591.0 
ethnicity White  925.0  BME 115.0 
The value of the objective function value of equation 5-18 with Table 5-10 is 4.58 and 
after the optimisation the value with Table 5-11 it is 0.00058. The sum of the absolute 
changes made between Table 5-10 and Table 5-11 is 4.66; which is just 0.4% of the 
population size. 
5.6.2 Health change drivers 
The impact of no changes in health status is measured by not ageing individuals and not 
applying the mortality, morbidity or migration probabilities in the health 
microsimulation and consequently not introducing Replenishers. This approach 
provides the same cohort of individuals to represent each gender, age and ethnic 
population in the LAD for all forecast years. Coupled with this is the need to have equal 
probability of selection for mortality and migration, else otherwise the prevalence rate 
within the sub population would change over times by virtue of disproportionately 
selecting individuals by their morbidity. 
5.6.3 Health decomposition implementation  
The health microsimulation can be used to estimate the number of individuals with a 
morbidity for all these health decomposition scenarios. The starting point is using the 
original population (Table 5-4) as input to the health microsimulation instead of the 
adjusted ETHPOP projections and not implementing any of the ageing, replenishment, 
ageing or selection mechanisms (in fact these mechanisms are not implemented until the 
final scenario). The second scenario is to repeat the exercise but use the 2011 Census 
population that is re-sized to the size of a population with no mortality improvement 
(Table 5-8). The third scenario substitutes the population with one that has undergone 
gender adjustment (Table 5-9); the fourth substitutes with a gender and ethnicity 
adjustment (Table 5-10); the fifth with a no mortality improvement structure adjustment 
(Table 5-7). The penultimate scenario uses the revised ETHPOP projections (Table 5-5) 
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without the health change drivers (e.g. ageing or updating of morbidities). The final 
scenario is the full model that uses the adjusted ETHPOP projections and the health 
change drivers e.g. ageing, replenishing the population, unequal selection probabilities 
and updating morbidities. 
The impact of each demographic and health driver can be quantified in terms of an 
incremental (I) and a relative (R) change in the size of the population at risk and those 
affected with the morbidity. The equations for the absolute changes are: 
ISg,a,e
LAD,y
 =MSg,a,e
LAD,y
‐ MOg,a,e
LAD,y
 5-19a 
IGg,a,e
LAD,y
 =MGg,a,e
LAD,y
‐ MSg,a,e
LAD,y
 5-19b 
IEg,a,e
LAD,y
 =MEg,a,e
LAD,y
‐ MGg,a,e
LAD,y
 5-19c 
INg,a,e
LAD,y
 =MNg,a,e
LAD,y
‐ MEg,a,e
LAD,y
 5-19d 
IMg,a,e
LAD,y
 =MMg,a,e
LAD,y
‐ MNg,a,e
LAD,y
 5-19e 
IHg,a,e
LAD,y
 =MHg,a,e
LAD,y
‐ MMg,a,e
LAD,y
 5-19f 
where  MOg,a,e
LAD,y
 is the number of individuals with the morbidity based on the 2011 
Census population; 
MSg,a,e
LAD,y
 is the number of individuals with the morbidity based on a re-sized 
population without mortality improvement; 
MGg,a,e
LAD,y
 is the number of individuals with the morbidity based on a population 
without mortality improvement adjusted by gender; 
MEg,a,e
LAD,y
 is the number of individuals with the morbidity based on a population 
without mortality improvement adjusted by gender and ethnicity; 
MNg,a,e
LAD,y
 is the number of individuals with the morbidity based on a population 
without mortality improvement adjusted by gender, ethnicity and age; 
MMg,a,e
LAD,y
 is the number of individuals with the morbidity based on a population 
with mortality improvement adjusted by gender, ethnicity and age but no health 
improvement; 
MHg,a,e
LAD,y
 is the number of individuals with the morbidity based on a population 
with mortality improvement adjusted by gender, ethnicity and age with health 
improvement. 
The final estimate of the number of individuals with a morbidity can be reconstructed 
from the original estimate MOg,a,e
LAD,y
 and the incremental estimates in equations 5-19a to 
5-19f using equation 5-20. 
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MHg,a,e
LAD,y
= MOg,e,q
LAD,y
+ISg,e,q
LAD,y
+IGg,e,q
LAD,y
+IEg,e,q
LAD,y
+INg,e,q
LAD,y
+IMg,e,q
LAD,y
+IHg,e,q
LAD,y
 5-20 
Alternatively, the impacts can be derived as a ratios: 
RSg,a,e
LAD,y
 =MSg,a,e
LAD,y
\ MOg,a,e
LAD,y
 5-21a 
RGg,a,e
LAD,y
 =MGg,a,e
LAD,y
\ MSg,a,e
LAD,y
 5-21b 
REg,a,e
LAD,y
 =MEg,a,e
LAD,y
\MGg,a,e
LAD,y
 5-21c 
RNg,a,e
LAD,y
 =MNg,a,e
LAD,y
\ MEg,a,e
LAD,y
 5-21d 
RMg,a,e
LAD,y
 =MMg,a,e
LAD,y
\ MNg,a,e
LAD,y
 5-21e 
RHg,a,e
LAD,y
 =MHg,a,e
LAD,y
\ MMg,a,e
LAD,y
   5-21f 
In which case the final estimate of the number of individuals with a morbidity can be re-
constructed using equation 5-22. 
MHg,a,e
LAD,y
= MOg,e,q
LAD,y
× RSg,e,q
LAD,y
×RGg,e,q
LAD,y
×REg,e,q
LAD,y
×RNg,e,q
LAD,y
×RMg,e,q
LAD,y
×RHg,e,q
LAD,y
 5-22 
5.6.4 Health decomposition scenarios  
It is possible to examine these ratios to gauge to what extent health outcomes are 
inevitable and which are modifiable.  The multipliers 
RSg,e,q
LAD,y
×RGg,e,q
LAD,y
×REg,e,q
LAD,y
×RNg,e,q
LAD,y
 are largely outside the control of the health services 
and other agencies, representing the natural change in population structure. The 
multiplier, RMg,e,q
LAD,y
, is a consequence of the postponement of death through: lifestyle 
and occupation changes, environmental improvements and good health care. 
If the value of the final multiplier, RHg,e,q
LAD,y
, is less than 1.00 then this measures the 
potential impact of intervening to reduce morbidity prevalence, or if it is greater than 
1.00, how much needs to be done to mitigate the future prevalence for the morbidity. 
5.7 PRESENTATION OF RESULTS 
The health microsimulation produces a large volume of output. The basic outputs from 
the health microsimulation are counts of individuals who do and do not have each of the 
three morbidities in the 324 LADs for the 10 forecast years. Since the microsimulation 
works at the level of individuals, these morbidity statistics can also be presented 
separately by gender, age, ethnicity and smoking status.  
To compare the outputs between areas, the prevalence counts can be converted into 
rates and expressed as a percentage using equation 5-23. 
prevalence rate%morbidity
LAD,y
=
prevalence count
population at risk
 ×100  5-23 
To provide insight into the outcomes of the modelling process, a number of differing 
formats are used. These outputs are tabular, graphical and maps but use is also made of 
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case study LADs. To this end, seven LADs are selected, one each from the ONS area 
type classification at the level of Super Groups (ONS, 2003). In each Super Group, the 
LAD ‘closest’ to the centre of the cluster is chosen as the case study LAD. These LADs 
and their distance from the centre are given in Table 5-12. Since there are three Super 
Groups orientated towards London, there is a large percentage of these case studies 
form Greater London. 
Table 5-12 : LADs cluster and distance to cluster centres 
Super Group LAD (distance) 
Cities and Services Leeds (1.22) 
London Suburbs Redbridge (3.07) 
London Centre Camden (1.49) 
London Cosmopolitan Haringey (3.87) 
Prospering UK Wiltshire (0.76) 
Coastal and Countryside Teignbridge (1.41) 
Mining and Manufacturing Rotherham (1.12) 
5.8 CONCLUSION 
In this chapter each component of the structure of the health microsimulation model has 
been introduced in order to satisfy the third objective.  Diagrammatically, this structure 
is illustrated in Figure 5-1. The structure involves many components: a spatial 
microsimulation to define a starting population for each LAD; a collection of ethnic 
population projections to define the structure of future LAD populations; a mechanism 
to evolve the population through time to 2031; and a series of hazard models to both 
identify significant characteristics in the population and to modify the status of the 
individuals in the population over time.  
A range of constraint tables are available for use in the spatial microsimulation and 
special care is taken in constructing these tables to ensure that the population size in 
consistent in each table. Individuals who are resident in institutional establishments as 
clients are included in the spatial microsimulation so here the spatial microsimulation 
covers the entire population, not just those resident in households. Too often these 
individuals are omitted from health models and, although small in number, their health 
care needs are distinct and critical.  
Use is made of an external aggregate population projection to ensure that the future 
population structure within each LAD evolves over time. In light of the subsequent 
release of 2011 Census tables these projections are re-based, adjusted and constrained to 
ONS sub-national population projections. 
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The health microsimulation takes as input these LAD starting populations and the 
adjusted population projections to evolve the population from 2011 to 2031 in biennial 
steps. This is achieved by: ageing the population; changing the morbidity status of 
individuals; replenishing the population at the younger ages; and constraining the 
population to the projected structure. 
In an attempt to understand how each of these dynamics affect the future morbidity 
status of the population, the changes in the structure of the population are decomposed 
into scenarios that reflect changes due to the size of the population and its gender, ethnic 
and age structure. An additional scenario is developed which does not implement any 
trends in improved morbidity outcomes. 
This thesis continues with a series of five results chapters which meet the fourth 
objective set out in section 1.4. The first three results chapters deal with one aspect of 
the methodology described in this chapter. They are the spatial microsimulation that 
defines the LADs base population in 2011 (Chapter 6); the revisions to the ETHPOP 
projections (Chapter 7); and the probability aspects of the methodology, e.g. estimation 
of hazard models and representing the chances of having smoked in the Replenishers 
(Chapter 8). Chapter 9 presents the outcome of the health microsimulation and the final 
results chapter, Chapter 10, describes the decomposition of the morbidity outcomes 
using an accounting system. 
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6 SPATIAL MICROSIMULATION 
Creating the Initial Population 
6.1 INTRODUCTION 
This chapter presents the result of the spatial microsimulation that establishes a 2011 
base population of those aged 50 and older for each LAD in England. This will be 
achieved by using a set of constraint tables derived from the 2011 Census and a sample 
population taken from wave 5 of ELSA. The aim of the spatial microsimulation is to 
estimate a series of LAD specific weights for the sample population so that the 
composition of the weighted sample population re-produces the LADs counts in the 
2011 Census tables.  
The chapter begins in section 6.2 with a re-cap of the candidate 2011 Census tables that 
have the potential to be used in the spatial microsimulation. Attention then turns in 
section 6.3 to the ELSA wave 5 data that are used to identify those constraints that 
contribute significantly to explaining the three outcome morbidities of CVD, DHBS and 
respiratory illness. In the spirit of Anderson (2007), the literature review and the 
outcome of hazard model fits are used to identify a set of constraint tables for use in 
both the spatial microsimulation and for validation purposes. Section 6.4 reports on the 
calibration fit of the spatial microsimulation providing a visual assessment of the path to 
convergence for each LAD. Section 6.5 reports the outcome of the spatial 
microsimulation summarised using the estimated prevalence of the three morbidities for 
each LAD in 2011. The important issue of how robust the weight estimation process is 
to the choice of random numbers is covered in section 6.6. The validation against a set 
of constraint tables that are not used in the spatial microsimulation is reported in section 
6.8.  The final section, 6.9, provides a summary of the finding of this chapter and point 
to how they will be used in a subsequent chapter on health microsimulation. 
6.2 CONSTRAINT TABLES 
In section 4.5 an overview is provided of the variables that are both consistent between 
the 2011 Census and ELSA and that have been found to influence individual’s health 
outcomes in the literature. More detail on how this compatibility is achieved is provided 
in sections 5.3.1 and 5.3.2 which describe the reformatting of the 2011 Census data and 
the wave 5 ELSA data. 
All the constraint tables are cross tabulations for two reasons. Firstly, it follows the 
advice of Hermes and Poulsen (2012a) who highlight that such cross tabulation may 
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account for an unequal distribution among the categories that is not apparent in a series 
of univariate tables. Secondly, this requirement implicitly accepts that such tabulations 
represent not just potential but actual significant interactions between their constituent 
variables which motivates the ONS to continue to produce such cross tabulations. 
Commonly two of the dimensions used in tables published by the ONS are gender and 
age. This age banding is of crucial importance here since there is a requirement to 
isolate the count information to just the 50 years and older population. The third 
constraint variable is then one of the potential socio-demographic (ethnicity, disability 
or living status) or socio-economic variables (highest level of qualification, vehicle 
ownership, tenure of accommodation or amount of unpaid care provided). 
6.3 CHOICE OF CONSTRAINT TABLES 
Looking at the health of the population using a general measure such as disability free 
life expectancy shows that there is a small difference in health status by gender. In 
section 2.8 the historic difference, with females having a slightly longer disability free 
life expectancy than males, is seen to persist but this may be diminishing over time. The 
literature review also suggests that there are potentially differing health outcomes for 
males and females for specific morbidities.  
Age is also a possible factor that may influence health status – as people get older their 
health tends to deteriorate.  There are also some morbidities, diabetes being a case in 
point, that has different prevalence by ethnicity. Other factors include various socio-
demographic factors that relate to affluence or deprivation through accumulated wealth 
or income, e.g.  educational qualification; social classification or tenure. 
6.3.1 Initial constraint selection 
Using morbidity outcomes in waves 1 to 6 of ELSA, hazard models are fitted to these 
data that attempts to measure the influence of various factors in predicting the incidence 
of these morbidities. Thinking forward to the health microsimulation it is important that 
the population of each LAD, in its composition, accurately reflects nature of the area so 
that future incidence and hence prevalence can be estimated. An initial set of variables 
that are strong candidates for inclusion arising out of a consideration of the literature are 
shown in Table 6-1 for each of the three morbidities. The table shows the deviance 
values, the degrees of freedom (dof) for the model, the change in deviance over the 
preceding model and its the significance level.  
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Table 6-1 : Model deviance values for initial constraints 
CVD deviance dof change  significance 
constant 4000.9 1    
wave 3999.8 2 1.10  29.4% 
wave + age 3915.7 3 84.08 
*** 
0.0% 
wave + age + gender 3903.0 4 12.69 
***
 0.0% 
wave + age + gender + disability 3788.9 5 114.11 
***
 0.0% 
wave + age + gender + disability + ethnicity
1
 3786.1 8 2.85  41.5% 
Diabetes or high blood sugar      
constant 4081.8 1    
wave 4079.3 2 2.50  11.4% 
wave + age 4078.9 3 0.41  52.1% 
wave + age + gender 4070.4 4 8.50 
***
 0.4% 
wave + age + gender + disability 4011.6 5 58.82 
***
 0.0% 
wave + age + gender + disability + ethnicity
1
 3986.6 8 24.94 
***
 0.0% 
Respiratory illness      
constant 3139.5 1    
wave 3129.5 2 9.95 
***
 0.2% 
wave + age 3128.3 3 1.20  27.4% 
wave + age + gender 3128.1 4 0.26  60.8% 
wave + age + gender + disability 3056.2 5 71.81 
***
 0.0% 
wave + age + gender + disability + ethnicity
1
 3053.7 8 2.54  46.8% 
Note : 
1 The three ethnic groups are: White; Asian; and Black, Mixed or Other. There are too few occurrences of 
the morbidities to reliably separate out the Mixed and the Other grouping. 
* significant at the 10% level, ** significant at the 5% level, *** significant at the 1% level 
The pattern of impact in Table 6-1 for each morbidity is inconsistent. The time trend, 
captured by the wave counter, is only significant for respiratory illnesses. This finding 
indicates that over time the probability of acquiring a respiratory illness has changed, all 
other things being equal. Age in only significant for the acquisition of CVD meaning 
that the probability of acquiring CVD varies by age.  It is important to understand that 
this latter result does not mean the prevalence of these other morbidities does not vary 
by age. Recall that the purpose of the hazard model is to identify those factors that 
influence the incidence of the morbidity. Where age is not a significant factor then this 
says that, all other things being equal, the probability of acquiring the morbidity does 
not change with age. However, looking at the prevalence in the population as a whole, 
and given that the acquisition of a morbidity is an absorbive event, people will carry any 
morbidities with them through the age ranges until they leave the population, either 
through death or migration. Incidences at younger ages therefore accumulate to higher 
prevalences at older ages. Gender is important for two morbidities, CVD and DHBS – 
for these morbidities, males have a different probability of acquiring these two 
morbidities than females. Unsurprisingly the presence of a disability is significant in 
predicting the onset of a morbidity – since the presence of one of these morbidities 
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would incline people to describe their day to day activities as being limited. The final 
variable in this initial set is ethnicity which is shown to only be influential in predicting 
the onset DHBS. All the constraints in this initial set are seen to be influential for at 
least one morbidity – none can be rejected as being totally irrelevant. CVD justifies the 
inclusion of all the potential constraints except ethnicity and DHBS justifies the 
inclusion of ethnicity. 
6.3.2 Socio-economic constraint selection 
As described in section 4.5 and Table 5-1, there remain a number of candidate socio-
economic constraint variables to help constrain the spatial population. These are: 
highest educational qualification, vehicle ownership and use, living arrangements, 
provision of unpaid care, social economic classification and tenure. From these 
candidate constraints it is useful to select both an additional constraint variable and one 
or two variables for validation purposes as outlined in section 5.3.3. As is done above in 
section 6.3.1 hazards models that build on the five variable models in that section are 
used to identify these constraints. However, here each candidate will be considered in 
turn and in isolation since there is a desire not to over-fit these data which can dilute the 
impact of other more informative variables, induce correlations between variables and 
make the model calibration more challenging than it needs to be. There is also the desire 
to retain some constraints, outwith the spatial microsimulation fit, for validation 
purposes. In Table 6-2 these hazard modelling results are shown in Table 6-1. 
As seen for Table 6-1, once again there is little unanimity in the outcomes. Few 
variables are significant for CVD whilst many are significant for DHBS. Vehicle 
ownership is significant at least at the 10% level for all morbidities. Living arrangements 
and NS-SEC are significant at least at the 5% level for DHBS and respiratory illness.  
Highest qualification and tenure are only significant for one morbidity. The provision of 
unpaid care is never significant. 
The results in Table 6-2 shows that vehicle ownership is the most import socio-
economic variable, followed by either living arrangements or NS-SEC.  The obvious 
choice would be to include vehicle ownership as a constraint variable in the spatial 
microsimulation, but here it is used instead as a measure to validate the model outputs. 
It is important that such a validation measure is itself significant and influential in 
determining the outcome of interest; otherwise its validation performance would be 
irrelevant. However there is still a need for a socio-economic constraint to include as a 
constraint variable. So, the next best constraint is used as the socio-economic constraint 
in the spatial microsimulation, leaving the third most important constraint available as a 
second validation. This logic means that living arrangements is chosen as the socio 
economic constraint variable to use in the spatial microsimulation since it outperforms 
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NS-SEC on two of the morbidities, leaving NS-SEC as the second validation constraint, 
in addition to vehicle ownership. 
Table 6-2 : Model deviance values for candidate socio-economic variables 
CVD deviance dof Change  significance 
Base (from Table 6-1) 3786.06 8    
Highest qualification 3783.10 11 2.96  39.9% 
Vehicle ownership  3770.48 10 15.58 
***
 0.04% 
Living arrangements 3778.98 14 7.07  31.4% 
Unpaid care 3782.30 11 3.76  28.9% 
NS-SEC 3781.85 12 4.20  37.9% 
Tenure 3785.67 11 0.39  94.3% 
Diabetes or high blood sugar 
Base (from Table 6-1) 3986.61 8    
Highest qualification 3974.70 11 11.91 
***
 0.77% 
Vehicle ownership  3973.68 10 12.93 
***
 0.16% 
Living arrangements 3964.09 14 22.52 
***
 0.10% 
Unpaid care 3985.37 11 1.24  74.3% 
NS-SEC 3966.22 12 20.39 
***
 0.04% 
Tenure 3935.52 11 51.09 
***
 0.00% 
Respiratory illness 
Base (from Table 6-1) 3053.70 8    
Highest qualification 3052.44 11 1.26  73.8% 
Vehicle ownership  3048.40 10 5.31 
***
 7.04% 
Living arrangements 3036.93 14 16.77 
**
 1.02% 
Unpaid care 3052.58 11 1.12  77.2% 
NS-SEC 3041.43 12 12.28 
**
 1.54% 
Tenure 3049.22 11 4.49  21.3% 
* significant at the 10% level, ** significant at the 5% level, *** significant at the 1% level 
6.4 SPATIAL MICROSIMULATION ESTIMATION 
Following on from the analysis in the previous section the constraint tables used in the 
spatial microsimulation are: gender by five year age band (LC1117) (Table 13-1); 
gender by age by ethnicity (DC2101) (Table 13-2); gender by age by disability 
(household residents) (LC3101) (Table 13-3); gender by age by disability (institutional 
residents who are clients) (DC3402) (Table 13-13) and gender by age by living 
arrangements (DC1108) (Table 13-10).  
The Flexible Modelling Framework (FMF) software package is used to derive the LAD 
specific spatial weights, using the default optimisation parameters for the software 
(Harland, 2013). This implementation of the CO approach to spatial microsimulation 
has been used in health planning (for local prevalence estimates, Clark et al., 2014 and 
Shulman et al., 2015), transport (to estimate the capacity for walking and cycling in 
Leeds, Phillips, 2015 and estimating carbon emissions in Beijing, Ma et al., 2014) and 
to examine the impacts of urban renewal (Jordan et al., 2010). 
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To derive the spatial weights for a population of just over 18 million people, the FMF 
takes 12 hours on a quad core i5-2300 PC with 4GB of RAM running Windows 7. The 
outputs of the FMF are contained in two files: a sample weights file that contains pairs 
of zone identifiers (i.e. LADs) and sample member identifiers (i.e. ELSA participants), 
the number of rows of which equals the size of the constraint population (in this case 
18,299,893); and a fit statistic file that reports the Total Absolute Error (TAE) at the end 
of each annealing stage for each zone (the TAE here is analogous to that of 5-5). Given 
the requirement that the size of the 50 and older population in each LAD is maintained, 
there is some degree of double counting in the TAE, i.e. if an individuals is miss-
allocated then the fit is out by |+1| for one constraint in a table (an over count), then for 
another constraint in the same table it must also be out by |-1| (an under count), making 
a total contribution to the TAE of +2. 
Figure 6-1 shows the rate of convergence of the TAE over the 100 annealing stages, 
categorised by the TAE at the end of the first iteration. There are 226 LADs whose 
initial TAE is below 100 and further iterations make modest reductions in this already 
good TAE. There are just 17 LADs with a TAE above 1,000, and even with these 
challenging LADs the FMF is able to quickly reduce the TAE to a range of between 6 
and 202. Recall that the TAE measures the differences between the implied counts 
(derived using the set of weights) and the actual constraint counts, summed over 16 + 
20 + 17 + 11 + 36 = 100 constraint counts. Whilst these TAEs are not zero, they are 
very small when compared to the size of the population within each LAD, which 
averages 56,000 and ranges from 15,443 to 292,565. In the context of the number of 
constraints to be satisfied and the size of the population, the fit can be declared good. 
6.5 ESTIMATING DISEASE PREVALENCE 
Using information in ELSA for waves 1 to 5 it is possible to establish at the time of the 
wave 5 interview whether an ELSA participant had a practitioner diagnosed morbidity 
of CVD, DHBS or respiratory illness. The weighted count of those individuals with a 
morbidity within the spatially microsimulated population for each LAD enables an 
estimate of the prevalence count for a morbidity to be made and this can be converted 
into a prevalence rate by dividing by the size of the 50 and older population. These 
prevalence counts and rates are shown in Figure 6-2. These maps show the prevalence 
for each morbidity as a colour scale and also the number of individuals with the 
morbidity as a circle, where the area of the circle is proportional to the number of 
individuals with the morbidity. Four maps are provided, one for each single morbidity 
and one for the CVD and DHBS comorbidity. Inset maps are provided for London and 
Greater Manchester and Merseyside. 
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Figure 6-1 : Change in TAE from the spatial microsimulation, categorised by initial 
TAE 
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Figure 6-2 : Prevalences and number of individuals with morbidities, LADs, 2011, from 
top left, CVD, top right, diabetes or high blood sugar, bottom left, respiratory 
illness and botton right CVD and diabetes or high blood sugar 
The 10 LADs with the highest and lowest estimated prevalences rates are shown in 
Table 6-3. For those LADs with high prevalences of CVD there is a range of types of 
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LAD, including urban cities, London boroughs and semi-rural LADs in southern 
England. There could be a number of explanations for this mix of LADs. Firstly, some 
LADs will have a population which is generally in poorer health, the causes of which 
could be employment history or lifestyle factors (e.g. Tendering). The second 
explanation could be due to the ethnic makeup of the area, with some ethnic groups 
tending to have a higher prevalence of the conditions that contribute to CVD (e.g. the 
south Asian community in Tower Hamlets which makes up a quarter of its 50 and older 
population). The final explanation could be related to a generally aged population living 
in the area, with the incidences of CVD accumulating in an older age structure (e.g. 
Eastbourne).  
For DHBS perhaps the sole defining characteristic is the ethnic composition of the 
LAD, with all the top ten LADs having a high proportion of their population from the 
BME community, in particular the south Asian community, which tends to have higher 
rates of DHBS than the general population (see table 2.7 of HSCIC, 2005b). With 
respiratory illness there appears to be both an ethnic and deprivation dimension to those 
LADs in the top ten, indicating that this morbidity affects individuals differently 
depending on their ethnicity or deprivation. The LADs with the highest prevalence for 
the comorbidity of CVD and DHBS appears to be those most influenced by patterns of 
DHBS prevalence, with very similar LADs featuring in the top ten for both DHBS and 
CVD and DHBS. 
The pattern for 10 LADs with the lowest prevalences appears clearer than for the 10 
highest. The vast majority of LADs are prosperous authorities located in Southern 
England, but there are also some London boroughs reporting low prevalences. Clearly 
the very diverse and cosmopolitan nature of this category of area type can lead to some 
divergence in the expected outcomes with respect to some morbidities. A case in point 
is the London borough of Southwark which has the lowest estimated prevalence rate for 
respiratory illness and a low prevalence for CVD. Southwark is an authority with a large 
black African and Caribbean population (in the 2011 Census this ethnic group makes up 
17% of the 50 and older population in Southwark). Again the report by the HSCIC 
(2005b) shows that illnesses due to the heart and circulatory system and to the 
respiratory system are lower for this ethnic group than the general population. Further, a 
study of standardised mortality ratios by Chaturved (2003) shows that people from this 
ethnic group, particularly men, have a mortality risk of dying from CVD of half that of 
the general population. In other Cosmopolitan London boroughs with a different ethnic 
mix (say a larger south Asian population) a different prevalence profile is relevant and 
this is borne out by an inspection of the top 10 prevalences in the same table. 
144 
 
Table 6-3 : Highest and lowest prevalences for CVD, diabetes or high blood sugar, respiratory illness and CVD and diabetes or high blood sugar, 
LADs, 2011 
Rank CVD Diabetes or high blood sugar Respiratory illness CVD and DHBS 
1 Leicester (CI) 18.9% Newham (LC2) 17.3% Leicester (CI) 22.2% Newham (LC) 7.3% 
2 Tendring (CC) 18.1% Brent (LC2) 17.1% Tower Hamlets (LC) 22.0% Leicester (CI) 7.2% 
3 Sandwell (CI) 18.0% Leicester (CI) 16.4% Newham (LC2) 21.3% Tower Hamlets (LC) 7.1% 
4 Tower Hamlets (LC) 18.0% Tower Hamlets (LC) 16.4% Sandwell (CI) 20.9% Brent (LC) 6.6% 
5 Eastbourne (RC) 18.0% Harrow (LS) 15.6% Wolverhampton (CI) 20.9% Harrow (LS) 6.2% 
6 Wolverhampton (CI) 17.9% Slough (LS) 15.5% Blackburn with Darwen (CI) 20.8% Hounslow (LS) 6.1% 
7 Rother (CC) 17.9% Hackney (LC2) 15.5% Knowsley (IH) 20.7% Ealing (LS) 6.1% 
8 Christchurch (CC) 17.9% Ealing (LS) 15.4% Hounslow (LS) 20.7% Slough (LS) 6.1% 
9 Thanet (CC) 17.8% Hounslow (LS) 15.3% Birmingham (CI) 20.6% Redbridge (LS) 5.9% 
10 Wyre (CC) 17.6% Redbridge (LS) 15.2% Slough (LS) 20.6% Manchester (CI) 5.6% 
       
  
315 South Northamptonshire (PST) 13.6% Elmbridge (PSE) 10.5% Surrey Heath (PSE) 17.1% South Hams (CC) 3.3% 
316 Daventry (PST) 13.6% Stroud (PST) 10.5% South Northamptonshire (PST) 17.1% South Cambridgeshire (PSE) 3.3% 
317 Basingstoke and Deane (PSE) 13.5% Bracknell Forest (PSE) 10.5% Waverley (PSE) 17.1% Bracknell Forest (PSE) 3.3% 
318 Milton Keynes (NGT) 13.4% South Northamptonshire (PST) 10.5% Mid Sussex (PSE) 17.0% Guildford (PSE) 3.3% 
319 Lambeth (LC2) 13.4% Wokingham (PSE) 10.5% Guildford (PSE) 17.0% South Northamptonshire (PST) 3.3% 
320 Southwark (LC2) 13.3% Uttlesford (PSE) 10.4% Kensington and Chelsea (LC) 16.9% Basingstoke and Deane (PSE) 3.3% 
321 Hart (PSE) 13.3% Chiltern (PSE) 10.4% Hart (PSE) 16.9% East Hertfordshire (PSE) 3.2% 
322 West Berkshire (PSE) 13.2% Mid Sussex (PSE) 10.4% Rutland (PST) 16.8% West Berkshire (PSE) 3.2% 
323 Wokingham (PSE) 13.2% East Hertfordshire (PSE) 10.4% Tandridge (PSE) 16.8% Surrey Heath (PSE) 3.2% 
324 Bracknell Forest (PSE) 13.1% West Berkshire (PSE) 10.3% Southwark (LC2) 16.8% Hart (PSE) 3.1% 
Note : CI Centres with Industry; CC Coastal and Countryside; LC London Centre; RC Regional Centres; PST Prospering Smaller Towns; PSE Prospering Southern England; NGT 
New and Growing Towns; LC2 London Cosmopolitan; LS London Suburbs; IH Industrial Hinterlands 
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6.6 ROBUSTNESS OF SPATIAL POPULATION 
The approach adopted by the FMF involves a stochastic mechanism that operates both 
through the selecting and de-selecting individuals and the ‘annealing’ decision on 
whether to accept a deterioration in model fit. These decisions are made through the 
generation of a sequence of pseudo random numbers and the values in this sequence are 
determined by a seed value. By varying this seed value a different sequence of random 
numbers will be used in the FMF. To explore the sensitivity of the outcomes to this seed 
value two additional runs of the FMF are conducted with differing seed values and, to 
assess the sensitivity of the final fit to this value, two comparisons are made. Firstly the 
final TAE value for each LAD in each run is compared and secondly the sensitivity of 
an outcome of interest, the prevalence of CVD, DHBS and respiratory illness is 
compared across runs. 
6.6.1 Stochastic TAE fit 
By comparing the TAE at the end of the spatial microsimulation an aggregate picture is 
obtained of the consistency of the optimisation process when using different seeds. 
Ideally that each optimisation would converge to a similar TAE value, and a scatter plot 
of these values will lie on a 45° line that passes through the origin. Figure 6-3 shows 
these scatter plots between pairs of spatial microsimulations runs with different seed 
values and the correlation coefficient (r
2
) between the two measures.  
 
Figure 6-3 : Comparison of final TAEs from three spatial microsimulations 
These plots clearly show that the quality of the final model fit is not sensitive to the 
random number seed used, with the correlations being near perfect. 
6.6.2 Stochastic prevalence estimates 
Whilst Figure 6-3 is re-assuring that the model fits in aggregate are consistent, there is 
value in performing a more detailed comparison of how an outcome of interest is 
influenced by the random number seed. In section 6.5 a method of estimating a 
morbidity outcome is defined, and measured as a prevalence rate for each LAD. Here 
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the spatially microsimulated populations generated for the TAE comparison in section 
6.6.1 is used to estimate two additional set of LAD prevalences. Once again a 
comparison of the consistency of these estimates is made using a scatter plot and again 
the points should line on a 45° straight line that passes through the origin. These plots 
are shown in Figure 6-4 along with the linear correlation coefficient r
2
. Whilst there is 
some scatter, the correlation between the two sources of estimates is reassuring and 
high. Once again this provides the reassurance that the composition of the spatially 
microsimulated population is not sensitive to the random number seed chosen. 
 
Figure 6-4 : Comparison of LAD prevalences from three spatial microsimulations, from 
top : CVD, diabetes or high blood sugar, respiratory illness and CVD and diabetes 
or high blood sugar 
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6.7 MODEL PARAMETERS 
In addition to specifying the random number seed the FMF also allows for the variation 
of various parameters used to govern the optimisation process. The first three 
parameters (maximum number of steps, maximum number of improvement steps and 
number of improvement to the optimisation before continuing) control the looping 
within the optimisation (Harland, 2013, page 30) and the larger the values the greater 
the search space that is explored. To check that the default parameters are sufficient to 
explore the search space, an additional run was conducted with these values increased 
by 30% (from 100 to 130 for the first two parameters and from 10 to 13 for the third, 
and the execution time increases from 12 to 20 hours as a consequence). The output 
from this run is compared with the run using the default parameters and a random seed 
of 10. 
The fourth parameter is the annealing reduction factor (set at the recommended value of 
0.9). The larger this factor  the more the search space is explored. This factor is varied 
to a larger value of 0.95 and two smaller values of 0.85 and 0.80. With a factor of 0.95 
the execution time increases to 18 hours, whilst with factors of 0.80 and 0.85 the 
execution time reduces to 10 hours. Again these three runs are compared with the run 
using the default parameters and a random seed of 10.  
Table 6-4 : Comparison of final TAE from alternative parameter runs 
Alternative model Correlation with default parameters and 
seed of 10 
Looping parameters plus 30% 0.9999 
Annealing reduction factor of 0.95 0.9999 
Annealing reduction factor of 0.85 0.9993 
Annealing reduction factor of 0.80 0.9992 
Table 6-4 provides the linear correlation coefficient in the final TAE values between the 
run with the default parameters and a seed of 10 and the four alternative runs described 
here. The top two rows show that the increase in the search space does not change the 
final TAE’s by much. The bottom two rows show marginal changes in the final TAE, 
the more so with the lowest factor. A similar comparison of the morbidity outcomes 
from these four alternative runs with the default parameter run is provided in Table 6-5. 
Again there is a reassuring agreement between the estimates from the default parameter 
run and these alternatives. 
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Table 6-5 : Comparison of prevalence counts from alternative parameter runs 
Alternative model CVD DHBS Respiratory Illness 
Looping parameters plus 30% 0.9731 0.9865 0.9629 
Annealing reduction factor of 0.95 0.9781 0.9829 0.9659 
Annealing reduction factor of 0.85 0.9775 0.9852 0.9673 
Annealing reduction factor of 0.80 0.9773 0.9868 0.9642 
From the results in Table 6-4 and Table 6-5 there is reassurance that the optimisation 
process is robust to the choice of the parameters. There is some evidence to suggest that 
the default parameters maybe too ambitious, causing the FMF to do more work than is 
strictly necessary, with lower parameter values possibly being acceptable. However the 
extra work is not too arduous (12 hour runs are eminently doable) and if the parameter 
values are reduced too far then the differentiation between LADs contained in the 
constraints would not be re-produced. 
6.8 VALIDATION 
In section 6.3 vehicle ownership or use and NS-SEC are chosen as validation variables 
to test how well the spatially microsimulated population re-produces a measure of 
interest that is not used as a constraint. To assess the level of agreement between the 
actual 2011 Census counts and the derived counts from the spatially microsimulated 
population a series of scatter plots are used. If the level of agreement between the two 
counts is good then most of these points should lie along a straight 45° line that passes 
through the origin. The degree of scatter away from this 45° line can be measured by the 
correlation coefficient. 
6.8.1 Vehicle ownership or use 
Figure 6-5 shows four scatter plots for the levels of vehicle ownership within the four 
sub-populations that are males aged between 50 and 64 (M50), males aged 65 and older 
(M65), females aged 50 to 64 (F50) and females aged 65 and older (F65). The same 
counts are also shown in Figure 6-6, however here each of the three scatter plot contains 
gender and age plots for each of the three levels of ownership.  Looking at these charts 
it is clear that the ownership of one vehicle is the most common category, irrespective 
of gender and age. Also owning two or more vehicles is more common amongst the 
younger age groups, irrespective of gender.  
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Figure 6-5 : Scatter plot of vehicle ownership or use by gender and age categories, 
LADs, 2011, clockwise from top left: males aged 50 to 64, females aged 50 to 64, 
females aged 65 and older and males aged 65 and older  
 
Figure 6-6 : Scatter plot of vehicle ownership or use by level of ownership or use 
categories, LADs, 2011, top row, left to right: no vehicles, one vehicle, bottom 
row, two or more vehicles 
The level of agreement between the two counts is generally good, with a slight tendency 
for the spatially microsimulated population to under-predict the number of individuals 
living in households without a vehicle and a consequent slight over prediction of the 
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number of multiple vehicle owning households. The agreement for individuals living in 
households with one vehicle is particularly good. The correlation coefficients in Table 
6-6 also shows that the degree of spread is least for individuals living in one vehicle 
households. 
Table 6-6 : Correlation coefficient between the census counts and the FMF derived 
counts for vehicle ownership 
 Gender Age Vehicle Ownership r
2
 
Male Aged 50 to 64 No vehicles 0.9465 
Male Aged 50 to 64 One vehicle 0.9830 
Male Aged 50 to 64 Two or more vehicles 0.9440 
Male Aged 65 and older No vehicles 0.9232 
Male Aged 65 and older One vehicle 0.9913 
Male Aged 65 and older Two or more vehicles 0.8777 
Female Aged 50 to 64 No vehicles 0.9383 
Female Aged 50 to 64 One vehicle 0.9871 
Female Aged 50 to 64 Two or more vehicles 0.9441 
Female Aged 65 and older No vehicles 0.9610 
Female Aged 65 and older One vehicle 0.9891 
Female Aged 65 and older Two or more vehicles 0.8631 
6.8.2 NS-SEC 
Figure 6-7 shows four gender by age scatter plots for NS-SEC with the four sub-
populations (the equivalent of Figure 6-5) and Figure 6-8 shows six NS-SEC scatter 
plots within which are plotted for the four gender by age categories (the equivalent of 
Figure 6-6). The level of agreement between the two counts here is less good than for 
vehicle ownership or use. There appears to be good agreement for the intermediate 
(class 2) and semi-routine and routine (class 5) classes. The other class of never worked 
or long-term unemployed (class O) is particularly poorly re-produced. This under 
prediction is coupled with an over prediction of higher managerial, administrative and 
professional occupations (class 1) and lower supervisory and technical occupations 
(class 4). The remaining class, small employers and own account workers (class 3) 
appears to be slightly under estimated in the spatially microsimulated populations. 
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Figure 6-7 : Scatter plot of NS-SEC by gender and age categories, LADs, 2011, 
clockwise from top left: males aged 50 to 64, females aged 50 to 64, females aged 
65 and older and males aged 65 and older 
Clearly the spatially microsimulated population has not re-produced well the nature of 
some LADs by their NS-SEC population. The performance is particularly poor for the 
group that defines those who have never worked or are long term unemployed. It is 
reasonable to assume that some of the reasons why individuals find themselves in this 
group are health related. 
Looking at the degree of scatter measured by the correlation coefficients in Table 6-7 
the scatter is greatest for class 3 and class O categories, which depending on the gender 
and age range.  
 
152 
 
 
Figure 6-8 : Scatter plot of NS-SEC by NS-SEC category, LADs, 2011 (as labelled). 
6.9 CONCLUSION 
In this chapter a description is provided of the process used to define and select the set 
of constraints to use for the calibration of the LAD specific weights and those to use for 
validation. This is in essence a two stage process. The literature informs the choice of 
constraint variables in the first stage, covering gender, age, ethnicity and disability. Here 
these constraints are largely givens, with the hazard model providing some context to 
the relative strength of each of these variables in determining the incidence for the 
morbidities. The literature also suggests that there are also socio-economic factors that 
contribute to health outcomes in an area. A range of such factors are considered in turn 
and using the outcome of hazard modelling, three are selected, either as constraint or 
validation variables. From an inconsistent set of results, the variable living 
arrangements is chosen as the final constraint variable, leaving vehicle ownership or use 
and NS-SEC classification as validation variables. 
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Table 6-7 : Correlation coefficient between the census counts and the FMF derived 
counts for NS-SEC 
Gender Age NS-SEC r
2
 
Male Aged 50 to 64 class 1 0.9203 
Male Aged 50 to 64 class 2 0.9237 
Male Aged 50 to 64 class 3 0.9355 
Male Aged 50 to 64 class 4 0.9089 
Male Aged 50 to 64 class 5 0.9401 
Male Aged 50 to 64 class O 0.6954 
Male Aged 65 and older class 1 0.9049 
Male Aged 65 and older class 2 0.9240 
Male Aged 65 and older class 3 0.8830 
Male Aged 65 and older class 4 0.9515 
Male Aged 65 and older class 5 0.9246 
Male Aged 65 and older class O 0.7149 
Female Aged 50 to 64 class 1 0.9499 
Female Aged 50 to 64 class 2 0.9679 
Female Aged 50 to 64 class 3 0.8189 
Female Aged 50 to 64 class 4 0.9517 
Female Aged 50 to 64 class 5 0.9468 
Female Aged 50 to 64 class O 0.9063 
Female Aged 65 and older class 1 0.9211 
Female Aged 65 and older class 2 0.9413 
Female Aged 65 and older class 3 0.7742 
Female Aged 65 and older class 4 0.9644 
Female Aged 65 and older class 5 0.9620 
Female Aged 65 and older class O 0.9452 
 
The weight estimation process is seen to produce fits that, whilst not perfect, are very 
good, with small TAE’s when measured relative to the size of the population being 
synthesised. Given the availability of a spatially microsimulated population for each 
LAD and information on the morbidity status of the individuals in this population, it is 
possible to estimate prevalence counts and rates for the morbidities in each LAD. The 
general picture is for these prevalence rates to be lowest in the more affluent LADs in 
southern England. The picture for those authorities with the highest prevalence is more 
mixed and specific to the morbidity. CVD is seen to be potentially influenced by a 
variety of factors, including deprivation; ethnicity and an aged population. With DHBS 
the picture is simpler; LADs with a high percentage south Asian population have high 
prevalences. For respiratory illness the main influence appears to be living in a densely 
populated urban area, which itself is probably an occupation or lifestyle impact. 
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Recognising that the spatial microsimulation process is driven to a large degree by a 
stochastic mechanism, a number of duplicate model runs are conducted with differing 
random number seeds. The consistency of these runs is measured in aggregate through 
the final TAE for model fits and in more detail through the morbidity estimates 
mentioned above. In both cases the agreement between the outcomes from each model 
run is seen to be satisfactory, allaying any concerns over the sensitivity of the outputs to 
this random number seed value. 
The final piece of work reported on here are the validation counts derived from the 
spatially microsimulated population against 2011 Census counts of vehicle ownership 
or use and the NS-SEC. The validation for vehicle ownership is seen to be good, with a 
slight under estimate in the spatially microsimulated population of individuals in 
households without a vehicle and a commensurate increase in those with one vehicle. 
For NS-SEC the validation is less good, in particular the number of people who had 
never worked or are long-term unemployed (class O) are underrepresented in the 
spatially microsimulated population. 
Notwithstanding this issue with NS-SEC class O, the outcome from this exercise is a 
spatially population that reflects the composition of each LADs 50 years and older 
population at the time of the 2011 Census. This is the base population that the health 
microsimulation evolves through time. This process is described in section 5.5 and the 
results shown in Chapter 9. Before then, however, the impact of the revision process on 
the ETHPOP population projection is described in Chapter 7 and the justification for the 
probabilities used in the health microsimulation is described in Chapter 8.  
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7 ETHPOP REVISIONS  
Development of Projected Ethnic Populations 
7.1 INTRODUCTION 
As discussed in the methodology chapter, the purpose of the ETHPOP population 
projections is to re-structure the future year’s population of those aged 50 and older in 
each LAD so that it represents some projected ethnic structure and size. The motivation 
behind this desire is that, firstly, the size of the population will have an impact on the 
number of individuals with a specific morbidity. Secondly, the literature has shown that 
the diversity of the population, by gender, age and ethnicity also impacts on the 
prevalence rates for some morbidities (HSCIC, 2005b). 
This chapter begins in section 7.2 with a discussion of the performance of the original 
ETHPOP population projections in re-producing the ethnicity counts in the 2011 
Census. In this section the performance is assessed using aggregate measures and a 
ranking of best and worst prediction performances and, in section 7.3, the predictive 
performance for the seven case study LADs are discussed in detail. The chapter then 
provides a discussion of the adjustment factors that form a pivotal role in revising the 
ETHPOP projections from 2013 to 2031 in section 7.4. Section 7.5 gives an overview of 
the impact of the revisions by comparing the original and revised ETHPOP projections 
for 2031. This impact is further explored in the context of the seven case study LADs in 
section 7.6. The chapter finishes with a summary of these findings and the potential 
issues raised. In these analyses, the ETHPOP data was obtained as a bulk download of 
the ethnic population projections available from the ETHPOP web site (University of 
Leeds, 2011).   
7.2 COMPARISON OF 2011 ETHPOP PROJECTIONS AND 2011 
CENSUS COUNTS 
At the time of the production of the original ETHPOP population projections, the 2011 
Census outputs were not available as a potential source of information on medium term 
trends in the structure of the ethnic population within LADs. The subsequent 
publication of 2011 Census data does, however, allow a validation check on the 
performance of the ETHPOP projections to be carried out. 
The task of producing population projections is a complex one that is subject to a 
number of assumptions that, whilst having historic veracity, many not hold well even 
for the short or medium term. Of the three main drivers of the demographic process, it is 
the mortality and migration drivers that are likely to influence most the size and 
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structure of the 50 year and older population. Figure 3-1 illustrates these national 
mortality assumptions used in ONS projections.  The general trend is for these 
assumptions to become more optimistic with each new set of projections – life 
expectancies increase. Migration is an even more complex phenomenon. Not only is it 
difficult to forecast what the future trends in migration might be, it also difficult to 
measure historic or current trends (see ONS, 2014h, of a review of the performance of 
migration methodologies). These difficulties in forecasting mortality and particularly 
migration are further compounded by the desire to measure and apply these at a sub-
national geography, e.g. English LADs. In particular migration now needs to capture the 
hitherto irrelevant internal migrations between these sub-national geographies.  
Added to the complexity of a detailed geography, there is further complexity if the 
definition of the population is expanded beyond gender and age, as is the requirement 
here by ethnicity. There is thus a need to measure and project these two significant 
demographic processes by ethnicity. Ethnic identification can itself be fluid, with the 
same individual identifying themselves as different ethnic groups over time, depending 
on the range of groups offered or their own assessment (Simpson et al., 2014). 
From an initial comparison at a national level between the 2011 ETHPOP projections 
and the 2011 Census output (Rees et al, 2013c), the recommendation is that the best 
outcome at prediction is reached if the mean of the TREND and UPTAP-ER scenarios 
are taken. This advice is followed in this study. The same report hints at some of the 
reasons behind the discrepancies identified by the comparison. The most relevant here is 
a tendency for the trended life expectancies of the projected population to be too high, 
particularly for the White ethnic group.  
Here the correspondence between the averaged ETHPOP TREND and UPTAP-ER 
projections and the 2011 Census outputs is judged using Census table DC2101, which 
provides cross tabulations of gender by age by ethnic group for LADs in England. The 
ages are banded into five year bands, providing eight such bands for the over 50’s. The 
ethnic groups are detailed by sixteen classes but for comparative purposes these groups 
are aggregated here into five broad groups to form: White, Mixed, Asian, Black and 
Other groups with the Chinese class re-allocated from Asian to Other (to maintain 
consistency with ELSA categorisations).  
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7.2.1 Difference by structure 
The first comparison is at a national 
scale between the ETHPOP 
projections and the 2011 Census 
counts and is provided in the form of 
population structure diagrams. 
Looking at this figure, the ETHPOP 
projections are good for the younger 
50 to 64 White ethnic group, but 
thereafter there is a tendency for the 
ETHPOP projections to be greater 
than the Census counts. This 
confirms that ETHPOP has under 
estimated the mortality for these 
older age bands. For the Mixed 
group, ETHPOP under predicts at all 
ages above 50, especially for the 
youngest 50 to 54 year old age band. 
The prediction performance for the 
Asian group is the opposite of that 
for the White group. Here the 
prediction performance is worst for 
the younger age bands (ETHPOP 
under predicts) but is generally good 
for the older age bands. The 
prediction performance for the Black 
ethnic group is good, especially for 
females. The prediction performance 
for Other females is also good but for 
Other males the performance is poor, 
with ETHPOP consistently under 
predicting the numbers in this ethnic 
group. 
  
Figure 7-1 : Comparison of English population 
structures, 2011, from top: White, Mixed, 
Asian, Black and Other 
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7.2.2 Direction of differences 
Subject to the qualifications mentioned above, the projection performance on a national 
scale appears reasonable; however, there may be local variations in this performance. In 
the remainder of this section these local measures of difference between the ETHPOP 
projections and the 2011 Census counts are explored. To quantify the agreement 
between the two counts a Total Error (TE) statistic is calculated for each LAD using 
equation 7-1. 
TE%e
LAD= 
∑ ∑ (Eg,a,e
LAD,2011‐ Cg,a,e
LAD,2011)8a=1
2
g=1
∑ ∑ (Cg,a,e
LAD,2011)8a=1
2
g=1
 7-1 
where: TE%e
LAD is the total error percentage between the ETHPOP and Census 
population counts for ethnicity e in local authority LAD; 
 Eg,a,e
LAD,2011
 is the ETHPOP sub-population of gender g,  aged a, of ethnicity e, in 
LAD for 2011; 
 Cg,a,e
LAD,2011
 is the 2011 Census sub-population of gender g,  aged a, of ethnicity 
e, in LAD for 2011. 
Note : Cg,a,e
LAD,2011and Eg,a,e
LAD,2011 are not contemporaneous (27th March vs 20th June respectively). 
Whilst this is a cause of genuine difference, it is likely to be of little practical importance when 
compared with other sources of variation. 
This measure provides an indication of the size of the aggregate discrepancy relative to 
the size of the population and the direction of this discrepancy is preserved, either as an 
under or an over prediction. If the percentage is positive then the ETHPOP projections 
are, in aggregate, over estimates (i.e. greater than those from the 2011 Census) and if it 
is negative then the ETHPOP projections are under estimates. To prevent any errors 
calculated on small counts inflating the outcome, if the Census population (i.e. the 
denominator of equation 7-1) is less than 160 then the calculation is not performed (this 
value is the equivalent of an average of ten people in each gender and age band 
combination). 
A frequency tabulation of TE% for each of the five broad ethnic groups is shown in 
Table 7-1. The smallest range of errors is for the White ethnic group. This is also the 
most symmetric group but still with a bias towards over prediction by ETHPOP. In 
contrast, all the remaining ethnic groups have been under predicted by ETHPOP. The 
scale of under prediction is particularly poor for the Mixed group, where 75 LADs have 
an under prediction of more than 30%. There are also a large number of LADs where 
the size of the aged 50 and older ethnic populations, for other than the White and Asian 
groups, is fewer than 160. 
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Table 7-1 : Distribution of LADs by total error percentages for each ethnic group 
 
 
White Mixed Asian Black Other ALL 
Population fewer than 160 0 139 74 181 134 0 
E
T
H
P
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er
 
p
re
d
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ts
 t
h
e 
C
en
su
s 
Less than -30% 0 75 39 15 53 0 
Between -25% and -30% 0 18 27 13 21 0 
Between -20% and -25% 0 23 22 13 18 0 
Between -15% and -20% 2 28 27 14 16 2 
Between -10% and -15% 5 20 39 21 11 4 
Between -5% and -10% 37 9 27 21 9 39 
 Between 5% and -5% 151 10 39 25 20 162 
E
T
H
P
O
P
 o
v
er
 
p
re
d
ic
ts
 t
h
e 
C
en
su
s 
Between 5% and 10% 54 1 7 7 11 59 
Between 10% and 15% 33 1 7 7 6 32 
Between 15% and 20% 14 0 4 4 5 9 
Between 20% and 25% 9 0 1 1 5 9 
Between 25% and 30% 7 0 4 0 5 6 
More than 30% 12 0 7 2 10 2 
Looking at the worst performing LAD’s both in terms of under and over prediction in 
Table 7-2, some commonalities are present. The ten LADs that are most under predicted 
for the White ethnic group are located in the south of England (except Ryedale in North 
Yorkshire) and all are prosperous in nature. The most over predicted are from Greater 
London or close by (Slough) and each is characterised by a cosmopolitan mix of ethnic 
groups. For the remaining four ethnicities there appears to be less of a pattern, with 
LADs that are geographically dis-located, affluent and deprived, and a range of ethnic 
diversities appearing in both the top ten under and over predictions. The performance of 
Cornwall and the Isles of Scilly is particularly bad for the black ethnicity, but this is due 
to the small population for the denominator in equation 7-1 (the values for the 
calculation are 393/179 = 220%). 
7.2.3 Extent of difference 
The calculation of the total error percentage in equation 7-1 allows cancellation of under 
and over predictions amongst the gender and age band combination to take place. If 
however the absolute value of these differences is taken, then this cancellation effect is 
removed: 
TAE%e
LAD = 
∑ ∑ |Eg,a,e
LAD,2011 − Cg,a,e
LAD,2011|8a=1
2
g=1
∑ ∑ (Cg,a,e
LAD,2011)8a=1
2
g=1
 7-2 
where TAE%e
LAD is the total absolute error percentage between the ETHPOP and 
Census population counts for ethnicity e in local authority LAD. 
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Table 7-2 : Top and bottom ten LADs by total error percentage performance 
  White   Mixed   Asian   Black   Other   
1 South Hams -17% East Lindsey -58% Rushmoor -74% Eastbourne -64% Wolverhampton -71% 
2 Rother -16% Thanet -55% Chichester -63% Basildon -47% Sandwell -68% 
3 South Somerset -12% Blackpool -54% Vale of White Horse -47% Southend-on-Sea -46% Oadby & Wigston -68% 
4 Ryedale -11% Barnsley -54% Tunbridge Wells -45% Woking -46% South Tyneside -66% 
5 Mid Suffolk -11% Wirral -53% Swindon -45% Wakefield -43% Poole -61% 
6 West Dorset -11% Test Valley -53% Ashford -44% Broxbourne -41% Blackburn with Darwen -61% 
7 Purbeck -10% Lewes -52% Surrey Heath -44% Dartford -34% Bury -56% 
8 East Devon -10% Eastleigh -51% Mole Valley -43% Hertsmere -34% Gravesham -56% 
9 Shepway -9% South Kesteven -51% Harborough -43% Thurrock -33% Tonbridge & Malling -55% 
10 Adur -9% Halton -51% Worthing -42% Stoke on Trent -33% Enfield -55% 
  
          
315 Lewisham 35% Cherwell -3% South Tyneside 27% Luton 14% Shropshire 31% 
316 Newham 36% Brighton & Hove -2% Sheffield 27% Kingston upon Hull 14% Canterbury 34% 
317 Tower Hamlets 38% Norwich -2% Portsmouth 27% Slough 15% Merton 40% 
318 Islington 39% Luton -1% Harrogate 31% Newham 17% Swindon 41% 
319 Slough 39% Guildford -1% Exeter 39% Bolton 18% Oxford 41% 
320 Southwark 42% Woking -1% Kingston upon Hull 46% Redbridge 18% Runnymede 41% 
321 Hammersmith & Fulham 42% Aylesbury Vale 0% County Durham 62% Cheshire East 20% Reading 46% 
322 Wandsworth 50% Sheffield 0% Northumberland 64% Wigan 22% Newham 50% 
323 Hackney 58% Kingston upon Thames 6% Shropshire 79% Wiltshire 31% County Durham 60% 
324 Lambeth 65% Ealing 12% Cornwall & Isles of Scilly 105% Cornwall & Isles of Scilly 220% Norwich 71% 
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The distribution of TAE% is shown in Table 7-3. Here there is no direction of 
prediction, either under or over. Instead this calculation assesses the size of the error, 
irrespective of direction. Very few LADs have a TAE% of less than 5% and even for 
the best performing White ethnic group, the minority have TAE%s less than 10%.  The 
remaining ethnicities have substantial numbers of LADs with TAE%s greater than 30%. 
Table 7-3 : Distribution of LADs by total absolute error percentages for each ethnic 
group 
 
White Mixed Asian Black Other ALL 
Population fewer than 160 0 139 74 181 134 0   
Less than 5% 8 0 0 1 0 5 
Between 5% and 10% 138 0 23 12 0 140 
Between 10% and 15% 120 5 32 20 2 127 
Between 15% and 20% 26 19 43 25 11 30 
Between 20% and 25% 13 17 42 26 36 11 
Between 25% and 30% 7 31 38 16 32 6 
More than 30% 12 113 72 43 109 5 
The ten best LAD and ten worst LAD performers on the TAE% calculation are shown 
in Table 7-4. The pattern seen for the White ethnic group in Table 7-2 holds true in this 
table too. Looking at the remaining ethnicities, the large urban authorities tend to 
perform best on this calculation, particularly for the Asian and Black ethnicities. The 
poor performance for Cornwall and the Isles of Scilly with the Asian and Black 
ethnicities persists into this table. 
The ETHPOP authors are aware of the errors in their projections (Rees et al., 2015) and 
are working on a complete revision of their projections but these new results are not 
expected until September 2015. Therefore in the meantime there is a need to implement 
an approximate correction that revises the ETHPOP projections so that they align with 
published 2001 and 2011 Census outputs, this correction was described in Section 5.4 
and the outcome of which is described here in Section 7.5.  
7.3 COMPARISON FOR CASE STUDY AUTHORITIES 
Whilst an overall assessment of projection performance might be gained from the 
appearance of Figure ‎7-1, the evidence in Table 7-2 and Table 7-4 suggests that there 
are local differences in this projection performance. In section 5.7 a number of case 
study LADs are identified using their representativeness of other LADs with the same 
ONS Super Group area classification. Here the population structure diagrams that 
compare the averaged 2011 ETHPOP projections and 2011 Census counts for these 
LADs are provided, with an accompanying discussion.  
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Table 7-4 : Best ten and worst ten LADs by total absolute error percentage performance 
  White   Mixed   Asian   Black   Other   
1 South Gloucestershire 3% Brighton & Hove 11% Bradford 6% Waltham Forest 5% Lambeth 12% 
2 Huntingdonshire 3% Hillingdon 12% Birmingham 6% Croydon 6% Southwark 12% 
3 Erewash 4% Sheffield 12% Wolverhampton 6% Southwark 6% Epsom & Ewell 16% 
4 Swindon 4% Manchester 14% Coventry 6% Haringey 7% Cambridge 16% 
5 Waverley 4% Ealing 15% Sandwell 7% Birmingham 8% Lewisham 16% 
6 North Somerset 4% Haringey 15% Luton 7% Lambeth 8% Elmbridge 17% 
7 Woking 5% Birmingham 16% Bristol 7% Barnet 8% Greenwich 18% 
8 Winchester 5% Leicester 16% Warwick 7% Islington 9% Harrow 18% 
9 Basildon 5% Wandsworth 16% Tower Hamlets 7% Leicester 9% Barnet 18% 
10 Rushcliffe 5% Kingston upon Thames 16% Leeds 7% Hackney 9% Liverpool 19% 
                      
315 Lewisham 35% Lewes 53% Vale of White Horse 47% Nuneaton & Bedworth 42% Bury 57% 
316 Tower Hamlets 38% Halton 54% Exeter 48% Broxbourne 44% Tonbridge & Malling 58% 
317 Newham 38% South Kesteven 54% Kingston upon Hull 48% Maidstone 46% Blackburn with Darwen 61% 
318 Islington 39% Rother 54% Isle of Wight 49% Plymouth 46% Poole 62% 
319 Slough 39% Wirral 55% County Durham 62% Basildon 47% South Tyneside 66% 
320 Southwark 42% Thanet 55% Chichester 63% Woking 49% County Durham 66% 
321 Hammersmith & Fulham 42% Blackpool 57% Northumberland 64% Wakefield 50% Oadby & Wigston 68% 
322 Wandsworth 50% Test Valley 58% Rushmoor 74% Southend-on-Sea 54% Sandwell 68% 
323 Hackney 58% East Lindsey 58% Shropshire 79% Eastbourne 67% Wolverhampton 71% 
324 Lambeth 65% Barnsley 59% Cornwall & Isles of Scilly 105% Cornwall & Isles of Scilly 220% Norwich 71% 
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7.3.1 Leeds (Cities and 
Services) 
The relative predictive performance 
for the White ethnic group in Leeds 
is reasonable for the younger age 
bands, but the performance 
deteriorates at the oldest age bands, 
particularly for those aged 80 and 
older. For males aged 85 and older 
the ETHPOP projection is over 
twice the 2011 Census count. 
Conversely, the Mixed ethnic group 
performs well at older ages but 
poorly at younger ages – although 
the difference when quantified as 
numbers is small. Of the five ethnic 
groups the best prediction 
performance is probably for the 
Asian group. The correspondence is 
good for all ages in this ethnic 
group that, after the White group, is 
the most numerous in Leeds for the 
50 and older population.  The Black 
ethnic group is the third largest in 
Leeds and, like the Mixed group, 
the ETHPOP performance is good 
at older ages but under predicts for 
the two younger age bands, 
especially for males. This pattern of 
under prediction of males is also 
evident within the Other group.  
  
Figure 7-2 : Comparison of Leeds population 
structures, 2011, from top: White; Mixed; 
Asian, Black and Other ethnicities 
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7.3.2 Redbridge (London 
Suburb) 
In Redbridge, the ETHPOP 
projections for the White ethnic 
group over predicts the population 
at most age bands, with the 
performance at predicting 65 to 69 
years olds being poor in both 
absolute and relative terms. 
However, in contrast to Leeds, the 
performance for the very old is very 
good indeed. The performance for 
the Mixed group is reasonable 
except for the very youngest age 
band where ETHPOP under 
predicts by a significant percentage, 
although the numbers involved are 
again small. As for Leeds, the 
performance with the Asian group 
is remarkably good for Redbridge 
whose Asian group is beginning to 
be as large as the White group. The 
Black group is also another sizeable 
demographic and the predictive 
performance of ETHPOP is better 
for the middle and older age bands. 
Relatively speaking the 
performance at predicting the Other 
group is the poorest of the five, 
ETHPOP under predicts by around 
a half the number of people in this 
group. 
  
Figure 7-3 : Comparison of Redbridge population 
structures, 2011, from top: White, Mixed, 
Asian, Black and Other ethnicities 
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7.3.3 Camden (London 
Centre) 
The White ethnic group is by far the 
largest in Camden, with none of the 
remaining ethnic groups being 
larger than 600 for any gender and 
age combination.  Again for this 
group, the tendency is for the 
ETHPOP projections to exceed the 
Census counts, and this is perhaps 
most pronounced for older males. 
With the Mixed group the 
performance is poor for the 
youngest age band (an under 
prediction by ETHPOP) but does 
improve for older age bands. 
Looking at the 2011 Census counts 
for the Asian group, there appears to 
be a disproportionately large 
number of females in the younger 
age bands. This feature has been 
replicated by the ETHPOP 
predictions, but not to the same 
extent. For the Black group at 
younger ages, the performance of 
ETHPOP reverses that seen for the 
Mixed group, with an over 
prediction at younger age bands. 
With the remaining Other group, the 
predictive performance for males is 
good but less so for females. 
  
Figure 7-4 : Comparison of Camden population 
structures, 2011, from top: White, Mixed, 
Asian, Black and Other ethnicities 
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7.3.4 Haringey (London 
Cosmopolitan)  
Here, the ETHPOP projections 
consistently over predict the 
number of individuals in the White 
ethnic group. Whilst these 
differences are similar in absolute 
number for each gender and age 
band, the proportionate impact is 
greater for the older age band. The 
prediction performance is much 
better for the Mixed group, 
particularly females. As with 
Camden, Haringey shows a 
disproportion number of females in 
the younger age Asian groups 
when compared to males. Other 
than this feature, the performance 
is reasonable.  Looking at the 
structure diagram for the Black 
ethnicity, this appears to be the 
group that shows evidence of a 
transition in its importance for 
Haringey. The 50 to 54 year old 
age band is almost twice that of the 
next oldest band and this dramatic 
transition has been well predicted 
by ETHPOP. ETHPOP 
consistently under predicts the size 
of the Other ethnic group.  
  
Figure 7-5 : Comparison of Haringey population 
structures, 2011, from top: White; Mixed; 
Asian, Black and Other ethnicities 
 
 
167 
 
7.3.5 Wiltshire (Prospering 
UK) 
Wiltshire is a large authority (both 
terms of geography and 
population) with a predominately 
White ethnic population. The 
resultant scale of the structure 
diagrams tends to mask the size of 
some of the differences between 
the ETHPOP projections and the 
2011 Census. For example the 
Female, aged 60 to 64, White 
ethnic group projections are 1,200 
fewer than the 2011 Census 
counts. The remaining four 
ethnicities are much smaller in 
size and there is a pattern of under 
prediction for the Mixed and 
Asian ethnic groups and an over 
prediction for the Black and Other 
groups. The transition in the size 
of the Black ethnic group between 
ages 50 to 54 and 55 to 59 as seen 
in other case study authorities, is 
also present here in rural 
Wiltshire, although to a less 
pronounced degree due to the 
smaller population size. 
  
Figure 7-6 : Comparison of Wiltshire population 
structures, 2011, from top: White, Mixed, 
Asian, Black and Other ethnicities 
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7.3.6 Teignbridge (Coastal 
and Countryside) 
The coastal and countryside area 
classification is probably the most 
heterogeneous of the ONS defined 
areas, ranging from the 
economically comfortable towns 
of Teignmouth in Devon to the 
more socially and economically 
challenged resort of Blackpool in 
the North West. Teignbridge is, 
like Wiltshire, a LAD with a 
predominantly White ethnic 
population, although it is smaller 
in size than Wiltshire. The 
ETHPOP projections are generally 
good for the White ethnic group, 
until the two older age bands, with 
the oldest age band, 85 and older, 
being greatly over predicted by 
ETHPOP.  The populations of the 
remaining four ethnicities are very 
small; indeed they are fewer than 
160, the cut off used in Table 7-1 
and Table 7-3. This makes it 
difficult to identify any reliable 
features in these population 
structures. 
  
Figure 7-7 : Comparison of Teignbridge population 
structures, 2011, from top: White; Mixed; 
Asian, Black and Other ethnicities 
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7.3.7 Rotherham (Mining and 
Manufacturing) 
Rotherham is once again a LAD 
where the White ethnic group 
dominates the 50 and over 
population. The predictive 
performance of ETHPOP is good 
for all White ethnic group ages and 
genders except for a sizeable under 
prediction of males aged 60 to 64 
and females aged 85 and older. 
After the age of 54 the Mixed 
ethnic group has a small population 
size that is not well predicted by 
ETHPOP. The Asian ethnic group 
is more substantial in number and 
the pattern is for ETHPOP to under 
predict this population. As for the 
Mixed ethnic group, the Black 
ethnic group is also small after age 
54, but does again show this 
transition pattern between ages 50 
54 and 55 to 59 mentioned 
elsewhere. For the remaining Other 
group, the populations are once 
again small (but greater than 160 in 
aggregate) with Rotherham 
showing a disproportionate large 
number of males aged 50 to 59 
relative to females. This feature has 
not been predicted by the ETHPOP 
projections. 
Figure 7-8 : Comparison of Rotherham population 
structures, 2011, from top: White, Mixed, 
Asian, Black and Other ethnicities 
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Looking at these representative LADs from within each of the ONS area classifications 
has revealed some common issues. Firstly the ETHPOP projections have tended to 
overestimate the size of the White ethnic group in each LAD, particularly for the oldest 
age bands, which is most probably influenced by the mortality assumptions used in the 
projections. The pattern for the remaining ethnic groups is less clear cut, but to some 
extent does reinforce the picture in Table 7-1 and Table 7-3, that the ETHPOP 
projections under predict these four ethnic groups. However whilst the percentages in 
these tables appear large, in many cases the number of people involved in these under 
predictions are small. Ethnic switching (Simpson et al., 2014) will also influence the 
relative projection performance between groups if individuals chose to define their 
ethnicity differently over time, particularly those in the Mixed group. 
7.4 PROJECTION ADJUSTMENT FACTORS 
In 5.4 the concept of an adjustment factor is defined to correct for the difference 
between the ETHPOP and 2011 Census population growths from 2001 to 2011 is 
introduced. This adjustment factor is itself a measure of the correspondence between the 
ETHPOP 2011 projections and the 2011 Census counts, the greater the departure from 
1.00 for this adjustment factor, the poorer the correspondence.  
However before these raw adjustments are used to adjust the trends in population 
change beyond 2011, the factors for each LAD are constrained to lie within a 
[10%,90%] area type specific confidence interval empirically derived for each ethnicity. 
In Figure 7-9 to Figure 7-13 a series of box plots type charts are provided that capture 
these distributions. In these charts, the centre line marks the median adjustment factor. 
The box marks the lower and upper quartiles, and the height of this box is the inter-
quartile range (IQR). The lower whisker marks the 10% ile whilst the upper whisker 
marks the 90% ile. The asterisks below the 10% ile are the 10% of factors that are less 
than the 10% ile whilst those above are the 10% of factors that are greater than the 90% 
ile. As outlined in section 5.4.1, it is these outlying values that are truncated to the 10 
and 90% ile. The difference between the highest and lowest factor is the range.  
If there is no relationship between these adjustment factors and a grouping of these 
factors by some criteria (here the ONS area type classification) each of the box type 
plots for each grouping would be similar, both in terms of their median level and the 
spread – in essence the grouping would just be a random sample of factors (the Other 
ethnic group shown in Figure 7-13 perhaps comes closest to this idea of there being no 
discriminatory information in the area type). Differences in the median level and/or 
spread indicate either a clustering of factors around a particular level and/or an inherent 
degree of variation in their estimation. 
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Figure 7-9 : Box type plots of the distribution of the adjustment factors in each area type 
for the White ethnic group 
The White ethnic group shows a wide variation in the median level of these adjustment 
factors. If this factor is greater than 1.0 then the ETHPOP projections are under 
estimates of the 2011 Census White population (the Census counts are larger than the 
ETHPOP projections in equation 5-6). The median adjustment factor is greater than 1.0 
only for the Prospering UK (1.0047) and Coastal and Countryside (1.0011) area types – 
ETHPOP has under estimated these populations in 2011. The IQRs also vary by area 
type, being the smallest for Mining and Manufacturing (0.0049) and Coastal and 
Countryside (0.0056). The IQR is greatest for London Centre (0.0132). Compared to 
some of the remaining ethnic groups, the range of factors by area type for the White 
group are fairly consistent. 
 
Figure 7-10 : Box type plots of the distribution of the adjustment factors in each area 
type for the Mixed ethnic group 
Like the remaining four ethnicities the contrast in median levels for the Mixed ethnic 
group is not so pronounced as for the White group. However, the spread in some types 
of area are quite different, with the London centric areas having a much narrower range 
of factors than the remaining areas. 
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Figure 7-11 : Box type plots of the distribution of the adjustment factors in each area 
type for the Asian ethnic group 
For the Asian ethnic group, the comments made for the Mixed group apply equally here 
except for the Coastal and Countryside area type where the IQR is much wider than that 
for any remaining area type. This suggests that the ETHPOP projection performance for 
LADs of this type in 2011 was particularly inconsistent. 
 
Figure 7-12 : Box type plots of the distribution of the adjustment factors in each area 
type for the Black ethnic group 
Once again, the Coastal and Countryside area type is distinct from the non-London 
centric area types, however, on this occasion the median level of the adjustment factors 
appears to be much lower here than the rest, signifying that ETHPOP has almost 
consistently over predicted this ethnic group for this area type. 
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Figure 7-13 : Box type plots of the distribution of the adjustment factors in each area 
type for the Other ethnic group 
Perhaps of all five ethnicities this Other group is the one where the distinction by area 
type is least informative. The median levels are very similar and the contrasts in the 
spread are not so stark as for the Mixed, Asian and Black ethnic groups. 
A more formal assessment of the agreement between the distributions of the adjustment 
factors within each area classification can be made by use of the Kruskal Wallis test for 
the equivalence of two distributions (Kruskal and Wallis, 1952). This test is used in 
preference to a one way ANOVA since there is evidence in the box type plots to 
indicate that some of these distributions are not normal. The null hypothesis is that the 
distribution of these adjustment factors is the same within each area type whilst the 
alternative hypothesis is that is at least one area type whose distribution is different to at 
least one other. The results of this test are shown Table 7-5. 
The results here corroborate the visual assessment of Figure 7-9 to Figure 7-13, with 
only the Other ethnic group having similar distributions within each area type. 
Table 7-5 : Results of the Kruskal Wallis test for the difference in the distribution of 
adjustment factors by area type 
Ethnic group Test statistic (K) Degrees of freedom Significance level 
White 138.231 6 0.000 
Mixed 29.704 6 0.000 
Asian 20.292 6 0.020 
Black 55.115 6 0.000 
Other 8.647 6 0.194 
Both the box type plots and the results in Table 7-5 do justify the constraining of the 
raw adjustment factors based on the characteristics that are captured in the area type. 
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Other groupings may exist that produce similar behaviour; however the advantage of 
using these area types is their established provenance from ONS and longevity of use. 
7.5 IMPACT OF ETHPOP REVISIONS 
Section 5.4.2 outlines the methodology that uses these adjustment factors, along with 
2011 Census counts, ETHPOP cohort projections and ONS sub national population 
projections to revise the ETHPOP projections from 2013 to 2031.  
The extent and impact of these revisions to the original ETHPOP projections for the 
final forecast year of 2031 can be calculated as a percentage change between the 
original 2031 ETHPOP 50 and over population and the revised projection (see equation 
7-3).  
TR%e
LAD= 
∑ ∑ (Pg,a,e
LAD,2031‐ Eg,a,e
LAD,2031)8a=1
2
g=1
∑ ∑ (𝐸𝑔,𝑎,𝑒
𝐿𝐴𝐷,2031)8a=1
2
g=1
 7-3 
Where: TR%e
LAD is the total revision percentage between the original ETHPOP and 
revised ETHPOP population counts for ethnicity e in local authority LAD; 
 Pg,a,e
LAD,2031
is the revised ETHPOP sub-population of gender g,  aged a, of 
ethnicity e, in LAD for 2031; 
 Eg,a,e
LAD,2031
is the original ETHPOP sub-population of gender g, aged a, of 
ethnicity e, in LAD for 2031. 
This equation is similar to equation 7-1 and generally it is reasonable to assume that a 
positive TR% indicates an upward revision to the original ETHPOP projections whilst a 
negative value indicates a downward revision. For the White ethnic group, the 
distribution of this TR% value within each area type is shown as traditional box plots in 
Figure 7-14 (the whiskers now represent the additional range of 1.5 times the IQR and 
there are no outliers present). 
Unsurprisingly the trends in this figure match those in Figure 7-9 since the adjustment 
factors shown there are used in the revision process. The greatest reductions in the size 
of the White ethnic group are those area types associated with London. Reductions are 
also seen in the Cities and Services area type, and to a lesser degree, the Mining and 
Manufacturing area type. Upward revisions are commonly seen for both the Prospering 
UK area type and, especially, the Coastal and Countryside area type. 
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Figure 7-14 : Distribution of the impact of the adjustment process on the White ethnic 
group 
The ten LADs with the greatest upward and downward revisions measured by TR% are 
identified for each ethnicity in Table 7-6. The changes seen for the White ethnic group 
are consistent with those highlighted in Figure 7-14 in that the London centre type of 
authority show the greatest downward revision in the size of this population whilst the 
Coastal and Countryside and Prospering UK type of authority show upward revisions. 
Revisions to the Mixed group tend to be consistently revised upward, with only three 
LADs showing a downward revision.  
Rushmoor shows a noteworthy ten fold revision in the size of its south Asian 50 and 
over population. The ETHPOP projections for 2001 and 2011 for the over 40 population 
in Rushmoor are for an increase from 494 to 718 (recall that the adjustment factors are 
calculated to adjust the size of the 40 and older population, not just the 50 and older). 
The equivalent Census counts are an increase from 468 to 3,081. This translates to a 
yearly adjustment factor on +16.3% which is constrained to a value of 5.9% (Rushmoor 
is the outlier for the Prospering UK area type in Figure 7-11). Coupled with this is the 
re-basing of the projections from 2011 to a population of 3,081 rather than 718 which 
also causes subsequent upward revisions to the projection. Clearly the observed growth 
in the Asian population between 2001 and 2011 in Rushmoor is not sustainable and the 
constraining stage has helped to moderate this substantial growth. Also, in a number of 
LADs the already small Black and Other ethnic populations have been eliminated as a 
consequence of these revisions. 
7.6 IMPACT OF REVISION ON CASE STUDY AUTHORITIES 
To further illustrate the impact of these revisions, the population structure diagrams 
showing the original ETHPOP and revised ETHPOP populations for the seven 
representative LADs are given below. These diagrams show the size of the population 
for just two projection years, 2021 and 2031. 
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Table 7-6 : Top ten LADs by upward and downward total revision percentage 
  White   Mixed   Asian   Black   Other   
1 Rother 51.0% Thanet 994.7% Rushmoor 1058.9% Wakefield 690.1% Sandwell 660.9% 
2 South Hams 49.8% Wirral 885.1% Tandridge 639.1% Basildon 678.3% Bury 594.5% 
3 Wealden 39.4% Knowsley 694.8% Ashford 617.1% Dartford 647.0% Dudley 574.1% 
4 Ryedale 38.6% Arun 572.3% Tunbridge Wells 606.5% Broxbourne 641.0% Wolverhampton 572.5% 
5 Mid Suffolk 37.0% East Riding of Yorkshire 571.8% Colchester 576.7% Thurrock 612.1% Slough 551.2% 
6 South Somerset 36.3% Winchester 528.9% South Cambridgeshire 575.0% South Gloucestershire 609.9% Enfield 538.9% 
7 East Dorset 32.3% Barnsley 528.8% Harborough 566.5% Crawley 601.7% Nuneaton and Bedworth 528.0% 
8 Broadland 31.9% Wigan 521.8% Chichester 550.0% West Berkshire 591.2% Gravesham 511.5% 
9 New Forest 31.5% Three Rivers 485.8% Chelmsford 521.4% Stevenage 555.1% Central Bedfordshire 498.2% 
10 Adur 31.0% Waverley 483.9% Vale of White Horse 506.5% Central Bedfordshire 530.1% North Hertfordshire 495.9% 
                      
315 Lewisham -52.1% Hillingdon 7.0% East Devon -86.2% South Hams -98.2% North Dorset -78.7% 
316 Islington -52.6% Ealing 5.3% Cornwall and Isles of Scilly -86.5% Scarborough -98.2% Norwich -80.0% 
317 Redbridge -52.9% Exeter 5.2% Weymouth and Portland -88.8% Carlisle -98.4% Lancaster -80.6% 
318 Southwark -54.3% Hounslow 2.7% West Somerset -90.3% East Devon -99.0% Preston -81.5% 
319 Brent -58.5% Forest Heath 1.5% South Hams -92.2% Craven -100.0% East Lindsey -81.5% 
320 Slough -59.7% Woking 1.1% West Devon -95.1% Eden -100.0% Great Yarmouth -82.6% 
321 Wandsworth -61.1% North Dorset 1.1% North Norfolk -95.3% Purbeck -100.0% North Norfolk -83.2% 
322 Hammersmith and Fulham -64.7% Barking and Dagenham -0.3% Ryedale -95.9% Ribble Valley -100.0% Forest Heath -84.2% 
323 Lambeth -67.6% Boston -10.6% Purbeck -96.6% Torridge -100.0% Boston -85.0% 
324 Hackney -71.6% Leicester -11.7% Torridge -97.0% West Devon -100.0% Purbeck -91.6% 
Population fewer than 240 0   86   0   22   67 
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7.6.1 Leeds (Cities and Services) 
The impact of the revision process on the White ethic group in Leeds is a reduction in 
the size of this group for all gender and age combinations. The population share of this 
group was 91.4% in 2031 using the original ETHPOP projections, but after the revision 
this falls to 82.0%. The revision prcess has nearly tripled the size of the Mixed ethnic 
group but even after the revision this is still a modest 2.9% of the population. The 
impact on the Asian ethnic group appears to be modest too, with a slight increase in this 
population at the younger ages. The greatest impact of the revision in Leeds is on the 
Black group. The larger cohort of 50 to 54 year olds seen in Figure ‎7-2 is seen to age to 
60 to 64 in 2021 and to 70 to 74 in 2031, with a following cohort of a substantive Black 
population.  After the revision process the Black ethnic groups share in 2031 increases 
from 1.5% using the original 2031 ETHPOP projections to 6.2% using these revised 
projections, more than quadrupling. The size of the Other ethnic group population 
continues to grow steadily and the revision process makes this group a little larger. 
7.6.2 Redbridge (London Suburb) 
The most noteworthy impact of the revision process in Redbridge is the reduction in the 
share of the White ethnic group (the original share was 52.0% and the revised share is 
27.6%) and the increase in the Asian group (share from 34.1% to 49.5%) and the Other 
group (share increases from 2.3% to 13.0%). Examing the dynamics of the White group 
first, the size of this group in Redbridge fell from 77,999 in 2001 to 65,454 in 2011. 
This dictates a yearly adjustment factor of -2% (which compunds over 20 year to a 33% 
reduction). Also since the revised ETHPOP projections are re-based to 2011 Census 
counts, the initial base for the White group is the much lower value of 65,454 rather 
than the original ETHPOP projection of 77,949. For the Asian group the year 
adjustment is +1.4% and the 2011 base is revised up to the 2011 Census count of 34,843 
(rather than 30,680). Finally, the yearly adjustment for the Other ethnic group is +6.1% 
and the base is now 3,702 (not 2,073) (the reason for the large yearly adjustment for the 
Other group is clear from looking at the bottom diagram in Figure ‎7-3). The picture is 
Redbridge is driven primarily by the reduction in the size of the White group (a result of 
a large reduction in its starting point and a moderate yearly downward adjustment) and 
significant increases in the Asian and Other populations, this latter dynamic driven by 
large values of the yearly adjustment. Otherwise, the progression of a smaller 50 to 54 
year old Black cohort in 2011 is seen to take place through the age bands. 
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Figure 7-15 : Leeds’ 2021 (left) and 2031 (right) original and revised ETHPOP 
population structure, for White (top), Mixed, Asian, Black and Other (bottom)  
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Figure 7-16 : Redbridge’s 2021 (left) and 2031 (right) original and revised ETHPOP 
population structure, for White (top), Mixed, Asian, Black and Other (bottom) 
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Figure 7-17 : Camden’s 2021 (left) and 2031 (right) original and revised ETHPOP 
population structure, for White (top), Mixed, Asian, Black and Other (bottom) 
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7.6.3 Camden (London Centre) 
For Camden, there is once again a reduction in the size and share of the White ethnic 
group (the share, using original ETHPOP projections, of 74.8% in 2031 falls to 61.5% 
after the revisions).  Here, increases are apparent for the Mixed and Asian groups, 
where the share for these two groups grows from the original ETHPOP 2031 projections 
of a 2.1% and 8.7% share to revised projections of 5.8% and 18.3% respectively. The 
yearly correction for the Mixed group is +2.7% (which over 20 years compounds to 
+69.0%). The yearly adjustment factor for the Asian ethnic group is a more modest 
1.6% but still compounds to a 37% growth over 20 years. The prediction for the Other 
ethnic group is good requiring little overall revision, whilst for the Black ethnic group 
the revised population is smaller for the majority of age bands than the original 
ETHPOP projection. 
7.6.4 Haringey (London Cosmopolitan) 
The revision process has once again had a dramatic impact on the size of the White 
ethnic group in Haringey. As for Redbridge, this is a combination of two factors. The 
2011 original ETHPOP population for this group was 76,425 whilst the 2011 Census 
count (and hence the new 2011 base) is just 59,865. The yearly adjustment factor is also 
substantial at -2.4%. In 2031 the share of the population which is of a White ethnicity 
falls from 71.5% to 44.5% as a result of the revision process (by way of context, the 
2011 Census has 65.9% of Haringey’s aged 50 and over population being White). The 
consequence of the reduction in the size of the White group and increases in the size of 
the remaining ethnic groups is an increase in the share of the population of Haringey for 
these remaining ethnic groups (less so with the Black group). After the White group, the 
Black group is predicted to be the largest in 2031 at 18.6%, followed by Other, 16.9%, 
Asian, 13.8% and Mixed at 6.2%. 
7.6.5 Wiltshire (Prospering UK) 
The revisions to the original ETHPOP projections for the White ethnic group in 
Wiltshire has increased the size of this group at nearly all ages, although the White 
group share of the population drops a little from 96.7% to 96.2%. The Mixed and Asian 
groups have larger populations than the original ETHPOP projections, whilst the Black 
ethnic group is smaller. The impact of the revisions for the Other group have been 
minor. 
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Figure 7-18 : Haringey’s 2021 (left) and 2031 (right) original and revised ETHPOP 
population structure, for White (top), Mixed, Asian, Black and Other (bottom) 
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Figure 7-19 : Wiltshire’s 2021 (left) and 2031 (right) original and revised ETHPOP 
population structure, for White (top), Mixed, Asian, Black and Other (bottom) 
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7.6.6 Teignbridge (Coastal and Countryside) 
The greatest impact on the White ethnic group in Teignbridge is a reduction in those 
aged 85 and older. This is a result of the final step of the revision process where the size 
of a particular gender and age combination is constrained to the ONS 2012 SNPP. Here 
the 2012 SNPP for those aged 85 and older is around half the size of the original 
ETHPOP projections. The impact of the overall revision process on the Mixed and 
Other ethnic group has been to increase them in size, whilst the remaining two groups, 
Asian and Black, have decreased. This is most dramatically seen for the Black ethnic 
group which has been virtually eliminated from the population of Teignbridge as a 
result of the revision process. Between the 2001 and 2011 Censuses the size of the 
Black ethnic group in Teignbridge decreased from 75 to 58, rather than the projected 
ETHPOP change from 83 to 251 in 2011. These values result is a large adjustment 
factor of -12.8% per annum. These large reductions are not uncommon with Coastal and 
Countryside type authorities for the Black group, as is evident in Figure 7-12. 
7.6.7 Rotherham (Mining and Manufacturing) 
The revision process has created larger populations for most ethnic groups in 
Rotherham. All the adjustment factors are greater than zero, ranging from +0.27% per 
annum for the White ethnic group to +7.0% for the Other group. Even with this 
(admittedly low) positive adjustment factor for the White group, the share of this 
population is revised down from 96.0% in the original ETHPOP population projection 
to 90.4% revised in the revised projections. 
7.6.8 Summary 
As was inferred by the comparisons between the 2011 ETHPOP projections and the 
2011 Census counts in section 7.2, the revision process has made some substantial 
changes to the original ETHPOP projections. For many LADs, the size of the White 
ethnic group has been reduced. Sometimes this reduction is substantial, especially so for 
the London based LADs (see also Figure 7-14 and Table 7-6). This reduction has come 
about by a combination of a re-basing of the starting points of the projections to the 
2011 Census counts, which can be substantially lower than the 2011 ETHPOP 
projections. Also since this 2011 ETHPOP White group projection is usually less than 
the 2011 Census count (see Figure 7-9), the adjustment factor has been large and 
negative, with small annual percentages compounding to large reductions over a 20 year 
time span. 
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Figure 7-20 : Teignbridge’s 2021 (left) and 2031 (right) original and revised ETHPOP 
population structure, for White (top), Mixed, Asian, Black and Other (bottom) 
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Figure 7-21 : Rotherham’s 2021 (left) and 2031 (right) original and revised ETHPOP 
population structure, for White (top), Mixed, Asian, Black and Other (bottom) 
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The Mixed ethnic group is consistently under predicted in all the seven case study 
LADs by the original ETHPOP projections. For the Asian group the picture is less clear. 
The revised Asian populations are larger for all types of authority, except for the 
Coastal and Countryside authority of Teignbridge where the population is smaller. With 
the Black ethnic group, there are variable outcomes. Only in the Cites and Services and 
Mining and Manufacturing types of authority has the revision increased the size of this 
group. At the extreme, the Black population of the Coastal and Countryside LAD, 
Teignbridge, has been virtually eliminated. The Other group is either predicted well or 
under predicted by the original ETHPOP projections. 
7.7 CONCLUSION 
In this chapter an assessment has been made of the ETHPOP population projections, 
which provides an important input into the health microsimulation model, helping to 
ensure that the future population structure reflects the gender, age and ethnic makeup of 
each LAD.  
The availability of 2011 Census data has allowed a comparison to be made between the 
ETHPOP projections for 2011 and the appropriate Census counts. The correspondence 
between these two data sources has been measured in terms of its direction (bias) and 
size (extent) for each of the five ethnic groups used in this study. The general trend has 
been for an over prediction of the White ethnic group and an under prediction of the 
remaining four groups. In percentage terms these differences are least for the White 
group, although this is undoubtedly due to the relatively large size of this group.  
The comparison between the original ETHPOP and 2011 Census data, coupled with 
similar data from 2001, has enabled the calculation of LAD specific adjustment factors 
to correct for any discrepancies in the projections over a 10 year time span. How these 
adjustment factors vary by the ONS area type classification shows that the factors vary 
in their level and variability by this area type. This, to an extent, justifies the use of 
[10%,90%] confidence intervals to constrain some of the more extreme adjustment 
factors. Even with these constraints in place however, some seemingly modest yearly 
adjustment factors can, when compounded over 20 years from 2011 to 2031, have a 
dramatic impact on the size of each ethnic group’s population in a LAD.  
The revision of the original ETHPOP projections involves not just these adjustment 
factors but a rebasing of projections to 2011 Census counts in 2011 and a final 
constraint to the ONS 2012 SNPP. Both these actions impact on the extent of the 
revisions. Overall the results of the revision are the most dramatic for the London 
centric types of LAD, with big downward revisions in the size of the White ethnic 
group and commensurate increases in some, but not all, of the remaining ethnic groups. 
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Perhaps another challenging result is the virtual elimination of already small ethnic 
populations in some more prosperous LADs by 2031. 
Not knowing what the future population in each LAD is makes it difficult to assess the 
plausibility of the revision process. The process does however, in an intelligent way, use 
a wide variety of data to achieve its goal. A consideration of how ETHPOP projected 
the change in population in each LAD in the past informs how these future projections 
beyond 2011 should be adjusted. Where these adjustments are less than credible they 
are moderated in the context of similar types of authority. The rebasing to 2011 Census 
counts makes sense since they are a known and trusted starting point for the revised 
projections beyond 2011. Finally, the constraint to the 2012-based SNPP provides the 
reassurance of a population whose gender and age structure matches an external source 
with good veracity. Whether the revisions (or indeed the original ETHPOP projections) 
are truly accurate will only become apparent when other more sophisticated/competing 
projections, or the actual data itself, become available. Indeed the health 
microsimulation is flexible enough to allow the use of alternative ethnic population 
projections to these revised estimates, be they either the unrevised ETHPOP projections 
or ethnic population projections available from other sources (e.g. the Greater London 
projections, Klodawski, 2009). 
So far in this thesis the base 2011 population for each LAD has been synthesised and a 
series of revised population projections by gender, age and ethnicity have been created. 
Before the health microsimulation can be conducted, however, further information is 
required concerning the probabilities for use in the Monte Carlo process that updates the 
status of individuals in the population. This is covered in the following chapter. 
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8 PROBABILITY MODELS 
The Dynamics of Change through Monte Carlo Simulation 
8.1 INTRODUCTION 
The health microsimulation model introduced in section 5.1 and illustrated in Figure 5-1 
is dynamic in so far as individuals naturally age over time, their morbidity status is 
changed to reflect their personal circumstances, new individuals are introduced into the 
population to replenish its membership and individuals leave the population through 
migration and mortality. 
The mechanism adopted to effect these changes in the population is the Monte Carlo 
approach. This requires an estimate of the probability that an event will take place and a 
method of sampling a pseudo random number. A comparison between these two 
probabilities enables the occurrence of an event to be simulated. If the estimated 
probability of occurrence is say, 0.10, and the sampled random number is less than or 
equal to 0.10, then the event is deemed to of occurred, otherwise it is deemed not to of 
occurred. The random sampling is relatively straight forward (akin to rolling a die), 
using a pseudo random number generation algorithm (Matsumoto and Kurita, 1994). 
The estimation of the probability of the event is more challenging. In this study, these 
probabilities are primarily estimated using hazard models fitted to ELSA data, although 
in one case probabilities based on HSfE survey data are used. 
The following section, 8.2, describes the estimation of the hazard models for each of the 
three morbidities studied in this thesis: CVD, DHBS and respiratory illness. These are 
the models that update an individual’s morbidity status. In section 8.3, hazard models 
are also described that estimate the probability of an individual dying or migrating. The 
purpose of these probabilities is to define the selection weights that are used in the 
process which reshapes the LAD population to some given structure. The fourth section, 
8.4 deals with the task of how to characterise the population that replenishes the 
population as it ages, i.e. introduce those aged 50 and 51. This involves firstly, the task 
of describing how estimates of morbidity prevalence rates at ages 50 and 51 are 
calculated for these future Replenishers. This is accomplished using the morbidity 
models discussed in section 8.2 to accumulate ‘historic’ morbidity incidence 
probabilities over time. Secondly, there is the task of estimating the probability that the 
Replenishers have ever smoked, and here, use is made of the 2011 edition of the HSfE. 
The final section will recap the work described in this section and lead onto the 
following chapter which presents the results of the health microsimulation. 
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8.2 MORBIDITY HAZARD MODELS 
As described in section 4.4.7 an adapted version of the ELSA wave 6 mechanism for 
determining the absence or presence of a morbidity at each wave is used here. The wave 
6 definition of the presence of a morbidity differs from that used in previous waves by 
not relying on the fed forward morbidity information provided at each wave. Instead 
each previous wave’s core data are explicitly examined for a new diagnosis or a feed 
forward of a diagnosis. The adaptation here is to discount the information on the feed 
forward status of a morbidity and instead rely only on explicit new diagnosis at the 
current or previous waves. 
The hazard models are estimated using the wave 6 longitudinal weights which correct 
for attrition of C1CM participants in the ELSA survey (see section 4.4.3). The 
explanatory variables available are those which are known in the sample or can be 
inferred for those who replenish the sample (see section 8.4.2). The chronological 
variables are wave, which acts as a time trend, each wave covering two years, age 
centred on age 50 (i.e. the value used in the model is the age in years minus 50) and also 
a centred age squared term. The socio-demographic variables are gender and ethnicity. 
As seen elsewhere in this thesis, the representation of BME groups is poor in ELSA and 
in order to ensure that there is sufficient event occurrence (i.e. the acquisition of a 
morbidity) some merging of the five ethnic groups is required. These three merged 
groupings are: a White group, an Asian group and Mixed/Black and Other group. 
Smoking status, recorded as whether someone has ever smoked a cigarette, is one 
reliable lifestyle indicator available for both existing members of ELSA and those who 
will replenish the sample at younger ages. In the case of CVD there is also an additional 
variable which is an indication of whether the individual had DHBS at the previous 
wave. This is to reflect the finding that those who have DHBS are at a greater risk of 
developing a CVD (Public Health England, 2013b). 
Whilst the above variables provide information about the socio-demographic, economic 
and lifestyle circumstances of the individual, there is also a potential role for contextual 
information. This contextual information is provided by information concerning the 
type of area in which the individual lives. In the more recent releases of ELSA data the 
(now abolished) Government Office Region of residence of the participant is provided, 
however, it is unlikely that this information will be sufficient in itself to capture these 
area type effects. On request, however, the actual LAD of residence at each wave is 
obtainable from the ELSA team. This extra level of geographical detail has been 
obtained and allows the inclusion of Group classes from the ONS area type 
classifications to be included as explanatory terms. It should be noted here that this 
classification is a general classification and not one aimed at distinguishing LADs by 
health outcomes (in the classification health is measured using just two variables, 
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disability and care provision, part of the eight variables for the socio economic domain, 
which itself is one of six domains used to construct the classification). 
In the estimation of statistical models sometimes the models are refined in stages to 
exclude insignificant terms from the model. The rationale behind this decision is that 
such terms do not contribute significantly in influencing the outcome but they do 
‘consume’ degrees of freedom thereby potentially undermining the assessment of the 
quality of the fit of the model. Here, however, the alternative approach is adopted where 
all terms are kept in the model, even if they are not significant. The justification is that, 
firstly, even an insignificantly estimated term is a measured effect that has some 
influence but it cannot be said, with a reasonable degree of confidence, that the effect is 
large enough to be present. Secondly, ELSA is a large data set, potentially providing 5 
observations on each of 5,000 individuals, so the reduction in the degrees of freedom 
for the regression on retaining some insignificant terms is negligible. The third 
justification is that by including some insignificant terms the heterogeneity of the 
outcomes is increased, even slightly, creating a population whose outcomes are more 
diverse than if the term was not included. However, this retention of insignificant terms 
is limited only to main effects in the model, interactions between main effects (e.g. 
wave and age) are only included if they are significant. 
When fitting hazard models there are issues around the censoring of data. Censoring 
happens when the event occurs outside the observation period. Right censorship, where 
the event occurs subsequent to the period of observation is not as problematic as left 
censoring, where the event occurs before the period of observation. With right censoring 
it is known that an event did not occur during the observation period and it is also 
known the circumstances of the individual during this period. This is valid and 
compatible information to use in the model. With left censoring it is known that the 
event occurred prior to the observation period but not necessarily the circumstances of 
this individual at the point of occurrence – it is outside the observation period and 
provides no information on occurrence (Singer and Willett, 2003). The usual approach 
to this problem is to drop those individuals who are left censored. The practical 
implication of this requirement is that our population starts at wave 2 with those 
individuals who did not have the morbidity at wave 1. The count at wave 2 will be those 
individuals who did not have the morbidity at wave 1 but acquired it by the time they 
were surveyed at wave 2. There are therefore just five waves of observation. The count 
of the number of individuals who acquired each of the three morbidities and the rate of 
this occurrence over these five waves is shown in Figure 8-1. 
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Figure 8-1 : Trends in morbidity incidence, count of individuals (lhs), rate in population 
(rhs), England. 
For CVD there appears to be a spike in incidence at wave 2 followed by a dip at wave 3. 
Any trend information in these data will be exaggerated by the high incidence at wave 2 
and diminished by the low incidence at wave 3 – potentially cancelling each other out. 
With DHBS, there appears to be a plateau for waves 2 to 4 followed by a reduction for 
the final two waves. For respiratory illness there is a significant spike in incidence at 
wave 2, the rate for this wave being nearly 1% higher than the other waves. This high 
initial peak may have a influence on any time trend term in models for this morbidity. 
8.2.1 CVD hazard model 
The estimation results for the hazard model to predict the onset of a CVD morbidity are 
shown in Table 8-1. The age and age squared terms are both significant and are 
concaved which means that the probability of acquiring a CVD increases to a maximum 
then decreases. The two year duration wave effect is also highly significant and negative 
which means that the probability of acquiring a CVD decreases over time. This term is 
capturing the impact of trends which are not accounted for in the other explanatory 
terms. These could be related to socio-demographic, socio-economic or health care 
influences (e.g. here the introduction of statins, Law et al., 2003). People of a south 
Asian ethnicity have a slightly increased probability of acquiring a CVD when 
compared to the White ethnic group whilst the remaining ethnic groups have a slightly 
reduced probability, although these ethnic effects are not statistically significant. The 
literature does support this enhanced risk for south Asian ethnic groups and reduced 
risks for the remaining non-White groups (i.e. Mixed, Black and Other (Chinese)). 
These ethnic parameter estimates are large and so are their standard errors, with the size 
of the standard errors being a reflection of the small sample size of observations for 
these ethnic groups. 
Having ever smoked or having DHBS at the previous wave both increase the probability 
of a CVD. Overall the type of LAD is only statistically significant at the 10% level, and 
individually only the individuals living in Industrial Hinterland type LAD’s show a 
statistically significant increased probability of a CVD over the reference LAD of 
 
 
193 
 
Manufacturing Towns. The type of LAD that shows the greatest reduction on the 
probability, relative to Manufacturing Towns, is Thriving London Periphery. The R
2
 
value is small, which is usual for such models. The Hosmer-Lemeshow statistic is not 
significant at the 0.1% or 5% but is significant at the 10% level. This suggests some 
weak evidence that the ordered expected and observed counts are not similar. 
Table 8-1 : Parameter estimates from CVD hazard model 
Variable beta  Se(beta) Wald dof Sig Odds 
Age minus 50 .1001 *** .0221 20.51 1 .000 1.105 
(Age minus 50)
2
 -.0011 ** .0005 5.16 1 .023 .999 
Wave -.1456 *** .0362 16.15 1 .000 .864 
Female -.2616 ** .1012 6.68 1 .010 .770 
Ethnicity 
 
  1.23 2 .541   
White (reference)        
South Asian .4548  .4504 1.02 1 .313 1.576 
Mixed/Black/Other -.1937  .4815 0.16 1 .688 .824 
Ever smoked .2307 ** .1096 4.43 1 .035 1.260 
Diabetes or hbs at previous wave .4326 *** .1527 8.03 1 .005 1.541 
LAD Type 
 
*  17.92 11 .083   
Manufacturing Towns (reference)        
Regional Centre -.3294  .2672 1.52 1 .218 .719 
Centre with Industry -.1899  .2400 0.63 1 .429 .827 
Thriving London Periphery -.6936  .4507 2.37 1 .124 .500 
London Suburban -.4741  .3222 2.16 1 .141 .622 
London Centre .0767  .4829 0.03 1 .874 1.080 
London Cosmopolitan -.5503  .4660 1.39 1 .238 .577 
Prospering Smaller Towns -.0797  .1823 0.19 1 .662 .923 
New and Growing Towns .0040  .2591 0.00 1 .988 1.004 
Prospering Southern England -.0428  .2165 0.04 1 .843 .958 
Coastal and Countryside -.0168  .2218 0.01 1 .939 .983 
Industrial Hinterlands .3717 * .2094 3.15 1 .076 1.450 
Constant -4.6958  .3116     
Nagelkerke R
2
 0.037   
Hosmer-Lemeshow 14.693 *  8 .065  
N 20,018   
* significant at the 10% level, ** significant at the 5% level, *** significant at the 1% level 
In the use of this and the remaining morbidity models there is the implicit assumption 
that the contextual impact on the morbidity estimated through the LAD area 
classification will remain constant beyond 2011 to 2031. Rees (2011) charts the changes 
in life expectancies by deprivation quintile and an alternative area classification over the 
period 1991 to 2007 in his figure 1.3 (reproduced here as Figure 8-2). This chart shows 
that the relative position by area type and, especially, deprivation quintile does not 
change much over time. This relative stability in life expectancies lends weight to the 
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assumption that in the short to medium term the relative influence of these area types 
remain consistent. 
 
Figure 8-2 : Graphs illustrating the stability of deprivation and area classification 
rankings over time (Rees, 2011) 
Motivated by the trend for the incidence of CVD in Figure 8-1 a revised model was 
fitted with two intervention terms to account for the potentially anomalous counts at 
waves 2 and 3. These interventions are coded as 0.0 for all values, except for the wave 
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they are relevant to, when they are coded as 1.0. These two intervention terms were not 
significant and the wave time trend remains high at -0.167. In light of this the model of 
Table 8-1, without the interventions, is preferred. 
8.2.2 Diabetes or high blood sugar hazard model 
The estimation results for the hazard model to predict the onset of DHBS are shown in 
Table 8-2. 
Table 8-2 : Parameter estimates from diabetes or high blood sugar hazard model 
Variable beta  Se(beta) Wald dof Sig Odds 
Age minus 50 .0525 ** .0223 5.56 1 .018 1.054 
(Age minus 50)
2
 -.0010 ** .00052 3.99 1 .046 .999 
Wave -.0785 ** .0362 4.70 1 .030 .925 
Female -.2098 ** .0994 4.46 1 .035 .811 
Ethnicity   ***   24.17 2 .000   
White (reference)        
South Asian .9377 *** .3102 9.14 1 .003 2.554 
Mixed/Black/Other 1.1624 *** .2749 17.88 1 .000 3.198 
Ever smoked .0716  .1053 0.46 1 .497 1.074 
LAD Type   *   18.59 11 .069   
Manufacturing Towns (reference)        
Regional Centre -.3401  .2513 1.83 1 .176 .712 
Centre with Industry .1424  .2005 0.50 1 .478 1.153 
Thriving London Periphery -.7306 * .4152 3.10 1 .078 .482 
London Suburban -.3527  .2750 1.64 1 .200 .703 
London Centre .3663  .3652 1.01 1 .316 1.442 
London Cosmopolitan -.5144  .3964 1.68 1 .194 .598 
Prospering Smaller Towns -.3361 * .1741 3.73 1 .054 .715 
New and Growing Towns -.1666  .2490 0.45 1 .503 .847 
Prospering Southern England -.3550 * .2129 2.78 1 .095 .701 
Coastal and Countryside -.3082  .2225 1.92 1 .166 .735 
Industrial Hinterlands -.1365  .2150 0.40 1 .526 .872 
Constant -3.8541  .2792     
Nagelkerke R
2
 0.015   
Hosmer-Lemeshow 11.461   8 .177  
N 21,312   
* significant at the 10% level, ** significant at the 5% level, *** significant at the 1% level 
Again, the age effect is concaved and significant and the wave time trend is negative 
and significant. Females are less likely to acquire DHBS than males. There are strong 
ethnic trends with this morbidity. Both the south Asian and the remaining group of 
Mixed/Black or Other have a much increased probability of developing this morbidity 
relative to the White ethnic group. The impact is strongest for the Mixed/Black or Other 
group which is contra to some studies that say, whilst the Asian and Black groups both 
have elevated risk of DHBS, the risk is highest for the south Asian group, but again the 
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standard errors for these estimates are large making and relative comparison difficult. 
The lifestyle variable of ever having smoked has only an insignificant small positive 
impact on the probability of acquiring this morbidity. As with CVD, the LAD area type 
effects are significant at the 10% level. The LAD type with the greatest increase in 
probability relative to Manufacturing Towns is London Centre authorities, and the 
greatest reduction is once more Thriving London Periphery. 
8.2.3 Respiratory illness hazard model 
The estimation results for the hazard model to predict the onset of respiratory illness are 
shown in Table 8-3. This model includes a significant intervention term for wave 2. A 
model without this intervention gives a wave effect of -0.136, a significantly higher 
trend effect than that shown in Table 8-3, caused by the high incidence at wave 2 which 
inflates the trend. This high incidence of respiratory illness at wave 2 could be a genuine 
one-off event or a potential issue in these data. In either case, to mitigate its lasting 
influence, the model with a wave 2 intervention term, see Table 8-3, is preferred. 
Unlike the previous two hazard models, here there is no significant age effect on the 
probability of developing a respiratory illness. There is also a weak negative time trend 
effect once the intervention at wave 2 is accounted for. Females are slightly more likely 
to acquire a respiratory illness although the effect is small and insignificant. Being a 
member of a BME group increases the probability of a respiratory illness and this is 
most pronounced for the Mixed/Black or Other group. As expected ever having smoked 
is a significant and positive contribution to the probability of having a respiratory 
illness. Overall the LAD area type does have a statistical significant impact of 
developing a respiratory illness relative to Manufacturing Towns. There are no instances 
of the onset of a respiratory illness in a London Centre type of authority, so to enable 
the estimation of a model with a LAD area type term this category is merged with 
London Cosmopolitan. Surprisingly the Coastal and Countryside area type has the 
greatest increase in probability and London Suburban the least.  
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Table 8-3 : Parameter estimates from respiratory illness hazard model 
Variable beta  Se(beta) Wald dof Sig Odds 
Age minus 50 .0308  .0250 1.53 1 .217 1.031 
(Age minus 50)
2
 -.0006  .0006 1.13 1 .287 .999 
Wave -.0379  .0617 0.38 1 .539 .963 
Wave 2 .4186  .1939 4.66 1 .031 1.520 
Female .0570  .1163 0.24 1 .624 1.059 
Ethnicity   ***    14.60 2 .001 
White (reference)        
South Asian .9878 ** .4290 5.30 1 .021 2.685 
Mixed/Black/Other 1.1903 *** .3642 10.68 1 .001 3.288 
Ever smoked .7516  .1394 29.06 1 .000 2.120 
LAD Type   **    18.57 10 .046 
Manufacturing Towns (reference)        
Regional Centre -.2473  .2983 0.69 1 .407 .781 
Centre with Industry -.2066  .2684 0.59 1 .441 .813 
Thriving London Periphery -.2011  .4246 0.22 1 .636 .818 
London Suburban -.9331 ** .4050 5.31 1 .021 .393 
London Centre and Cosmopolitan -.6521  .4214 2.39 1 .122 .521 
Prospering Smaller Towns -.2036  .2091 0.95 1 .330 .816 
New and Growing Towns -.4364  .3242 1.81 1 .178 .646 
Prospering Southern England -.0406  .2421 0.03 1 .867 .960 
Coastal and Countryside .3023  .2358 1.64 1 .200 1.353 
Industrial Hinterlands .1228  .2478 0.25 1 .620 1.131 
Constant -4.8359  .4063 141.64    
Nagelkerke R
2
 0.024       
Hosmer-Lemeshow 5.300    8 .724  
N 19,379       
* significant at the 10% level, ** significant at the 5% level, *** significant at the 1% level 
8.3 SELECTION WEIGHTS 
In section 5.5.4 the process of re-shaping the population within each LAD to match a 
predefined ethnic composition is introduced. This is primarily achieved through the 
process of cloning existing individuals within the population to mimic both population 
growth through in migration and population decline through mortality and out 
migration. Since these selections are stochastic in nature, there is a need to choose 
individuals in the population to be cloned or removed. This is done here using a Monte 
Carlo approach with unequal selection probabilities or weights. The justification for the 
unequal selection is that the characteristics that individuals possess will influence their 
probability of mortality or migration. The operation of these unequal selection 
probabilities can have a large impact on the prevalence rates within the population, as 
exemplified in Box 5-11. In this section the hazard model that predicts the probability of 
mortality and the one that predicts migration are discussed. It should be emphasised that 
these models in application are not meant to predict how many people are going to die 
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or move between LADs, since this is a component implicitly included in the population 
projections. What these models do is predict which individuals are likely to die or 
move. 
8.3.1 Mortality hazard model 
The knowledge of the death of a participant in the ELSA study is recorded well (but see 
Figure 8-3 below). Not only is the death of a participant potentially apparent when a 
wave interview is attempted, but the death of all participants, be they core members, 
partners of core members or sample members, is recorded using information contained 
in the NHS Central Register. Thus there are fewer issues around attrition for this 
outcome than for morbidities – indeed there are no suitable weights in ELSA to help to 
correct for attrition in regards to mortality.  
This lack of participation in all waves for those who have died does cause an issue with 
establishing if they have a morbidity when they die. If someone is recorded as having a 
morbidity at an earlier wave then due to the absorptive nature of the way the morbidity 
is defined they will have the morbidity at death. Thus for someone who died between 
waves 3 and 4 but was only observed at wave 1, at which time they had CVD, then it is 
correct to assume they had the morbidity when they died. The converse is however not 
true, if they did not have CVD at wave 1 and were never surveyed again, it is not 
possible to infer if they had CVD at death. If it is thought that the morbidity status 
makes a significant contribution to the probability of mortality, then there is a dilemma. 
A ‘quantity’ approach keeps individuals in the sample but at the expense that the 
morbidity information known about the individual up to death is not certain. A ‘quality’ 
approach only includes those individuals in the sample whose morbidity status is known 
during the period up to death. It is this latter approach that is adopted here. This is 
driven by the potential utility of the morbidity status to influence mortality and 
hypothesising that the highest quality and relevant information is most likely to lead to 
an informed outcome. The drawback is that the sample size is diminished by around 
50%, but this still leaves a substantial sized sample on which to estimate the hazard 
model. 
The mortality wave variable (‘when died in relation to ELSA wave’) is recorded in the 
Index File which is only currently available for waves 1 to 5 so the analysis here is 
limited to the first five waves of ELSA. As with morbidities, left censoring means that 
the counts for the first wave are not provided. Figure 8-3 plots the number of mortalities 
at each wave and in this figure there appears to be an unusual spike of mortalities at 
wave 2. To prevent the presence of this spike having undue influence on the wave trend 
term in the hazard model, a wave 2 intervention term is used in the model (as was 
similarly used for the respiratory illness hazard model in section 8.2.3). 
 
 
199 
 
 
Figure 8-3 : Trends in mortality incidence, count of individuals (lhs), rate in population 
(rhs), England. 
A critical hypothesis is that the probability of death may be influenced by the 
characteristics of the participant, some of which are not contained in the Index File (e.g. 
ethnicity or morbidity status). This information is transferred to the participant from the 
wave core files as outlined in section 4.4.7. 
The parameter estimates from the mortality hazard model are shown in Table 8-4. As 
individuals get older the probability of dying increases, a not unexpected result. Over 
time however the probability of death is decreasing but there is a significant interaction 
between these two chronological events.  The interaction is positive indicating that the 
reduction in mortality for older people in future years will be less pronounced. All other 
things being equal, females are less likely to die than males and there is some evidence 
of an ethnic influence, with the south Asian population having a smaller probability of 
death than the remaining ethnic groups. Someone who has ever smoked and has one of 
the studied morbidities is more likely to die, although DHBS has the least impact (of the 
three morbidities DHBS is the least likely to be recorded as the main cause of death, 
ONS, 2014d). The pseudo R
2
 statistic is good for models of this kind and the Hosmer-
Lemeshow test estimates no significant difference between the expected and observed 
counts in each ordered decile. 
Whilst the estimates provided in Table 8-4 are rational in terms of their significance and 
direction of impact, there may be issues around the actual scale of the impacts. In 
particular the time trend reduction looks dramatic, even when the potential outlier at 
wave 2 is accounted for. However recall the purpose of these probabilities, they provide 
weights for the probability of selection for removal from the synthesised population and 
not to predict actual death. The actual mortality and migration impacts on the size of the 
population are implicitly contained in the population projections that determine how 
many (but not which) individuals should be selection for removal. The true utility of the 
results in Table 8-4 come from the smoking and morbidity status variables which do 
explicitly allow for a differentiation of the weight of selection by these characteristics. 
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Table 8-4 : Parameter estimates from the mortality hazard model 
Variable beta  Se(beta) Wald dof Sig Odds 
Age minus 50 .0846 *** .0085 99.378 1 .000 1.088 
Wave -.3156 *** .0875 12.998 1 .000 .729 
Wave 2 .2362 ** .1047 5.089 1 .024 1.266 
Wave by age minus 50 .0062 ** .0025 6.106 1 .013 1.006 
Female -.4281 *** .0599 51.086 1 .000 .652 
Ethnicity in 3 classes   *   5.265 2 .072   
White (reference)        
South Asian -.5658  .4551 1.546 1 .214 .568 
Mixed/Black/Other .5508 * .2878 3.663 1 .056 1.735 
Ever smoked .4863 *** .0706 47.429 1 .000 1.626 
Has CVD .4132 *** .0615 45.181 1 .000 1.512 
Has diabetes or hbs .1768 ** .0827 4.569 1 .033 1.193 
Has respiratory illness .2559 *** .0682 14.075 1 .000 1.292 
Constant -4.6630 *** .3141 220.355 1 .000 .009 
Nagelkerke R
2
 0.213  
Hosmer-Lemeshow 7.618   8 0.473  
N 24,383  
* significant at the 10% level, ** significant at the 5% level, *** significant at the 1% level 
There may still however be some re-assurance gained by comparing the probability 
estimates from the hazard model of Table 8-4 with other sources of similar outcomes. 
One such source is the National Life Tables for England covering the period 2010-2012 
(ONS, 2014e). These life tables are produced separately by gender but not by ethnicity. 
In Figure 8-4 a number of demographic scenarios are presented. In each chart the solid 
blue and red lines are the male and female estimates of mortality probability by age for 
the general population and do not vary between the charts in this figure. To calculate 
this probability, account needs to be taken of the fact that the hazard model estimates 
the mortality over a two year duration, so the mortality probabilities in the published life 
tables for two successive ages are compounded (equation 8-1).  
𝑞2 𝑥 = 1 − (1 − 𝑞1 𝑥 ) × (1 − 𝑞1 𝑥+1) 8-1 
where 𝑞𝑖 𝑥 is the mortality rate between age x and (x +1) over interval i. 
The dotted lines are estimates of mortality probabilities for various demographic 
populations as estimated using the hazard model of Table 8-4 at wave 5. The chart in 
the top left and corner shows these probabilities for individuals from the south Asian 
ethnic group who do not smoke and have no morbidities. This is the healthiest 
combination of characteristics and the morality probability for this group is less than 
half that of the general population. The next three charts are for the majority ethnic 
group of White. The top right charts show the mortality probability for the non smokers 
who have no morbidities, the middle left the probability for smokers without a 
morbidity and the middle right for smokers with a respiratory illness – showing an 
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increasing trend for morbidity in each successive chart. It is these trends that influence 
how more likely a member of the White ethnic group who smokes and has a respiratory 
illness is to die than someone of the same ethnicity who, say, doesn’t smoke or have a 
respiratory illness. Note that only for the combination of the White ethnic group, who 
smoke and have a respiratory illness are the probabilities close to those from the 
national life table. The remaining two charts at the bottom of Figure 8-4 provide two 
scenarios for the Mixed, Black or Other population. The left hand chart is for someone 
in this ethnic grouping who smokes but has no morbidities whilst final right hand chart 
is also for this same combination but instead does have a respiratory illness. 
  
  
 
 
Figure 8-4 : Comparison of ONS life table and hazard model mortality probabilities 
Clearly the morbidity probabilities of the general population are a weighted calculation 
of the various combinations of characteristics, some of which are shown in Figure 8-4. 
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However, without access to the actual population estimates of the size of these sub 
populations it is difficult to re-construct a general population estimate for the model in 
Table 8-4. What the charts do illustrate however is the impact of the smoking and 
morbidity characteristics on the relative weight for selection during the health 
microsimulation. 
8.3.2 Migration hazard model 
In contrast to the case for mortality, where the information on the occurrence of a death 
is well recorded, and supplemented using an administrative source external to ELSA, 
the occurrence of a move between LADs is more problematic. Information on the LAD 
of residence is not normally available with the publicly released ELSA data but on 
request, the information on LAD of residence may be obtained from the ELSA team. 
This information has been received for waves 1 to 6 and it is therefore possible to 
identify those ELSA participants who moved between LADs in the two year period 
between ELSA interviews. Figure 8-5 shows these migrations as migration counts and  
rates. 
 
Figure 8-5 : Trends in migration, count of individuals (lhs), rate in population (rhs), 
England. 
These data are quite erratic; with a sharp dip in migration between waves 2 and 3 and a 
spike between waves 3 and 4. If these two outliers are averaged then the series is more 
level. As was done with other hazard models, to prevent these features having an undue 
influence on the wave trend estimate, two intervention terms are included, one for wave 
3 and a second for wave 4. 
There will also be other participants who left ELSA through having moved house and 
did not provide a follow up address – an outcome of ‘Moved – unable to trace’. These 
people are known movers, however use of this information becomes problematic. What 
is required for the health microsimulation is a probability that a person has moved LAD 
between waves - moves with the LAD are of no interest. The ELSA outcome cannot 
distinguish between these inter and intra LAD moves. Also recall that the longitudinal 
weights that correct for attrition within ELSA are provided as part of the ELSA data set 
only for those C1CM participants in every wave. Those who left ELSA with a ‘Moved - 
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unable to trace’ outcome will not have a longitudinal weight. If they are to be used in 
the sample for estimation then it is not possible to use the longitudinal weight and 
therefore not possible to correct for attrition due to other reasons.  
By restricting ourselves to those participants whose migration journey is known, it is 
likely that these migrations probabilities will be an underestimate of the true migration 
probabilities – people who do not migrate are more likely to be retained in the sample 
and those who move and are untraceable will be missed. However, as for the mortality 
hazard model, the aim here is not to exactly replicate migration probabilities but to 
differentiate migration probabilities within a population defined by its gender, age band 
and ethnicity for a particular wave. 
The parameter estimates from the migration hazard model are shown in Table 8-5. The 
occurrence of a move is a rare event and becomes even rarer when disaggregated by 
various factors, for example, there are only three recorded moves by BME participants 
who are C1CM and responded at all waves. Thus the level of disaggregation by this 
ethnic characteristics is restricted. 
Table 8-5 : Parameter estimates from the migration hazard model 
Variable beta  Se(beta) Wald dof Sig Odds 
Age minus 50 -.0788 *** .0191 16.94 1 .000 .924 
(Age minus 50)
2
 .0015 *** .0004 13.83 1 .000 1.002 
Wave .0071  .0422 0.03 1 .867 1.007 
Wave 3 -.9267 *** .1977 21.97 1 .000 .396 
Wave 4 .5299 *** .1135 21.81 1 .000 1.699 
Female .0978  .1070 0.84 1 .361 1.103 
BME -1.3391 ** .5648 5.62 1 .018 .262 
Ever smoked -.0344  .1101 0.10 1 .755 .966 
Has CVD .2747 ** .1375 3.99 1 .046 1.316 
Has diabetes or hbs -.0004  .1676 0.00 1 .998 1.000 
Has respiratory illness .1153  .1284 0.81 1 .369 1.122 
Constant -3.4444 ** .2356 213.76 1 .000 .032 
Nagelkerke R
2
 0.025   
Hosmer-Lemeshow 2.332   8 0.969  
N 23,441   
* significant at the 10% level, ** significant at the 5% level, *** significant at the 1% level 
The age impact on migration is quadratic and convexed, which indicates that there is an 
age at which migration is least likely. Once the anomalous observations at wave 3 and 4 
are accounted for there appears to be only a weak positive time trend. The gender effect 
is also insignificant with a slight indication that females have a heightened probability 
of migration. Perhaps the largest impact is on the migration probability is due to 
ethnicity. As noted above, moves by such groups are rare and this is reflected in a large 
estimate in the reduction in the probability of migration for members of the BME group. 
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The standard error for this estimate is also large, a result of the groups small sample 
size. The lifestyle characteristic of having smoked and the morbidity statuses are largely 
insignificant except for having CVD, which, apparently increases the probability of 
migration. The pseudo R
2
 value is not very large but the Hosmer-Lemeshow test is 
insignificant which shows there is no significant difference between the ordered 
expected and observed counts. 
As was done for the case of the mortality hazard, it is useful to benchmark the migration 
probabilities against other measures. This is possible using the migration output from 
the 2011 Census.  Table MM01 provides an origin destination matrix of moves between 
LADs categorised by age. The three age bands used here are 50 to 64, 65 to 74 and 75 
and older. The number of individuals moving between LADs is the sum of the off 
diagonal terms in each of these three matrices. The number of such moves, the 
population within the appropriate age band, and the resultant estimate of the proportion 
who move over 1 and 2 years is show in Table 8-6. 
Table 8-6 : 2011 Census estimates of migration proportions 
Age range Movers Population Migration probabilities 
(one year) [a] 
Migration 
probabilities (two 
years) [1 - (1 - a)
2
] 
50 to 64 182,564 9,569,364 1.91% 3.8% 
65 to 74 56,440 4,552,283 1.24% 2.5% 
75 and older 56,451 4,108,246 1.37% 2.7% 
The tendency to migrate is greatest in the youngest age band and least in the middle age 
band. The initial high rate of migration may be caused by individuals in newly retired 
households moving home and leaving the LAD. As people get older however the 
tendency to migrate will naturally decrease, but at the oldest ages there may be a need to 
migrate once more to access care and social support, particularly from family and 
friends. This pattern of migration is consistent with the figures in Table 8-6.  
The migration probabilities estimated using the hazard model in Table 8-5 for non-
smoking individuals without a morbidity of both genders and ethnicities are shown in 
Figure 8-5 (lhs). The 2011 Census equivalent estimates over a two year wave are shown 
as horizontal dotted lines. The convexed nature of both the relationships is apparent, 
although the hazard model probabilities tend to be at their minimum a little after the 
2011 Census data would suggest. 
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Figure 8-6 : Migration probabilities from the migration hazard model - single wave (lhs) 
and compounded (rhs), England, 2011 Census 
Clearly the hazard model under predicts the probability of migration across the whole 
age range. This is however to be expected since there are a whole class of movers who 
leave ELSA and are untraceable. If this under recording is ‘corrected’ by assuming that 
the estimated probabilities should be compounded over two waves, then the 
probabilities are now as shown in Figure 8 5 (rhs). Here the agreement between the 
hazard probabilities and the 2011 Census derived estimate is good, especially for those 
aged 65 and older. This compounding of the two year duration wave migrations is not 
ideal but is driven by these data (using hazard model probabilities only) and corrects for 
an expected and observed under estimate. The migration probabilities between LADs of 
the BME ethnic group are substantially less than those of the White group. 
Having mentioned earlier that these migration probabilities are not intended to 
determine the degree of migration but just to differentiate the propensity of individuals 
to migrate, the question arises as to why is it important that the compounding happens. 
Instead why not just use the probabilities shown in Figure 8-6 (lhs)? The reasoning is 
discussed below. 
8.3.3 Use of selection weights 
As discussed in 5.5.4 the mortality and migration hazard models are used to create 
weights of selection for individuals for the restructuring of the population to agree with 
a population projection. Individually these mortality and migration probabilities (after 
compounding in the latter case) were shown to be ‘ball park’ when compared with 
official administrative and 2011 Census data sources. When selecting individuals for 
removal both the mortality and migration probabilities are combined to produce the 
weight. This means that across all age ranges these two weights contribute their own 
influence. At younger ages the migration probability will have the most influence on the 
individual’s weight whilst at older ages the mortality probability will have the most 
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influence. To ensure that the relative influence of these two demographic effects is 
correct the relative probabilities of mortality and migration need to be correct. Without 
compounding the migration impact will be less influential than mortality, especially at 
younger ages.  
8.4 STATUS OF REPLENISHERS 
In section 5.5.3 the concept of Replenishers was introduced to ensure that the projected 
population for future years covered the full age range of 50 years of age and older. The 
creation of Replenishers required some knowledge of their characteristics. The gender, 
age and ethnicity are given by the interpolated counts of 50 and 51 year olds from the 
revised ETHPOP projections estimated using Sprague’s method (Sprague, 1880).  What 
is further required is their morbidity status with regards to CVD, DHBS and respiratory 
illnesses and their smoking status at age 50 or 51. How these requirements are satisfied 
is explained in the following two sections. 
8.4.1 Morbidity status at 50 or 51 
It would clearly be mistaken to assume that individuals aged 50 and 51 who replenish 
the sample at future waves will be in perfect health with no morbidities. Instead it will 
be necessary to estimate the probability of Replenishers having each morbidity as they 
enter the sample. This estimate is arrived at using the same hazard models as those used 
to update the morbidity status of individuals for future waves described in section 8.2. 
The calculation of prevalence at age 50 or 51 is based on the assumption that the 
individual did not have the morbidity at age 30 but has the potential to acquire the 
morbidity thereafter. The morbidity hazard models predict the probability of incidence 
at a given wave and age (and gender, ethnicity and smoking status) and may be applied 
historically (since waves are just a manifestation of time) to estimate accumulated 
incidence between ages 30 and 49 and hence prevalence at age 50 or 51.  
For illustrative purposes consider those who will replenish the survey at synthetic wave 
6 and will be aged 50 or 51 in the period 2012-13 (see Table 8-7). They would have 
been aged 30 at wave minus 4 (1992-93) and it is possible to calculate the probability 
that they acquired the morbidity at that time using the equations in section 8.2. Moving 
onto when they are aged 32 in wave minus 3 (1994-95), the incidence for those who do 
not have the morbidity from wave minus 4 can be estimated and combined with those 
who do have the morbidity at wave minus 4 to give the prevalence at wave minus 3. 
This is repeated until they arrive at wave 6, with an accumulated morbidity prevalence. 
The general equation for this is equation 8-2: 
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PR50
W  = 1 ‐ ∏ (1 ‐ h50‐2 × (W‐i)
i )
W‐1
i=W‐10
 8-2 
where PR50
W  is the prevalence rate for those aged 50 at synthetic wave W (W>5); 
 ha
w is the hazard probability at age a for wave w; 
 50 – 2 x (W-i) translates the wave that is i waves previous to W into an age. 
There is also an equivalent for those who are aged 51 at wave W (P51
W), equation 8-3. 
PR51
W  = 1 ‐ ∏ (1 ‐ h51‐2 × (W‐i)
i )
W‐1
i=W‐10
 8-3 
In the same way that someone’s morbidity status changes in the full synthetic wave 
population, a Monte Carlo draw is used to compare against this accumulated prevalence 
rate and if the random number drawn is less than the rate then the Replenisher has their 
morbidity status when ‘joining’ ELSA set to having the morbidity. This same technique 
is used for all future cohorts of Replenishers. 
Table 8-7 : Example of replenishing cohorts 
 
 
Wave Years First cohort 
Replenishers’ Age 
Last cohort 
Replenishers’ Age 
H
is
to
ri
c 
‘w
av
es
’ -4 1992-1993 30 31   
-3 1994-1995 32 33   
-2 1996-1997 34 35   
-1 1998-1999 36 37   
0 2000-2001 38 39   
A
ct
u
al
 w
av
es
 
1 2002-2003 40 41   
2 2004-2005 42 43   
3 2006-2007 44 45   
4 2008-2009 46 47   
5 2010-2011 48 49 30 31 
S
y
n
th
et
ic
 ‘
w
a
v
es
’ 6 2012-2013 50 51 32 33 
7 2014-2015   34 35 
… ...   … … 
14 2028-2029   48 49 
15 2030-2031   50 51 
To see what these future prevalence rates are, a simplified version of the hazard models 
is used that does not distinguish by LAD. This simplification reduces the combination 
208 
 
of possible Replensher prevalences for illustrative purposes, however in the actual 
health microsimulation, the LAD terms are used (just as they would be in updating a 
participant’s morbidity status). Staying with the simplified model, Table 8-8 shows that 
in the simplified model the parameter estimates of the remaining non-LAD terms do not 
change much when the LAD term is not used. The exceptions to this are the ethnicity 
parameters and the constant. Since there are few members of the ELSA sample from the 
BME community who develop a morbidity, the estimates of these parameters are 
imprecise and a structural change to the model has moved the estimates somewhat. The 
constant has changed to reflect the loss of what is in effect the LAD specific constants 
in the models described in section 8.2. 
Table 8-8 : Hazard model parameter estimates for models with and without LAD 
 CVD Diabetes or high 
blood sugar 
Respiratory illness 
With 
LAD 
Without 
LAD 
With 
LAD 
Without 
LAD 
With 
LAD 
Without 
LAD 
Age minus 50 .1001 .0997 .0525 .0515 .0308 .0328 
(Age minus 50)
2
 -.0011 -.0011 -.0010 -.0010 -.0006 -.0007 
Wave -.1456 -.1454 -.0785 -.0778 -.0379 -.0364 
Wave 2   .4186 .4214 
Female .2616 -.2639 -.2098 -.2112 .0570 .0662 
South Asian .4548 .2614 .9377 .9574 .9878 .6407 
Mixed/Black/Other -.1937 -.3549 1.1624 1.2149 1.1903 .8194 
Ever smoked .2307 .2250 .0716 .0697 .7516 .7404 
Diabetes at previous 
wave 
.4326 .4532  
Constant -4.6958 -4.7430 -3.8541 -4.0602 -4.8359 -4.9657 
When the simplified hazard models described in Table 8-8 are used to estimate this 
prevalence rate on Replenishers joining at future synthetic waves of ELSA the resultant 
prevalence probabilities for 51 year olds in different ethnic groups and with different 
smoking status are shown in Table 8-9 for CVD, Table 8-10 for DHBS and Table 8-11 
for respiratory illness.  
The ELSA wave 6 report provides some comparable estimates for 2012-2013 (wave 6) 
covering the age range 50 to 54, keeping in mind that the rates here are for those joining 
aged 51. For CHD (which is CVD without taking account of strokes and will thus be an 
underestimate of CVD) the prevalence rate for males aged 50 to 54 is 2.2% (95% 
confidence interval, 0.4% to 4.0%) and for females it is 1.3% (0.1% to 2.5%). These 
ELSA estimates are not differentiated by ethnicity or smoking status so are a weighted 
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combination of equivalent data on the wave 6 row of Table 8-9. It is likely however that 
the most weight will be for the White ethnic group and these ELSA wave 6 report 
estimates compare well with those in Table 8-9. The trend is for significant reductions 
in these initial prevalences so that by synthetic wave 15, the rates are around a third of 
those for synthetic wave 6. 
Table 8-9 : Estimated prevalence rates for CVD in replenishing population 
Male non-smokers smokers 
Synthetic 
wave White 
South 
Asian 
Mixed/ Black/ 
Other White 
South 
Asian 
Mixed/ Black/ 
Other 
6 2.4% 3.1% 1.7% 2.9% 3.8% 2.1% 
7 2.0% 2.6% 1.4% 2.6% 3.3% 1.8% 
8 1.8% 2.3% 1.2% 2.2% 2.9% 1.6% 
9 1.5% 2.0% 1.1% 1.9% 2.5% 1.3% 
10 1.3% 1.7% 0.9% 1.7% 2.1% 1.2% 
11 1.1% 1.5% 0.8% 1.4% 1.9% 1.0% 
12 1.0% 1.3% 0.7% 1.2% 1.6% 0.9% 
13 0.9% 1.1% 0.6% 1.1% 1.4% 0.8% 
14 0.7% 1.0% 0.5% 0.9% 1.2% 0.7% 
15 0.6% 0.8% 0.5% 0.8% 1.0% 0.6% 
       Female non-smokers smokers 
Synthetic 
wave White 
South 
Asian 
Mixed/ Black/ 
Other White 
South 
Asian 
Mixed/ Black/ 
Other 
6 1.8% 2.4% 1.3% 2.3% 2.9% 1.6% 
7 1.6% 2.0% 1.1% 2.0% 2.5% 1.4% 
8 1.4% 1.8% 1.0% 1.7% 2.2% 1.2% 
9 1.2% 1.5% 0.8% 1.5% 1.9% 1.0% 
10 1.0% 1.3% 0.7% 1.3% 1.7% 0.9% 
11 0.9% 1.1% 0.6% 1.1% 1.4% 0.8% 
12 0.8% 1.0% 0.5% 1.0% 1.2% 0.7% 
13 0.7% 0.9% 0.5% 0.8% 1.1% 0.6% 
14 0.6% 0.7% 0.4% 0.7% 0.9% 0.5% 
15 0.5% 0.6% 0.3% 0.6% 0.8% 0.4% 
The ELSA wave 6 estimates for DHBS are 4.0% (1.6% to 6.4%) for males and 6.8% 
(4.3% to 9.4%) for females. The synthetic wave 6 estimates in Table 8-10 for males are 
greater than this 4.0% estimate, nearly twice as large.  For females however the ELSA 
wave 6 report weights are similar to those in the table. What are also different are the 
relative prevalence rates by gender for this youngest age band, here they are higher for 
males than females. However, this higher rate for males is also seen in the ELSA wave 
6 report in all the age bands covering 55 to 79, meaning that overall, the prevalence of 
DHBS is higher for males both here and in the ELSA report. Once again these initial 
prevalence rates diminish over time, although not to the same degree as seen for CVD. 
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Table 8-10 : Estimated prevalence rates for diabetes or high blood sugar in replenishing 
population 
Male non-smokers smokers 
Synthetic 
wave White 
South 
Asian 
Mixed/ Black/ 
Other White 
South 
Asian 
Mixed/ Black/ 
Other 
6 7.8% 19.0% 23.8% 8.4% 20.2% 25.3% 
7 7.3% 17.8% 22.3% 7.8% 18.9% 23.7% 
8 6.8% 16.6% 20.8% 7.2% 17.6% 22.1% 
9 6.3% 15.4% 19.5% 6.7% 16.4% 20.7% 
10 5.8% 14.4% 18.2% 6.2% 15.3% 19.3% 
11 5.4% 13.4% 16.9% 5.8% 14.3% 18.0% 
12 5.0% 12.5% 15.8% 5.3% 13.3% 16.8% 
13 4.6% 11.6% 14.7% 5.0% 12.4% 15.7% 
14 4.3% 10.8% 13.7% 4.6% 11.5% 14.6% 
15 4.0% 10.0% 12.7% 4.3% 10.7% 13.6% 
       Female non-smokers smokers 
Synthetic 
wave White 
South 
Asian 
Mixed/ Black/ 
Other White 
South 
Asian 
Mixed/ Black/ 
Other 
6 6.4% 15.7% 19.8% 6.8% 16.8% 21.1% 
7 5.9% 14.7% 18.5% 6.4% 15.6% 19.7% 
8 5.5% 13.7% 17.3% 5.9% 14.6% 18.4% 
9 5.1% 12.7% 16.1% 5.5% 13.6% 17.1% 
10 4.7% 11.8% 15.0% 5.1% 12.6% 16.0% 
11 4.4% 11.0% 14.0% 4.7% 11.7% 14.9% 
12 4.1% 10.2% 13.0% 4.4% 10.9% 13.9% 
13 3.8% 9.5% 12.1% 4.0% 10.1% 12.9% 
14 3.5% 8.8% 11.2% 3.7% 9.4% 12.0% 
15 3.2% 8.2% 10.5% 3.5% 8.8% 11.2% 
The comparable ELSA wave 6 report estimates for respiratory illness in males aged 50 
to 54 is 10.2% (6.6% to 13.8%) and for females it is 10.7% (7.5% to 13.9%). These 
estimates are greater than those in Table 8-11 for 51 year olds at synthetic wave 6, 
especially for non-smokers. This implies that the Replenishers who join at synthetic 
wave 6 and subsequently may under estimate the true prevalence of this illness for these 
cohorts. The slight differential in favour of lower rates for males seen in the ELSA 
report is replicated in Table 8-11. 
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Table 8-11 : Estimated prevalence rates for respiratory illness in replenishing population 
Male non-smokers smokers 
Synthetic 
wave White 
South 
Asian 
Mixed/ Black/ 
Other White 
South 
Asian 
Mixed/ Black/ 
Other 
6 4.3% 7.9% 9.4% 8.7% 15.8% 18.6% 
7 4.1% 7.6% 9.1% 8.4% 15.3% 18.0% 
8 4.0% 7.4% 8.7% 8.1% 14.8% 17.4% 
9 3.8% 7.1% 8.5% 7.8% 14.3% 16.8% 
10 3.7% 6.9% 8.2% 7.6% 13.8% 16.3% 
11 3.6% 6.6% 7.9% 7.3% 13.4% 15.8% 
12 3.4% 6.4% 7.6% 7.1% 12.9% 15.2% 
13 3.3% 6.2% 7.4% 6.8% 12.5% 14.7% 
14 3.2% 6.0% 7.1% 6.6% 12.1% 14.3% 
15 3.1% 5.8% 6.9% 6.4% 11.7% 13.8% 
       Female non-smokers smokers 
Synthetic 
wave White 
South 
Asian 
Mixed/ Black/ 
Other White 
South 
Asian 
Mixed/ Black/ 
Other 
6 4.5% 8.4% 10.0% 9.3% 16.8% 19.7% 
7 4.4% 8.1% 9.6% 8.9% 16.2% 19.1% 
8 4.2% 7.9% 9.3% 8.6% 15.7% 18.4% 
9 4.1% 7.6% 9.0% 8.3% 15.2% 17.9% 
10 3.9% 7.3% 8.7% 8.1% 14.7% 17.3% 
11 3.8% 7.1% 8.4% 7.8% 14.2% 16.7% 
12 3.7% 6.8% 8.1% 7.5% 13.7% 16.2% 
13 3.5% 6.6% 7.8% 7.3% 13.3% 15.7% 
14 3.4% 6.4% 7.6% 7.0% 12.9% 15.1% 
15 3.3% 6.2% 7.3% 6.8% 12.4% 14.7% 
8.4.2 Smoking status at 50 or 51 
As implied by the evidence presented in Box 5-10, few people begin smoking after the 
age of 30. Therefore someone’s smoking status during the ages 30 to 49 is likely to 
remain unchanged when they reach 50 or 51. To examine the smoking status of this 
demographic (which is outside the ELSA age range) use is made of the 2011 HSfE. 
Here the derived variable of ‘Cigarette Smoking Status - Never/Ex-reg/Ex-occ/Current’ 
is used to indicate smoking status, where ‘Never’ is taken to be never smoked whilst the 
remaining three categories are taken to be someone who has smoked. In the tabulations 
that follow, the counts are weighted using the weight provided for the analysis of the 
core interview sample (and hence the counts are not always integer). The cross 
tabulation count of gender, age and ethnicity for the smoking status variable is shown in 
Table 8-12 and also as percentages in Table 8-13. 
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Table 8-12 : Cross tabulation counts of smoking status by gender, age and ethnicity 
 
Ever smoked? 
White Mixed Asian Black Other 
No Yes No Yes No Yes No Yes No Yes 
Male Age 30 to 39 247.7 322.3 6.2 5.3 44.5 37.7 10.7 8.4 4.4 5.4 
Age 40 to 49 305.7 379.0 3.1 6.6 38.7 26.2 26.8 15.6 6.7 3.6 
Female Age 30 to 39 274.6 313.0 6.6 5.0 60.7 8.8 26.3 7.6 12.6 2.8 
Age 40 to 49 338.4 363.7 7.8 5.1 53.1 6.3 19.7 8.6 2.2 0.8 
Table 8-13 : Cross tabulation percentage of smoking status by gender, age and ethnicity 
 
Ever smoked? 
White Mixed Asian Black Other 
No Yes No Yes No Yes No Yes No Yes 
Male Age 30 to 39 43% 57% 54% 46% 54% 46% 56% 44% 45% 55% 
Age 40 to 49 45% 55% 32% 68% 60% 40% 63% 37% 65% 35% 
Female Age 30 to 39 47% 53% 57% 43% 87% 13% 78% 22% 82% 18% 
Age 40 to 49 48% 52% 61% 39% 89% 11% 70% 30% 74% 26% 
Clearly it is possible to use these percentages as thresholds within the Monte Carlo 
approach to determine if a Replenisher of a particular gender, age cohort and ethnicity 
combination has ever smoked. However, some of these probability estimates are based 
on very small samples, particularly the Mixed and Other groups. If these estimates are 
to be made more reliable then there is a need to merge some categories. A χ
 2 
test of 
each of the three dimensions in Table 8-12 shows that only for age is there no 
significant difference between its levels (Table 8-14). 
Table 8-14 : Results of χ
 2
 test to identify significant factors 
Factor χ
 2
 dof Sig 
Age cohort 0.059     1 0.808 
Gender 12.812
***
 1 0.000 
Ethnicity 87.756
***
 4 0.000 
Custom Groups 116.804
***
 2 0.000 
Recalculating the percentages in Table 8-13 without the age cohort, provides Table 
8-15. In this table there is evidence for a potential cluster of three grouping in regards to 
smoking status. Those with the lowest rates of ever having smoked are Asian, Black and 
Other females (~80% never smoked). The next lowest is Asian, Black, Other males or 
 
 
213 
 
Mixed females (~60% never smoked) whilst the highest are White or Mixed males 
(~45% never smoked). If this customised grouping is adopted and a χ
 2
 conducted to test 
for the significance of this grouping, it is seen to be highly significant in Table 8-14.  
Table 8-15 : Cross tabulation percentage of smoking status by gender and ethnicity 
 
Ever smoked? 
White Mixed Asian Black Other 
No Yes No Yes No Yes No Yes No Yes 
Male 44% 56% 44% 56% 57% 43% 61% 39% 55% 45% 
Female 48% 52% 59% 41% 88% 12% 74% 26% 81% 19% 
The actual probabilities used are thus estimated based on these groupings and shown in 
Table 8-16. The advantage of these estimated probabilities over those in Table 8-15 is 
that they are more reliable, being based on aggregated larger samples that have retained 
a degree of homogeneity with regard to smoking status.  
Table 8-16 : Custom Monte Carlo probabilities to determine the smoking status of 
Replenishers 
Grouping Never smoked Smoked Count 
Asian, Black, Other Females 83% 17% 210 
Asian, Black, Other Males or Mixed Females 58% 42% 253 
White or Mixed Males 46% 54% 2,565 
8.5 CONCLUSION 
In this chapter the results of further preparatory work for the health microsimulation has 
been presented. The theme of the material is the estimation of the probabilities that 
determine how an individual’s characteristics change or are defined through the 
modelling process. 
The morbidity hazard models are critical to the operation of the health microsimulation 
since they model the incidence of morbidities over time which in turn defines the 
prevalence. Whilst initially the morbidity status of the population within each LAD will 
largely be defined by the surveyed status of individuals at ELSA wave 5, as the health 
microsimulation progresses to future synthetic waves the contribution of these survey 
individuals to the count for each morbidity will diminish. They will be augmented either 
by those in the same cohort who did not initially have the morbidity but the hazard 
model predicts they will subsequently acquire the morbidity or by those who replenish 
the population aged 50 to 51 and become a new ageing cohort. For CVD and DHBS 
there are significant time impacts, both in the chronological age and the wave trend. 
There is also evidence that females have lower probabilities of acquiring these two 
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morbidities. The south Asian ethnic group are more likely to acquire DHBS or a 
respiratory illness than the White group, but the highest probability for these two 
morbidities is the Mixed, Black or Other group. With CVD the ethnic grouping is not 
significant, but the lowest incidence is amongst the Black ethnic group, with a negative 
estimate, which supports the finding in the literature of the lowest prevalence for this 
group. Ever having smoked significantly increases the probability of CVD and 
respiratory illness but not DHBS (where the parameter is still positive, but not 
significant). The contextual type of LAD has a moderating impact on the probabilities. 
A general pattern is for those living in the more prosperous types of LAD to have a 
lower probability of acquiring a morbidity. 
The second set of hazard models are used to define the selection weights that determine 
who is selected for cloning or removal in order to achieve a required population 
structure. Whilst it is not required that these estimates accord exactly with other similar 
sources of estimates, some insight is gained by carrying out this comparison. In 
particular it was found that the expected under counting of migration between LADs 
was indeed present and substantial, and an adaptation is required to better represent the 
probabilities of such moves. 
The final piece of work reported defined the characteristics of those who replenish the 
populations at younger ages within each LAD. These characteristics are their morbidity 
status when they join the population and whether they have ever smoked. The morbidity 
status was estimated using the existing morbidity hazard models to accumulate their 
incidences over a 20 year period during which they aged from 30 to 49. In comparison 
with current prevalences reported in wave 6 of ELSA these prevalences were similar for 
males and females with CVD and for females with DHBS. For males with DHBS the 
accumulated hazard estimates were higher than those in the ELSA report and for 
respiratory illness they were lower for both males and females. 
These three preceding results chapters have provided the basis to enable the modelling 
within the health microsimulation to take place. They have provided a spatially relevant 
and representative 2011 base population for each LAD; provided projections on how 
this population will evolve in terms of its gender, age and ethnic composition and here, 
provided mechanisms to dynamically change the characteristics of this population 
through time. The following chapter provides the results of implementing this 
modelling methodology to predict the number of individuals with each of the three 
morbidities in each LAD to 2031. 
  
 
 
215 
 
9 HEALTH MICROSIMULATION 
Estimating Morbidity Outcomes for Local Authorities 
9.1 INTRODUCTION 
In this chapter the results of the model which forecasts the number of individuals within 
each English LAD with specific morbidities are presented. This is the fulfilment of the 
substantive research question of this thesis identified in section 1.4.  
The methodology adopted is a hybrid approach where the population is studied at the 
individual or micro scale, modelling each individual’s behaviour, but the composition of 
the population is adapted over time to an aggregate or macro structure.  This is 
described in detail in Chapter 5 and in order to achieve these results there are a number 
of pre-requisites. Firstly, there is a need to construct a base population representing the 
LAD population in 2011. This is provided through the spatially microsimulated 
population which is described in Chapter 6. Secondly, there is the need to have a 
projection of the ethnic population in each LAD covering the forecasting period 2011 to 
2031. The application of the mechanism to produce these projections is described in 
Chapter 7. What remains are models that update the morbidity status of individuals 
through time, creating new incidences of the morbidities and models that allow for the 
weighted selection of individuals to achieve a desired population structure. The models 
which provide these estimates are described in Chapter 8. This chapter presents the 
modelled outcomes, both at a national (section 9.3) and subnational level (sections 9.4 
and 9.5), and in some detail for the seven case study LADs (section 9.6).  
9.2 HEALTH MICROSIMULATION 
The task of running the health microsimulation is done using a piece of bespoke C code. 
The C code reads in the spatially microsimulated population as output from the FMF for 
each LAD. It reads in the characteristics of the ELSA sample population to give these 
individuals their attributes, e.g. gender, age, ethnicity, presence of a morbidity and 
smoking status (here shadow individuals are also created, see section 5.5.4). The 
parameter values for the various hazard functions are also read in. In execution, the non-
parallelised code takes about 30 minutes to produce the forecast prevalence counts 
biennially for the years 2011 to 2031. The output consists of gender, five year age band 
and ethnic group counts of those with and without each morbidity and additionally those 
with the comorbidity of CVD and DHBS. These prevalence counts may then be 
interpreted as the demand on local health care services associated with the morbidity or, 
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when divided by the population at risk, a prevalence rate to allow for a comparison over 
time and amongst LADs.  
9.3 RESULTS FOR ENGLAND 
The morbidity prevalence rates for the whole of England, calculated by the aggregation 
of the counts for each constituent LAD are shown in Table 9-1, Table 9-2, Table 9-4 
and Table 9-5 for each biennial forecast year and each five year age band. The values in 
the cells in the entire table are rendered, with the intensity of the colour increasing as 
the prevalence increases, from white (low) to blue (CVD), red (DHBS), purple 
(respiratory illness) or grey (CVD and DHBS). 
The general expectation in these tables is that the prevalence will increase with age 
reading across the tables. Individuals will acquire the morbidity at young ages and, if 
they survive, carry this morbidity to later ages. The trends reading down forecast years 
may however differ for each morbidity, once again driven by the ageing of the 
population. In each table there will exist cohort effects, where the progress of a group 
with a particularly high or low prevalence may be followed through the table. Such a 
cohort has been highlighted in the DHBS table. The group aged 50 to 54 during 2015 
and 2017 has appreciably higher prevalences than the same aged group in 2013 or 2019. 
They will all have moved into the 55 to 59 year age band by 2018 to 2022, contributing 
this higher prevalence for the forecast periods up to 2019, 2021 and 2023.  They will 
similarly be in the 60 to 64 age band for the forecast periods 2025 and 2017. This cohort 
of higher prevalences are shown as thick boxes in Table 9-2. 
Table 9-1 : Forecast CVD prevalences for England 
 
50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 plus Total 
2011 2.9% 5.7% 8.1% 16.4% 20.6% 30.8% 39.8% 42.1% 18,229,893 
2013 3.0% 4.0% 8.6% 12.9% 21.9% 25.9% 39.4% 41.2% 18,964,704 
2015 2.4% 4.4% 7.7% 12.0% 20.1% 24.5% 35.5% 41.1% 19,689,593 
2017 2.2% 4.5% 6.1% 11.0% 17.7% 23.8% 30.4% 40.8% 20,400,332 
2019 1.9% 3.4% 6.0% 10.2% 15.0% 23.2% 27.3% 39.0% 21,083,429 
2021 1.6% 3.2% 5.8% 9.9% 13.1% 21.5% 26.1% 35.7% 21,732,680 
2023 1.4% 2.6% 5.2% 7.3% 12.6% 17.8% 26.0% 32.5% 22,304,919 
2025 1.2% 2.3% 4.3% 7.3% 11.4% 16.3% 23.6% 30.7% 22,755,033 
2027 1.1% 2.0% 3.8% 6.8% 9.4% 14.7% 20.7% 28.5% 23,129,460 
2029 0.9% 1.7% 3.3% 5.5% 8.8% 13.4% 18.0% 26.7% 23,539,913 
2031 0.8% 1.5% 2.9% 4.9% 8.4% 12.7% 16.0% 24.7% 24,029,232 
The most dramatic reductions in morbidity to 2031 occur for CVD, with all age bands 
showing large reductions in the prevalence over the 20 year forecast period (Table 9-1). 
The youngest age bands show the greatest relative reduction, the rate amongst 50 to 54 
years olds is nearly a quarter of that in 2011 whilst for the oldest age band it is nearly a 
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half of the 2011 prevalence by 2031.  This dramatic reduction in the prevalence of CVD 
is in line with the recent trends in the reduction in standardised death ratios for CHD 
shown in Figure 3-3. 
Table 9-2 : Forecast diabetes or high blood sugar prevalences for England 
 
50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 plus Total 
2011 7.0% 8.3% 9.7% 13.6% 15.5% 19.7% 14.6% 19.0% 18,229,893 
2013 7.2% 9.0% 11.3% 14.0% 16.0% 17.9% 19.9% 19.0% 18,964,704 
2015 8.4% 9.6% 11.7% 13.6% 17.2% 18.6% 22.1% 19.3% 19,689,593 
2017 8.4% 9.7% 12.7% 13.9% 17.8% 18.3% 22.1% 20.8% 20,400,332 
2019 7.3% 10.2% 13.2% 14.8% 17.0% 19.2% 22.2% 22.3% 21,083,429 
2021 6.7% 11.4% 12.6% 15.6% 16.9% 20.0% 21.5% 23.0% 21,732,680 
2023 6.1% 10.1% 12.8% 15.5% 17.9% 20.0% 21.2% 22.8% 22,304,919 
2025 5.4% 9.3% 13.9% 15.4% 18.0% 19.3% 22.2% 23.5% 22,755,033 
2027 4.9% 8.5% 13.5% 15.0% 18.9% 19.4% 22.4% 22.9% 23,129,460 
2029 4.5% 7.8% 12.3% 15.3% 18.7% 20.1% 21.4% 23.4% 23,539,913 
2031 4.0% 7.2% 11.5% 16.5% 17.6% 20.6% 21.2% 23.4% 24,029,232 
For DHBS the pattern in less uniform (Table 9-2). For the very youngest age bands, 
aged 50 to 59, there are reductions in the prevalence rate when comparing the start and 
end of the forecast period. For the remaining age bands the prevalence increases by 
between 2% and 4% points from 2011 to 2031. These forecasts suggest that DHBS will 
become a morbidity much more concentrated in the middle-old and old-old population. 
An anomaly here is for the 80 to 84 age band where the 2011 prevalence forecast looks 
untypically low. There is a constant dip in the published DHBS prevalence for those 
aged 80 or older in the successive ELSA wave reports. Figure 9-1 charts these trends 
using published figures in table H3a of each ELSA wave report. There is an almost 
universal trend of a drop in the prevalence for this older age band for both genders and 
for all waves. (Incidentally, this figure also shows that prevalences for DHBS are 
increasing over time; wave 5 rates are higher than those in earlier waves). Elsewhere, 
using the 2008 to 2012 HSfE, Morrissey et al. (2014) also report a drop in prevalence 
rates for diabetes for males aged 75 or older (although there may be some endogeneity 
here since ELSA participants are recruited from previous respondents to the HSfE). 
There are a number of potential explanations for this phenomenon. Firstly, it may be an 
artefact of the way the information was collected in ELSA. Secondly, this outcome may 
be correct for the ELSA cohort (and by implication HSfE population) but anomalous for 
the population as a whole. The third explanation is the existence of a ‘golden cohort’ 
whose health outcomes, particularly for diabetes, are better than younger cohorts 
(Goldring et al, 2011). 
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Figure 9-1 : Prevalence rates for diabetes or high blood sugar in each ELSA wave, male 
(lhs), female (rhs), England 
(source : ELSA wave reports, 2003-2014) 
To further explore this feature, using the ELSA wave 5 core data files this oldest age 
band can be split into two, those aged 80 to 84 and those aged 85 and older. These 
prevalences are provided in Table 9-3 for males. Here it is seen that the published 80 
years and older rate of 15.7% is made up of a 15.1% rate for those aged 80 to 84 and a 
16.3% rate for those aged 85 and older – the published reduction in prevalence is for the 
80 and older population is almost all a result of the low prevalence at ages 80 to 84. 
Table 9-3 : Male diabetes or high blood sugar prevalences from ELSA wave 5 
Age band Prevalence rate 
Aged 52 to 54 6.9% 
Aged 55 to 59 10.7% 
Aged 60 to 64 12.0% 
Aged 65 to 69 15.0% 
Aged 70 to 74 17.6% 
Aged 75 to 79 18.5% 
Aged 80 to 84 15.1% 
Aged 85 and older 16.3% 
All 13.8% 
The pattern of prevalences for respiratory illnesses is similar to that for DHBS, with 
decreases in prevalence over the period 2011 to 2031 for the age band 50 to 69; and 
increases for the age bands after. These reductions in the younger age bands are present 
here too. As the health microsimulation progresses these younger age bands will be 
composed almost entirely of Replenishers and it was noted in section 8.4.1 that the 
prevalence of these Replenishers for this morbidity was less than that found in the 
equivalent ELSA wave 6 prevalence table.  
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Table 9-4 : Forecast respiratory illness prevalences for England 
 
50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 plus Total 
2011 15.8% 14.1% 17.4% 20.3% 22.1% 21.6% 24.0% 23.3% 18,229,893 
2013 9.5% 15.6% 16.5% 20.5% 23.9% 21.8% 23.3% 23.8% 18,964,704 
2015 6.4% 16.9% 16.6% 19.9% 23.4% 22.8% 24.9% 24.2% 19,689,593 
2017 5.1% 14.2% 17.7% 18.7% 23.0% 25.4% 24.4% 24.7% 20,400,332 
2019 4.4% 10.0% 17.8% 19.9% 22.5% 25.5% 24.5% 24.6% 21,083,429 
2021 4.1% 7.0% 20.0% 19.3% 22.6% 24.9% 25.8% 24.9% 21,732,680 
2023 3.7% 6.2% 13.9% 20.6% 21.4% 25.0% 27.3% 24.4% 22,304,919 
2025 3.3% 5.8% 10.3% 21.2% 21.4% 24.7% 26.6% 25.9% 22,755,033 
2027 3.0% 5.4% 8.4% 18.4% 22.2% 23.2% 26.6% 26.9% 23,129,460 
2029 2.8% 5.0% 7.8% 14.0% 22.1% 24.1% 26.0% 26.4% 23,539,913 
2031 2.5% 4.7% 7.4% 10.4% 24.0% 23.5% 26.2% 26.8% 24,029,232 
The prevalences for those who have both morbidities of CVD and DHBSs are shown in 
Table 9-5. As would be expected, these rates are composites of those for the same two 
morbidities in isolation. The anomalous low prevalence for DHBS for the 80 to 84 year 
old age band in 2011 is replicated here. For CVD the pattern within each age band was 
for reductions in prevalence for future years whilst for DHBS these reductions were 
only seen in the 50 to 59 year old age band, here the long term pattern of the CVD 
prevalence trends appears to dominate. However, there are some moderating influences. 
Firstly the reductions over the 20 year period are not so dramatic, particularly for the 
old-old and there appears to be a peak in prevalences during the forecast periods 2013 to 
2021 for this old-old band. The rate of this comorbidity in the Replenisher population is 
low. 
Table 9-5 : Forecast CVD and diabetes or high blood sugar prevalences for England 
 
50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 plus Total 
2011 1.6% 1.8% 1.8% 4.3% 5.4% 9.1% 7.4% 9.9% 18,229,893 
2013 0.7% 1.5% 2.2% 3.5% 6.0% 6.4% 11.1% 9.8% 18,964,704 
2015 0.3% 1.8% 2.2% 2.9% 5.8% 6.6% 10.8% 10.2% 19,689,593 
2017 0.3% 1.5% 2.0% 2.7% 5.1% 6.7% 9.0% 11.0% 20,400,332 
2019 0.2% 0.5% 2.2% 3.0% 4.0% 6.5% 8.6% 11.3% 21,083,429 
2021 0.2% 0.5% 2.1% 3.0% 3.4% 6.3% 8.0% 10.5% 21,732,680 
2023 0.1% 0.4% 1.3% 2.3% 3.7% 5.3% 7.8% 9.6% 22,304,919 
2025 0.1% 0.3% 0.8% 2.5% 3.5% 4.5% 7.5% 9.5% 22,755,033 
2027 0.1% 0.2% 0.7% 2.0% 3.1% 4.1% 6.5% 8.8% 23,129,460 
2029 0.1% 0.2% 0.5% 1.1% 3.0% 4.3% 5.2% 8.5% 23,539,913 
2031 0.0% 0.2% 0.4% 1.1% 2.8% 4.1% 4.6% 7.9% 24,029,232 
Whilst morbidity prevalences are informative when it comes to making comparisons 
between time periods and areas, in terms of health care planning it is the number of 
individuals with the morbidity and their location that is important. This spatial aspect to 
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both the prevalence and the number of individuals with morbidities is discussed in the 
next section but to finish this picture for England as a whole, Figure 9-2 shows the 
number of individuals with each morbidity in England and the total 50 years and older 
population from 2011 to 2031 and, for context, the equivalent prevalences are provided. 
 
Figure 9-2 : Trends in the prevalence count (lhs) and rate (rhs) for morbidities, England, 
2011 to 2031 
There are three contrasting patterns here. With CVD and the comorbidity of CVD and 
DHBS both the prevalence counts and rates decrease. In contrast, the prevalence count 
for DHBS increases and this increase is greater than that seen in the general population, 
giving an increased prevalence rate. Finally the prevalence count for respiratory illness 
stays fairly constant, although given the rise in the population, this translates to a fall in 
the prevalence. 
9.4 RESULTS FOR NHS LOCAL AREA TEAMS 
Within England there are 25 NHS Local Area Teams (LATs) whose primary roles are to 
provide a strategic function that focuses on local priorities and also balances resources 
and strategies across a wide and coherent geographic area. Mostly these LATs are 
composed of a number of LADs, although some LADs do span more than one LAT. 
The best fit, by area, of these LADs to Local Area Teams is shown in Figure 14-2. 
Table 9-6 gives the forecasts of the prevalence of CVD in each LAT across all ages. For 
each year (rather than the entire table) the cells are shaded so that for each forecast year 
the LAT with the highest prevalence has the darkest shade and the LAT with the lowest 
prevalence has the lightest shade. Intermediate prevalences will have a graduated shade. 
Using this shading, an LAD that has consistently high prevalences from 2011 to 2031 
will feature as a dark band across the table. 
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Table 9-6 : Trends in CVD prevalence for NHS Local Area Teams 
LAT 2011 2013 2015 2017 2019 2021 2023 2025 2027 2029 2031 
Cheshire, Warrington & Wirral 15.6% 14.9% 14.2% 13.3% 12.6% 11.9% 11.0% 10.5% 9.8% 9.1% 8.6% 
Durham, Darlington & Tees 16.3% 15.8% 15.4% 14.7% 14.0% 13.5% 12.5% 12.0% 11.4% 10.7% 10.1% 
Greater Manchester 16.3% 15.0% 14.1% 12.9% 11.9% 11.1% 10.0% 9.5% 8.7% 8.0% 7.4% 
Lancashire 16.5% 15.3% 14.3% 13.2% 12.2% 11.5% 10.4% 9.8% 9.1% 8.3% 7.8% 
Merseyside 16.7% 15.9% 15.1% 14.2% 13.4% 12.8% 11.7% 11.1% 10.4% 9.6% 9.1% 
Cumbria, Northumberland, Tyne & Wear 16.1% 15.4% 14.8% 13.9% 13.1% 12.5% 11.6% 11.0% 10.3% 9.6% 9.1% 
North Yorkshire & Humber 15.7% 14.8% 14.0% 13.1% 12.3% 11.7% 10.8% 10.2% 9.5% 8.8% 8.3% 
South Yorkshire & Bassetlaw 16.6% 15.4% 14.4% 13.3% 12.2% 11.4% 10.3% 9.7% 8.9% 8.2% 7.7% 
West Yorkshire 15.9% 14.7% 13.7% 12.5% 11.5% 10.7% 9.6% 9.0% 8.2% 7.5% 7.0% 
Arden, Herefordshire & Worcestershire 15.5% 14.8% 14.0% 13.0% 12.2% 11.5% 10.6% 10.1% 9.3% 8.7% 8.1% 
Birmingham & the Black Country 17.2% 15.9% 14.8% 13.6% 12.4% 11.5% 10.3% 9.7% 8.9% 8.1% 7.5% 
Derbyshire & Nottinghamshire 16.1% 15.0% 14.1% 13.1% 12.1% 11.4% 10.4% 9.8% 9.1% 8.4% 7.9% 
East Anglia 15.7% 14.9% 14.1% 13.2% 12.4% 11.7% 10.7% 10.1% 9.5% 8.7% 8.2% 
Essex 15.4% 14.6% 13.8% 12.8% 12.0% 11.3% 10.3% 9.8% 9.1% 8.4% 7.8% 
Hertfordshire & the South Midlands 14.7% 13.8% 13.1% 12.2% 11.4% 10.7% 9.8% 9.2% 8.5% 7.9% 7.4% 
Leicestershire & Lincolnshire 16.1% 15.0% 14.2% 13.2% 12.3% 11.6% 10.6% 10.1% 9.4% 8.7% 8.2% 
Shropshire & Staffordshire 15.7% 15.0% 14.3% 13.4% 12.5% 11.9% 10.9% 10.4% 9.7% 9.0% 8.5% 
London 15.4% 14.0% 12.7% 11.5% 10.4% 9.5% 8.3% 7.8% 7.0% 6.2% 5.7% 
Bath, Gloucestershire, Swindon & Wiltshire 15.1% 14.3% 13.5% 12.6% 11.9% 11.2% 10.3% 9.7% 9.0% 8.4% 7.9% 
Bristol, North Somerset, Somerset & South Gloucestershire 15.7% 14.7% 13.8% 12.8% 11.9% 11.2% 10.3% 9.7% 9.0% 8.3% 7.7% 
Devon, Cornwall & Isles of Scilly 16.2% 15.3% 14.5% 13.6% 12.7% 12.0% 11.1% 10.5% 9.8% 9.1% 8.5% 
Kent & Medway 15.5% 14.6% 13.8% 12.9% 12.1% 11.5% 10.5% 10.0% 9.3% 8.6% 8.0% 
Surrey & Sussex 15.6% 14.8% 13.9% 13.0% 12.1% 11.4% 10.5% 9.9% 9.2% 8.5% 8.0% 
Thames Valley 14.3% 13.6% 12.8% 12.0% 11.2% 10.5% 9.6% 9.2% 8.5% 7.9% 7.4% 
Wessex 15.7% 14.8% 14.0% 13.1% 12.2% 11.5% 10.6% 10.1% 9.4% 8.7% 8.2% 
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Table 9-7 : Trends in diabetes or high blood sugar prevalence for NHS Local Area Teams 
LAT 2011 2013 2015 2017 2019 2021 2023 2025 2027 2029 2031 
Cheshire, Warrington & Wirral 11.5% 12.0% 12.5% 12.7% 12.8% 13.0% 12.8% 12.9% 12.9% 12.7% 12.7% 
Durham, Darlington & Tees 12.1% 12.8% 13.5% 13.8% 14.1% 14.3% 14.3% 14.4% 14.4% 14.2% 14.1% 
Greater Manchester 12.5% 13.5% 14.5% 15.0% 15.3% 15.7% 15.7% 16.0% 16.1% 16.0% 15.9% 
Lancashire 12.2% 13.0% 13.7% 14.1% 14.3% 14.5% 14.4% 14.5% 14.6% 14.4% 14.3% 
Merseyside 12.5% 13.0% 13.5% 13.8% 13.9% 14.1% 13.9% 14.0% 13.9% 13.7% 13.6% 
Cumbria, Northumberland, Tyne & Wear 11.9% 12.4% 13.0% 13.2% 13.4% 13.5% 13.4% 13.5% 13.4% 13.2% 13.1% 
North Yorkshire & Humber 11.4% 12.0% 12.6% 12.9% 13.1% 13.3% 13.1% 13.2% 13.2% 13.0% 12.9% 
South Yorkshire & Bassetlaw 12.4% 13.2% 13.9% 14.3% 14.5% 14.8% 14.7% 14.8% 14.8% 14.7% 14.6% 
West Yorkshire 12.4% 13.6% 14.6% 15.2% 15.6% 16.0% 16.0% 16.3% 16.4% 16.4% 16.3% 
Arden, Herefordshire & Worcestershire 11.6% 12.5% 13.2% 13.6% 13.8% 14.1% 14.0% 14.2% 14.2% 14.1% 14.0% 
Birmingham & the Black Country 13.8% 15.5% 16.9% 17.9% 18.5% 19.0% 19.2% 19.7% 19.9% 19.9% 19.8% 
Derbyshire & Nottinghamshire 12.1% 13.0% 13.8% 14.3% 14.6% 14.9% 14.9% 15.1% 15.2% 15.1% 15.1% 
East Anglia 11.4% 11.9% 12.4% 12.7% 12.8% 13.0% 12.9% 12.9% 12.9% 12.7% 12.6% 
Essex 11.3% 11.9% 12.5% 12.8% 12.9% 13.1% 13.1% 13.2% 13.2% 13.1% 13.1% 
Hertfordshire & the South Midlands 11.4% 12.1% 12.8% 13.1% 13.4% 13.6% 13.6% 13.8% 13.8% 13.7% 13.6% 
Leicestershire & Lincolnshire 12.2% 12.9% 13.6% 13.9% 14.1% 14.4% 14.3% 14.5% 14.5% 14.3% 14.2% 
Shropshire & Staffordshire 11.8% 12.4% 13.1% 13.5% 13.7% 13.9% 13.8% 13.9% 13.9% 13.8% 13.7% 
London 13.7% 14.9% 15.9% 16.6% 17.0% 17.3% 17.2% 17.6% 17.7% 17.4% 17.2% 
Bath, Gloucestershire, Swindon & Wiltshire 11.1% 11.7% 12.2% 12.4% 12.6% 12.8% 12.6% 12.7% 12.7% 12.6% 12.6% 
Bristol, North Somerset, Somerset & South Gloucestershire 11.4% 11.9% 12.4% 12.6% 12.8% 12.9% 12.8% 12.8% 12.8% 12.6% 12.5% 
Devon, Cornwall & Isles of Scilly 11.5% 12.0% 12.5% 12.8% 12.8% 13.0% 12.9% 13.0% 12.9% 12.7% 12.5% 
Kent & Medway 11.4% 12.0% 12.6% 13.0% 13.2% 13.4% 13.3% 13.5% 13.5% 13.4% 13.3% 
Surrey & Sussex 11.2% 11.8% 12.3% 12.6% 12.8% 12.9% 12.8% 13.0% 12.9% 12.8% 12.8% 
Thames Valley 11.1% 11.7% 12.2% 12.5% 12.6% 12.8% 12.7% 12.9% 12.8% 12.7% 12.7% 
Wessex 11.3% 11.8% 12.4% 12.6% 12.8% 13.0% 12.9% 13.0% 13.0% 12.9% 12.8% 
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All LATs show a reduction in the prevalence of CVD, echoing what was seen in Table 
9-1, but the rate of reduction varies by LAT. The best performing LAT is London where 
the prevalence falls from one of the lowest in 2011 to a distinctly low prevalence, by 
some margin, by 2031 (its shading lightens across the table). The reason behind this 
good performance in London is attributable to the ethnic mix of the population, its 
younger age structure and the effect captured by the ONS area type of the London 
LADs (see Table 8-1 and Figure 14-2). Another LAT whose performance is good is 
Birmingham & the Black Country which moves from being the LAT with the highest 
prevalence in 2011 to a mid-table position in 2031, for much the same reasons as 
London, especially driven by its large Black ethnic population. The Durham, Darlington 
& Tees LAD shows the poorest improvement in the prevalence rate by 2031, its 
constituent LADs are mainly of the Industrial Hinterland type (see Figure 14-2). Here 
the impact attributable to the area type classification is probably driving this effect, 
where deprivation, lifestyle and the environment of the LADs that belong to this LAT 
are causing this adverse trend. Another LAT whose relative position worsens is the 
Thames Valley LAT, which moves from having the lowest prevalence in 2011 to 
having the fourth lowest in 2031. 
Table 9-7 shows the prevalence rates for DHBS. Again, the trend seen in Table 9-2  for 
increased prevalence of this morbidity in England more generally is apparent here too. 
However, there appears to be less ‘dynamism’ in the changes in relative prevalence 
between the LATs. Birmingham and the Black Country remains the LAT with the 
highest prevalence rates and this position is further entrenched by 2031. This is in 
contrast to London which starts with a similar prevalence to Birmingham and the Black 
County in 2011 and whilst it remains one of the highest, it is has rates somewhat lower 
than Birmingham and the Black Country by 2031. Birmingham and the Black Country 
has a sizeable south Asian and Black ethnic communities and both these communities 
have higher prevalence rates for DHBS than the White ethnic group. Also the LADs 
within Birmingham and the Black Country are predominantly of the Centre with 
Industry type which has a positive effect on the probability of people living in such 
authorities to acquire DHBS (see Table 8-2).  The London pattern is less clear. The 
same ethnic drivers as seen for Birmingham and the Black Country apply to London, 
i.e. a large BME population, but in London there are a mix of ONS LAD types, some of 
which increase the probability (London Centre) and some that decrease the probability 
(London Suburban and Cosmopolitan). The LATs that have consistently low 
prevalences for DHBS are mainly in the prosperous South of England 
.
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Table 9-8 : Trends in respiratory illness prevalence for NHS Local Area Teams 
LAT 2011 2013 2015 2017 2019 2021 2023 2025 2027 2029 2031 
Cheshire, Warrington & Wirral 18.7% 17.9% 17.6% 17.1% 16.5% 16.4% 15.6% 15.3% 14.9% 14.4% 14.2% 
Durham, Darlington & Tees 19.6% 19.0% 18.9% 18.5% 18.0% 18.0% 17.2% 16.9% 16.6% 16.0% 15.7% 
Greater Manchester 19.6% 18.6% 18.2% 17.6% 16.8% 16.6% 15.7% 15.4% 14.9% 14.2% 14.0% 
Lancashire 19.3% 18.5% 18.3% 17.8% 17.2% 17.0% 16.2% 15.9% 15.4% 14.8% 14.6% 
Merseyside 20.0% 19.2% 18.9% 18.4% 17.8% 17.8% 16.8% 16.5% 16.1% 15.5% 15.2% 
Cumbria, Northumberland, Tyne & Wear 19.2% 18.6% 18.5% 18.2% 17.7% 17.7% 17.0% 16.8% 16.4% 15.8% 15.6% 
North Yorkshire & Humber 18.4% 17.8% 17.6% 17.2% 16.7% 16.7% 16.0% 15.7% 15.3% 14.8% 14.5% 
South Yorkshire & Bassetlaw 19.5% 18.7% 18.4% 17.8% 17.1% 16.9% 16.0% 15.7% 15.2% 14.6% 14.4% 
West Yorkshire 19.3% 18.3% 18.0% 17.4% 16.8% 16.5% 15.6% 15.3% 14.8% 14.2% 13.9% 
Arden, Herefordshire & Worcestershire 18.5% 17.8% 17.5% 17.0% 16.4% 16.2% 15.5% 15.2% 14.7% 14.2% 13.9% 
Birmingham & the Black Country 20.2% 19.2% 19.0% 18.4% 17.7% 17.4% 16.5% 16.2% 15.7% 15.1% 14.9% 
Derbyshire & Nottinghamshire 19.0% 18.3% 17.9% 17.4% 16.8% 16.6% 15.8% 15.5% 15.0% 14.5% 14.2% 
East Anglia 18.2% 17.6% 17.4% 17.0% 16.5% 16.4% 15.7% 15.4% 15.0% 14.4% 14.2% 
Essex 18.2% 17.5% 17.2% 16.8% 16.3% 16.2% 15.5% 15.2% 14.8% 14.3% 14.1% 
Hertfordshire & the South Midlands 18.0% 17.0% 16.7% 16.2% 15.6% 15.4% 14.6% 14.3% 13.9% 13.4% 13.1% 
Leicestershire & Lincolnshire 18.9% 18.1% 17.9% 17.5% 16.9% 16.8% 16.1% 15.8% 15.4% 14.8% 14.5% 
Shropshire & Staffordshire 18.8% 18.2% 17.9% 17.5% 16.9% 16.8% 16.0% 15.7% 15.3% 14.7% 14.5% 
London 18.8% 17.3% 16.6% 15.8% 14.8% 14.4% 13.3% 13.0% 12.4% 11.7% 11.3% 
Bath, Gloucestershire, Swindon & Wiltshire 17.9% 17.1% 16.7% 16.2% 15.6% 15.4% 14.7% 14.3% 13.9% 13.4% 13.2% 
Bristol, North Somerset, Somerset & South Gloucestershire 18.2% 17.5% 17.1% 16.6% 16.1% 16.0% 15.2% 14.9% 14.5% 14.0% 13.7% 
Devon, Cornwall & Isles of Scilly 18.5% 18.5% 18.6% 18.6% 18.4% 18.5% 18.0% 17.9% 17.6% 17.2% 17.0% 
Kent & Medway 18.3% 17.7% 17.5% 17.1% 16.6% 16.6% 15.8% 15.6% 15.2% 14.7% 14.5% 
Surrey & Sussex 17.9% 17.4% 17.3% 17.0% 16.6% 16.6% 15.9% 15.7% 15.4% 15.0% 14.9% 
Thames Valley 17.6% 17.0% 16.8% 16.4% 16.0% 15.9% 15.3% 15.1% 14.8% 14.3% 14.2% 
Wessex 18.1% 17.5% 17.4% 17.1% 16.6% 16.6% 15.9% 15.7% 15.4% 14.9% 14.7% 
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Table 9-9 : Trends in CVD and diabetes or high blood sugar prevalence for NHS Local Area Teams 
 
2011 2013 2015 2017 2019 2021 2023 2025 2027 2029 2031 
Cheshire, Warrington & Wirral 3.8% 3.7% 3.6% 3.4% 3.2% 3.1% 2.9% 2.7% 2.5% 2.3% 2.2% 
Durham, Darlington & Tees 4.2% 4.0% 4.0% 3.9% 3.7% 3.6% 3.4% 3.2% 3.1% 2.9% 2.7% 
Greater Manchester 4.4% 4.2% 4.1% 3.8% 3.5% 3.4% 3.0% 2.9% 2.7% 2.4% 2.3% 
Lancashire 4.3% 4.1% 4.0% 3.7% 3.5% 3.3% 3.0% 2.8% 2.6% 2.4% 2.3% 
Merseyside 4.3% 4.1% 4.0% 3.8% 3.6% 3.5% 3.1% 3.0% 2.8% 2.5% 2.4% 
Cumbria, Northumberland, Tyne & Wear 4.1% 3.9% 3.8% 3.6% 3.4% 3.3% 3.0% 2.9% 2.7% 2.5% 2.3% 
North Yorkshire & Humber 3.8% 3.7% 3.6% 3.4% 3.2% 3.0% 2.8% 2.6% 2.4% 2.2% 2.1% 
South Yorkshire & Bassetlaw 4.3% 4.1% 4.0% 3.7% 3.5% 3.3% 3.0% 2.8% 2.6% 2.4% 2.2% 
West Yorkshire 4.3% 4.1% 4.0% 3.7% 3.5% 3.3% 2.9% 2.8% 2.6% 2.4% 2.2% 
Arden, Herefordshire & Worcestershire 3.9% 3.8% 3.7% 3.5% 3.3% 3.1% 2.9% 2.8% 2.6% 2.4% 2.2% 
Birmingham & the Black Country 5.1% 4.9% 4.8% 4.5% 4.1% 3.9% 3.5% 3.4% 3.1% 2.9% 2.7% 
Derbyshire & Nottinghamshire 4.2% 4.0% 3.8% 3.6% 3.4% 3.2% 2.9% 2.8% 2.6% 2.4% 2.3% 
East Anglia 3.8% 3.6% 3.6% 3.4% 3.2% 3.0% 2.8% 2.6% 2.4% 2.2% 2.1% 
Essex 3.7% 3.6% 3.5% 3.3% 3.1% 2.9% 2.7% 2.6% 2.4% 2.2% 2.1% 
Hertfordshire & the South Midlands 3.8% 3.6% 3.5% 3.3% 3.1% 3.0% 2.7% 2.6% 2.4% 2.2% 2.1% 
Leicestershire & Lincolnshire 4.3% 4.1% 4.0% 3.7% 3.5% 3.3% 3.0% 2.9% 2.7% 2.5% 2.4% 
Shropshire & Staffordshire 4.0% 3.9% 3.8% 3.6% 3.4% 3.2% 3.0% 2.8% 2.6% 2.4% 2.3% 
London 4.9% 4.5% 4.3% 4.0% 3.6% 3.4% 3.0% 2.9% 2.6% 2.3% 2.1% 
Bath, Gloucestershire, Swindon & Wiltshire 3.7% 3.5% 3.4% 3.2% 3.1% 2.9% 2.7% 2.5% 2.4% 2.2% 2.1% 
Bristol, North Somerset, Somerset & South Gloucestershire 3.8% 3.6% 3.5% 3.3% 3.1% 2.9% 2.7% 2.5% 2.3% 2.1% 2.0% 
Devon, Cornwall & Isles of Scilly 3.9% 3.7% 3.6% 3.4% 3.2% 3.1% 2.9% 2.7% 2.5% 2.3% 2.1% 
Kent & Medway 3.8% 3.7% 3.6% 3.4% 3.2% 3.1% 2.8% 2.7% 2.5% 2.3% 2.2% 
Surrey & Sussex 3.8% 3.7% 3.6% 3.4% 3.2% 3.0% 2.8% 2.7% 2.5% 2.3% 2.2% 
Thames Valley 3.6% 3.5% 3.4% 3.2% 3.0% 2.9% 2.6% 2.5% 2.4% 2.2% 2.1% 
Wessex 3.8% 3.6% 3.5% 3.3% 3.1% 3.0% 2.7% 2.6% 2.4% 2.3% 2.2% 
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For the prevalences of respiratory disease in Table 9-8 the general trend for reductions 
in the illness is apparent, although to varying degrees amongst LATs.  The London LAT 
shows a large reduction in the prevalence, from a mid-table position in 2011 to the LAT 
with the lowest prevalence in 2031. In Table 8-3 the hazard model parameter estimates 
shows that the incidence of respiratory illness amongst the BME community is greater 
than the White ethnic group, however this effect appears not to feed through to the 
prevalences here (as it did for DHBS). However, there are two other important 
influences at work for this morbidity. Firstly, smoking is a significant influence on the 
morbidity, but the smoking rates from the HSfE in Table 8-13  show lower smoking 
rates amongst the BME population. This implies that the smoking influence will have 
less impact on this population, particular those who are female. Secondly, the area type 
parameter estimates for the London type authorities predicts that there is a lower 
probability of acquiring a respiratory illness amongst the inhabitants of such authority 
types, all other things being equal. The converse trend to London appears to be taking 
place for the Devon, Cornwall and Isles of Scilly LAT. This LAT sees only a modest 
reduction in the prevalence. The ethnic population of these areas is predominately 
White and thus will have the higher smoking rates shown in Table 8-13, which will feed 
through to a higher prevalence. Also 8 of the 11 LADs within this LAT are Coastal and 
Countryside ONS area types and the parameter estimate for this type of authority is 
positive which means that people in such authorities have a higher incidence of 
respiratory illnesses. No other LAT has such a large concentration of Coastal and 
Countryside type authorities within its borders. Such Coastal and Countryside LADs are 
popular retirement destinations for the mobile elderly who may have lived and worked 
in more urban type LADs and on retirement moved to these less urban LADs (Rural 
Evidence Research Centre, 2005 and Raymer et al., 2007). A consequence of this is that 
their early life lifestyle behaviours are transplanted to these more rural LADs. The LAD 
area type estimate is capturing some of this contextual behaviour.  
The prevalence for the comorbidity of CVD and DHBS is shown in Table 9-9. Whilst 
there is no explicit hazard model for this comorbidity in the modelling framework, it is 
clearly shaped by the pattern in Table 9-6 and Table 9-7. The Birmingham and the 
Black Country LAT has a consistently high prevalence for this comorbidity. For CVD 
this LAT has the highest prevalence in 2011 but by 2031 its prevalence is mid table. 
However, for DHBS the prevalence remains high for this LAT. London starts with a 
high prevalence for this comorbidity but by 2031 it has moved into the third of LATs 
with the lowest prevalence.  Whilst the prevalence of DHBS remains high in London, 
the prevalence for CVD reduces considerably in London. This low prevalence for CVD 
accounts for the different trend in London. The position of Durham, Darlington & Tees 
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deteriorates by 2031, and this appears to be driven by its trend to relatively high CVD 
rates by 2031, rather than DHBS. 
Recent trends in reported prevalences for a range of morbidities arising from the NHS 
Quality and Outcomes Framework (QOF) show some corroborative year on year 
changes in these morbidities (HSCIC, 2014b). Data are published at national, LATs, 
CCG level and GP practice level. Looking at the changes in the reported prevalence at 
LAT level of CVD related morbidities, for CHD the average yearly reduction is 1.39% 
whilst for strokes there is a 0.93% increase. The picture is similarly mixed for 
respiratory illnesses, with asthma showing an average yearly 1.16% reduction but 
COPD a much higher 2.47% increase. For diabetes there is a large yearly 3.14% 
average increase in its QOF prevalence. These are recent but very short term trends, 
2012-13 to 2013-14, but if these trends were to persist then the longer term reduction in 
CVD prevalence and increase in diabetes prevalence seen here look plausible. 
9.5 RESULTS FOR LOCAL AUTHORITIES 
Whilst the tables in the previous sections provide a picture of trends by age and year for 
the whole of England and regionally, there will be local variations to these national 
trends.  To illustrate the local picture a series of maps of English LADs are provided for 
the 2031 forecasts (as was done for 2011 in Figure 6-2). Durham in the North East of 
England has both a high prevalence rate of CVD (it is coloured red) and a high 
prevalence count (the circle is large). However, looking just south of Durham to Leeds a 
different picture emerges. Here the circle is almost as large as Durham’s but the 
prevalence is much lower. This is due to the greater size of Leeds’ population. Thus 
Leeds has a lower prevalence rate of the morbidity but in terms of treatments and health 
care resources for CVD, its need is as almost as large as Durham’s. Copeland on the 
coast of the North West has a high prevalence (red) like Durham but low number of 
individuals (small circle) so its requirements for health care resources is less than 
Durham’s even though it has a similar prevalence rate. 
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Figure 9-3 : Prevalences and number of individuals with morbidities, LADs, 2031, from 
top left, CVD, top right, diabetes or high blood sugar, bottom left, respiratory 
illness and botton right CVD and diabetes or high blood sugar   
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One distinct pattern in the DHBS map is high prevalence rates in LADs located in West 
Yorkshire, Greater Manchester, the West Midlands and London plus Derby, 
Nottingham and Leicester. These are all authorities with large BME communities in 
2011 and the size of 50 and older population in these communities is projected to 
increase by 2031. The high prevalences for respiratory illnesses appear to be 
concentrated around the coast and in large rural LADs in the north of England 
(particularly the North West). However in terms of individuals with the morbidity these 
LADs have small numbers (with the exception of Cornwall which has both a high 
prevalence count and rate). Hot spots for the comorbidity of CVD and DHBS appear to 
be confined to LADs in and around London, and Leicester and Oadby and Wigston 
(which is located just south of the City of Leicester). 
9.6 RESULTS FOR CASE STUDY AUTHORITIES 
In this section trends in the prevalence rates of each morbidity within the seven case 
study authorities are illustrated and described. These trends are presented in terms of 
both the overall prevalence within the LADs and their ranking for the morbidity 
amongst all LADs (with a low ranking indicating a low prevalence). 
9.6.1 Cardio Vascular Disease 
The trend charts for CVD are shown in Figure 9-4. The trend in all LADs is for a 
decrease in the prevalence rate of CVD, although this rate of decline varies by LAD. 
Haringey has much the lower prevalence of all the case study LADs in 2011 and this 
difference is perpetuated and increased by 2031. The population of this LAD in 2011 
has a sizeable black and Afro Caribbean population (see Figure ‎7-5) which is beginning 
to age into the 50 year and older age band, and by 2031 (see Figure 7-18) this ethnic 
group is sizeable. Both the literature and the hazard models presented in Table 8-1  
shows that this ethnic group has a lower than average prevalence of this morbidity in 
comparison to the remaining ethnic groups. Also in Table 8-1, Haringey is a London 
Cosmopolitan type of LAD and people living in these types of authority have a lower 
probability of acquiring CVD, relative to most other area types. In terms of trends, 
Haringey remains one of the LADs with the lowest CVD prevalence. Also in the trend 
chart, the two LADs that show the greatest improvement in their relative prevalence 
rates for CVD by 2031 are Leeds and Redbridge.  
The ethnic mix of Redbridge has a large south Asian population and the expectation is 
that this should actually increase the probability of acquiring CVD (See Table 8-1) 
relative to the remaining ethnic groups. However there is also the lifestyle element of 
smoking behaviour (as discussed in 3.3.1.1), with this south Asian group having lower 
rates of smoking (see Table 8-13) and therefore the contribution to the probability from 
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smoking is reduced in this population.  Redbridge is also a London Suburban type of 
authority and this type of authority has one of the largest negative parameters in Table 
8-1. The third element contributing the improved performance of this LAD is that it is 
located in London and as seen in Figure 2-5, retains its youthful 50 years and older 
population, ageing from 65.5 years of age in 2011 to just 66.1 years in 2031 and 
therefore the age contribution to the probability of acquiring CVD will be relatively 
small for this LAD. Some of these same effects are seen to influence the relatively good 
performance of Leeds, a diverse, Cities and Services type of LAD with a young 
population, although additionally, Leeds does retain a sizeable Black ethnic group, 
which has a lower incidence of CVD than the White and Asian groups.  
 
Figure 9-4 : Prevalence rates (top) and rankings (bottom) for CVD, case study LADs, 
2011 to 2031 
Over the 20 year time span the case study authority whose relative position deteriorates 
the most is Wiltshire. The ethnic mix of this LAD remains almost homogeneously 
White over the 20 year time period, but does, like other large rural LADs, age from 66.3 
years of age in 2011 to 69.6 in 2031. The ONS area type of Wiltshire is Prospering 
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Smaller Towns which has a modest and insignificant negative impact on the probability 
of acquiring CVD relative to Manufacturing Towns.  
9.6.2 Diabetes or high blood sugar 
Looking at the trend charts in Figure 9-5 the general pattern is for increases in the 
prevalence of DHBS, the exception being Haringey which shows a slight reduction.  For 
the ranks, the relative position for most of the LADs does not change much, except, 
again, for Haringey and possibly Leeds. The parameter estimates in Table 8-2, show 
that smoking is not a significant influence on acquiring DHBS making the differential 
smoking rates by ethnicity less of a factor here than for CVD.  
The main driver for the stark increase in the prevalence for Camden is its ONS area 
classification of London Centre. This type of authority is one of only two that has a 
positive contribution to the probability of acquiring the morbidity relative to 
Manufacturing Towns, and it has the largest such contribution. In terms of ethnicity, 
Figure 7-17 would indicate that there is a sizeable cohort from the Black ethnic group 
ageing into the 50 years and older population, and this ethnic group has the largest 
positive influence on acquiring DHBS in Table 8-2. Camden ages only modestly, from 
65.5 years of age in 2011 to 66.3 years in 2031.  
Nearby Haringey is a London Cosmopolitan type of authority and so has the second 
most negative influence on the acquisition of this morbidity. It does however have a 
sizeable BME population and this would tend to increase the probability of acquiring 
the morbidity. As seen earlier, and like most London LADs, the population of Haringey 
remains young, making the contribution of the age related element of the hazard model 
minor. 
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Figure 9-5 : Prevalence rates (top) and rankings (bottom) for diabetes or high blood 
sugar, case study LADs, 2011 to 2031 
9.6.3 Respiratory Illness 
All the case study authorities show a reduction in the prevalence of respiratory illnesses 
between 2011 and 2031 (even Teignbridge which shows a rather modest -0.1% 
reduction). The greatest relative reductions are in the London authorities of Redbridge, 
Camden and Haringey. 
All the ONS area types specifically connected to London LADs have large negative 
parameter estimates in Table 8-3. The LAD estimate for London Suburban type LADs 
is particularly negative and large. This will drive the reductions in the incidence of 
respiratory illness in these types of authority. Here the role of ethnicity will again be 
confounded by the impact of smoking; whilst the BME ethnic group have a higher 
incidence of respiratory illness, they have lower rates of smoking and, unsurprisingly, 
smoking is an important influence on respiratory illness. Teignbridge is an authority 
with a predominately White ethnic population and as such will, following the 
probabilities in Table 8-16, have the highest smoking rates both in the original ELSA 
sample and the Replenishers. Also, the Coastal and Countryside area type has the most 
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positive estimate of all area types in Table 8-3  and therefore will increase the incidence 
of respiratory illness relative to LADs of other types. 
 
Figure 9-6 : Prevalence rates (top) and rankings (bottom) for respiratory illnesses, case 
study LADs, 2011 to 2031 
9.6.4 CVD and diabetes or high blood sugar 
As for the NHS LAT forecasts in Table 9-9 the interpretation of the trends for this 
comorbidity are influenced by the combined effects of the individual morbidities. All 
case study authorities show a reduction in the prevalence of this comorbidity. The 
reductions are the greatest, and almost equal, in Redbridge and in Haringey, although 
Redbridge starts with a much higher prevalence in 2011. The dynamic that drives the 
low comorbidity prevalence for Haringey is that the prevalence rates for both CVD and 
DHBS in Haringey fall over the 20 year period, more so for CVD than DHBS. This 
naturally reduces the rate for the comorbidity. With Leeds there is also a reduction in 
the CVD prevalence rate, although the DHBS rate increases slightly, but this 
combination still produces a reduction in the comorbidity prevalence rate, but not to the 
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same extent as seen in Haringey. The comorbidity rate for Camden is kept high by the 
increase in the prevalence of DHBS even in the context of a reduction in its CVD rate. 
Looking at the relative performance, both Haringey and Leeds improve their position 
somewhat over the 20 year period, largely due to their relative improvements in CVD 
prevalence seen in Figure 9-4. Whilst Redbridge also improves its relative position for 
CVD in Figure 9-4, its relative position on DHBS in Figure 9-5 stays poor, which limits 
the potential for similar improvements for the comorbidity. 
 
Figure 9-7 : Prevalence rates (top) and rankings (bottom) for comorbidity of CVD and 
diabetes or high blood sugar, case study LADs, 2011 to 2031 
9.7 ROBUSTNESS OF HEALTH MICROSIMULATION 
The approach adopted in the health microsimulation is stochastic in its use of pseudo 
random numbers for Monte Carlo draws. As with the spatial microsimulation in section 
6.6, some assessment of how sensitive the model outputs are to the sequence of random 
numbers is required. This is achieved in a similar manner here by performing two 
additional model runs where the initial random seed for the random number generator is 
varied. The measure used to assess the correspondence between the outputs amongst all 
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three model runs is the prevalence rate of the morbidity in the LAD for the final forecast 
year of 2031. This is illustrated visually by a scatter plot of these prevalences and the 
points should ideally lie on a straight line with slope 1.0 and passing through the origin 
with minimal scatter around the straight line. These scatter plots are shown in Figure 
9-8 for three health microsimulation runs with different sequences of random numbers 
along with the linear correlation coefficient r
2
, whose value should ideally be close to 
1.0.  
As seen earlier in Figure 6-3 there is some degree of scatter in the plots (although to a 
lesser degree than seen in Figure 6-3) but the correspondence between the forecasts is 
good which means that the outputs from the health microsimulation appear to be 
insensitive to stochastic nature of the microsimulation. 
 
Figure 9-8 : Comparison of LAD prevalences in 2031 from three health 
microsimulations, top : CVD, middle : diabetes or high blood sugar, bottom : 
respiratory illness 
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9.8 COMPARISON WITH OTHER FORECASTS 
There is the potential for some insight to be gained by comparing the forecasts derived 
here with alternative forecasts. Such comparative forecasts are, however, difficult to 
obtain. The POPPI project (Poppi User Guide, 2011) produces a series of updated 
forecasts for English LADs of a range of socio demographic and economic factors, 
including prevalence rates for a number of morbidities. The three relevant morbidities 
for this study are the number of people who have experienced a heart attack, a stroke 
and the number who have diabetes. The POPPI model uses gender and age band 
specific rates for morbidity prevalences and applies these to the latest ONS subnational 
population projections to arrive at the number of people with the morbidity. This can be 
converted back to a prevalence rate for the whole population by dividing by the size of 
the population. The current gender and age rates used by POPPI are shown in Table 
9-10a to Table 9-10c. 
Table 9-10a : POPPI stroke prevalence rates, Great Britain, 2007 
Age range Males Females 
65-74 2.8% 1.2% 
75+ 3.8% 1.9% 
(source : POPPI, 2011) 
Table 9-10b : POPPI heart attack prevalence rates, Great Britain, 2007 and ELSA CHD 
rates, England, wave 5 
 POPPI ELSA 
Age range Males Females Males Females 
65-69 
6.5% 2.6% 
19.9% 10.6% 
70-74 21.0% 14.5% 
75-79 
5.7% 5.1% 
32.0% 21.4% 
80+ 34.2% 25.7% 
(source : POPPI, 2011, and Institute for Fiscal Studies, 2012) 
Table 9-10c : Diabetes prevalence rates from POPPI, 2006, and ELSA, England, wave 5 
Age range 
POPPI ELSA 
Males Females Males Females 
65-69 
15.7% 10.4% 
15.0% 10.0% 
70-74 17.6% 11.3% 
75-79 
13.5% 10.6% 
18.5% 15.8% 
80+ 15.7% 13.7% 
(source : POPPI, 2011, and Institute for Fiscal Studies, 2012) 
To ensure compatibility between the forecasts, the health microsimulation prevalence 
rates are re-calculated on the 65 and older population as opposed to the usual 50 and 
older population. There remain however some compatibility issues. Firstly CVD 
includes a diagnosis of angina but POPPI does not have a prevalence rate for this 
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morbidity. This will lead POPPI to under estimate the morbidity of CVD. Secondly, if 
the counts of individuals with a stroke or heart attack diagnosis from POPPI are added 
together, there will be a double counting of those who have had both a stroke and heart 
attack. In the health microsimulation, they will only be counted once. This will lead to 
an overestimate by POPPI. Finally POPPI rates are for diabetes alone and not DHBS, 
and this will lead to an under estimate by POPPI. The scatter plot of the health 
microsimulation forecasts and the equivalent POPPI rates for English LADs in 2031 are 
shown in Figure 9-9. 
 
Figure 9-9 : Comparison of health microsimulation and POPPI prevalence rates, CVD 
(lhs) and Diabetes (rhs), LADs, 2031 
The agreement between the two prevalences is best for CVD. Except for a sizeable 
cluster to the right hand side of the plot, there appears to be a positive relationship 
between the two forecasts. However, the level of the POPPI forecasts of strokes or heart 
attacks is much lower and has a more narrow a range than for CVD from the health 
microsimulation. The correspondence between the two forecasts for diabetes is poor, 
with only a slight hint of a positive relationship. Again the level and range of POPPI 
forecasts are lower. Mason et al. (2015) conclude that the use of simple age based 
models, like POPPI, will tend to under estimate the level of morbidity in a population, a 
result not found here. There are a number of explanations as to why this is so. Firstly, 
this is not a like for like comparison, as discussed above. Secondly, the cross sectional 
(and historic) POPPI rates for the morbidities are lower than those in ELSA, see Table 
9-10c which provides a comparison of prevalence rates for diabetes used by POPPI 
versus DHBS rates published from ELSA. For CVD, unfortunately ELSA does not 
publish rates to compare directly with Table 9-10a and Table 9-10b, but the CHD rates 
are provided for some context in the case of heart attacks (heart attacks are a morbidity 
that forms part of CHD, strokes do not). Thirdly, the model forecasts in Table 9-2 
shows that DHBS is a morbidity that is predicted to be more concentrated in the old-old 
population by 2031, a dynamic which the constant POPPI rates does not capture. 
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9.9 CONCLUSION 
In this chapter the results of the health microsimulation have been presented. The 
microsimulation produces a population of individuals for each LAD that represents its 
projected gender, age and ethnic composition along with the smoking status of each 
individual. As the microsimulation progresses through each simulation time step the 
morbidity status of individuals is updated using a Monte Carlo approach. These outputs 
can be summarised in a number of ways, the two used here are prevalence counts of 
individuals with a morbidity and the prevalence rate of the morbidity within the 
population. These statistics can be aggregated to other higher geographies, to produce 
morbidity forecasts at the national or health region level. 
An overview of the trends in the three morbidities and the comorbidity shows that the 
number of individuals with CVD and respiratory illness will decrease over the forecast 
20 year time period. This decrease will occur in all LADs for CVD, and in all but 11 
LADs for respiratory illness. These trends are driven by reductions in the population 
who have smoked and a general negative time trend in the incidence of these 
morbidities that reflects non-quantifiable causes, e.g. occupation, lifestyles and air 
quality. The trend for DHBS is the reverse, in all but 15 LADs there are increases in the 
prevalence of this morbidity from 2011 to 2031. This morbidity has a strong ethnic 
gradient, being more prevalent in the BME population and the demographic projections 
are for the relative size of the BME population within the 50 year and older population 
to increase. Also, this morbidity is not influenced by smoking so the same extent as the 
other morbidities thereby negating the improvements attributable to this lifestyle 
change. The comorbidity of CVD and DHBS is driven by the trends in both its 
component morbidities and the reduction in the CVD prevalence means that the 
prevalence of the comorbidity falls in all but one LAD.  
These trends are also examined using both the sub national, health related, geography of 
NHS LATs and the public health geography of LADs in general. All the influences 
discussed above come to play in the dynamics that drive particular trends within LATs. 
The influence of having a large BME population in some LATS is seen to greatly 
increase their DHBS prevalences. 
Looking at case study authorities, whilst there is some unanimity in the trends across 
LADs, as highlighted above, the actual level of the morbidity in each LAD varies. This 
is a result of different starting levels in 2011 and different gradients in the trends.  These 
geographically disparities in both prevalence counts and rates are mapped for 2031. 
These maps illustrate that to gain a full picture of the health status and health demands 
of an area both these measures are insightful. 
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An examination of the robustness of the health microsimulation to the Monte Carlo 
aspect of its operation, as was done for the spatial microsimulation, shows the 
robustness to be good. The final section provides a comparison with some alternative 
forecasts of related morbidities. The task here is doubly complicated by the paucity of 
such alternatives and differences in the definition of each morbidity and its framing. 
The general impact on the total burden of ill health associated with these three 
morbidities can inform the headline trends seen in Figure 2-10 which show modest 
improvements in disability free life expectancies over time. In this study, CVD and 
respiratory illness are seen to reduce over time helping to extend disability free life 
expectancy whilst increases in DHBS will reduce disability free life expectancy. Whilst 
these three morbidities capture a large proportion of the morbidity cases in the 
population, they do not capture all; and changes in the prevalences of other morbidities 
(e.g. cancer, arthritis and dementia) will similarly influence the disability free life 
expectancy trend. It is therefore difficult to infer how the trends seen with these three 
case study morbidities will drive future disability free life expectancies. 
Whilst these results have provided a ‘headline’ picture of likely future local trends in the 
morbidities there is certainly further insight to be gained by decomposing these trends 
and attributing them to various demographic and health improvement factors. This are 
the second and third research questions and they are addressed in the following chapter 
which examines how the changing gender, ethnic, age mix of a LAD and the health 
improvements contribute towards this headline picture. 
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10 DECOMPOSITION OF HEALTH TRENDS 
An Accounting System 
10.1 INTRODUCTION 
In Chapter 9 the morbidity outcomes from the health microsimulation are presented 
biennially from 2011 to 2031 at national, NHS LAT and LAD geographies. There are 
clearly a number of influences at work that are causing the observed trends. The most 
frequent question asked about a complex forecasting technique such as the health 
microsimulation is “what factors are driving it?” A method is therefore needed that 
quantifies how much influence is attributable to each factor. 
Whilst there are explicit trends embodied in the probabilities of health outcomes 
captured by the hazard models there are also important demographic influences at work. 
Even if there were no changes to the health outcomes, these demographic influences 
have the potential to affect both the morbidity prevalence count and rate within the 
population. In this chapter the influence of five main demographic factors will be 
examined using an accounting system framework similar to that proposed by Bongaarts 
and Bulatao (1999) and Rees et al. (2013b). In addition the influence of the health 
improvements embodied in the health microsimulation will be examined to complete 
the picture.  
The demographic factors are related back to the original population which is the 2011 
Census population of the LAD. The first demographic factor is the size of the 
population, and, all other things being equal, a larger population will lead to a larger 
prevalence count but the same prevalence rates. The next demographic factor is the 
gender split in the population, and this outcome represents how the change in the size of 
the population and the relative sizes of the two genders influences prevalence counts 
and rates. The third additional demographic factor is the projected ethnic split of the 
population, whose influence will once again be felt on the prevalences. The next two 
demographic influences are age related. One captures the re-structuring of the 
population along size, gender, ethnic and age projections but with an assumption that 
there is no improvement in mortality over time. The final demographic influence allows 
for the projected influence of mortality improvement to take place. In all these scenarios 
the prevalence rates within the various sub-populations will remain constant over time. 
No one’s morbidity status will be updated and any changes in the prevalence rate for the 
whole population occurs through a simple re-weighing of these prevalence rates for the 
sub-populations whose sizes change in line with the demographic projections. The final 
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outcome is the situation when these health outcomes change according to the hazard 
models in Chapter 8. This is the outcome described in Chapter 9. Here the prevalence 
rates over time will vary as the incidence probabilities predicted by the hazard models 
vary according to time, age, gender, ethnicity, smoking status, presence of 
comorbidities and type of LAD. There will also be further impacts through a 
recruitment of healthier ‘Replenishers’ into the future synthetic waves and the increased 
mortality of those who have a morbidity. 
It should be made clear at this stage that only the final outcome is thought to be 
plausible. All the previous outcomes in terms of the demography within a LAD are 
purely artificial constructs whose purpose is to provide stepping stones from an original 
population to one that has evolved over time, both in its structure and its health 
outcomes. Also the sequence in which demographic changes are considered may be 
varied. For example rather than the sequence: size, gender, ethnicity, age, mortality, 
used here, alternative sequences are possible, e.g.: size, gender, age, ethnicity, mortality. 
Section 10.2 of this chapter describes how these various decomposition scenarios have 
been implemented and the degree to which the necessary population structures have 
been achieved. The third section, 10.3, provides a picture of the impact of the 
decomposition at the national level, looking at the outcomes measured by the 
prevalence counts and rates and the ratios in equation 5-21a (page 132). This is 
followed by section 10.4 which discusses the distribution of these decomposition ratios 
amongst the English LADs. The penultimate section 10.5 looks in detail at the 
differences in these ratios amongst the seven case study authorities and the final section, 
10.6, summaries the finding of this chapter. 
10.2 IMPLEMENTATION 
The implementation of each of these decomposition scenarios is achieved using the 
same C code that is used in Chapter 9 to produce the health microsimulation outcomes. 
The various demographic influences are represented by changing the input data used by 
the program and not performing the full range of population dynamics. 
10.2.1 Adapting the input data 
To capture each demographic influence the only data that needs to change is the data 
that define the size and shape of the population in each LAD by gender, age and 
ethnicity. The information contained in the ELSA population, e.g. gender, age in 2011, 
ethnicity, smoking and morbidity status in 2011, is required but does depend on the 
scenario. Information on the number of Replenishers at each future synthetic wave is 
not required since no one ages and, since there are no changes to individual’s morbidity 
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status or a need to weight individuals for selection, no hazard model parameter 
estimates are required. 
As described in 5.6 the structure of these artificial population projections is achieved in 
a number of ways. What is required initially is the size of each LAD population without 
mortality improvement (PN+,+,+
LAD,y
in equation 5-12). For the structure where the original 
population increases to this size, equation 5-14 is used. This population has the same 
gender, age and ethnic structure as the original 2011 Census population, but the size of 
the population is that without mortality improvement in each forecast year. The next 
two structures, where the gender (equation 5-15) and then the gender and ethnic 
structure (equation 5-16) are in line with revised ETHPOP projections, is achieved in 
two stages. The first stage is to use simple multipliers (as shown in equations 5-15 and 
5-16) as reasonable starting points to achieve these structures, followed by a second 
optimisation stage. The impact of this optimisation is measured in how accurately the 
required structure is achieved and what scale of changes are necessary to achieve it. It is 
these two projections that this section is most concerned with. The remaining two 
demographic structures are simply PNg,a,e
LAD,y
(gender, age and ethnic structures in line 
with revised ETHPOP but the population size does not incorporate mortality 
improvement) and Pg,a,e
LAD,y
 (the revised ETHPOP projections).  
The results of this optimisation, like the revision of ETHPOP projections, produces non 
integer population counts for each gender, age and ethnic combination. By the way that 
the health microsimulation works, these fractional projections are integerised by 
rounding to the nearest integer. 
10.2.1.1 Optimised for gender 
Here the task is to minimise the objective function 5-17 that measures how far the 
counts obtained from applying the simple multipliers are from reproducing the gender 
split from the revised ETHPOP and the age by ethnicity splits from the 2011 Census 
counts. Figure 10-1 illustrates the outcome and the impact of the optimisation process 
from optimisations of the 324 LADs, with one optimisation for each forecast year. The 
value of the TAEG at the end of the optimisation is shown in the upper left chart. The 
sum over the 2 +  (8 x 5) = 42 marginal constraints in equation 5-17 is never greater 
than 5.0. The resultant reduction in TAEG is shown in the upper right chart. These 
reductions are modest , suggesting that the initial count estimates from applying the 
multipliers were already close to those required. These improvements have been 
obtained by changing the 2 * 8 * 5 = 80 individual gender by age by ethnicity counts in 
each LAD. The absolute sum of these changes expressed as a percentage of the LAD 
population, are shown in the lower left hand chart. These percentages are small, with no 
LAD requiring more than a total of a 1.1% change over all its constituent counts. The 
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greatest adjustment that was required in each LAD for any forecast year is shown in the 
lower right chart. For only four years was there a need to make an adjustment to an age, 
gender and ethnic group category that was greater than 100.  
 
Figure 10-1 : Impact of optimisation to reproduce revised ETHPOP gender splits 
The charts in Figure 10-1 show that the adjustment process was successful in achieving 
the stated objective and this was achieved by only conservative changes to the initial 
estimates obtained by applying the multipliers. This is consistent with the assumption 
that the gender splits with each LAD are stable over time. 
10.2.1.2 Optimised for gender and ethnicity 
Here the task is to minimise the objective function 5-18 that measures how far the 
counts obtained from applying the simple multipliers are from reproducing the gender 
by ethnicity splits from the revised ETHPOP projections and the age splits from the 
2011 Census counts. As previously, the impact of this process is illustrated in a series of 
charts in Figure 10-2. 
Once again the optimisation has achieved a set of projections that reproduce the 
required marginal totals well. In this case there are (2 x 5) + 8 = 18 such marginal totals. 
No year within a LAD has an optimised TAEGE greater than 2.0 (upper left). However 
to achieve this optimisation there has been some large reductions from the initial TAEGE 
(upper right). These large reductions have been obtained by some substantial changes to 
the initial gender by age by ethnicity counts both measured using the sum of the 
absolute changes expressed as a percentage of the LAD population (lower left) and the 
maximum adjustment made (lower right).  
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Figure 10-2 : Impact of optimisation to reproduce revised ETHPOP gender and 
ethnicity splits 
To adjust for both gender and ethnicity is always a more complex task than just 
adjusting for gender alone, and consequently the changes illustrated in Figure 10-2 are 
much more substantial than in Figure 10-1. This implies that there is the potential for 
significant changes in the gender by ethnicity split within LADs over the forecast years 
that cannot be addressed by simply applying the multipliers. 
10.2.2 Simplifying the software 
Of critical importance to the implementation of the accounting system is that the 
morbidity rates within the spatially microsimulated population should not change. This 
is achieved by ensuring in the bespoke C program that a number of actions do not take 
place. Firstly, individuals do not age, so for example, a person who represents a 54 year 
old south Asian male in 2011, represents this same demographic in all forecast years. 
Since nobody ages then there is no need to introduce Replenishers into the sample. 
Indeed to do so would affect the prevalence rate at the younger age bands. Secondly, 
individuals are selected for cloning or removal within the population with equal weight. 
To allow this weight to vary, for example by morbidity status, would target certain 
individuals within the population and, since having a morbidity increases the chances of 
selection for removal, the prevalence rate would fall. Thirdly, and perhaps most 
importantly, the morbidity status of the individuals does not change - if they do not have 
the morbidity in 2011 then they cannot acquire the morbidity at any stage. This once 
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again ensures that the prevalence rates do not change, so if the 54 year old south Asian 
male in 2011 does not have the morbidity in 2011, they will not have it by 2031 as well. 
In practice, however, the prevalence rates are not constant since they are influenced by 
the Monte Carlo sampling that still takes place to re structure the population and if any 
shadow individuals are required then their morbidity status will affect the overall 
prevalence rate. In practice, however, these sampling effects are minimal. 
10.3 TRENDS IN ENGLAND 
Using the health microsimulation software and the range of input data produces a series 
of model outputs in a consistent output format. The size of the population at risk in each 
scenario is shown in Table 10-1. There are a number of features in this table. Firstly, for 
the original population, the size of the population is the same as the 2011 Census 
population in each forecast year. Re-sizing increases the size of the population, to the 
size of a population for the LAD without mortality improvements. For the next three 
scenarios: gender; gender and ethnicity; and gender, ethnicity and age the population 
sizes are very similar, influenced only by different patterns of integerisation. 
Incorporating mortality improvement into the projections increases the size of the 
population and this is the same population that is used in the health microsimulation. 
Table 10-1 : Population at risk totals under the decomposition scenarios 
Total Original Re-size Gender 
Gender  
and Ethnicity 
Gender 
 Ethnicity 
and Age 
Mortality 
Improvement 
Health 
Microsimulation 
2011 18,229,893 18,229,893 18,229,893 18,229,893 18,229,893 18,229,893 18,229,893 
2013 18,229,893 18,964,511 18,964,471 18,964,753 18,964,704 18,964,704 18,964,704 
2015 18,229,893 19,612,338 19,612,286 19,612,399 19,612,348 19,689,593 19,689,593 
2017 18,229,893 20,211,922 20,211,911 20,211,990 20,211,925 20,400,332 20,400,332 
2019 18,229,893 20,754,507 20,754,524 20,754,526 20,754,480 21,083,429 21,083,429 
2021 18,229,893 21,240,004 21,240,081 21,240,073 21,239,982 21,732,680 21,732,680 
2023 18,229,893 21,628,697 21,628,633 21,628,713 21,628,634 22,304,919 22,304,919 
2025 18,229,893 21,880,739 21,880,726 21,880,821 21,880,775 22,755,033 22,755,033 
2027 18,229,893 22,046,432 22,046,369 22,046,350 22,046,344 23,129,460 23,129,460 
2029 18,229,893 22,238,128 22,238,072 22,238,203 22,238,105 23,539,913 23,539,913 
2031 18,229,893 22,502,369 22,502,421 22,502,405 22,502,352 24,029,232 24,029,232 
Difference    0 4,272,476 4,272,528 4,272,512 4,272,459 5,799,339 5,799,339 
10.3.1 Decomposition of CVD 
The number of individuals with CVD in each forecast year under the various 
decomposition scenarios is given in Table 10-2. 
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Table 10-2 : Individuals with CVD under the decomposition scenarios 
With CVD Original Re-size Gender 
Gender  
and Ethnicity 
Gender 
 Ethnicity 
and Age 
Mortality 
Improvement 
Health 
Microsimulation 
2011 2,873,694 2,873,694 2,873,694 2,873,694 2,873,694 2,873,694 2,873,694 
2013 2,873,694 2,992,904 2,994,784 3,002,632 3,027,879 3,027,330 2,803,706 
2015 2,873,694 3,093,818 3,097,418 3,111,044 3,138,662 3,164,032 2,737,698 
2017 2,873,694 3,187,593 3,192,244 3,212,994 3,240,308 3,303,070 2,634,641 
2019 2,873,694 3,272,072 3,278,106 3,307,879 3,354,343 3,464,498 2,531,619 
2021 2,873,694 3,347,778 3,354,152 3,395,654 3,455,898 3,622,299 2,451,228 
2023 2,873,694 3,408,292 3,414,993 3,469,429 3,587,731 3,818,306 2,292,377 
2025 2,873,694 3,447,070 3,454,076 3,523,048 3,705,034 4,005,625 2,207,095 
2027 2,873,694 3,472,578 3,478,763 3,564,194 3,825,943 4,201,724 2,076,336 
2029 2,873,694 3,502,031 3,507,667 3,611,815 3,946,325 4,403,298 1,943,832 
2031 2,873,694 3,543,279 3,548,232 3,672,311 4,053,720 4,593,366 1,858,903 
Difference    0 669,585 674,538 798,617 1,180,026 1,719,672 -1,014,791 
Using the counts in Table 10-1 and Table 10-2 it is possible to calculate the prevalence 
rates for this morbidity which is given as Table 10-3. In this table the trend in the 
prevalence rates within each decomposition scenario over time is highlighted using red 
shading, from dark red for years with high prevalence to white for the lowest 
prevalence. Even though there is some gradation in the prevalences for the re-sized and 
gender scenarios, the actual prevalences are not much different and are mainly 
attributable to the Monte Carlo sampling that takes place to re structure the population. 
In this table, re-sizing make very little difference to the prevalence rate, whilst the 
impact of changing the gender split makes a similarly modest difference to the 
prevalence rates. Changing both the gender and ethnic splits to be in line with revised 
ETHPOP projections does cause the prevalence rate to increase over time, and this 
quantifies the impact of the changing ethnic structure of the English population on this 
morbidity. Changing the gender, ethnic and age structure (but having no mortality 
improvement) further increases the prevalence rate over time. The final demographic 
scenario of using the revised ETHPOP projections, which incorporates mortality 
improvements, forecasts the highest prevalence by 2031. Only in this case, when the 
health improvements indicated by the hazard models and the selective weight of 
mortality or migration in Chapter 8 are incorporated are improvements in the prevalence 
rate forecast (as reported in Chapter 9). 
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Table 10-3 : CVD prevalence rates under the decomposition scenarios 
CVD Original Re-size Gender 
Gender  
and Ethnicity 
Gender 
 Ethnicity 
and Age 
Mortality 
Improvement 
Health 
Microsimulation 
2011 15.76 15.76 15.76 15.76 15.76 15.76 15.8 
2013 15.76 15.78 15.79 15.83 15.97 15.96 14.8 
2015 15.76 15.77 15.79 15.86 16.00 16.07 13.9 
2017 15.76 15.77 15.79 15.90 16.03 16.19 12.9 
2019 15.76 15.77 15.79 15.94 16.16 16.43 12.0 
2021 15.76 15.76 15.79 15.99 16.27 16.67 11.3 
2023 15.76 15.76 15.79 16.04 16.59 17.12 10.3 
2025 15.76 15.75 15.79 16.10 16.93 17.60 9.7 
2027 15.76 15.75 15.78 16.17 17.35 18.17 9.0 
2029 15.76 15.75 15.77 16.24 17.75 18.71 8.3 
2031 15.76 15.75 15.77 16.32 18.01 19.12 7.7 
Perhaps most revealing are the ratio multipliers as defined in equation 5-20a to 5-20f 
and which can be calculated from Table 10-2 and are provided here in Table 10-4 (with 
the column headings identifying the relevant ratio multiplier). These ratios are 
multiplicative, as illustrated in equation 5-21.  
Table 10-4 : CVD decomposition ratio multipliers 
CVD 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improvement 
(RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.04 1.00 1.00 1.01 1.00 0.93 0.98 
2015 1.08 1.00 1.00 1.01 1.01 0.87 0.96 
2017 1.11 1.00 1.01 1.01 1.02 0.80 0.92 
2019 1.14 1.00 1.01 1.01 1.03 0.73 0.87 
2021 1.16 1.00 1.01 1.02 1.05 0.68 0.85 
2023 1.19 1.00 1.02 1.03 1.06 0.60 0.80 
2025 1.20 1.00 1.02 1.05 1.08 0.55 0.76 
2027 1.21 1.00 1.02 1.07 1.10 0.49 0.71 
2029 1.22 1.00 1.03 1.09 1.12 0.44 0.67 
2031 1.23 1.00 1.03 1.10 1.13 0.40 0.63 
Looking at Table 10-4, re-sizing the population, unsurprisingly increases the number of 
individuals with the morbidity. However, for the resizing scenario (RS, using the 
notation of equations 5-20 and 5-21) the increase in the number of individuals with 
CVD relative to the original population is in proportion to the increase in the at risk 
population (this ratio can be calculated using Table 10-1) and so does not affect the 
prevalence, as seen in Table 10-3. By 2031 the gender scenario (RG) has little impact 
on the number with CVD in comparison to the re-size scenario.  The size, gender and 
ethnicity scenario (RE) increases those with CVD by a factor of 1.03 by in 2031. 
Further increases are seen for the size, gender, ethnicity and age (RN) and mortality 
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improvement ratios (RM) – these reflect a society that is changing its ethnic structure, 
ageing and living longer. All these impacts cause there to be greater numbers with 
CVD. This trend for an increase in the population with CVD continues, until the health 
improvements are incorporated using the health microsimulation, which dramatically 
lowers the ratio. By 2031 there are just 0.40 times as many individuals with CVD, 
compared with the previous scenario of mortality improvements. The 0.35 reduction 
from 2011 to 2031 in the number of individuals with CVD seen in the final column of 
Table 10-2 is composed of a 1.57 increase due to demographic changes in the English 
population which is then offset by a 0.60 reduction due to forecast health improvements 
and selective mortality and migration.  
10.3.2 Decomposition of diabetes or high blood sugar 
Table 10-5 provides the counts of individuals with DHBSs under the various 
decomposition scenarios (the population at risk is the same for all morbidities and is 
given in Table 10-1 and using these two tables the reader is able to calculate the 
prevalence of DHBS). 
Table 10-5 : Individuals with diabetes or high blood sugar under the decomposition 
scenarios 
Diabetes or high  
blood sugar Original Re-size Gender 
Gender  
and Ethnicity 
Gender 
 Ethnicity 
and Age 
Mortality 
Improvement 
Health 
Microsimulation 
2011 2,189,938 2,189,938 2,189,938 2,189,938 2,189,938 2,189,938 2,189,938 
2013 2,189,938 2,276,801 2,278,310 2,293,971 2,296,726 2,297,138 2,424,851 
2015 2,189,938 2,354,167 2,357,184 2,386,839 2,382,834 2,396,726 2,656,947 
2017 2,189,938 2,426,042 2,429,929 2,475,466 2,464,241 2,497,686 2,834,345 
2019 2,189,938 2,491,301 2,495,686 2,560,065 2,550,691 2,608,150 2,979,780 
2021 2,189,938 2,550,083 2,554,500 2,638,726 2,636,668 2,723,639 3,128,636 
2023 2,189,938 2,597,227 2,601,630 2,707,846 2,731,366 2,851,741 3,191,523 
2025 2,189,938 2,628,044 2,632,876 2,762,728 2,811,236 2,968,168 3,300,025 
2027 2,189,938 2,648,832 2,653,463 2,809,809 2,883,514 3,077,822 3,358,974 
2029 2,189,938 2,673,327 2,677,338 2,863,466 2,967,637 3,203,789 3,386,244 
2031 2,189,938 2,706,720 2,710,272 2,928,029 3,060,763 3,340,327 3,436,486 
Difference    0 516,782 520,334 738,091 870,825 1,150,389 1,246,548 
Using the information in Table 10-5, the ratio multipliers for DHBS are calculated as 
shown in Table 10-6. 
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Table 10-6 : Diabetes or high blood sugar decomposition ratio multipliers 
Diabetes 
or high 
blood 
sugar 
Re-size 
(RS) 
Gender 
(RG) 
Gender and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improvement 
(RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.04 1.00 1.01 1.00 1.00 1.06 1.11 
2015 1.07 1.00 1.01 1.00 1.01 1.11 1.21 
2017 1.11 1.00 1.02 1.00 1.01 1.13 1.29 
2019 1.14 1.00 1.03 1.00 1.02 1.14 1.37 
2021 1.16 1.00 1.03 1.00 1.03 1.15 1.42 
2023 1.19 1.00 1.04 1.01 1.04 1.12 1.46 
2025 1.20 1.00 1.05 1.02 1.06 1.11 1.51 
2027 1.21 1.00 1.06 1.03 1.07 1.09 1.54 
2029 1.22 1.00 1.07 1.04 1.08 1.06 1.55 
2031 1.24 1.00 1.08 1.05 1.09 1.03 1.58 
Here the pattern of contribution for each scenario is different to that for CVD with all 
scenarios showing an increase in the number of individuals with DHBS by 2031. After 
the re-size scenario (RS), the greatest increase is from the mortality improvement 
scenario (RM), which itself is just larger than that for the gender and ethnicity scenario 
(RE). The pattern for health improvements implemented in the health microsimulation 
show a peak in its contribution, occurring around 2021, and the longer term trend in this 
column suggests that soon after 2031 this ratio should fall below 1.00. Overall, the 
trends in Table 10-6 indicate that the increased number of individuals with DHBS is 
mainly attributable to changes in the ethnic composition of England (RE) and general 
improvements in life expectancies (RM).  
10.3.3 Decomposition of respiratory illnesses 
In terms of the absolute number of individuals with a respiratory illness, Table 10-7 
shows that under the five demographic decomposition scenarios the number of 
individuals with such an illness increases, with only the health microsimulation scenario 
showing a slight reduction in the numbers with a respiratory illness (however the 
prevalence in 2031 will be much lower than in 2011 since the population is much larger 
in 2031, see Table 10-1). 
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Table 10-7 : Individuals with a respiratory illness under the decomposition scenarios 
Respiratory 
 illness Original Re-size Gender 
Gender  
and Ethnicity 
Gender 
 Ethnicity 
and Age 
Mortality 
Improvement 
Health 
Microsimulation 
2011 3,408,810 3,408,810 3,408,810 3,408,810 3,408,810 3,408,810 3,408,810 
2013 3,408,810 3,549,744 3,549,489 3,551,121 3,555,658 3,555,688 3,396,242 
2015 3,408,810 3,670,182 3,669,021 3,672,768 3,680,422 3,697,798 3,469,615 
2017 3,408,810 3,782,064 3,779,818 3,787,692 3,797,642 3,840,417 3,495,865 
2019 3,408,810 3,883,385 3,880,363 3,893,839 3,906,242 3,981,644 3,490,010 
2021 3,408,810 3,973,542 3,971,271 3,992,476 4,003,948 4,116,560 3,562,378 
2023 3,408,810 4,045,735 4,043,389 4,074,072 4,089,857 4,244,890 3,477,186 
2025 3,408,810 4,092,263 4,090,041 4,131,986 4,161,921 4,363,131 3,482,338 
2027 3,408,810 4,122,784 4,120,848 4,175,443 4,229,128 4,479,240 3,439,145 
2029 3,408,810 4,158,318 4,156,446 4,224,881 4,305,979 4,609,816 3,366,595 
2031 3,408,810 4,207,681 4,206,100 4,289,796 4,395,539 4,754,767 3,376,245 
Difference    0 798,871 797,290 880,986 986,729 1,345,957 -32,565 
Calculating the ratio multipliers in Table 10-8 shows a similar pattern to that for CVD 
in Table 10-4, with the demographic scenarios showing increases in the numbers with 
the morbidity which is moderated down by the health improvements in the health 
microsimulation (although not to the same extent as seen for CVD). 
Table 10-8 : Respiratory illness decomposition ratio multipliers 
Respiratory 
illness 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.04 1.00 1.00 1.00 1.00 0.96 1.00 
2015 1.08 1.00 1.00 1.00 1.00 0.94 1.02 
2017 1.11 1.00 1.00 1.00 1.01 0.91 1.02 
2019 1.14 1.00 1.00 1.00 1.02 0.88 1.02 
2021 1.17 1.00 1.01 1.00 1.03 0.87 1.06 
2023 1.19 1.00 1.01 1.00 1.04 0.82 1.02 
2025 1.20 1.00 1.01 1.01 1.05 0.80 1.03 
2027 1.21 1.00 1.01 1.01 1.06 0.77 1.01 
2029 1.22 1.00 1.02 1.02 1.07 0.73 0.99 
2031 1.23 1.00 1.02 1.02 1.08 0.71 0.98 
10.3.4 Decomposition of CVD and diabetes or high blood sugar 
The trends in the table that show how many individuals have both CVD and DHBS 
under the various decomposition scenarios more closely resembles that for CVD (Table 
10-2) rather than that for DHBS (Table 10-5). All the demographic decomposition 
scenarios show increasing numbers with the comorbidity whilst the incorporation of 
health improvements in the health microsimulation substantially reduces the numbers 
with the morbidity.  
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Table 10-9 : Individuals with CVD and diabetes or high blood sugar under the 
decomposition scenarios 
CVD and 
diabetes or 
high blood 
sugar Original Re-size Gender 
Gender  
and Ethnicity 
Gender 
 Ethnicity 
and Age 
Mortality 
Improvement 
Health 
Microsimulation 
2011 748,821 748,821 748,821 748,821 748,821 748,821 748,821 
2013 748,821 779,985 780,548 789,555 796,235 796,221 746,541 
2015 748,821 806,124 807,617 822,957 829,627 836,168 751,172 
2017 748,821 830,644 832,746 855,450 859,343 875,039 733,176 
2019 748,821 853,097 855,477 887,488 895,339 921,947 708,491 
2021 748,821 873,242 875,844 917,963 931,018 971,756 696,057 
2023 748,821 889,565 892,243 945,474 977,212 1,033,286 648,791 
2025 748,821 900,200 903,049 968,380 1,015,126 1,088,451 630,625 
2027 748,821 907,438 910,163 988,852 1,051,486 1,142,294 592,600 
2029 748,821 916,056 918,502 1,011,360 1,092,203 1,202,593 552,603 
2031 748,821 927,517 929,946 1,037,631 1,134,712 1,265,497 533,763 
Difference    0 178,696 181,125 288,810 385,891 516,676 -215,058 
These changes in the numbers with the comorbidity are also reflected in the multipliers 
shown in Table 10-10. 
Table 10-10 : CVD and diabetes or high blood sugar decomposition ratio multipliers 
CVD and 
diabetes or 
high blood 
sugar 
Re-
size 
(RS) 
Gender 
(RG) 
Gender and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improvement 
(RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.04 1.00 1.01 1.01 1.00 0.94 1.00 
2015 1.08 1.00 1.02 1.01 1.01 0.90 1.01 
2017 1.11 1.00 1.03 1.00 1.02 0.84 0.98 
2019 1.14 1.00 1.04 1.01 1.03 0.77 0.95 
2021 1.17 1.00 1.05 1.01 1.04 0.72 0.93 
2023 1.19 1.00 1.06 1.03 1.06 0.63 0.87 
2025 1.20 1.00 1.07 1.05 1.07 0.58 0.84 
2027 1.21 1.00 1.09 1.06 1.09 0.52 0.79 
2029 1.22 1.00 1.10 1.08 1.10 0.46 0.73 
2031 1.24 1.00 1.12 1.09 1.12 0.42 0.71 
10.3.5 Summary 
The results presented in this section all clearly identify that there are significant 
demographic drivers that show, all other things being equal, the number of individuals 
in the population with a morbidity should increase significantly. This is primarily 
caused by changes in the ethnic structure of the population, its ageing due to cohort 
replacement and increases in life expectancy. However, in the case of CVD and 
respiratory illness, these demographic impacts are mitigated to a large degree by various 
health trends that affect the incidence of the morbidities. Firstly there are time trends 
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that take account of the impact of influences not explicitly included in the hazard 
models. The trends for these morbidities are negative which will lead to both reductions 
in future incidence for the synthetic population in each LAD and reduced prevalence in 
the Replenisher cohorts who join the sample at future synthetic waves. Secondly the 
health microsimulation incorporates a selection weight that is influenced by various 
factors, including the presence of a morbidity. As illustrated in Box 5-11, this will tend 
to reduce the prevalence rate by disproportionately reducing the numerator (those with 
the morbidity) in the prevalence rate calculation (equation 5-23). Without this selection 
weight, as is the case in all the demographic scenarios which all have equal weights, the 
prevalence is higher. 
10.4 DECOMPOSITION FOR LOCAL AUTHORITY 
Whilst section 10.3 provides a picture for the whole of England, there will be variation 
in the decomposition ratios by LADs. In this section this variation is examined using the 
distribution of the 2031 ratios within each scenario. A traditional box plot chat will be 
used to identify the distribution by its medians, inter quartile ranges, whiskers (1.5 x the 
interquartile range beyond the quartile) and outliers below and above the whiskers. 
10.4.1 Cardio Vascular Disease 
The distribution of the population re-sizing ratio (RS) in Figure 10-3 represents the 
pro-rata increase in the number of individuals with the morbidity relative to the size of 
the population at risk. This is to be anticipated and is consistent across all morbidities 
since they all experience the same growth in population. The scenario that changes the 
future population to reflect the LADs gender structure (RG) shows very little impact, 
with the ratio being close to 1.0 with very little deviation. Again, this feature is 
consistent across all the morbidities, suggesting that the relative sizes of the two genders 
in each LAD either remains static or that the differential in health outcomes associated 
with each gender are not critical. 
With the scenario that reflects both projected gender and ethnic structures (RE), there 
are a range of ratios, with the distribution having a median near 1.0 that is positively 
skewed towards higher values for this ratio. This shows that future changes to the ethnic 
structure of LADs will, after size and gender changes, tend to increase the number of 
individuals with CVD. The ratios derived from changes in the gender, ethnic and age 
structure in LADs (RN) also shows a wide range of ratios, and the median is again 
greater than 1.0. This means that the changing age structure will tend to increase those 
with CVD, but for some authorities the change will reduce those with CVD. These latter 
LADs are primarily London area type authorities, whose population is not anticipated to 
age a great deal in the next 20 years (see Figure 2-5). The impact of mortality 
254 
 
improvement (RM) is always to cause an increase in those with CVD, although the 
impact is consistent and small. The health trends embodied in the health 
microsimulation (RH) cause a dramatic reduction in those with CVD, after having 
accounted for potential growths associated with the demographic transitions in each 
LAD. The median is 0.42 and the quartiles are very close to this median. A consequence 
is that there are a large percentage (15%) of LADs that are considered outliers. The 
lower outliers are mainly London authorities and Cities and Services centres, e.g. cities 
and large towns in southern England. The larger outliers are mainly LADs of type 
Mining and Manufacturing.  
 
Figure 10-3 : Distribution of decomposition ratios in LADs for CVD, 2031 
Key RS : Re-size; RG : Gender; RE : Gender and Ethnicity; RN Gender, Ethnicity and Age; 
RM : Mortality Improvement; RH : Health microsimulation 
10.4.2 Diabetes or high blood sugar 
The box plots for the distribution of the 2031 decomposition ratios for DHBS show 
some contrasts to those for CVD. Firstly the spread of these ratios for the scenario 
where the gender and ethnic structures are adapted (RE) is more skewed with a longer 
positive tail of high ratios. In contrast, the subsequent scenario where age is also 
adapted (RN), shows a smaller spread.  The median ratio for the health microsimulation 
scenario (RH) is just less than 1.0 but contains a distinct cluster of high values. These 
values are all London Centre type authorities and the reasons for these outliers is 
discussed in the context of this area type case study authority (see section 10.5.3). Even 
discounting these outliers there appears to be considerable spread in these ratios. 
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Figure 10-4 : Distribution of decomposition ratios in LADs for diabetes or high blood 
sugar, 2031 
10.4.3 Respiratory Illness 
Excepting the re-size and health microsimulation scenarios, the distribution of the ratios 
for respiratory illness show a tightness of distribution, with the difference in upper and 
lower quartiles and the upper and lower whiskers being small. The medians are also just 
slightly above 1.0, which indicates that these scenarios are fairly neutral relative to the 
previous scenarios. There are sizeable reductions in the number of individuals with this 
morbidity as a result of the health trends embodied in the health microsimulation (RH) 
scenario, but to a lesser degree than for CVD. 
 
Figure 10-5 : Distribution of decomposition ratios in LADs for respiratory illness, 2031 
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10.4.4 CVD and diabetes or high blood sugar 
The comorbidity shows sizeable spreads in the distribution of all its decomposition 
ratios (excepting gender, RG), which is in contrast to the distribution for the single 
morbidities of CVD and DHBS which contain a variety of spreads. This suggests that 
both the morbidities are playing a role in influencing the variety in the number of 
individuals with the comorbidity in each scenario. Only in the case of this comorbidity 
does the spread in ratios for the scenario with no morbidity increase (RM) appear large. 
The distribution of ratios for the final health microsimulation (RH) more closely 
resembles that for CVD than for DHBS. 
 
Figure 10-6 : Distribution of decomposition ratios in LADs for CVD and diabetes or 
high blood sugar, 2031 
10.4.5 Summary 
What the box plots in this section have shown is that there are important local variations 
in how the changing ethnic and age structure of individual LADs impacts on the 
morbidity prevalence counts. This most starkly reflected in the ranges of the middle 
three ratios (RE, RN and RM), which is some case can be large. The impact of these 
demographic factors is different depending on the morbidity. With CVD it is an ageing 
population that is important whilst for DHBS it is the ethnic composition of the LAD. 
Respiratory illness shows the most consistency in the ratios whilst the comorbidity 
shows least consistency, having greater variability. Excepting the re-sizing ratio, the 
health improvements associated with the health microsimulation (RH) embody some of 
the largest variation in impacts. 
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10.5 DECOMPOSITION FOR CASE STUDY AUTHORITIES 
In this section potentially different trends in the decomposition scenarios for LADs are 
explored in detail using the ratios for each morbidity in the seven case study authorities. 
Insight into these trends is gained by making comparisons with the national trends 
shown in Table 10-4, Table 10-6, Table 10-8 and Table 10-10 and by highlighting some 
contrasting features amongst the LADs. 
10.5.1 Leeds (Cities and Services) 
In the tables for Leeds the four critical demographic scenario multipliers (RG, RE, RN 
and RM) are not dissimilar to those for England. The shift to a more diverse ethnic 
population increases those with a morbidity and the changing age structure does 
likewise (although there is a slight dip from 2017 to 2021 for CVD, Table 10-11, and 
for DHBS, Table 10-12, and the comorbidity, Table 10-14). As the life expectancy of 
the population increases, the number of individuals with a morbidity increases. The 
improvement in health through the mechanisms covered in the health microsimulation 
occurs for all the morbidities by 2031, and more so than for England. In particular for 
DHBS, there is a reduction in those with this morbidity which is in contrast to the 
situation for England as a whole, where it the ratio is still greater than 1.00 by 2031. 
Table 10-11 : Decomposing multipliers for CVD, Leeds, 2011 to 2031 
CVD 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.03 1.00 1.00 1.00 1.00 0.90 0.93 
2015 1.05 1.00 1.00 1.00 1.01 0.82 0.87 
2017 1.08 1.00 1.00 0.99 1.02 0.74 0.81 
2019 1.10 1.00 1.01 0.99 1.03 0.67 0.76 
2021 1.12 1.00 1.01 0.99 1.05 0.61 0.72 
2023 1.14 1.00 1.01 1.00 1.06 0.54 0.66 
2025 1.14 1.01 1.01 1.02 1.08 0.48 0.61 
2027 1.15 1.01 1.02 1.04 1.09 0.42 0.56 
2029 1.16 1.01 1.02 1.06 1.11 0.37 0.52 
2031 1.17 1.01 1.02 1.07 1.13 0.33 0.48 
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Table 10-12 : Decomposing multipliers for DHBS, Leeds, 2011 to 2031 
Diabetes 
or high 
blood 
sugar 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.03 1.00 1.01 1.00 1.00 1.02 1.06 
2015 1.05 1.00 1.02 1.00 1.01 1.05 1.14 
2017 1.08 1.00 1.03 0.99 1.01 1.07 1.19 
2019 1.10 1.00 1.04 0.99 1.02 1.06 1.22 
2021 1.12 1.00 1.05 0.99 1.03 1.06 1.27 
2023 1.14 1.00 1.06 0.99 1.04 1.02 1.27 
2025 1.14 1.00 1.07 1.00 1.05 1.01 1.29 
2027 1.15 1.00 1.08 1.01 1.06 0.98 1.30 
2029 1.16 1.00 1.09 1.02 1.08 0.95 1.32 
2031 1.17 1.00 1.11 1.03 1.08 0.91 1.31 
Table 10-13 : Decomposing multipliers for respiratory illness, Leeds, 2011 to 2031 
Respiratory 
Illness 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.03 1.00 1.00 1.00 1.00 0.94 0.97 
2015 1.05 1.00 1.00 1.00 1.01 0.92 0.98 
2017 1.08 1.00 1.00 1.00 1.02 0.88 0.97 
2019 1.10 1.00 1.00 1.00 1.02 0.84 0.94 
2021 1.12 1.00 1.00 1.00 1.03 0.83 0.96 
2023 1.14 1.00 1.00 1.00 1.03 0.78 0.92 
2025 1.15 1.00 1.00 1.00 1.04 0.76 0.91 
2027 1.15 1.00 1.00 1.01 1.05 0.72 0.88 
2029 1.16 1.00 1.00 1.02 1.06 0.68 0.85 
2031 1.17 1.00 1.00 1.03 1.07 0.66 0.85 
Table 10-14 : Decomposing multipliers for comorbidity of CVD and DHBS, Leeds, 
2011 to 2031 
CVD and 
diabetes or 
high blood 
sugar 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.03 1.00 1.02 1.01 1.01 0.90 0.96 
2015 1.05 1.00 1.03 1.00 1.02 0.84 0.93 
2017 1.07 1.01 1.03 0.99 1.03 0.77 0.87 
2019 1.10 1.01 1.05 0.98 1.04 0.70 0.83 
2021 1.12 1.01 1.06 0.99 1.05 0.64 0.80 
2023 1.13 1.01 1.07 1.01 1.07 0.55 0.73 
2025 1.14 1.01 1.08 1.02 1.08 0.50 0.68 
2027 1.15 1.01 1.10 1.03 1.09 0.43 0.62 
2029 1.16 1.01 1.11 1.06 1.11 0.38 0.58 
2031 1.17 1.01 1.12 1.07 1.12 0.33 0.52 
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10.5.2 Redbridge (London Suburb) 
The trends in Redbridge show some contrasting features to those for England as a 
whole. Firstly the scenario that adapts to the projected gender and ethnic composition 
(RE) estimates a much greater impact for this scenario, and this is true for all three 
morbidities and the comorbidity.  Clearly the changing ethnic makeup of this LAD is an 
important influence on the number of individuals with each morbidity. This is 
contrasted with sharp reductions in the number of individuals with a morbidity when the 
changes incorporated into the health microsimulation are implemented. In particular, 
like Leeds, the mechanisms within the health microsimulation that determine the 
prevalence counts of DHBS in Redbridge results in a reduction in those with such a 
morbidity in 2031 compared with 2011 (Table 10-16). 
Table 10-15 : Decomposing multipliers for CVD, Redbridge, 2011 to 2031 
CVD 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.05 1.00 1.02 0.99 1.01 0.88 0.94 
2015 1.08 1.00 1.03 0.99 1.02 0.80 0.90 
2017 1.12 1.00 1.04 0.98 1.02 0.73 0.85 
2019 1.14 1.00 1.06 0.98 1.03 0.64 0.78 
2021 1.18 1.00 1.07 0.97 1.05 0.58 0.75 
2023 1.21 1.00 1.09 0.97 1.06 0.49 0.66 
2025 1.25 1.01 1.11 0.98 1.07 0.44 0.65 
2027 1.28 1.01 1.13 0.98 1.09 0.39 0.61 
2029 1.33 1.01 1.15 0.99 1.10 0.33 0.56 
2031 1.38 1.01 1.17 0.99 1.12 0.30 0.54 
Table 10-16 : Decomposing multipliers for DHBS, Redbridge, 2011 to 2031 
Diabetes 
or high 
blood 
sugar 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.03 1.00 1.03 0.99 1.01 1.07 1.14 
2015 1.06 1.00 1.06 0.98 1.02 1.11 1.25 
2017 1.10 1.00 1.09 0.97 1.02 1.12 1.33 
2019 1.13 1.00 1.11 0.97 1.03 1.11 1.39 
2021 1.16 1.00 1.14 0.97 1.04 1.11 1.48 
2023 1.19 1.01 1.16 0.98 1.05 1.07 1.54 
2025 1.23 1.01 1.19 0.99 1.06 1.05 1.63 
2027 1.27 1.01 1.21 0.99 1.07 1.01 1.66 
2029 1.31 1.00 1.23 1.01 1.08 0.96 1.69 
2031 1.36 1.00 1.25 1.02 1.08 0.92 1.72 
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Table 10-17 : Decomposing multipliers for respiratory illness, Redbridge, 2011 to 2031 
Respiratory 
Illness 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.04 1.01 1.01 1.01 1.00 0.89 0.95 
2015 1.07 1.00 1.01 1.01 1.01 0.84 0.93 
2017 1.11 1.00 1.03 1.02 1.02 0.78 0.93 
2019 1.14 1.00 1.04 1.02 1.02 0.71 0.88 
2021 1.18 1.00 1.05 1.02 1.04 0.67 0.88 
2023 1.21 1.00 1.07 1.02 1.05 0.61 0.85 
2025 1.24 1.00 1.09 1.02 1.06 0.57 0.83 
2027 1.28 1.00 1.11 1.02 1.07 0.52 0.81 
2029 1.33 1.00 1.13 1.02 1.08 0.47 0.78 
2031 1.38 0.99 1.15 1.02 1.10 0.45 0.79 
Table 10-18 : Decomposing multipliers for comorbidity of CVD and DHBS, Redbridge, 
2011 to 2031 
CVD and 
diabetes or 
high blood 
sugar 
Re-
size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.05 1.01 1.06 0.98 1.00 0.93 1.02 
2015 1.08 1.01 1.09 0.97 1.02 0.85 1.00 
2017 1.12 1.02 1.13 0.95 1.02 0.77 0.96 
2019 1.15 1.01 1.17 0.96 1.03 0.67 0.90 
2021 1.18 1.01 1.22 0.95 1.04 0.60 0.86 
2023 1.21 1.01 1.25 0.98 1.05 0.50 0.79 
2025 1.25 1.02 1.29 0.99 1.06 0.45 0.78 
2027 1.29 1.02 1.34 0.99 1.07 0.39 0.73 
2029 1.32 1.02 1.38 1.01 1.08 0.32 0.65 
2031 1.38 1.02 1.42 1.01 1.09 0.30 0.66 
 
10.5.3 Camden (London Centre) 
For Camden perhaps the most critical impact is the large ratios for the health 
microsimulation with DHBS (Table 10-20). By 2031 the ratio is far larger than that seen 
for England as a whole, and this increase is seen to be most rapid in the early period 
2011 to 2019. All the London Centre type LADs exhibit this feature in the health trend, 
implying large increases in those with this morbidity. A further consequence of this 
high ratio for DHBS is that the ratio for the comorbidity is also higher for Camden than 
that for England. 
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Table 10-19 : Decomposing multipliers for CVD, Camden, 2011 to 2031 
CVD 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.05 1.00 1.01 1.01 1.00 0.94 1.01 
2015 1.09 1.00 1.02 1.00 1.01 0.89 1.00 
2017 1.13 1.01 1.02 0.99 1.02 0.84 0.99 
2019 1.17 1.01 1.03 0.99 1.03 0.77 0.96 
2021 1.21 1.01 1.03 0.99 1.04 0.72 0.93 
2023 1.25 1.00 1.04 1.00 1.05 0.64 0.87 
2025 1.29 1.01 1.05 1.00 1.06 0.60 0.87 
2027 1.32 1.01 1.06 1.01 1.08 0.54 0.83 
2029 1.36 1.00 1.06 1.02 1.09 0.48 0.77 
2031 1.41 1.00 1.07 1.02 1.10 0.44 0.74 
Table 10-20 : Decomposing multipliers for DHBS, Camden, 2011 to 2031 
Diabetes 
or high 
blood 
sugar 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.05 1.00 1.02 0.98 1.00 1.24 1.30 
2015 1.09 1.00 1.03 0.98 1.01 1.42 1.58 
2017 1.14 1.00 1.04 0.97 1.02 1.56 1.83 
2019 1.17 1.00 1.05 0.96 1.02 1.63 1.96 
2021 1.21 1.00 1.07 0.97 1.03 1.68 2.17 
2023 1.26 1.00 1.08 0.97 1.04 1.68 2.31 
2025 1.30 1.00 1.10 0.97 1.05 1.69 2.46 
2027 1.33 1.00 1.12 0.98 1.06 1.67 2.58 
2029 1.36 1.00 1.13 0.99 1.06 1.63 2.63 
2031 1.41 1.00 1.14 1.00 1.07 1.59 2.73 
Table 10-21 : Decomposing multipliers for respiratory illness, Camden, 2011 to 2031 
Respiratory 
Illness 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.04 1.00 1.00 1.00 1.01 0.92 0.97 
2015 1.09 1.00 1.00 1.00 1.01 0.89 0.98 
2017 1.13 1.00 1.01 1.00 1.02 0.83 0.97 
2019 1.17 1.00 1.01 1.00 1.03 0.76 0.93 
2021 1.21 1.00 1.02 1.00 1.04 0.73 0.94 
2023 1.25 1.00 1.02 1.00 1.05 0.67 0.90 
2025 1.29 1.01 1.03 0.99 1.05 0.65 0.91 
2027 1.32 1.01 1.04 1.00 1.06 0.60 0.88 
2029 1.35 1.01 1.05 1.00 1.07 0.56 0.86 
2031 1.40 1.00 1.07 1.00 1.09 0.53 0.87 
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Table 10-22 : Decomposing multipliers for comorbidity of CVD and DHBS, Camden, 
2011 to 2031 
CVD and 
diabetes or 
high blood 
sugar 
Re-
size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.05 0.99 1.05 1.00 0.99 0.96 1.04 
2015 1.09 0.99 1.07 0.99 1.01 0.97 1.12 
2017 1.13 1.00 1.09 0.98 1.03 0.94 1.17 
2019 1.17 1.00 1.10 0.98 1.02 0.88 1.13 
2021 1.20 1.01 1.13 0.99 1.03 0.85 1.19 
2023 1.25 1.01 1.16 1.00 1.03 0.76 1.15 
2025 1.28 1.01 1.19 1.01 1.03 0.73 1.17 
2027 1.31 1.00 1.22 1.02 1.04 0.66 1.12 
2029 1.35 1.00 1.25 1.02 1.04 0.59 1.06 
2031 1.40 1.00 1.27 1.04 1.05 0.55 1.07 
10.5.4 Haringey (London Cosmopolitan) 
Looking at the results in Chapter 9, Haringey is a LAD whose health outcomes are 
either good or forecast to improve. Looking at the gender, ethnicity and age ratios (RN) 
in Table 10-23 and Table 10-24 the impacts here are seen to be less than that for 
England as a whole, which shows that in this LAD there are no large increases in the 
numbers with these two morbidities as a result of changes to its age structure – 
Haringey is projected to retain a younger over 50 population relative to other LADs 
over the forecast period. However, it is clear in all these tables that these overall health 
improvements mostly derive from the impacts of the dynamics within the health 
microsimulation, which are consistently lower than those for England as a whole. 
Table 10-23 : Decomposing multipliers for CVD, Haringey, 2011 to 2031 
CVD 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.07 1.00 1.00 1.00 0.99 0.89 0.94 
2015 1.14 1.00 1.01 0.99 1.00 0.79 0.90 
2017 1.20 1.00 1.01 0.99 1.00 0.70 0.84 
2019 1.25 1.00 1.02 0.99 1.01 0.62 0.79 
2021 1.31 1.00 1.02 0.98 1.02 0.55 0.73 
2023 1.36 1.00 1.03 0.99 1.03 0.45 0.64 
2025 1.40 1.01 1.04 1.00 1.04 0.41 0.63 
2027 1.45 1.01 1.05 1.01 1.05 0.35 0.57 
2029 1.50 1.01 1.06 1.02 1.06 0.30 0.52 
2031 1.56 1.00 1.07 1.03 1.07 0.26 0.48 
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Table 10-24 : Decomposing multipliers for DHBS, Haringey, 2011 to 2031 
Diabetes 
or high 
blood 
sugar 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.07 1.00 1.01 0.96 1.00 1.03 1.07 
2015 1.13 0.99 1.02 0.95 1.00 1.06 1.15 
2017 1.19 0.99 1.04 0.94 1.01 1.08 1.26 
2019 1.25 0.98 1.05 0.93 1.01 1.09 1.32 
2021 1.30 0.98 1.06 0.94 1.01 1.07 1.37 
2023 1.35 0.98 1.06 0.94 1.02 1.02 1.37 
2025 1.39 0.98 1.07 0.95 1.03 1.01 1.44 
2027 1.44 0.98 1.08 0.97 1.04 0.98 1.51 
2029 1.49 0.98 1.09 0.98 1.05 0.93 1.52 
2031 1.56 0.98 1.10 0.99 1.05 0.88 1.54 
Table 10-25 : Decomposing multipliers for respiratory illness, Haringey, 2011 to 2031 
Respiratory 
Illness 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.07 1.00 1.01 0.99 0.99 0.93 0.99 
2015 1.13 1.00 1.00 0.99 1.00 0.89 1.00 
2017 1.19 1.00 1.00 0.98 1.00 0.84 0.98 
2019 1.24 1.00 1.01 0.98 1.01 0.80 0.99 
2021 1.30 0.99 1.01 0.98 1.01 0.77 0.99 
2023 1.35 0.99 1.02 0.98 1.02 0.70 0.95 
2025 1.39 0.99 1.02 0.99 1.03 0.67 0.96 
2027 1.43 0.99 1.03 1.00 1.03 0.63 0.95 
2029 1.48 0.99 1.04 1.00 1.04 0.58 0.92 
2031 1.55 0.99 1.05 1.01 1.04 0.55 0.93 
Table 10-26 : Decomposing multipliers for comorbidity of CVD and DHBS, Haringey, 
2011 to 2031 
CVD and 
diabetes or 
high blood 
sugar 
Re-
size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.05 0.99 1.02 0.98 0.99 0.88 0.91 
2015 1.11 0.98 1.05 0.97 1.00 0.79 0.88 
2017 1.17 0.98 1.06 0.97 1.01 0.70 0.83 
2019 1.22 0.98 1.08 0.98 1.00 0.62 0.78 
2021 1.28 0.97 1.09 0.99 1.02 0.54 0.74 
2023 1.33 0.97 1.10 1.01 1.03 0.43 0.63 
2025 1.37 0.98 1.10 1.04 1.04 0.38 0.61 
2027 1.42 0.98 1.11 1.06 1.04 0.33 0.56 
2029 1.47 0.98 1.13 1.07 1.06 0.27 0.50 
2031 1.53 0.97 1.14 1.09 1.07 0.23 0.45 
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10.5.5 Wiltshire (Prospering UK) 
In contrast to the previous three London LADs the changing ethnic structure of 
Wiltshire hardly impacts on the number of individuals with a morbidity, the gender and 
ethnicity (RE) ratios are close to 1.00 and lower than those for England as a whole. The 
gender, ethnicity and age (RN) ratios are conversely larger than for England as a whole, 
which suggests that in contrast to the London LADs, the ageing of the 50 and older 
population in Wiltshire causes a disproportionate increase in those with morbidities. 
Again the health improvements implemented in the health microsimulation have a net 
effect of reducing those with each morbidity by 2031 (but only just so for DHBS, Table 
10-28). 
Table 10-27 : Decomposing multipliers for CVD, Wiltshire, 2011 to 2031 
CVD 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.05 1.00 1.00 1.01 1.00 0.94 1.00 
2015 1.10 1.00 1.01 1.02 1.01 0.88 1.01 
2017 1.14 1.00 1.01 1.02 1.02 0.82 0.98 
2019 1.18 1.00 1.01 1.03 1.03 0.75 0.95 
2021 1.21 1.00 1.01 1.04 1.05 0.70 0.93 
2023 1.24 0.99 1.02 1.06 1.07 0.62 0.88 
2025 1.25 0.99 1.02 1.09 1.09 0.57 0.85 
2027 1.27 0.99 1.02 1.12 1.11 0.51 0.81 
2029 1.27 0.99 1.02 1.15 1.13 0.46 0.77 
2031 1.28 0.99 1.02 1.17 1.15 0.42 0.73 
Table 10-28 : Decomposing multipliers for DHBS, Wiltshire, 2011 to 2031 
Diabetes 
or high 
blood 
sugar 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.05 1.00 1.00 1.00 1.00 1.04 1.09 
2015 1.10 1.00 1.00 1.01 1.01 1.08 1.21 
2017 1.14 1.00 1.00 1.00 1.02 1.10 1.28 
2019 1.18 1.00 1.01 1.01 1.02 1.10 1.35 
2021 1.21 1.00 1.01 1.02 1.03 1.10 1.41 
2023 1.24 1.00 1.01 1.03 1.04 1.07 1.44 
2025 1.26 1.00 1.01 1.04 1.06 1.06 1.49 
2027 1.27 1.00 1.02 1.05 1.08 1.04 1.53 
2029 1.27 0.99 1.02 1.06 1.09 1.01 1.50 
2031 1.28 0.99 1.02 1.08 1.10 0.99 1.52 
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Table 10-29 : Decomposing multipliers for respiratory illness, Wiltshire, 2011 to 2031 
Respiratory 
Illness 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.05 1.00 1.00 1.00 1.00 0.96 1.01 
2015 1.10 1.00 1.00 1.00 1.00 0.93 1.02 
2017 1.14 1.00 1.00 1.00 1.01 0.91 1.05 
2019 1.18 1.00 1.00 1.01 1.02 0.88 1.07 
2021 1.21 1.00 1.00 1.01 1.03 0.87 1.10 
2023 1.24 1.00 1.00 1.01 1.04 0.83 1.08 
2025 1.25 1.00 1.01 1.01 1.05 0.81 1.08 
2027 1.26 1.00 1.01 1.02 1.06 0.78 1.07 
2029 1.27 1.00 1.01 1.03 1.07 0.74 1.05 
2031 1.28 1.00 1.01 1.03 1.08 0.73 1.05 
Table 10-30 : Decomposing multipliers for comorbidity of CVD and DHBS, Wiltshire, 
2011 to 2031 
CVD and 
diabetes or 
high blood 
sugar 
Re-
size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.06 1.00 1.00 1.02 1.00 0.94 1.02 
2015 1.10 1.00 1.01 1.02 1.02 0.89 1.03 
2017 1.15 0.99 1.01 1.02 1.02 0.84 1.00 
2019 1.18 1.00 1.01 1.03 1.03 0.79 1.00 
2021 1.22 0.99 1.01 1.04 1.04 0.74 0.98 
2023 1.24 0.99 1.01 1.07 1.06 0.65 0.91 
2025 1.26 0.99 1.02 1.09 1.08 0.60 0.90 
2027 1.27 0.99 1.02 1.11 1.10 0.54 0.85 
2029 1.27 0.99 1.02 1.14 1.11 0.49 0.80 
2031 1.28 0.99 1.02 1.15 1.14 0.46 0.78 
10.5.6 Teignbridge (Coastal and Countryside) 
Like Wiltshire, changing the gender and ethnic composition of Teignbridge has very 
little impact on the number of individuals with the morbidities, the gender and ethnicity 
ratio (RE) is consistently close to 1.00. It is the age and mortality related ratios (RN and 
RM) that show the largest ratios and these are mostly greater than those for England as 
a whole. Here only for CVD (Table 10-31) and the comorbidity (Table 10-34) does the 
health microsimulation reverse some of these demographic health trends. For DHBS the 
health microsimulation has a neutral impact by 2031 (Table 10-32) and the health 
improvement for respiratory illness is meagre (Table 10-33), certainly in comparison to 
England as a whole and the other case study authorities.  
  
266 
 
Table 10-31 : Decomposing multipliers for CVD, Teignbridge, 2011 to 2031 
CVD 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.04 1.00 1.00 1.00 1.00 0.94 0.98 
2015 1.07 1.01 1.00 1.00 1.01 0.89 0.97 
2017 1.10 1.01 1.00 1.00 1.02 0.83 0.94 
2019 1.12 1.01 1.00 1.01 1.04 0.77 0.91 
2021 1.15 1.01 1.00 1.02 1.06 0.71 0.89 
2023 1.16 1.01 1.00 1.04 1.08 0.65 0.86 
2025 1.17 1.01 1.00 1.07 1.10 0.60 0.83 
2027 1.17 1.01 1.00 1.09 1.12 0.54 0.78 
2029 1.17 1.01 1.00 1.12 1.13 0.49 0.73 
2031 1.18 1.01 1.00 1.14 1.15 0.45 0.70 
Table 10-32 : Decomposing multipliers for DHBS, Teignbridge, 2011 to 2031 
Diabetes 
or high 
blood 
sugar 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.04 1.00 1.00 1.00 1.00 1.03 1.07 
2015 1.07 1.00 1.00 1.00 1.01 1.07 1.16 
2017 1.11 1.00 1.00 1.00 1.03 1.09 1.25 
2019 1.13 1.00 1.00 1.00 1.04 1.08 1.27 
2021 1.15 1.00 1.00 1.01 1.05 1.09 1.33 
2023 1.16 1.00 1.00 1.01 1.07 1.06 1.33 
2025 1.17 1.00 1.00 1.03 1.08 1.05 1.37 
2027 1.17 1.00 1.00 1.03 1.09 1.05 1.38 
2029 1.17 1.00 1.00 1.05 1.10 1.02 1.38 
2031 1.18 1.00 1.00 1.06 1.12 1.00 1.40 
Table 10-33 : Decomposing multipliers for respiratory illness, Teignbridge, 2011 to 
2031 
Respiratory 
Illness 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.04 1.00 1.00 1.00 1.00 1.01 1.05 
2015 1.08 1.00 1.00 1.00 1.01 1.03 1.12 
2017 1.10 1.00 1.00 1.00 1.01 1.03 1.14 
2019 1.13 1.00 1.00 1.00 1.02 1.02 1.18 
2021 1.15 0.99 1.01 1.00 1.03 1.04 1.23 
2023 1.16 0.99 1.01 1.01 1.04 1.02 1.24 
2025 1.17 0.99 1.01 1.01 1.05 1.01 1.25 
2027 1.17 0.99 1.01 1.01 1.07 1.00 1.26 
2029 1.17 0.99 1.01 1.02 1.08 0.96 1.24 
2031 1.18 0.99 1.01 1.02 1.10 0.96 1.27 
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Table 10-34 : Decomposing multipliers for comorbidity of CVD and DHBS, 
Teignbridge, 2011 to 2031 
CVD and 
diabetes or 
high blood 
sugar 
Re-
size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.04 1.00 0.99 1.01 1.00 0.95 0.99 
2015 1.08 1.01 0.99 1.00 1.02 0.92 1.01 
2017 1.12 1.00 0.99 1.00 1.03 0.87 0.99 
2019 1.14 1.01 0.98 1.01 1.05 0.82 0.98 
2021 1.17 1.00 0.98 1.02 1.07 0.76 0.95 
2023 1.18 1.01 0.98 1.03 1.10 0.68 0.90 
2025 1.18 1.01 0.98 1.05 1.12 0.64 0.88 
2027 1.19 1.01 0.98 1.07 1.13 0.58 0.83 
2029 1.18 1.01 0.98 1.10 1.14 0.53 0.78 
2031 1.20 1.00 0.97 1.12 1.16 0.50 0.76 
10.5.7 Rotherham (Mining and Manufacturing) 
Rotherham is perhaps the most typical of England as a whole of these seven LADs in 
terms of its outcome ratios. By 2031, and for many of the intervening years, the values 
for the ratios compare well with those for England. The only exception to this is the 
outcome for DHBS which peaks at a higher value for 2021 (Table 10-36), and 
consequently falls away to a value that is still higher than for England by 2031. This 
high mid period peak for DHBS also contributes to a lower 2031 reduction for the 
comorbidity (Table 10-38). 
Table 10-35 : Decomposing multipliers for CVD, Rotherham, 2011 to 2031 
CVD 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.03 1.00 1.00 1.01 1.00 0.93 0.97 
2015 1.06 1.00 1.00 1.02 1.00 0.87 0.94 
2017 1.08 1.00 1.00 1.02 1.01 0.81 0.90 
2019 1.11 1.00 1.01 1.03 1.02 0.74 0.87 
2021 1.13 1.01 1.01 1.04 1.04 0.69 0.86 
2023 1.14 1.01 1.01 1.05 1.05 0.61 0.78 
2025 1.14 1.01 1.01 1.08 1.07 0.56 0.75 
2027 1.13 1.01 1.02 1.11 1.09 0.50 0.70 
2029 1.13 1.01 1.02 1.13 1.11 0.45 0.66 
2031 1.13 1.01 1.03 1.15 1.12 0.41 0.62 
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Table 10-36 : Decomposing multipliers for DHBS, Rotherham, 2011 to 2031 
Diabetes 
or high 
blood 
sugar 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.03 1.00 1.00 1.01 1.00 1.07 1.11 
2015 1.06 1.00 1.01 1.01 1.01 1.13 1.23 
2017 1.09 1.00 1.01 1.01 1.02 1.16 1.32 
2019 1.11 1.00 1.02 1.01 1.02 1.19 1.39 
2021 1.14 1.00 1.02 1.01 1.03 1.21 1.46 
2023 1.15 1.00 1.03 1.03 1.05 1.18 1.51 
2025 1.15 1.00 1.04 1.04 1.06 1.18 1.56 
2027 1.14 1.00 1.04 1.05 1.07 1.17 1.56 
2029 1.13 1.00 1.05 1.06 1.08 1.13 1.53 
2031 1.13 1.00 1.07 1.06 1.10 1.11 1.56 
Table 10-37 : Decomposing multipliers for respiratory illness, Rotherham, 2011 to 2031 
Respiratory 
Illness 
Re-size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.03 1.00 1.00 1.00 1.00 0.95 0.98 
2015 1.06 1.00 1.00 1.01 1.00 0.93 1.00 
2017 1.09 1.00 1.00 1.01 1.00 0.91 1.00 
2019 1.11 1.00 1.00 1.01 1.01 0.88 1.00 
2021 1.14 1.00 1.00 1.01 1.01 0.87 1.01 
2023 1.15 1.00 1.00 1.01 1.02 0.83 0.98 
2025 1.15 1.00 1.00 1.02 1.03 0.82 0.99 
2027 1.14 1.00 1.00 1.02 1.04 0.79 0.96 
2029 1.14 1.00 1.01 1.03 1.05 0.76 0.95 
2031 1.14 1.00 1.01 1.04 1.06 0.74 0.94 
Table 10-38 : Decomposing multipliers comorbidity of CVD and DHBS, Rotherham, 
2011 to 2031 
CVD and 
diabetes or 
high blood 
sugar 
Re-
size 
(RS) 
Gender 
(RG) 
Gender 
and 
Ethnicity 
(RE) 
Gender 
Ethnicity 
and Age 
(RN) 
Mortality 
Improve-
ment (RM) 
Health 
Micro-
simulation 
(RH) Product 
2011 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
2013 1.03 1.00 1.01 1.01 1.00 0.95 1.00 
2015 1.06 1.00 1.02 1.01 1.01 0.92 1.01 
2017 1.09 1.00 1.02 1.01 1.03 0.85 0.98 
2019 1.11 1.00 1.03 1.01 1.04 0.80 0.96 
2021 1.13 1.00 1.04 1.02 1.05 0.76 0.96 
2023 1.14 1.00 1.05 1.03 1.07 0.67 0.88 
2025 1.14 1.00 1.06 1.05 1.09 0.63 0.87 
2027 1.13 1.01 1.07 1.06 1.11 0.57 0.82 
2029 1.13 1.01 1.09 1.08 1.12 0.51 0.77 
2031 1.13 1.01 1.11 1.09 1.13 0.46 0.72 
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10.5.8 Summary 
The results discussed in this section show that it is a combination of the changing 
demographics of the population of England and the health trends over time associated 
with these demographics that determine the health outcomes. The demographic 
scenarios are incremental in their application. All other things being equal, little of the 
forecast changes in health outcomes can be attributed the changing gender structure of 
the population in each LAD. This is not however true for ethnicity, ageing or changes in 
life expectancies. For some more ethnically diverse LADs the changing ethnic structure 
of the LAD can indicate large increases in those with particular morbidities, although 
with these same LADs the increases associated with age and life expectancies are less 
pronounced. Conversely there are other less ethnically diverse LADs where the increase 
attributable to a changing ethnic mix is negligible but most of the change can be 
attributed to an ageing of the population and increased life expectancies. 
Clearly the health microsimulation is a complex process, with influences on health 
outcomes taking place through the incidence models and the models that determine the 
selection weight for morbidity or migration. For CVD, respiratory illness and the 
comorbidity of CVD and DHBS, nearly all the health improvements can be attributed to 
the mechanisms inside the health microsimulation – although this assertion is borderline 
for respiratory illness in some Coastal and Countryside type authorities. In contrast, for 
DHBS, in most authorities by 2031 the health microsimulation forecasts an increase in 
the number of people with this morbidity, even after accounting for the demographic 
changes, but this influence appears to be on a downward trend by 2031. 
10.6 CONCLUSION 
In this chapter an investigation into the relative contribution of various demographic 
and health related factors in influencing the number of individuals with each morbidity 
is provided. This is achieved by utilising the same C program in all scenarios but 
varying the input data and the functionality within the program. The input data are 
synthesised using a combination of adjustment factors and an optimisation to meet a set 
of demographic constraints. These changes to the input data define the five 
demographic scenarios. Of critical importance to the implementation of these 
demographic scenarios is that the mechanisms associated with morbidity incidence, 
mortality selection and migration selection are not in place. 
Generally the demographic factors are seen to increase the number of individuals with 
the morbidities, although the relative impact of each demographic factor varies by LAD. 
For those LADs with diverse ethnic communities it is ethnicity that is seen to have the 
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greatest influence whilst for those with less ethnic diversity, changing age structures and 
improvements in life expectancy have greatest influence. 
The impact of the health microsimulation for CVD, respiratory illness and the 
comorbidity of CVD and DHBS reduces the numbers with the morbidity. The net 
impact of the demographic and health improvement scenarios for these morbidities is a 
reduction in those with the morbidity. For DHBS, the health microsimulation generally 
increases those with the morbidity and, when combined with the demographic factors, 
the number with this morbidity increases over time.  
Just as the five demographic factors accumulate to potentially large impacts (i.e. RS x 
RG x RE x RN x RM) the health microsimulation in itself has a large impact. To an 
extent the drivers behind these impacts can be inferred using the parameter estimates in 
the morbidity, mortality and migration hazard models. Such an investigation is not 
however possible for the demographic factors (where there are no model parameters 
available) so the utility of this chapter remains in its consideration of the five 
demographic scenarios and the health microsimulation impact merely completes the 
picture. 
This chapter is the final chapter of the five results chapters of this thesis. In the 
remaining chapter a summary of the work, its main conclusions, the policy implications 
of these findings and the recommendations for future work are covered. 
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11 CONCLUSION 
Thesis Summary, Policy Implications and Further Work 
11.1 INTRODUCTION 
In this thesis a body of work is presented that forecasts the number of individuals in the 
50 year and older population of each Local Authority District (LAD) in England who 
have one or more of three specific morbidities. These morbidities are CVD, DHBS and 
respiratory illness. Together they are cited as the main cause of nearly 50% of all deaths 
in the 50 and older population of England and more than 20% of hospital admissions. In 
addition the numbers of individuals with the commonly diagnosed comorbidity of CVD 
and DHBS are also provided. The significance of this work is driven by a realisation 
that in western societies, an ageing population is almost inevitable and that the 
resources available to care for these individuals are limited. By better understanding this 
phenomenon, policies and plans can be put in place to help meet the populations’ health 
care needs. 
In section 11.2 of this chapter the material presented in the earlier chapters is 
summarised and the findings from the work highlighted. The policy implications that 
arise from the work are covered in section 11.3 which addresses the final research 
question in section 1.4. Section 11.4 illustrates how the work may be improved and 
taken forward. The final section describes how the objectives set out in chapter one of 
this thesis have been met 
11.2 SUMMARY OF WORK 
11.2.1 Demographics 
There is a consistent pattern amongst Western European nations of a projected increase 
in the size and proportion of their older population. However, the rate of this ageing 
varies by nation and the UK is one of those where this phenomenon is less pronounced. 
Using sub national population projections provided at the LAD level by ONS it is also 
possible to examine this phenomenon more locally. Unsurprisingly, the most populous 
LADs, either through their large geographic size or dense urban populations are those 
with the largest population aged 50 and older, and also show the greatest increases from 
2011 to 2031. However, when measured as percentage changes, these LADs with larger 
50 and older populations in 2011 show smaller percentage increases in comparison to 
other LADs. Thus the relative impact of an ageing population is more keenly felt on 
small to midsize LADs. 
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Coupled with the size of this demographic, the health status of the population will also 
have an influence on the total health care demand. Both life expectancies and disability 
free life expectancies show historic increases, and whilst people are living longer, the 
age to which that they are living without a disability is also increasing. These increases 
are not however occurring at the same rate, so that the difference between these two 
measures appears to be increasing. These points to an expansion in morbidity. Females 
tend to have higher life expectancies than males but similar disability free life 
expectancies, which means that females spend most of these extra years of life living 
with a disability. These life and disability free life expectancies can be estimated for 
local areas too. When mapped at the Clinical Commissioning Group (CCG) level they 
show distinct regional variation. Areas in the Midlands and Northern England 
(particularly the urban areas) have low life and disability free life expectancies, whilst 
areas in the South, outside London, (particularly rural areas) have high expectancies. 
This concentration of an ageing population and populations with lower disability free 
life expectancies in urban areas is corroborated when looking at demand for hospital 
care, measured using FCEs. As well as a concentration of demand in the urban areas, 
the provision of hospital health care is also concentrated in the cities within such areas. 
The general context of the aged population in England is a population which is getting 
larger, older and living longer but not necessarily healthier. 
11.2.2 Literature 
The health care demands associated with an elderly population and what determinants 
affect this demand is a well-studied field. Some studies examine the prevalence of 
specific morbidities, others look at either general health or presence of limiting 
activities and many (particularly those from the United States) model health care costs 
as a proxy for ill health. The general findings are that as people get older they are more 
prone to develop morbidities or be in generally worse health which means that an older 
population will tend to have worse health. However, age itself may not be the actual 
influence. Some studies have reported that it is the remaining years of life that are 
important, with an individual’s health deteriorating in the final months or years before 
death. Others take the argument further and suggest that it is not age or the remaining 
years of life that are important but the presence of a disabling condition. 
Gender and ethnic difference influence health status as well. As mentioned above, 
females live longer than males but these extra years are not necessarily spent in good 
health. There are some morbidities that are more associated with certain ethnic groups, 
e.g. DHBS in the south Asian population. A person’s socio-economic status can be 
measured using income, wealth, education or employment indicators. These are all 
correlated and can all influence health. 
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A range of data exists to study the health outcomes of an aged population. Population 
Censuses provide extensive coverage of the characteristics of the population and 
provide rich detail on the many determinants often cited as important for health 
outcomes. However, the actual information collected on health is general and rarely 
touches on specific morbidities and the time interval between Censuses can be large. To 
try and overcome these issues, governments often commission national sample surveys 
that can either be generic or targeted on a particular public policy issue, such as health. 
Finally, bespoke, one-off surveys are commissioned by local government or academics 
that are designed to study a particular health outcome in a specific place. In an era 
where administrative systems are increasingly being implemented and coordinated, 
scope has arisen to use such data for researching health status.  
The literature also contains details of the modelling approaches used in studies of 
elderly health care. The two main approaches are either statistical modelling or 
simulation. Statistical modelling is the most often used approach. The advantage of this 
approach is that it is grounded in statistical theory which allows for various 
interpretative and testing regimes to be followed. The disadvantage is that statistical 
modelling is rigid in both its outcome and the reliance on the assumptions that underlie 
the modelling technique. Just as are there are a wide variety of statistical techniques 
which can be used, there are also a wide variety of simulation techniques. These 
techniques attempt to replicate the composition or behaviour of a population, either real 
or hypothetical.  They commonly use the technique of Monte Carlo simulation to 
replicate a decision making process between alternatives within the simulation system. 
The advantage of such an approach is that it can be built using simple rules that are 
informed by either an understanding of the dynamics of health care or informed by data. 
The drawback is that it is sometimes difficult to disentangle these dynamics, particularly 
when unexpected or little understood interactions occur. 
Whilst most of the literature studied has focused on health care demand, there also 
related studies of health care delivery, with an increasing move to more 
pharmacological and technological treatments of morbidities delivered through GP 
clinics or at home. There are some concerns that such treatments many absent such 
cases from administrative recording mechanisms, although there are moves to capture 
such treatments e.g. the proposed release of GP patient data as part of the English 
NHS’s care.data initiative, NHS England (2015).  
11.2.3 Data 
The review of the literature identified a number of useful data sources for this study. 
The two which emerged as having most utility were the 2011 UK population Census 
and ELSA. The 2011 Census is able to provide a comprehensive picture of the 
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population in England at a variety of geographic scales. The information captured by the 
Census includes most of those that are determinants identified in the literature as being 
important determinants. However, the range of actual health information in the Census 
is limited with no information on specific morbidities. In contrast, ELSA is able to 
provide the detailed information about individuals and their morbidities. It is also a 
longitudinal survey so it is possible to gain a contemporaneous understanding of their 
circumstances when an event of significance occurs, i.e. the acquisition of a morbidity. 
Whilst the sample size of ELSA is large, its coverage is still not sufficient to provide 
robust estimates of health status at geographies smaller than region. 
Since both of these potentially useful data sources have their advantages and 
disadvantages, a modelling technique is required to best utilise the advantages of each 
data set. Before this is accomplished a consideration of the compatibility of information 
between the two sources is required. This compatibility found to be good in terms of the 
main socio-demographic measures, opening the way for using both data sets in the 
suggested modelling approach. 
11.2.4 Methodology 
The methodological approach adopted in this study utilises a variety of individual 
components. A spatial microsimulation model is used to create a synthetic base 
population of those aged 50 and older in each English LAD for 2011. The 2011 Census 
counts provide the constraint population and ELSA provides the sample population. 
This 2011 base population is then evolved through time, biennially, from 2011 to 2031. 
During this process the population is aged, is replenished at the younger ages of 50 and 
51 and the morbidity status of individuals is updated. This updating is influenced by a 
range of hazard models that predict the probability of a morbidity, mortality or 
migration event occurring. Also information on the likely future smoking status of 
cohorts as they become part of future synthetic ELSA waves is derived. It is of critical 
importance that the size and structure of these future LAD populations evolve along the 
projected lines. This is achieved by constraining the populations for each forecast year 
to agree with an external population projection of gender by age by ethnicity. However, 
a comparison of these projections with 2011 Census counts highlighted the need to 
revise these projections in light of the mismatch between the Census counts and the 
2011 projections. To gain further understanding of how the trends in morbidity status 
are influenced by the ‘natural’ demographic changes in the population, an accounting 
system to apportion changes in this status to various demographic factors is formulated 
and applied. 
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11.2.5 Spatial microsimulation results 
The methodology requires that a synthetic base population for the year 2011 is 
established in each LAD. This is achieved by conducting a spatial microsimulation 
using 2011 Census data and wave 5 data from ELSA. A consideration of the 
commonality of variables between these two data sources identified a number of 
potentially useful constraint variables. To select those that were likely to be of use a 
multi-faceted strategy was adopted. Firstly, the variable needs to have a common 
definition and interpretation in the constraint and sampling population. This was 
achieved by consulting the relevant documentation for the variable and examining its 
coding. Secondly, the variable must have been identified in the literature to be an 
important determinant of elderly health status in aggregate. This is informed by the 
literature. Thirdly, this importance needed to be demonstrated at the individual level. 
Here this is tested using hazard models to explain morbidity incidence.  
A set of initial constraint variables are identified, based on the literature, namely age, 
gender, disability status and ethnicity. Of these four, not surprisingly, disability status 
was the most consistently important, as measured by the reduction in deviance. The next 
most consistently important constraint is gender, which is important for the linked 
morbidities of CVD and DHBS but not respiratory illness. Age was important for CVD 
and finally, ethnicity is particularly important for DHBS, a finding which is strongly 
supported by the literature. 
The next stage was to identify a number of variables to capture the socio-economic 
impact on morbidity incidence. Here there is a need to identify not only additional 
constraint variables but also validation variables to investigate how well the spatially 
microsimulated population reproduces counts for the validation variable. After 
examining the goodness of fit of a range of candidate variables, vehicle ownership was 
found to be the socio-economic variable that is most important in explaining morbidity 
incidence, and given the need to have a reliable validation outcome, it is used as a 
validation variable. The next most important variable is living arrangements, which is 
important for DHBS and respiratory illness. This used as an additional constraint 
variable. The third and final socio-economic variable to be used as an additional 
validation variable is social status (recorded through the NS-SEC).  
The spatial microsimulation was performed using a combinatorial optimisation 
implementation with five constraint tables containing: age and gender, disability 
(household residents), disability (clients resident in institutional establishments), 
ethnicity and living arrangements. The optimisation performed well, quickly achieving 
low and stable values of the Total Absolute Error goodness of fit measure. The 
validation of the synthetically derived LAD population was seen to be generally good, 
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although the size of the ‘Other’ social class was consistently under estimated in the 
synthetic populations. 
There is additional utility in the synthetic LAD populations from being able to estimate 
the prevalence of morbidities in the LAD for 2011, employing the information on 
whether each member of the ELSA sample has a morbidity at wave 5.  This analysis 
revealed both ethnic and wealth gradients in the estimated prevalences. LADs with a 
large south Asian population that were also less affluent are seen to have high 
prevalences of both CVD and respiratory illness. Many of the LADs with high DHBS 
prevalence are located in central London and have a diverse ethnic composition. The 
more prosperous and affluent LADs in southern England have low prevalences for all 
three morbidities.  
11.2.6 ETHPOP adjustment results 
As part of the evolution of the base LAD population through time it is important that its 
size and structure accord with some likely population projection. Whilst the ONS 
regularly produce subnational population projections for LADs in England, they are 
only disaggregated by gender and age. These two demographic factors may not 
accurately reflect the changing nature of English LADs. A more credible outcome is 
possible if some additional demographic characteristic could also be incorporated. 
Probably the most useful and available is an ethnic dimension and this study has used 
such a projection that arose from a University of Leeds research project in the ESRC 
Understanding Population trends and Processes (UPTAP) initiative, branded ETHPOP. 
An initial assessment of the performance of these projections for the 50 and older 
population against 2011 Census outcomes showed some differences. In the ethnically 
diverse LADs the ETHPOP projections tended to overestimate the White ethnic group 
and under estimate the BME group, in both absolute numbers and share of the LAD 
population. In LADs with a more homogeneous White population, the projections are 
much more accurate when looking at absolute numbers, but for the BME groups, which 
have small numbers, the percentage differences are large. 
In light of these discrepancies between 2011 ETHPOP projections and 2011 Census 
counts, a methodology is deployed that attempts to revise projections beyond 2011 in 
light of this past performance. Firstly, any projections are re-based to have the 2011 
Census counts as their starting point; secondly the ETHPOP projections beyond 2011 
are then corrected by use of a linear adjustment factor and finally constrained to 2012 
ONS sub national projections. The range of the actual adjustment factors used are 
limited by a distribution derived from corresponding factors in other similar types of 
authority. The impact of these revisions on 2021 and 2031 projections are discussed for 
a number of case study authorities. 
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11.2.7 Hazard models and probabilities 
The health microsimulation is implemented using the Monte Carlo technique of 
randomly determining outcomes using draws from a probability distribution. In order to 
implement this technique a range of probabilities of certain events occurring need to be 
defined. The most obvious are the probabilities that measure whether an incidence of a 
morbidity will take place. These probabilities are estimated using a hazard model 
estimated on wave 1 to 6 ELSA data. These hazard models are also used to forecast the 
morbidity status of those aged 50 and 51 who replenish future artificial waves. 
Hazard models are also use to estimate a set of weights to be used for selecting 
individuals for cloning or removal from the LAD population. It is this mechanism that 
re-structures the population to an external projection (here the revised ETHPOP 
projections). Using the hazard model probabilities allows for the chance of removal 
(due to mortality or out-migration) or inclusion (due to in-migration) to be influenced 
by a person’s characteristics, including their morbidity status. Notwithstanding the 
utility of these weights in regards to determining who rather than how many individuals 
to select, a comparison with actual mortality and migration rates is insightful. This 
comparison is done with contemporary official mortality statistics and migration counts 
from the 2011 Census. The trends in the mortality predicted by the hazard models agree 
well with the official mortality probabilities but the level of morbidity is, for some types 
of individual, much less than these official probabilities. The migration probabilities are 
also less than those estimated from the 2011 Census and a compounding of probabilities 
is necessary to increase this agreement.  
Not only do the Replenishers for the future artificial waves need to have a morbidity 
status on joining, they also need a smoking status. Using evidence from the 2011 HSfE, 
a tabulation of whether someone aged 30 to 50 had ever smoked revealed that there was 
little difference by birth cohort within this age range but there were gender and ethnic 
differences. 
Together, these probability models and rates allow the health microsimulation to be 
dynamic in its health status and its composition over time. 
11.2.8 Health microsimulation results 
The outcome of the health microsimulation is an individual population that represents 
the projected population of each LAD biennially from 2011 to 2031. Each individual 
will have their own morbidity status and this information can be used to estimate both 
the prevalence count for morbidities, or a combination of morbidities, and also a 
prevalence rate. Aggregated national trends for England from the microsimulation show 
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a reduction in the prevalence and number of people with CVD and respiratory illness 
but an increase in the number and prevalence with DHBS. 
To begin to explore how these prevalences and trends over time vary locally, the overall 
prevalence rates in each NHS Local Area Team (LAT) is provided. For CVD the 
national trends seen for reductions in the prevalence are apparent in all LATs although 
to varying degrees. The London LAT sees a substantial reduction in its prevalence rate 
and whilst the prevalence for Durham, Darlington and Tees also reduces by 2031, this 
reduction is more modest. For DHBS, there is much more stability in prevalence rates, 
all LATs show increases and, generally, LATs with high prevalences in 2011 also have 
high prevalences in 2031, and vice-versa, with Birmingham and the Black Country and 
the London LATs retaining high prevalences. The pattern with respiratory illness is 
similar to that for CVD. Whilst the reductions in prevalence are less pronounced, the 
London LAT again shows an improvement in both prevalence and its relative position 
amongst LATs whilst Devon, Cornwall and Isles of Scilly becomes the LAT with the 
highest prevalence. The comorbidity prevalences have elements from both the CVD and 
the DHBS trends, so whilst all the prevalences reduce, London improves its relative 
position, Birmingham and the Black Country remains one of the highest, and Durham, 
Darlington and Tees joins it as the LATs with the higher prevalences in 2031. 
Inspection of the trends in the seven individual case study authorities corroborates some 
of the features reported for the LATs. Many of the case study authorities are based in 
London and so see the improvements in both their prevalence and position relative to all 
other LADs - as the LAT results would imply. Leeds also tends to improve its rankings 
for most morbidities, for reasons similar to those in London. The two more prosperous 
LADs, Wiltshire and Teignbridge, retain their relatively good position for most 
morbidities, but show deteriorations for respiratory illness, especially so for 
Teignbridge. The remaining LAD, Rotherham, exhibits changes in line with the national 
trends and a stability in terms of its relative performance amongst LADs.  
These results predict that both nationally and locally the incidence and prevalence of 
CVD will fall up to 2031. For DHBS there will be increases in both the prevalence 
count and rate. The number of individuals with respiratory illness will remain largely 
constant. However, given the larger population, this will translate to a reduced 
prevalence rate. Within these national trends however there are geographic differences 
which are apparent at both the regional and local level. 
11.2.9 Decomposition Results 
Whilst the parameter estimates from the hazard models provide some insight into how 
the characteristics of the population in a LAD affect the health outcomes, the impact of 
relative shifts in demographic factors is not so clear. To gain this insight an accounting 
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system has been adopted to decompose the health trends attributable to these shifting 
demographics. On a national level these demographic impacts are seen to increase the 
number of individuals with morbidities. For CVD and respiratory illness and the 
comorbidity of CVD and DHBS these increases are reversed when the health trends in 
the health microsimulation are applied. For DHBS, however, over the forecast period 
2011 to 2031, there is also an increase attributable to the health microsimulation. 
Looking at the case study LADs, there is a distinct patterning amongst them. The more 
ethnically cosmopolitan LADs show the largest increases associated with changes in the 
ethnic composition of the LAD and not so much the changes in the age composition or 
life expectancy of their populations. For the more prosperous LADs the relative impacts 
are reversed, changing the ethnic composition of the LADs does not increase the 
number of individuals with a morbidity but changing the age composition and life 
expectancy does. 
11.3 POLICY IMPLICATIONS 
As discussed elsewhere in this thesis, for the foreseeable future, the English population 
is expected to age. As the House of Lords (2013) report says: 
 “The ageing of the population is inevitable, and affects us all.” 
The impact of this ageing has consequences for society, both financial and social. One 
sector where there is the potential for this ageing to be most significantly felt is health. 
“The NHS is facing a major increase in demand and cost consequent on ageing and will 
have to transform to deal with this. Because of this rising demand, …, needs will remain 
unmet and cost pressures will rise inexorably.” House of Lords (2013) 
This research has demonstrated that there are indeed significant demographic drivers in 
society that would lead to the conclusion that there will be greater pressure on health 
care services linked to the three morbidities studied here. An older population which is 
more ethnically diverse, has an older structure and incorporates increases in life 
expectancies will mean that more people will have one or more of these morbidities. 
However all is not what it seems. There are other trends in the population that help to 
potentially mitigate or exaggerate these demographic influences. The shift away from 
types of employment associated with ill health (e.g. heavy industry, chemicals or 
textiles), better employment practices (health and safety regulations), reduced 
prevalence of smoking in the population and better air quality all have the potential to 
improve health at all ages but, given that many of these factors have their impacts later 
in life, more so at older ages. There are however trends working in the opposite 
direction that will lead to poorer health outcomes. The oft cited trends are related to diet 
and lifestyle. Increases in obesity seen at younger ages may affect later life health status, 
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especially if this obesity is carried forward into later life (“Obesity is the new smoking”, 
Guardian, 2015).  
The results presented in this thesis have corroborated these trends to a large degree. Of 
the two morbidities that show improvements in population health, CVD and respiratory 
illness, these are often cited as having links to those trends which are improving, e.g. 
occupation, housing, smoking, air quality and medications. In addition, medication with 
statins, first used in the UK in 1987 (Chatterjee, 2008), has been shown to reduce the 
level of LDL (‘bad’) cholesterol thereby avoiding occurrence of CVD (Law et al, 2003). 
The morbidity which shows an increase, both in those with the morbidity and its 
prevalence, is diabetes and this has a strong lifestyle link to obesity. 
This suggests at least three public policy messages. Firstly, there are reassuring trends in 
health improvements with two of the largest causes of death and hospital admission 
showing substantial reductions.  Public health and policy work in this area is clearly 
successful, having an impact and should continue.  Secondly, more work is required 
with DHBS. On current trends the number of individuals with this morbidity and its 
prevalence are projected to increase. Clearly more attention is needed to try and identify 
and mitigate this trend. Factors that would be worthy of investigation include the 
targeting of public health messages at locations and communities where the growth in 
DHBS is anticipated to be greatest. To what extent the ‘boat has sailed’ on this issue 
(Singh et al, 2008) and that any public health intervention taken now is unlikely to yield 
significant impacts before 2031 is debatable but this should not stop work commencing 
in this area (Reilly, 2003). Thirdly, given the difference in forecast trends with these 
morbidities, in a period of constraints on resources available for public health, 
consideration should be given to tilting the balance of such resources towards DHBS. 
There are distinct geographic trends in the future prevalence counts and rates. 
Examination of the dynamics of both prevalence counts and rates in NHS Local Area 
Teams (LAT) (Table 9-6 to Table 9-9) and case study authorities, together with the 
differences evident in the 2011 and 2031 LAD maps shown in Figure 6-2 and Figure 
9-3, illustrate this point. The area covered by the Darlington, Durham and Tees LAT 
stands out as an area that performs badly in terms of health outcomes. Whilst there are 
some improvements in prevalence rates over time, the improvements are not as marked 
as in other LATs. The Birmingham and Black Country LAT is also an area whose 
health status deteriorates relative to others. The more prosperous LATs, primarily 
located in southern England outside London largely retain their relatively positive 
health status from 2011 to 2031. In London the situation is mixed but, excepting DHBS, 
its relative performance amongst LATs and LADs improves markedly. This is 
contrasted with the situation that many health care resources are actually centralised in 
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London, given its historic importance, attractiveness, prestige and population. To be 
fairer in the resourcing of such health care it makes sense to relocate some of these 
resources to areas such as the Midlands and North East where the relative need is seen 
to increase.  
As well as the revealed need demonstrated in these findings, the findings also point to 
locations where there is a need for screening services to identify individuals potentially 
at risk of developing a morbidity. Such initiatives help to capture individuals at risk and 
provide appropriate treatment before potential problems from the morbidity’s symptoms 
manifest  and complications become apparent (see also section 11.4.4 for how 
undiagnosed cases in the population can be explicitly modelled). As an illustration of 
the importance of screening services, the work of Kanavos (2012) is reported by 
Diabetes UK (2015a) and they report that the annual inpatient care, to treat short and 
long term complications of diabetes, is estimated at between £1,800 and £2,500 per 
patient. This compares with annual outpatient costs, which include the cost of 
medications and monitoring supplies, estimated at between £300 and £370 per patient. 
Clearly, mitigating longer term complications can provide not only a better quality of 
life for the patient but also financial savings. 
Here the medical need is quantified as prevalence counts and rates for each LAD. It is 
possible to transform these prevalences into alternative measure of health care need 
through the application of rates. One such calculation allows the costs associated with 
morbidities to be estimates. Research based on residents of Shropshire reports that a 
healthy patient costs the NHS about £293 a year, those with one long-term condition 
cost an estimated £795, those with two cost £1,655 and those with three cost £2,726 
each. For patients with four or more such conditions, their need for frequent treatment 
and monitoring  costs £4,549 a year, those with five conditions cost £5,841 and those 
with six conditions about £7,325 Those with seven or more conditions cost £11,233 per 
annum (Kasteridis et al., 2012). Where available, morbidity specific cost may also be 
used. For example the diabetes cost quoted above could be used to calculate a total cost 
to the NHS in each LAD for  diabetes. Performing this calculation for all the 
morbidities and allowing differential costs by gender, age and location is possible to do 
but requires access to sensitive person-level hospital data. As well as costs it may be 
also possible to attach other resources costs to each patient, e.g. clinician or general 
practitioner time or specialist equipment . 
11.4 FURTHER WORK 
In this thesis a grounding has been provided in defining a methodological structure to 
forecast the number of individuals with specific morbidities in each LAD to 2031.  
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There are a number of ways in which this work may be taken forward. In this section 
some of these ways are introduced and guidance offered on how to achieve them. 
11.4.1 Revised area types 
In the constraining of the ETHPOP adjustment factors, the morbidity hazard models and 
the selection of the case study authorities, the 2001 ONS area classifications are used. 
The role of these classifications is to capture some element of the socio-economic 
background of the individuals who live in a LAD. There may, however, be questions 
around it being fit for purpose. Firstly, it is designed for general use in a variety of 
contexts and not specifically geared towards differentiating on health outcomes for the 
50 and older population. Such health classifications do exist; Experian (CACI, 2007) 
produced a health outcome classification (Health Acorn) at unit postcode level for Great 
Britain which has some potential utility, although the geography is not compatible with 
that provided within ELSA.  Secondly, some of the clustering in the ONS classification 
is unhelpful. For example, the small seven member Group of London Centre contains 
LADs as diverse as Camden, Kensington and Chelsea, Southwark and Tower Hamlets. 
The Coastal and Countryside Group is also diverse encompassing the economically 
challenged LAD of Blackpool and prosperous rural Ryedale. Whether the differentials 
in health outcomes are consistent in these types of LADs is debatable. Finally, these 
classifications are clearly becoming out of date. Since December 2014 the ONS has 
been promising the release of updated LAD area classifications based on 2011 Census 
data, but as of late Spring 2015 they are not yet available. It will be insightful to see 
how these area classifications differ, not only in their nomenclature or characteristics 
but also their membership. If this scrutiny is sustained then it will be worthwhile re-
fitting the hazard morbidity models using these updated area type classifications and re-
running the health microsimulation. 
11.4.2 Health microsimulation decomposition 
As mentioned in Chapter 10, the impacts of the health microsimulation can be discerned 
on an individual level through the interpretation of the parameters estimated in the 
hazard models. Further insight into aggregate impacts can, however, be obtained by 
attempting a similar accounting system for the health influences and how they 
decompose the total impact. This can be done by maintaining the full functionality of 
the health microsimulation and the input data but using more parsimonious hazard 
models. A possible regime would be to re-estimate and use models that initially 
contained just the wave and age influences, and then re-fitted models that successively 
introduced gender, ethnicity, smoking status, co-morbidities and LAD area types. 
Extensions of equations 5-18a-f, 5-19, 5-20a-f and 5-21 would enable these impacts to 
be measured.  
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The main concern with this proposal is whether the goodness of fit of these 
parsimonious models with so few explanatory terms would be adequate to the task. If 
the models were not of sufficient quality then the acquisition of a morbidity may be a 
random or even counter intuitive event. Also the use of the morbidity hazard models for 
other purposes would need to be taken account of. To retain consistency consideration 
would need to be given to the use of either the full models as described in section 8.2 or 
the more parsimonious morbidity hazard models to calculate the accumulated incidence 
from age 30 to 49 to ensure that the Replenishers aged 50 and 51 joined the future 
synthetic wave with an appropriate level of morbidity. Also an assessment would need 
to be made of whether to use the full models or similarly parsimonious hazard models 
for the estimation of the mortality and migration selection weights. 
11.4.3 Other morbidities 
Both CVD and respiratory illness account for a larger number of causes of death and 
hospital admissions in the 50 and older population. Also DHBS, whilst not an important 
cause of death or hospital admission (except through complications), is often cited as a 
comorbidity with CVD and may still affect individual’s quality of life and perception of 
their disability status. These rationales influence the choice of morbidities to study in 
this thesis. However there are still other morbidities that are also important and could be 
modelling using this framework. Firstly, there are the cancers or neoplasms. These are 
differentiated by ELSA which collects information on the organ or part of body in 
which the cancer started (lung, breast, prostate, colon, bowel or rectum, lymphoma, 
leukaemia, melanoma or other skin cancer or somewhere else). Clearly cancer is a 
complex morbidity arising at a number of sites in the body and predicated by a variety 
of factors, which gives the view that cancer is almost a collection of comorbidities with 
a challenging and diverse range of determinants. Other potential morbidities that are 
worthy of consideration if the work is taken forward are those which are not life 
threatening but can severely affect the quality of life and incur significant health care 
resources, such as arthritis, Parkinson disease, dementia or depression. Of the six 
morbidities reported in the ELSA wave reports, arthritis has the highest prevalence and 
is particularly prevalent amongst the female population (Institute for Fiscal Studies, 
2012). Dementia is a little understood morbidity with few treatments available meaning 
that the quality of life for suffers and their carers is poor with many resorting to 
expensive institutionalise care. This makes it worthy of further study. 
11.4.4 Undiagnosed cases 
Not only can the health microsimulation be extended to include other morbidities but it 
can also be used to estimate or forecast the extent of undiagnosed or potential 
prevalence within each LAD. Such knowledge will help to identify those locations at 
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which to target screening services. Using biomarker data collected at a nurse visit it is 
possible to identify those individuals with a potentially undiagnosed morbidity or a high 
risk of developing a morbidity. For CVD these indicators include the level of 
fibrinogen, the systolic and diastolic blood pressure (linked to hypertension), and the 
balance of HDL-C (‘good’ cholesterol) and LDL-C (‘bad’ cholesterol). The risk for the 
stroke component of CVD can be tested for by measuring triglycerides in the blood. The 
potential presence of diabetes can be picked up using levels of glucose in the urine or 
blood, an oral glucose test or Hemaglobin Alc (HBAlc) levels. Finally, the ratio of the 
Forced Vital Capacity to the Forced Expiratory Volume (FVC/FEV1) or a peak flow 
test can indicate reduced lung capacity due to respiratory illness. Levels of these 
biomarkers that indicate a potential medical issue are shown in Table 11-1. 
Table 11-1 : Levels of biomarkers to indicate morbidity risk or undiagnosed 
Morbidity Measure Criteria for concern 
CVD 
Fibrinogen
1
 ≥ 3.43g/l 
Systolic and diastolic blood pressure
2
 
Systolic ≥140 and  
diastolic ≥ 90mmHg 
HDL-C
3
 
≤ 1mmol/l (men) 
≤ 1.2 mmol/l (females) 
LDL-C
4
 ≥ 4.15mmol/l 
Diabetes 
Blood glucose
5
 ≥ 7.0 mmol/l 
Oral glucose
5
 ≥ 11.1 mmol/l 
HbAlc
5
 
≥ 48.0mmol/mol 
or ≥ 6.5% 
Respiratory 
illness 
FEV1/FVC
6
 < 70% 
Peak flow
7
 Depends on device 
1
 Kannel et al, (1987), 
2
 Rapsomaniki et al, (2015), 
3
 Heart UK (2015a), 
4
 Heart UK (2015b),  
5
 Diabetes UK (2015b), 
6
 National Institute for Health and Care Excellence (2015), 
7
 Clement 
Clarke International (2015). 
The simplest way to assess this degree of undiagnosis or risk prevalence is to assume 
that the morbidity profile for the population with the morbidity is not dis-similar to this 
‘unknown’ population. This allows the population in each LAD to be defined by the 
same constraints as those that have the morbidity. Using the biomarker information for 
the ELSA participants those at risk or with an undiagnosed morbidity can be identified 
and this information can be attached to their morbidity profile and, just as with 
diagnosed cases, the prevalence rate estimated. A more complex approach would be to 
treat these undiagnosed or at risk morbidities as separate incidences and examine how to 
include them as outcomes in their own right. This would require further hazard 
modelling as described in section 8.2. 
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There are however a number of issues with this approach to identifying undiagnosed or 
at risk prevalences. Firstly, the sample population is composed of wave 5 ELSA 
participants but there was no biomarker data collected at wave 5. Instead information 
from such data collected at waves 4 and 6 may be used to infer their undiagnosed or at 
risk status at wave 5. Secondly, the biomarker data are only collected for core members 
(i.e. C1CM, C3CM, C3CM and C6CM) whilst the sampling population used in the 
spatial microsimulation is composed of all individuals at wave 5 with the required 
information, irrespective of their participation status. Thus there will be some members 
of the sampling population whose undiagnosed or potential prevalence is unknown. 
Thirdly, not all core members consented to a nurse visit to collect the biomarker data 
(the response rate is about 85% at the three nurse visit waves, NATCEN, 2014) so there 
will be sample members who are core members without this biomarker data. Clearly it 
would be possible to redefine the spatial microsimulation sample population to only 
include those participants who had the required biomarker data. However, this would be 
at the cost of a deterioration in the heterogeneity and coverage of the sample population. 
11.4.5 Capturing uncertainty 
The results from the health microsimulation are based on information that is, to a 
degree, uncertain. The population projection used to re-structure future populations is a 
projection and subject to the uncertainties in the assumptions that underlie the 
projection. The hazard models are estimated using a survey sample of data. The spatial 
microsimulation and health microsimulation involve a stochastic element and whilst this 
is seen to have little impact on the outcomes, it is still a source of uncertainty.  
These uncertainties are not necessarily fatal to any attempt at modelling, in fact they can 
be exploited to provide some measure of uncertainty around any outcomes. If the range 
of this uncertainly is credible it can then be used to lend confidence to any observed 
trends and differentials found in the outcomes. Perhaps the easiest way to incorporate 
the uncertainty is by exploiting the stochastic nature of methods within the health 
microsimulation. As demonstrated, this can be achieved by the use of different random 
number seeds that create different streams of pseudo random numbers to be used in the 
Monte Carlo sampling. Based on the available evidence the amount of variance 
introduced by this approach is not great.  
The next easiest mechanism to incorporate uncertainty recognises the fact that the 
hazard models are based on a sample of survey results. The parameter estimates from 
the hazard models are point estimates and have associated standard errors and also 
equivalent variance and covariances. These variance-covariance matrices are trivially 
provided in most statistical estimation software. If it is assumed that the parameter 
estimates to use in the health microsimulation are actually sample draws from some 
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multivariate distribution with its mean set to the point estimates and its variance set to 
the variance-covariance matrix then it can be run a number of times using different 
draws for the parameter estimates. Those estimates with low standard errors whose 
point estimates are therefore more reliable will be consistent amongst these draws, 
whilst those with high standard errors will vary considerably, capturing the uncertainty 
associated with their estimates. 
A multivariate normal distribution is the most credible such sampling distribution and 
one of these draws can be efficiently made at the start of each health microsimulation 
using the parameter estimates and an estimated variance covariance matrix.  The 
requirement to draw such a sample will be computationally trivial since there are 
typically just 10-15 parameters in each hazard model. The health microsimulation takes 
about 30 minutes to run on a reasonable desktop PC and, if there are multiple 
processing cores available, then more than one run can take place at a time. The impact 
of this modification on the variation in outcomes is likely to be greater than the use of 
different random number seeds.  
The third source of uncertainty is perhaps the easiest to implement but the most difficult 
to define. It simply involves using different population projections as input to the health 
microsimulation. However the provenance of such projections is a challenge. Whilst 
variants exist for national ONS projections they do not exist for the ONS sub national 
projections. But even if they did, a question arises as to whether they represent 
sufficient credible uncertainty in the projections. Many of the variants are designed to 
produce ‘extreme’ outcomes and to use these would give far too much weight to 
unlikely outcomes. What are required in reality are probabilistic forecasts that follow 
some distributional outcomes, where moderate outcomes are more likely to occur than 
extreme outcomes. Such models are not unknown in the literature (Alkema, 2015) but at 
the moment the projections from models are not available at the geography required 
here. It is difficult to assess the likely impact of using probabilistic projections since the 
variation in the health microsimulation outcomes will be related to the variability of the 
projections. However, it is likely to be greater than the use of random number seeds. 
The three methods for introducing uncertainly here are all credible sources of variation 
within the model and can be implemented with just superficial changes to the code and 
input data. They can also be incorporated incrementally and variously to assess each 
method’s impact on estimation uncertainty.  
11.4.6 Composition of the ELSA population 
The ELSA survey is a large and complex survey that captures well the dynamics 
associated with ageing in the general population. Whilst the size of the survey is large 
and stringent efforts are deployed to reduce attrition within the survey, there are issues 
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for this study in the size of the BME population. Proportionately ELSA may reflect well 
the size of the aged 50 and older BME population, but what this means in practice is 
that the number of BME individuals in the sample is small. This is evidenced in Table 
5-3  where some merging of age bands is required to ensure that there is at least, some 
representation of all BME populations in each gender and age band. However, the 
question arises as to whether these small numbers are truly representative of the specific 
ethnic group, where a bias towards a few individuals having (or not having) a morbidity 
could sway the prevalence estimates for those LADs with high BME populations. Also 
the standard errors for the BME parameters in Table 8-1, Table 8-2 and Table 8-3  are 
large. At the moment it is difficult to deal with this issue with these data. Ideally what 
should have been given some consideration is an over sampling of the BME population 
at an early stage of ELSA or during one of the refresher cohorts.  
11.5 CONCLUSION 
In the first chapter of this thesis a number of research questions are posed and the 
objectives that go towards answering these research questions are highlighted. The first 
and substantive research question concerns a desire to forecast the likely number of 
people aged 50 and older, who will have one or more of the specific morbidities in each 
LAD, to 2031. This has been achieved by the using the outlined modelling approach 
described in the Methodology chapter, Chapter 5, and reported in the Health 
Microsimulation chapter, Chapter 9. 
Of critical importance to the health microsimulation is that its operation is informed by 
knowledge about the socio-demographic and socio-economic makeup of each LAD. 
This has been gained through the contextual information and literature review provided 
in Chapters 2 and 3 and the modelling work in Chapters 6 and 8. These influences have 
been incorporated through the selection of constraints that define the 2011 base 
population in each LAD and the hazard models that predict morbidity incidence, 
mortality and migration. This allows the production of forecasts that answer the second 
research question which is how these morbidities vary by the gender, age, ethnicity and 
other socio-demographic characteristics of the population in the area.  
To gain a deeper understanding of these local area trends an accounting system 
approach has been adopted to show how are these forecasts are influenced by both 
changes in the demographic composition of an area and by changing trends in health 
outcomes. This work fulfils the third research question and is covered in Chapter 10. 
Whilst the first research question is the most substantive, the final question around what 
are the public policy implications of the work is perhaps the most important. This issue 
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has been addressed at points throughout this thesis but are drawn into focus in this 
chapter.  
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12 GLOSSARY 
 
BHPS British Household Panel Survey 
BME Black and Minority Ethnic 
C1CM Cohort 1 Core Member 
C1CP Cohort 1 Core member Partner 
C1NP1 Cohort 1 New Partner at wave 1 
C1NP2 Cohort 1 New Partner at wave 2 
C1NP3 Cohort 1 New Partner at wave 3 
C1NP4 Cohort 1 New Partner at wave 4 
C1NP5 Cohort 1 New Partner at wave 5 
C1NP6 Cohort 1 New Partner at wave 6 
C1OP Cohort 1 Older Partner 
C1SM Cohort 1 Sample member 
C1YP Cohort 1 Younger Partner 
C3CM Cohort 3 Core Member 
C3CP Cohort 3 Core member Partner 
C3NP3 Cohort 3 New Partner at wave 3 
C3NP4 Cohort 3 New Partner at wave 4 
C3NP5 Cohort 3 New Partner at wave 5 
C3NP6 Cohort 3 New Partner at wave 6 
C3OP Cohort 3 Older Partner 
C3SM Cohort 3 Sample Member 
C3YP Cohort 3 Younger Partner 
C4CM Cohort 4 Core Member 
C4CP Cohort 4 Core member Partner 
C4NP4 Cohort 4 New Partner at wave 4 
C4NP5 Cohort 4 New Partner at wave 5 
C4NP6 Cohort 4 New Partner at wave 6 
C4OP Cohort 4 Older Partner 
C4SM Cohort 3 Sample Member 
C4YP Cohort 4 Younger Partner 
C6CM Cohort 6 Core Member 
C6CP Cohort 6 Core member Partner 
C6NP6 Cohort 6 New Partner at wave 6 
C6OP Cohort 6 Older Partner 
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C6SM Cohort 6 Sample Member 
C6YP Cohort 6 Younger Partner 
CCG Clinical Commissioning Groups 
CHD Coronary Heart Disease 
CO Combinatorial Optimisation 
COPD Chronic Obstructive Pulmonary Disease 
CT Computerised Tomography 
CVD Cardio Vascular Disease 
DC Detailed Characteristics 
DES Discrete Event Simulation 
DHBS Diabetes or high blood sugar 
ELSA English Longitudinal Survey of Ageing 
ELOB Expected years Of Life at Birth 
ESRC Economic and Social Science Research Council 
ETHPOP ETHnic POPulation projections 
EU European Union 
FCE Finished Consultant Episode 
FMF Flexible Modelling Framework 
GCSE General Certificate of Secondary Education 
GDP Gross Domestic Product 
GHS General Household Survey 
GP General Practitioner doctor 
HDL High-Density Lipoprotein 
HES Hospital Episode Statistics 
HSCIC Health and Social Care Information Centre 
HSfE Health Survey for England 
ICD-10 International Statistical Classification of Diseases 10
th
 Revision 
IHD Ischaemic Heart Disease 
IPF Iterative Proportional Fitting 
IQR Inter-Quartile Range 
KS Key Statistics 
LAD Local Authority District 
LAT NHS Local Area Teams 
LC Local Characteristics 
LDL Low-Density Lipoprotein 
LSOA Lower Super Output Areas 
MRI Magnetic resonance imaging 
MSOA Middle Super Output Areas 
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NHS National Health Service 
NS-SEC National Statistics socio-economic classification  
OA Output Areas 
OECD Organisation for Economic Co-operation and Development  
ONS Office for National Statistics 
PCO Primary Care Organisations 
QS Quick Statistics 
RI Respiratory Illness 
SD Systems Dynamic 
SHA Strategic Health Authorities 
SNPP Sub national Population Projections 
SPSS Statistical Package for the Social Sciences 
TAE Total Absolute Error 
TREND UPTAP trend forecast 
UK United Kingdom of Great Britain and Northern Ireland 
UKHLS United Kingdom Household Longitudinal Study 
UPTAP Understanding Population Trends and Processes 
UPTAP-ER UPTAP Emigration Ratio forecast 
WHO World Health Organisation 
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13 APPENDIX 
Structure of Constraint and Sampling Population Tables for 
the Spatial Microsimulation 
Table 13-1 : Gender by age (DC1117) 
Usual Residents Male Female 
Aged 50 to 54 M50 F50 
Aged 55 to 59 M55 F55 
Aged 60 to 64 M60 F60 
Aged 65 to 69 M65 F65 
Aged 70 to 74 M70 F70 
Aged 75 to 79 M75 F75 
Aged 80 to 84 M80 F80 
Aged 85 and older M85 F85 
Table 13-2 : Gender by age by ethnicity (DC2101) 
Usual residents White Mixed Asian Black Other 
Male 
Aged 50 to 64 M50W M50M M50A M50B M50O 
Aged 65 and older M65W M65M M65A M65B M65O 
Female 
Aged 50 to 64 F50W F50M F50A F50B F50O 
Aged 65 and older F65W F65M F65A F65B F65O 
Table 13-3 : Gender by age by disability (household residents) (LC3101) 
Household residents plus institutional  
residents who are not clients 
No LLTI LLTI 
Male 
Aged 50 to 64 M50N M50L 
Aged 65 to 74 M65N M65L 
Aged 75 to 84 M75N M75L 
Aged 85 and older M85N M85L 
Female 
Aged 50 to 64 F50N F50L 
Aged 65 to 74 F65N F65L 
Aged 75 to 84 F75N F75L 
Aged 85 and older F85N F85L 
Institutional residents who are clients INSTITUTION 
Table 13-4 : gender by age by disability (institutional residents) (DC3402) 
Institutional residents who are clients No LLTI LLTI 
Male 
Aged 50 to 64 
M50N 
M50L 
Aged 65 to 74 M65L 
Aged 75 to 84 M75L 
Aged 85 and older M85L 
Female 
Aged 50 to 64 
F50N 
F50L 
Aged 65 to 74 F65L 
Aged 75 to 84 F75L 
Aged 85 and older F85L 
Household residents plus institutional residents who are not clients HOUSEHOLD 
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Table 13-5 : Gender by age by provision of unpaid care (LC3301) 
Household residents plus institutional residents 
who are not clients 
No care 
Between 1 and 
19 hours per 
week 
Between 20 
and 49 hours 
per week 
Fifty or more 
hours per 
week 
Male 
Aged 50 to 64 M50C0 M51C1 M520C20 M550C50 
Aged 65 and older M65C0 M65C1 M65C20 M65C50 
Female 
Aged 50 to 64 F50C0 F51C1 F520C20 F550C50 
Aged 65 and older F65C0 F65C1 F65C20 F65C50 
Institutional residents who are clients INSTITUTION 
Table 13-6 : Gender by age by vehicle availability (DC4109) 
Household residents plus institutional residents who 
are not clients 
No vehicles One vehicle 
Two or more 
vehicles 
Male 
Aged 50 to 64 M50V0 M51V1 M52V2 
Aged 65 to 74 M65V0 M65V1 M65V2 
Aged 75 to 84 M75V0 M75V1 M75V2 
Aged 85 and older M85V0 M85V1 M85V2 
Female 
Aged 50 to 64 F50V0 F51V1 F52V2 
Aged 65 to 74 F65V0 F65V1 F65V2 
Aged 75 to 84 F75V0 F75V1 F75V2 
Aged 85 and older F85V0 F85V1 F85V2 
Institutional residents who are clients INSTITUTION 
Table 13-7 : Gender by age by tenure (DC3408) 
Household residents plus institutional residents who are 
not clients 
Owned 
outright 
Mortgaged 
Social 
rented 
Private 
rented 
Male 
Aged 50 to 64 M50O M50M M50S M50P 
Aged 65 and older M65O M65M M65S M65P 
Female 
Aged 50 to 64 F50O F50M F50S F50P 
Aged 65 and older F65O F65M F65S F65P 
Institutional residents who are clients INSTITUTION 
Table 13-8 : Gender by age by highest qualification (DC5107) 
Usual residents No qualifications 
Qualification 
below degree 
Degree 
Other or 
foreign 
Male 
Aged 50 to 64 M50LN M50L123A M50L4 M50LO 
Aged 65 to 74 M65LN M65L123A M65L4 M65LO 
Aged 75 to 84 M75LN M75L123A M75L4 M75LO 
Aged 85 and older M85LN M85L123A M85L4 M85LO 
Female 
Aged 50 to 64 F50LN F50L123A F50L4 F50LO 
Aged 65 to 74 F65LN F65L123A F65L4 F65LO 
Aged 75 to 84 F75LN F75L123A F75L4 F75LO 
Aged 85 and older F85LN F85L123A F85L4 F85LO 
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Table 13-9 : Gender by age by NS-SEC (DC6114) 
Usual residents 
Managerial and 
Professional  
Intermediate 
occupations 
Small employer and 
own account 
Lower supervisory 
Semi-routine and 
routine 
Other (never worked and 
long term unemployed) 
Male 
Aged 50 to 64 M50S1 M50S2 M50S3 M50S4 M50S5 M50SO 
Aged 65 and older M65S1 M65S2 M65S3 M65S4 M65S5 M65SO 
Female 
Aged 50 to 64 F50S1 F50S2 F50S3 F50S4 F50S5 F50SO 
Aged 65 and older F65S1 F65S2 F65S3 F65S4 F65S5 F65SO 
Table 13-10 : Gender by age by living arrangement (DC1108) 
Household residents plus institutional residents who are not 
clients 
Married Co-habiting Single 
Married  
(not in couple) 
Separated Widowed 
Male 
Aged 50 to 64 M50M M50C M50A M50N M50S M50B 
Aged 65 to 74 M50M M50C M50A M50N M50S M50B 
Aged 75 and older M50M M50C M50A M50N M50S M50B 
Female 
Aged 50 to 64 F50M F50C F50A F50N F50S F50B 
Aged 65 to 74 F65M F65C F65A F65N F65S F65B 
Aged 75 and older F75M F75C F75A F75N F75S F75B 
Institutional residents who are clients INSTITUTION 
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Table 13-11 : Sample of LC1117 (Gender and age) constraint table (usual residents) 
CODE M50 M55 M60 M65 M70 M75 M80 M85 F50 F55 F60 F65 F70 F75 F80 F85 
Hartlepool 3,229 2,762 2,878 2,095 1,799 1,469 940 588 3,235 2,833 2,959 2,141 2,139 1,858 1,301 1,268 
Middlesbrough 4,556 3,845 3,739 2,794 2,402 1,856 1,269 766 4,677 4,088 3,792 2,886 2,751 2,422 1,846 1,699 
Redcar and Cleveland 4,656 4,094 4,606 3,798 3,159 2,292 1,539 1,010 4,773 4,364 4,905 3,978 3,483 2,725 2,165 2,103 
Stockton-on-Tees 6,533 5,760 5,733 4,278 3,456 2,718 1,730 1,119 6,866 5,849 5,915 4,467 3,901 3,371 2,549 2,362 
                 Plymouth 8,310 6,782 7,442 6,000 4,598 3,628 2,491 1,757 8,057 7,173 7,698 6,156 5,245 4,492 3,487 3,861 
 
Table 13-12 : Sample of LC3301 (disability) constraint table (household residents) 
CODE M50N M50L M65N M65L M75N M75L M85N M85L F50N F50L F65N F65L F75N F75L F85N F85L INSTITUTION 
Hartlepool 6,049 2,768 1,827 2,023 718 1,607 79 436 5,916 3,074 2,084 2,162 834 2,169 124 829 795 
Middlesbrough 8,461 3,572 2,681 2,466 1,050 2,003 125 560 8,431 4,075 2,881 2,712 1,295 2,820 192 1,198 866 
Redcar and Cleveland 9,621 3,657 3,748 3,147 1,274 2,461 168 757 9,877 4,113 3,959 3,435 1,470 3,229 212 1,533 989 
Stockton-on-Tees 13,556 4,291 4,402 3,251 1,636 2,653 151 837 13,628 4,930 4,633 3,658 1,863 3,770 251 1,649 1,448 
                  Plymouth 16,347 6,048 5,928 4,586 2,198 3,758 297 1298 16,344 6,485 6,403 4,876 2,650 5,043 490 2,653 1,773
 
Table 13-13 : Sample of DC3402 (disability) constraint table (institutional residents) 
CODE M50N M50L M65L M75L M85L F50N F50L F65L F75L F85L HOUSEHOLD 
Hartlepool 14 46 44 79 70 18 37 33 149 305 32,699 
Middlesbrough 17 97 45 70 80 17 50 43 147 300 44,522 
Redcar and Cleveland 5 75 60 96 85 7 49 66 191 355 52,661 
Stockton-on-Tees 97 97 76 151 129 46 69 75 271 437 65,159 
            Plymouth 41 115 74 157 161 55 88 114 275 693 85,404
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Table 13-14 : Extract of the sample population derived from ELSA wave 5 
idauniq DC1117 LC3301 DC2101 DC1108 DC4109 DC6114 LC3301 DC3408 DC3402 
103717 M85 M85L M65W M75B M65V1 M65S4 M65C0 M65O HOUSEHOLD 
103722 M85 M85L M65W M75B M65V0 M65S1 M65C0 M65M HOUSEHOLD 
103724 F75 F75L F65W F75D F65V1 F65S2 F65C0 F65M HOUSEHOLD 
103725 M60 M50N M50B M50C M50V2 M50S3 M50C0 M50S HOUSEHOLD 
103726 M60 M50N M50W M50D M50V1 M50S5 M50C20 M50S HOUSEHOLD 
103727 F60 F50N F50W F50M F50V2 F50S4 F50C0 F50S HOUSEHOLD 
103729 F60 F50L F50W F50B F50V1 F50S5 F50C0 F50M HOUSEHOLD 
103730 M85 INSTITUTION M65W INSTITUTION INSTITUTION M65S1 INSTITUTION INSTITUTION M85L 
103731 F60 F50L F50W F50M F50V1 F50S3 F50C0 F50P HOUSEHOLD 
103734 F65 F65L F65W F65B F65V1 F65S5 F65C0 F65S HOUSEHOLD 
103943 F60 F50N F50W F50M F50V2 F50S5 F50C1 F50O HOUSEHOLD 
103945 M65 M65N M65W M65M M65V1 M65S3 M65C0 M65O HOUSEHOLD 
103946 M65 M65N M65A M65M M65V1 M65S4 M65C0 M65M HOUSEHOLD 
103947 M70 M65L M65W M65D M65V1 M65S5 M65C0 M65M HOUSEHOLD 
103949 F65 F65N F65W F65M F65V2 F65S2 F65C0 F65M HOUSEHOLD 
103955 F75 INSTITUTION F65W INSTITUTION INSTITUTION F65S5 INSTITUTION INSTITUTION F75L 
103956 M60 M50N M50W M50M M50V1 M50S3 M50C0 M50O HOUSEHOLD 
103957 M70 M65L M65W M65M M65V1 M65S4 M65C50 M65S HOUSEHOLD 
103960 F70 F65N F65W F65M F65V2 F65S5 F65C0 F65P HOUSEHOLD 
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14 MAPS 
 
Figure 14-1 : Former English Government Regions, Metropolitan Counties and Home 
Counties 
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Figure 14-2 : ONS area types and NHS Local Area Teams 
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Figure 14-3 : Northern English LADs 
Name  Region ONS Code Label No 
Hartlepool North East E41000001 1 
Middlesbrough North East E41000002 2 
Redcar and Cleveland North East E41000003 3 
Stockton on Tees North East E41000004 4 
Darlington North East E41000005 5 
Halton North West E41000006 6 
Warrington North West E41000007 7 
Blackburn with Darwen North West E41000008 8 
Blackpool North West E41000009 9 
Kingston upon Hull Yorkshire and The Humber E41000010 10 
East Riding of Yorkshire Yorkshire and The Humber E41000011 11 
North East Lincolnshire Yorkshire and The Humber E41000012 12 
North Lincolnshire Yorkshire and The Humber E41000013 13 
York Yorkshire and The Humber E41000014 14 
County Durham UA North East E41000047 47 
Northumberland UA North East E41000048 48 
Cheshire East UA North West E41000049 49 
Cheshire West and Chester UA North West E41000050 50 
Allerdale North West E41000065 65 
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Name  Region ONS Code Label No 
Barrow-in-Furness North West E41000066 66 
Carlisle North West E41000067 67 
Copeland North West E41000068 68 
Eden North West E41000069 69 
South Lakeland North West E41000070 70 
Burnley North West E41000149 149 
Chorley North West E41000150 150 
Fylde North West E41000151 151 
Hyndburn North West E41000152 152 
Lancaster North West E41000153 153 
Pendle North West E41000154 154 
Preston North West E41000155 155 
Ribble Valley North West E41000156 156 
Rossendale North West E41000157 157 
South Ribble North West E41000158 158 
West Lancashire North West E41000159 159 
Wyre North West E41000160 160 
Craven Yorkshire and The Humber E41000189 189 
Hambleton Yorkshire and The Humber E41000190 190 
Harrogate Yorkshire and The Humber E41000191 191 
Richmondshire Yorkshire and The Humber E41000192 192 
Ryedale Yorkshire and The Humber E41000193 193 
Scarborough Yorkshire and The Humber E41000194 194 
Selby Yorkshire and The Humber E41000195 195 
Bolton North West E41000257 257 
Bury North West E41000258 258 
Manchester North West E41000259 259 
Oldham North West E41000260 260 
Rochdale North West E41000261 261 
Salford North West E41000262 262 
Stockport North West E41000263 263 
Tameside North West E41000264 264 
Trafford North West E41000265 265 
Wigan North West E41000266 266 
Knowsley North West E41000267 267 
Liverpool North West E41000268 268 
St Helens North West E41000269 269 
Sefton North West E41000270 270 
Wirral North West E41000271 271 
Barnsley Yorkshire and The Humber E41000272 272 
Doncaster Yorkshire and The Humber E41000273 273 
Rotherham Yorkshire and The Humber E41000274 274 
Sheffield Yorkshire and The Humber E41000275 275 
Gateshead North East E41000276 276 
Newcastle upon Tyne North East E41000277 277 
North Tyneside North East E41000278 278 
South Tyneside North East E41000279 279 
Sunderland North East E41000280 280 
Bradford Yorkshire and The Humber E41000288 288 
Calderdale Yorkshire and The Humber E41000289 289 
Kirklees Yorkshire and The Humber E41000290 290 
Leeds Yorkshire and The Humber E41000291 291 
Wakefield Yorkshire and The Humber E41000292 292 
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Figure 14-4 : Midlands LADs 
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Name  Region ONS Code Label No 
 
Name  Region ONS Code Label No 
Derby East Midlands E41000015 15 
 
South Northamptonshire East Midlands E41000187 187 
Leicester East Midlands E41000016 16 
 
Wellingborough East Midlands E41000188 188 
Rutland East Midlands E41000017 17 
 
Ashfield East Midlands E41000196 196 
Nottingham East Midlands E41000018 18 
 
Bassetlaw East Midlands E41000197 197 
Herefordshire West Midlands E41000019 19 
 
Broxtowe East Midlands E41000198 198 
Telford and Wrekin West Midlands E41000020 20 
 
Gedling East Midlands E41000199 199 
Stoke on Trent West Midlands E41000021 21 
 
Mansfield East Midlands E41000200 200 
Shropshire UA West Midlands E41000051 51 
 
Newark and Sherwood East Midlands E41000201 201 
Amber Valley East Midlands E41000071 71 
 
Rushcliffe East Midlands E41000202 202 
Bolsover East Midlands E41000072 72 
 
Cannock Chase West Midlands E41000213 213 
Chesterfield East Midlands E41000073 73 
 
East Staffordshire West Midlands E41000214 214 
Derbyshire Dales East Midlands E41000074 74 
 
Lichfield West Midlands E41000215 215 
Erewash East Midlands E41000075 75 
 
Newcastle-under-Lyme West Midlands E41000216 216 
High Peak East Midlands E41000076 76 
 
South Staffordshire West Midlands E41000217 217 
North East Derbyshire East Midlands E41000077 77 
 
Stafford West Midlands E41000218 218 
South Derbyshire East Midlands E41000078 78 
 
Staffordshire Moorlands West Midlands E41000219 219 
Blaby East Midlands E41000161 161 
 
Tamworth West Midlands E41000220 220 
Charnwood East Midlands E41000162 162 
 
North Warwickshire West Midlands E41000239 239 
Harborough East Midlands E41000163 163 
 
Nuneaton and Bedworth West Midlands E41000240 240 
Hinckley and Bosworth East Midlands E41000164 164 
 
Rugby West Midlands E41000241 241 
Melton East Midlands E41000165 165 
 
Stratford-on-Avon West Midlands E41000242 242 
North West Leicestershire East Midlands E41000166 166 
 
Warwick West Midlands E41000243 243 
Oadby and Wigston East Midlands E41000167 167 
 
Bromsgrove West Midlands E41000251 251 
Boston East Midlands E41000168 168 
 
Malvern Hills West Midlands E41000252 252 
East Lindsey East Midlands E41000169 169 
 
Redditch West Midlands E41000253 253 
Lincoln East Midlands E41000170 170 
 
Worcester West Midlands E41000254 254 
North Kesteven East Midlands E41000171 171 
 
Wychavon West Midlands E41000255 255 
South Holland East Midlands E41000172 172 
 
Wyre Forest West Midlands E41000256 256 
South Kesteven East Midlands E41000173 173 
 
Birmingham West Midlands E41000281 281 
West Lindsey East Midlands E41000174 174 
 
Coventry West Midlands E41000282 282 
Corby East Midlands E41000182 182 
 
Dudley West Midlands E41000283 283 
Daventry East Midlands E41000183 183 
 
Sandwell West Midlands E41000284 284 
East Northamptonshire East Midlands E41000184 184 
 
Solihull West Midlands E41000285 285 
Kettering East Midlands E41000185 185 
 
Walsall West Midlands E41000286 286 
Northampton East Midlands E41000186 186 
 
Wolverhampton West Midlands E41000287 287 
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Figure 14-5 : Southern English LADs 
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Name  Region ONS Code Label No 
 
Name  Region ONS Code Label No 
Bath and North East Somerset South West E41000022 22 
 
East Devon South West E41000079 79 
Bristol South West E41000023 23 
 
Exeter South West E41000080 80 
North Somerset South West E41000024 24 
 
Mid Devon South West E41000081 81 
South Gloucestershire South West E41000025 25 
 
North Devon South West E41000082 82 
Plymouth South West E41000026 26 
 
South Hams South West E41000083 83 
Torbay South West E41000027 27 
 
Teignbridge South West E41000084 84 
Bournemouth South West E41000028 28 
 
Torridge South West E41000085 85 
Poole South West E41000029 29 
 
West Devon South West E41000086 86 
Swindon South West E41000030 30 
 
Christchurch South West E41000087 87 
Peterborough East of England E41000031 31 
 
East Dorset South West E41000088 88 
Luton East of England E41000032 32 
 
North Dorset South West E41000089 89 
Southend-on-Sea East of England E41000033 33 
 
Purbeck South West E41000090 90 
Thurrock East of England E41000034 34 
 
West Dorset South West E41000091 91 
Medway South East E41000035 35 
 
Weymouth and Portland South West E41000092 92 
Bracknell Forest South East E41000036 36 
 
Eastbourne South East E41000093 93 
West Berkshire South East E41000037 37 
 
Hastings South East E41000094 94 
Reading South East E41000038 38 
 
Lewes South East E41000095 95 
Slough South East E41000039 39 
 
Rother South East E41000096 96 
Windsor and Maidenhead South East E41000040 40 
 
Wealden South East E41000097 97 
Wokingham South East E41000041 41 
 
Basildon East of England E41000098 98 
Milton Keynes South East E41000042 42 
 
Braintree East of England E41000099 99 
Brighton and Hove South East E41000043 43 
 
Brentwood East of England E41000100 100 
Portsmouth South East E41000044 44 
 
Castle Point East of England E41000101 101 
Southampton South East E41000045 45 
 
Chelmsford East of England E41000102 102 
Isle of Wight South East E41000046 46 
 
Colchester East of England E41000103 103 
Cornwall UA South West E41000052 52 
 
Epping Forest East of England E41000104 104 
Wiltshire UA South West E41000053 53 
 
Harlow East of England E41000105 105 
Bedford UA East of England E41000054 54 
 
Maldon East of England E41000106 106 
Central Bedfordshire UA East of England E41000055 55 
 
Rochford East of England E41000107 107 
Aylesbury Vale South East E41000056 56 
 
Tendring East of England E41000108 108 
Chiltern South East E41000057 57 
 
Uttlesford East of England E41000109 109 
South Buckinghamshire South East E41000058 58 
 
Cheltenham South West E41000110 110 
Wycombe South East E41000059 59 
 
Cotswold South West E41000111 111 
Cambridge East of England E41000060 60 
 
Forest of Dean South West E41000112 112 
East Cambridgeshire East of England E41000061 61 
 
Gloucester South West E41000113 113 
Fenland East of England E41000062 62 
 
Stroud South West E41000114 114 
Huntingdonshire East of England E41000063 63 
 
Tewkesbury South West E41000115 115 
South Cambridgeshire East of England E41000064 64 
 
Basingstoke and Deane South East E41000116 116 
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Name  Region ONS Code Label No 
 
Name  Region ONS Code Label No 
East Hampshire South East E41000117 117 
 
Norwich East of England E41000180 180 
Eastleigh South East E41000118 118 
 
South Norfolk East of England E41000181 181 
Fareham South East E41000119 119 
 
Cherwell South East E41000203 203 
Gosport South East E41000120 120 
 
Oxford South East E41000204 204 
Hart South East E41000121 121 
 
South Oxfordshire South East E41000205 205 
Havant South East E41000122 122 
 
Vale of White Horse South East E41000206 206 
New Forest South East E41000123 123 
 
West Oxfordshire South East E41000207 207 
Rushmoor South East E41000124 124 
 
Mendip South West E41000208 208 
Test Valley South East E41000125 125 
 
Sedgemoor South West E41000209 209 
Winchester South East E41000126 126 
 
South Somerset South West E41000210 210 
Broxbourne East of England E41000127 127 
 
Taunton Deane South West E41000211 211 
Dacorum East of England E41000128 128 
 
West Somerset South West E41000212 212 
East Hertfordshire East of England E41000129 129 
 
Babergh East of England E41000221 221 
Hertsmere East of England E41000130 130 
 
Forest Heath East of England E41000222 222 
North Hertfordshire East of England E41000131 131 
 
Ipswich East of England E41000223 223 
St Albans East of England E41000132 132 
 
Mid Suffolk East of England E41000224 224 
Stevenage East of England E41000133 133 
 
St Edmundsbury East of England E41000225 225 
Three Rivers East of England E41000134 134 
 
Suffolk Coastal East of England E41000226 226 
Watford East of England E41000135 135 
 
Waveney East of England E41000227 227 
Welwyn Hatfield East of England E41000136 136 
 
Elmbridge South East E41000228 228 
Ashford South East E41000137 137 
 
Epsom and Ewell South East E41000229 229 
Canterbury South East E41000138 138 
 
Guildford South East E41000230 230 
Dartford South East E41000139 139 
 
Mole Valley South East E41000231 231 
Dover South East E41000140 140 
 
Reigate and Banstead South East E41000232 232 
Gravesham South East E41000141 141 
 
Runnymede South East E41000233 233 
Maidstone South East E41000142 142 
 
Spelthorne South East E41000234 234 
Sevenoaks South East E41000143 143 
 
Surrey Heath South East E41000235 235 
Shepway South East E41000144 144 
 
Tandridge South East E41000236 236 
Swale South East E41000145 145 
 
Waverley South East E41000237 237 
Thanet South East E41000146 146 
 
Woking South East E41000238 238 
Tonbridge and Malling South East E41000147 147 
 
Adur South East E41000244 244 
Tunbridge Wells South East E41000148 148 
 
Arun South East E41000245 245 
Breckland East of England E41000175 175 
 
Chichester South East E41000246 246 
Broadland East of England E41000176 176 
 
Crawley South East E41000247 247 
Great Yarmouth East of England E41000177 177 
 
Horsham South East E41000248 248 
Kings Lynn and West Norfolk East of England E41000178 178 
 
Mid Sussex South East E41000249 249 
North Norfolk East of England E41000179 179 
 
Worthing South East E41000250 250 
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Figure 14-6 : London LADs 
 
Name  ONS Code Label No 
 
Name  ONS Code Label No 
Barking and Dagenham E41000293 293 
 
Hounslow E41000309 309 
Barnet E41000294 294 
 
Islington E41000310 310 
Bexley E41000295 295 
 
Kensington and Chelsea E41000311 311 
Brent E41000296 296 
 
Kingston upon Thames E41000312 312 
Bromley E41000297 297 
 
Lambeth E41000313 313 
Camden E41000298 298 
 
Lewisham E41000314 314 
Croydon E41000299 299 
 
Merton E41000315 315 
Ealing E41000300 300 
 
Newham E41000316 316 
Enfield E41000301 301 
 
Redbridge E41000317 317 
Greenwich E41000302 302 
 
Richmond upon Thames E41000318 318 
Hackney E41000303 303 
 
Southwark E41000319 319 
Hammersmith and Fulham E41000304 304 
 
Sutton E41000320 320 
Haringey E41000305 305 
 
Tower Hamlets E41000321 321 
Harrow E41000306 306 
 
Waltham Forest E41000322 322 
Havering E41000307 307 
 
Wandsworth E41000323 323 
Hillingdon E41000308 308 
 
Westminster & City of London E41000324 324 
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